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1 INTRODUCTION 
In this thesis, three different aspects of RNA biology are investigated, all of which depend on 
the interplay between RNA and proteins. The first part examines the processing of ribosomal 
RNAs (rRNAs) which are the catalytic part of mature ribosomes and thus essential for protein 
biosynthesis. The genetic information is transmitted to the ribosomes in form of messenger 
RNA (mRNA). In order to be stably expressed, exported and translated, mRNAs are bound by 
RNA-binding proteins, thereby forming messenger ribonucleoproteins (mRNPs). In 
metazoans, the multimeric exon-junction complex (EJC) is an integral component of mRNPs. 
As a mark on spliced mRNAs, EJCs constructively influence gene expression. The assembly and 
regulatory functions of the EJC and its peripheral interacting factors are examined as the 
second part of this thesis. Finally, mRNAs undergo turnover to allow the cell to adapt its gene 
expression landscape to current demands. In the third part of the thesis, mRNA degradation 
pathways are described and a new method to study the contribution of different decay 
pathways is presented. All processes in this thesis are described for human cells, except when 
mentioned otherwise. 
1.1 Regulation of gene expression on the level of RNA 
Gene expression is mediated and regulated by a multitude of RNA species in the cell. 
Quantitatively, mRNAs as the transmitter of genetic information represent only about two 
percent of total cellular RNAs (Frith et al., 2005). The bulk of the total RNA pool is made up of 
non-coding RNAs (Mattick, 2001). These include transfer RNAs (tRNAs) and rRNAs as 
important members of the protein synthesis machinery. Additionally, a vast landscape of small 
non-coding RNAs has been described which are involved in regulatory processes such as 
splicing (small nuclear RNAs, snRNAs), ribosomal biogenesis (small nucleolar RNAs, snoRNAs) 
and RNA silencing (small interfering RNAs, siRNAs and microRNAs, miRNAs). In gene 
expression steps such as splicing and translation, RNA fulfills a catalytic role, an ability which 
for a long time had been attributed exclusively to proteins (Cech, 2009).  
A diverse set-up of RNA polymerases and RNA processing pathways underlie the production 
of these RNAs in the nucleus. This chapter describes the synthesis and processing of rRNAs 
and mRNAs.  
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1.1.1 Ribosomal RNA maturation and ribosomal biogenesis 
Ribosomes as the sites of protein biosynthesis play an essential part in the gene expression 
apparatus. The eukaryotic 80S ribosome comprises two subunits, the 40S small subunit (SSU) 
and the 60S large subunit (LSU) (Khatter et al., 2015). Four rRNA species and more than 80 
proteins must be produced, processed and assembled to form mature ribosomes. This highly 
complex process requires spatial and temporal coordination across different compartments 
of the cell as well as the assistance of more than 200 ribosome biogenesis factors (Figure 1A) 
(Tafforeau et al., 2013).  
 
Figure 1: Overview of ribosomal biogenesis. A: The nucleolus is the hub of ribosomal biogenesis within the nucleus. It forms 
around clusters of ribosomal RNA (rRNA) genes which are the sites of rRNA transcription by RNA polymerase I. Here, the 47S 
pre-mRNA is cleaved, modified and associates with ribosomal proteins. The 5S rRNA is transcribed by RNA Polymerase III and 
travels to the nucleolus to be assembled into the large ribosomal subunit. The final maturation of the small and large ribosomal 
subunits occurs after export into the cytoplasm. B: Schematic depiction of the 47S pre-rRNA that harbors the 18S, 5.8S and 
28S rRNAs. These rRNAs are produced by cleaving the precursor at the indicated endonucleolytic cleavage sites. The external 
and internal transcribed spacers (ETS and ITS) are removed by combined endo- and exonucleolytic cleavage. 
Ribosomal biogenesis begins in the nucleolus, which exists as a membrane-less 
subcompartment within the nucleus (McStay, 2016). Reminiscent of bacterial gene 
expression, the 47S rRNA precursor (pre-rRNA) carrying the 18S, 5.8S and 28S rRNAs is 
transcribed by RNA polymerase I as a polycistronic transcript (Figure 1B) (Henras et al., 2015). 
The rRNAs are separated by internal transcribed spacers (ITS1 and 2) and encompassed by 5′ 
and 3′ external transcribed spacers (5′-ETS and 3′-ETS). An essential part of rRNA maturation 
is exonucleolytic trimming from the 5′- and 3′-end as well as endonucleolytic cleavage 
(endocleavage) steps during which the transcribed spacers are removed. The separation of 
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the rRNAs required for both ribosomal subunits occurs by cleavage within the ITS1 region. 
After final processing, the 18S rRNA is incorporated into the SSU, while the 5.8S and 28S rRNA 
are constituents of the LSU (Henras et al., 2015).  
Co-transcriptionally, the pre-rRNA associates with ribosomal proteins and ribosome 
biogenesis factors forming pre-ribosomes. In these large dynamic structures, rRNA folding and 
modification as well as the assembly of ribosomal proteins takes place (Kressler et al., 2017).  
The modification of rRNA residues is essential for proper rRNA folding and ribosome function 
(Sloan et al., 2017). This process is carried out by ribonucleoprotein complexes formed by 
snoRNAs and associated proteins (snoRNPs). The two major types of modification are 
pseudouridylation catalyzed by box H/ACA and methylation by box C/D snoRNPs (Figure 1A) 
(Watkins & Bohnsack, 2012). These modifications occur predominantly in functionally 
important regions (Sloan et al., 2017). 
The genes encoding for ribosomal proteins are transcribed in the nucleus by RNA polymerase 
II, translated in the cytoplasm and the proteins reimported and transported to the nucleolus 
(Kressler et al., 2017). The fourth rRNA species, the 5S rRNA transcribed by RNA polymerase 
III, also joins the pre-ribosomes in the nucleolus as a preassembled RNP (Ciganda & Williams, 
2011). The fully assembled subunits are then transported out of the nucleus and undergo 
further maturation in the cytoplasm (Kressler et al., 2017). 
Ribosomal biogenesis is a process which is highly energy consuming for the cell (Warner, 
1999). It requires the transcription of RNAs by all three RNA polymerases, the synthesis of the 
most abundant RNAs and proteins in the cell and the production of ribosome biogenesis 
factors. It is therefore a tightly controlled process and undergoes quality surveillance (Pena et 
al., 2017). Furthermore, the nucleolus as a hub of ribosome biogenesis serves as a cellular 
stress sensor (Golomb et al., 2014). The impairment of rRNA transcription, rRNA processing, 
and ribosome subunit assembly results in nucleolar stress, leading to the stabilization of the 
tumor suppressor p53 and subsequent cell cycle arrest (Bursac et al., 2014).  
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1.1.2 Messenger RNA processing 
Protein-coding genes are transcribed by RNA Polymerase II (Figure 2) (Cramer, 2019a). As soon 
as the first nucleotides of pre-mRNA emerges from RNA polymerase II during transcription 
elongation, maturation is initiated by distinct machineries that are spatially  
 
Figure 2: Steps of post-transcriptional gene regulation that affects messenger RNAs. After transcription initiation, mRNA 
processing occurs co-transcriptionally. The phosphorylation of the RNA polymerase II C-terminal domain (CTD) and the rate of 
transcription affect the recruitment of the RNA processing machinery. Factors involved in capping, splicing, RNA modification 
and polyadenylation are present at the site of transcription. Erroneously transcribed or processed mRNAs are degraded in the 
nucleus. mRNA transcription is therefore directly coupled to quality control by mRNA processing and degradation machineries. 
For representational reasons, the depiction of messenger ribonucleoprotein particles (mRNPs) focuses on mRNA bound by 
exon junction complexes (EJCs). After transcription, mRNA-binding export factors mediate the export through the nuclear pore. 
In the cytoplasm, translation is initiated by interactions between the cap binding complex, translation initiation factors, and 
the small ribosomal subunit. Upon stress, mRNAs can be moved to membrane-less compartments such as P-bodies and stress 
granules and remain translationally silent. All transcripts undergo turnover by the degradation machinery. mRNA degradation 
is also directly coupled to translation during mRNA surveillance, e.g. in the nonsense-mediated mRNA decay (NMD) pathway 
which will be described in detail below. Following translation, gene expression is modulated on the protein level. This includes 
post-translational modifications that influence the function of proteins or alterations to the stability of a protein. 
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and functionally linked. Central to this process is the C-terminal domain (CTD) of RNA 
polymerase II which consist of heptad repeats that are post-translationally modified (Harlen 
& Churchman, 2017). These modifications as a so-called CTD code change dynamically 
throughout the transcription process (Buratowski, 2003). They are crucial for the transcription 
steps and are required for 5′ capping, splicing and 3′ end processing (Harlen & Churchman, 
2017). By coupling transcription to processing, certain checkpoints are established that 
protect the cell against the production of aberrant mRNAs (Peck et al., 2019).  
1.1.2.1 Capping 
The first co-transcriptional modification is the capping of the mRNA which occurs after the 
transcription of 25-30 nucleotides (Ramanathan et al., 2016). In three enzymatic steps, a 7-
methylguanosine cap is added to the first nucleotide of the nascent transcript (Ghosh & Lima, 
2010). The binding of the capping enzymes to the CTD phosphorylated at the Serine-5 position 
(Ser5) is required for efficient capping (McCracken et al., 1997, Komarnitsky et al., 2000, 
Schroeder et al., 2000). The 5′ cap is bound co-transcriptionally by a nuclear cap-binding 
complex (CBC). This complex directly interacts with components of the splicing machinery and 
thus links capping to splicing (Pabis et al., 2013). 
1.1.2.2 Splicing 
The splicing reaction requires the assembly of five small nuclear ribonucleoproteins (snRNPs) 
U1, U2, U4, U5 and U6 as well as 85 non-snRNP proteins as the core spliceosome (Kastner et 
al., 2019). The spliceosome catalyzes the excision of an intron in a two-step transesterification 
reaction. Recently published spliceosome cryo-electron microscopy (cryo-EM) structures have 
illuminated the compositional dynamics and structural rearrangements of the splicing 
reaction in yeast and humans (Kastner et al., 2019). It is estimated that the majority of splicing 
reactions occur co-transcriptionally, but some introns are spliced out after transcription 
termination (Coulon et al., 2014). Supporting this notion, the Ser5 phosphorylated CTD of RNA 
polymerase II was found to interact with components of catalytically active spliceosomes 
(Nojima et al., 2018). 
The U1 and U2 snRNAs are essential for splice site selection by base paring to splice site 
consensus sequences (Figure 3) (Papasaikas & Valcarcel, 2016). Since the genome contains a 
myriad of potential splice sequences, additional mechanisms exist to define exons and introns 
for correct splicing. In human cells, typically short exons (median length of ~ 130 nucleotides) 
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are separated by longer introns (median length of ~1.7 kilobases) (Piovesan et al., 2016). It 
was proposed that splicing complexes would form across an exon (exon definition model) 
(Robberson et al., 1990). Indeed, exon-covering complexes that contain all snRNPs have been 
identified (Schneider et al., 2010). The sequences flanking potential splice sites can either 
enhance or inhibit exon inclusion by their interaction with splicing factors that can positively 
or negatively influence splice site selection (De Conti et al., 2013). Exonic splicing enhancers 
(ESE) are commonly bound by proteins of the serine/arginine-rich family (SR) which promote 
spliceosomal complex formation (Graveley et al., 2001). The repressing effect of exonic 
splicing silencing regions (ESS) is primarily mediated by proteins of the hnRNP family (Zhu et 
al., 2001). 
 
Figure 3: Conserved sequences at 5′ and 3′ splice sites in metazoans. R: purine, Y: pyrimidine, N: nucleotide. The 5′ splice 
site, branch point and 3′ splice site are marked in red. According to Will & Luhrmann (2011). 
It is estimated that the vast majority of eukaryotic genes undergoes alternative splicing (Pan 
et al., 2008). Alternative splicing increases the number of potential gene products that are 
encoded within a genomic region. Furthermore, it can have a regulatory function, e.g. by 
switching from a stable mRNA isoform to an isoform that is subject to mRNA decay (Nasif et 
al., 2018). Alternative splicing can be regulated by RNA-binding proteins and changes 
depending on transcription elongation speed (Dujardin et al., 2014, Fong et al., 2014, Ule & 
Blencowe, 2019). Transcription by RNA polymerase II does not occur at a steady pace. 
Depending on transcription elongation factors, histone dynamics and DNA/RNA hybrid 
stability, RNA polymerase II can pause in the proximity of the promoter, backtrack and 
proceed at varying speeds (Saldi et al., 2016, Core & Adelman, 2019, Cramer, 2019b). Changing 
the elongation rate potentially influences the selection of splice sites or RNA structures that 
determine the outcome of splicing (Saldi et al., 2016). It was hypothesized that binding of 
competing splice factors is influenced by the duration of which splice sites are available, 
although this model only explains a subset of observed events (Fong et al., 2014). The function 
of the transcription elongation rate in transcription termination is better described (see 
below). 
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1.1.2.3 3′ processing 
The 3′ end processing machinery scans the pre-mRNA for the polyadenylation site, performs 
cleavage and adds a polyA tail (Kumar et al., 2019). Since the Ser2 phosphorylation of the CTD 
is a prerequisite for the recruitment of cleavage/polyadenylation factors, 3′ end processing is 
also directly coupled to transcription (Ahn et al., 2004). Premature 3′ cleavage at cryptic 
polyadenylation sites is prevented by the telescripting activity of the U1 snRNP in a complex 
with cleavage and polyadenylation factors (So et al., 2019). There are two leading hypotheses 
on how transcription termination occurs. Firstly, a conformational or functional change of the 
transcription elongation complex (allosteric model) or secondly, degradation of the nascent 
transcript after 3′ cleavage by the 5′-3′ exonuclease XRN2 (torpedo model) (Porrua & Libri, 
2015). Recently, a model termed sitting duck was proposed that connects these hypotheses: 
when the RNA Polymerase II elongation complex has proceeded downstream of the polyA site, 
the dephosphorylation of a transcription elongation factor slows down RNA Polymerase II 
(Cortazar et al., 2019). This enables XRN2 to catch up with the decelerated elongation 
complex. 
1.2 Functions of the EJC in the lifetime of an mRNA  
The cellular fate of an mRNA is determined by RNA-binding proteins (Gehring et al., 2017). A 
prime example is the EJC which is deposited on transcripts during splicing and stays bound 
until it is removed during translation (Dostie & Dreyfuss, 2002, Lejeune et al., 2002). The 
complex serves as a mark of spliced mRNAs and acts as a binding platform for peripheral EJC-
associated factors. Both EJC core components and peripheral interacting factors generally 
have a stimulatory effect on gene expression. Furthermore, the EJC has a well-characterized 
function in the nonsense-mediated mRNA decay (NMD) pathway.  
1.2.1 Assembly of the EJC core during splicing 
The assembly of the EJC starts with the recruitment of EIF4A3 by the spliceosome component 
CWC22 (Alexandrov et al., 2012, Barbosa et al., 2012, Steckelberg et al., 2012, Steckelberg et 
al., 2015). EIF4A3 directly binds to the mRNA in a sequence-independent manner by 
interacting with the sugar-phosphate backbone of the RNA (Chan et al., 2004, Ferraiuolo et 
al., 2004, Palacios et al., 2004, Shibuya et al., 2004, Andersen et al., 2006, Bono et al., 2006). 
It is a member of the DEAD-box family of ATP-dependent RNA helicases (Linder & Jankowsky, 
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2011). The binding of the heterodimer MAGOH-RBM8A locks EIF4A3 into its RNA-bound 
conformation by preventing the release of ATP hydrolysis products (Nielsen et al., 2009). The 
mapping of the EJC position showed that eight nucleotides at a conserved position 20-24 
nucleotides upstream of an exon-exon junction are protected from RNase H digestion by the 
EJC (Le Hir et al., 2000). High-throughput analyses of RNA-interaction sites of EJC components 
confirmed the canonical position of the EJC upstream of exon-exon junctions (Sauliere et al., 
2012, Singh et al., 2012).  
It is possible to assemble the EJC in vitro by combining recombinant EJC components together 
with single stranded RNA and a non-hydrolysable analogue of ATP (Ballut et al., 2005). These 
experiments have shown that the addition of the EJC interacting domain of CASC3 (called 
SELOR domain) enhances the stability of in vitro formed EJCs. Furthermore, early studies found 
that in vivo expressed EJC components form a tetrameric complex (Tange et al., 2005). It was 
therefore concluded that CASC3 together with EIF4A3, RBM8A and MAGOH represent the 
essential EJC core. In the crystal structures of the EJC, EIF4A3, RBM8A and MAGOH as well as 
two fragments of SELOR are resolved (Figure 4) (Andersen et al., 2006, Bono et al., 2006). 
These structures revealed interaction sites between the factors and between the EJC and RNA. 
Unlike MAGOH-RBM8A, SELOR is also able to bind EIF4A3 in an open, RNA-unbound 
conformation (Bono et al., 2006). By doing so, the ATPase activity of EIF4A3 is increased (Noble 
& Song, 2007).  
 
Figure 4: The structure of the EJC. A: The crystal structure of the EJC (pdb: 2J0S) rendered with Chimera v.1.14rc consisting of 
EIF4A3 (orange), MAGOH (blue), RBM8A (green) and CASC3 (magenta). Six nucleotides are bound by EIF4A3 and are shown 
in beige. B: Schematic depiction of the complex.  
Several observations contradict the concept of CASC3 as part of the tetrameric EJC core. 
CASC3 is a nucleocytoplasmic shuttling protein that is mainly located in the cytoplasm, 
whereas the other EJC core components are predominantly detected in the nucleus (Kataoka 
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et al., 2000, Le Hir et al., 2001a, Degot et al., 2002, Palacios et al., 2004, Shibuya et al., 2004). 
It was hypothesized that the low concentration of CASC3 in the nucleus could prevent the 
spontaneous assembly of the EJC and that it had to be actively recruited during splicing (Tange 
et al., 2005). However, in vitro splicing experiments showed that the deposition of EIF4A3, 
MAGOH and RBM8A is strictly dependent on splicing, whereas CASC3 can associate with a 
preformed trimeric EJC (Gehring et al., 2009a). Unlike the other three EJC core components, 
CASC3 was not identified in purified spliceosomal C complexes (Bessonov et al., 2008, 
Agafonov et al., 2011). Physiological studies of mice depleted of EJC components have also 
hinted at a differential function of CASC3: the EJC is essential for survival as was demonstrated 
by MAGOH (-/-) mice that die during an embryonic development stage (Silver et al., 2010). 
Mice that are haploinsufficient for MAGOH or RBM8A display severe developmental and 
neurological defects (Silver et al., 2010, Mao et al., 2015). While CASC3 (-/-) mice are also not 
viable, developmental defects in CASC3 haploinsufficient mice are much milder compared to 
the other EJC components (Mao et al. 2017). For these reasons, the term “core EJC” will be 
subsequently used to describe the trimeric pre-EJC formed by EIF4A3, MAGOH and RBM8A.  
1.2.2 Regulatory function in transcription and splicing 
Since the deposition of the EJC is dependent on splicing itself, the finding that the correct 
splicing of the MAPK gene in Drosophila requires the core EJC components was intriguing. 
(Ashton-Beaucage et al., 2010, Roignant & Treisman, 2010). The absence of the EJC results in 
the skipping of multiple exons resulting in impaired MAPK protein expression. While the fly 
homologue of CASC3 was not implicated for this function, depletion of the EJC interactor and 
the previously characterized splicing factor RNPS1 also caused alternative splicing of the MAPK 
mRNA. Transcriptome-wide, the splicing of long introns was specifically shown to be 
dependent on the EJC in Drosophila. RNPS1 forms together with ACIN1 and SAP18 the ASAP 
complex that interacts with the EJC (Schwerk et al., 2003, Tange et al., 2005). An alternative 
complex with PNN instead of ACIN1 can also be formed (Murachelli et al., 2012). Components 
of the ASAP complex together with the EJC were found to prevent intron retention of the Piwi 
mRNA (Hayashi et al., 2014, Malone et al., 2014). It was proposed that the deposition of the 
EJC and subsequent recruitment of interacting splice factors could have an exon defining 
function necessary for the splicing of large neighboring introns (such as MAPK) or introns with 
weak splice consensus sequences (such as Piwi). Interestingly, for the Piwi mRNA the splicing 
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of downstream junctions affected intron retention upstream (Malone et al., 2014). This argues 
against a strict 5′-3′ hierarchy of splicing order for this particular transcript. 
In Drosophila, the knockdown of EJC core components leads to a decrease of RNA polymerase 
II occupancy at the 5′ end of transcripts and an increase on the gene body during transcription 
(Akhtar et al., 2019). This reduction of promoter proximal pausing of RNA polymerase II is 
partly caused by increased phosphorylation of Ser2 in the CTD. In Drosophila, this process was 
proposed to be the cause of a subset of alternative splicing events observed upon EJC 
knockdown (Akhtar et al., 2019). 
The first analysis of transcriptome-wide EJC-dependent splicing in human cells yielded a high 
number of transcripts that were affected (Wang et al., 2014b). Similarly to the observations 
made in Drosophila, it was reported that in human cells the depletion of EJC core components 
leads to an increase in the transcription elongation speed on selected genes, potentially 
affecting alternative splicing. In contrast to the studies performed in Drosophila, the trimeric 
EJC core factors as well as CASC3 affected EJC-dependent genes in the same manner.  
1.2.3 Role in mRNA export  
Mature mRNAs are transported out of the nucleus through the nuclear pore complex for their 
translation in the cytoplasm. Components of the transcription and export (TREX) complex are 
associated with the mRNA during its maturation (Strasser et al., 2002). Export occurs when 
the nuclear export factor 1 (NXF1, also known as TAP) is recruited by TREX adaptor proteins. 
NXF1 forms a heterodimer with NXT1 (also known as p15) and mediates translocation through 
the nuclear pore (Heath et al., 2016). 
Splicing has been shown to promote mRNA export (Valencia et al., 2008). Since the TREX 
components DDX39B (UAP56) and ALYREF were found to interact with the EJC it was 
suggested that the EJC stimulates export as a binding platform for mRNA export factors (Le 
Hir et al., 2000, Le Hir et al., 2001b). ALYREF recruitment was shown to be 5′ cap dependent 
and that binding occurs in the first exon (Cheng et al., 2006). A short linear motif in ALYREF is 
required for its interaction with EIF4A3 and the CBC (Gromadzka et al., 2016). The preferential 
deposition of ALYREF towards the 5′ end of a transcript was also observed in iCLIP experiments 
(Viphakone et al., 2019).  
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Furthermore, UAP56 and its paralog DDX39 interact with mRNA in an EJC and 5′ cap-
dependent manner (Gromadzka et al., 2016). Of note, SR proteins can also link mRNAs with 
NXF1 and provide another connection between splicing and export (Muller-McNicoll et al., 
2016). Therefore, the EJC assists but is likely not essential for the export of spliced mRNAs.  
1.2.4 Localization of mRNA 
In highly polarized cells, the spatial enrichment of mRNAs is important to provide local protein 
synthesis. In order to be locally translated, exported mRNAs are actively transported as mRNPs 
by motor proteins along the cytoskeleton to their destination. This process has been intensely 
studied in the Drosophila oocyte (Weil, 2014). Furthermore, neuronal cells strongly depend 
on mRNA transport to establish a local proteome in dendrites and axons (Glock et al., 2017, 
Das et al., 2019). 
The splicing-dependent deposition of all four EJC proteins has been shown to be essential for 
the correct localization of oskar mRNA in the posterior pole of the Drosophila embryo 
(Newmark & Boswell, 1994, Hachet & Ephrussi, 2001, Mohr et al., 2001, van Eeden et al., 2001, 
Palacios et al., 2004). The transport occurs via kinesin I and microtubules (Pokrywka & 
Stephenson, 1995, Brendza et al., 2000). How exactly the EJC is linked to mRNP transport is 
not yet clear. Besides the deposition of an EJC, the splicing of the first intron in the oskar mRNA 
leads to the formation of an RNA secondary structure which is also essential for transport 
(Ghosh et al., 2012, Simon et al., 2015). Whether an interplay between this structure and the 
neighboring EJC supports mRNP mobility remains to be investigated.  
Although EJC components have been found in neuronal transport granules, there is no 
evidence so far that the EJC is essential for the localization of any other transcript than the 
oskar mRNA (Wang et al., 2017). 
1.2.5 Stimulation of translation and translation-dependent removal of the EJC 
Spliced mRNAs yield more gene products in comparison to their intronless counterparts (Nott 
et al., 2003). Part of this effect is due to splicing-dependent enhanced mRNA levels (Le Hir et 
al., 2003). Furthermore, spliced mRNAs are translated more efficiently (Lu & Cullen, 2003). 
The EJC and peripheral interacting proteins have been shown to be largely responsible for the 
stimulatory effect of splicing on translation (Wiegand et al., 2003, Nott et al., 2004). 
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Several observations have been made that functionally link the EJC to translation. Firstly, it 
has been suggested that the EJC-interacting protein SKAR is involved in mediating the 
downstream translation stimulatory effect of mTOR signaling (Ma et al., 2008). Secondly, it 
was reported that EIF4A3 is recruited to the 5′ end of CBC-bound mRNAs and could potentially 
enhance translation by unwinding secondary structures in the 5′ untranslated region (UTR) 
(Choe et al., 2014). Thirdly, the EJC component CASC3 has been implicated to directly link the 
EJC to the translation machinery (Chazal et al., 2013). CASC3 interacts with the translation 
initiation complex EIF3 and stimulates the translation of spliced mRNAs.  
During the first round of translation, EJCs are normally removed by the processing ribosome 
(Dostie & Dreyfuss, 2002, Lejeune et al., 2002). EJC disassembly might be aided by the 
ribosome-bound factor PYM (Diem et al., 2007, Gehring et al., 2009b). PYM has a strong 
affinity for the MAGOH-RBM8A heterodimer and presumably destabilizes mature EJCs via 
transient interactions with MAGOH-RBM8A (Gehring et al., 2009b). Since the depletion of 
PYM results in a reduced translation efficiency of certain transcripts, it has been proposed that 
PYM also functions to promote the enhanced translation of EJC-bound transcripts (Diem et 
al., 2007). Another interpretation is that PYM is crucial to recycle EJC core components and 
that it promotes translation by maintaining the available pool of EJC factors. This notion is 
supported by the fact that PYM is essential in Drosophila cells when levels of EJC components 
are reduced by a knockdown (Ghosh et al., 2014). However, since PYM does not associate with 
the ribosome in Drosophila, the coupling of translation and disassembly by PYM might be 
limited to human cells (Ghosh et al., 2014). In both Drosophila and human cells, the 
overexpression of PYM results in excess free PYM that destabilizes EJCs (Gehring et al., 2009b, 
Ghosh et al., 2014). Thus, the activity of PYM must be tightly regulated to prevent the global 
instability of EJCs. 
After disassembly, the MAGOH-RBM8A heterodimer is reimported into the nucleus by 
importin-13 (Bono et al., 2010). How EIF4A3 is transported back to the nucleus is not yet 
known.  
1.2.6 EJC-dependent nonsense-mediated mRNA decay  
During translation, the EJC fulfills an important role in mRNA surveillance. Transcripts that 
contain a premature termination codon (PTC) are degraded by the NMD pathway to prevent 
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the production of truncated and potentially toxic proteins. Since canonical termination codons 
are commonly located in the last exon, an EJC present more than 50 nucleotides downstream 
of a termination codon is a signal for NMD (Nagy & Maquat, 1998). Premature termination 
codons can arise for various reasons. Firstly, point mutations in the DNA or errors during 
transcription can turn coding codons into termination codons. Secondly, alternative splicing 
can lead to transcripts harboring a PTC. An example is the inclusion of intronic sequences with 
PTCs into the transcripts as poison cassette exons (Lareau et al., 2007). Furthermore, 
frameshifts caused by alternative splicing can also lead to the introduction of PTCs. NMD is 
however not only a quality control pathway that prevents the accumulation of truncated 
proteins that would arise from erroneous transcript. Instead, by switching from a stable 
isoform to an NMD-sensitive variant via alternative splicing, the output of gene products can 
be regulated. This regulatory function is well described for the expression of SR proteins which 
are autoregulated by coupling alternative splicing and NMD (Lareau et al., 2007, Ni et al., 
2007). 
Many factors have been identified that are involved in EJC-dependent NMD (Figure 5). Via 
these proteins, the presence of a downstream EJC is communicated to a set of nucleases that 
degrade the targeted transcript. When the ribosome terminates at a PTC, the information of 
an EJC present downstream must be passed on to the NMD machinery. Any termination codon 
is recognized by the eukaryotic release factor 1 (eRF1) and eRF3 which trigger ribosome 
recycling and peptide release in a GTP-dependent manner (Schuller & Green, 2018). Based on 
interaction studies, a model was postulated by which the EJC is bridged to NMD factors via 
the SURF complex formed of SMG1-UPF1-eRF1-and eRF3 (Kashima et al., 2006). According to 
this model, eRF1 and eRF3 at the translation termination codon recruit UPF1 which can be 
phosphorylated by SMG1. This phosphorylation is required for NMD (Yamashita et al., 2005b). 
UPF3B directly interacts with the EJC with its exon junction complex binding motif (EBM) and 
bridges the EJC via UPF2 to UPF1. The phosphorylated UPF1 N- and C-termini recruit SMG5, 
SMG6 and SMG7 (Okada-Katsuhata et al., 2012). The endonuclease SMG6 cleaves the mRNA 
in the vicinity of the PTC which results in a 5′ and 3′ fragment that are degraded involving the 
RNA exosome or the cytoplasmic 5′-3′ exonuclease XRN1 (Huntzinger et al., 2008, Eberle et 
al., 2009, Boehm et al., 2014). The SMG5/7 heterodimer promotes the deadenylation of the 
transcript leading to decapping and 5′-3′ decay by XRN1 as well as 3′-5′ exonucleolytic 
degradation (Loh et al., 2013). Analyses of the relative participation of these SMG6- and 
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SMG5/7-dependent pathways in the degradation of an NMD target have shown that they can 
act redundantly (Colombo et al., 2017). Under normal conditions, SMG6-mediated 
endocleavage is the dominating pathway in human cells (Lykke-Andersen et al., 2014, Schmidt 
et al., 2015).  
 
Figure 5: Model of translation termination at a premature termination codon (PTC). A: Translation termination at a 
canonical termination codon. The eukaryotic release factor 1 (eRF1) binds to the termination codon together with eRF3. The 
hydrolysis of GTP by eRF3 results in in its dissociation and subsequent steps that cause peptide release and ribosome recycling. 
The cytoplasmatic polyA-binding protein (PABP) stimulates translation termination. UPF1 is probably bound in the 3′ UTR but 
remains inactive. B: Aberrant translation termination event leading to nonsense-mediated mRNA decay. A long distance 
between PABP and the termination codon reduces its stimulatory effect on termination. The stalling of the ribosome due to 
inefficient termination causes the activation of bound UPF1. An EJC present downstream strongly stimulates NMD potentially 
by acting as a binding platform for UPF3B which can be bridged to UPF1 by UPF2. C: The kinase SMG1 phosphorylates the N- 
and C-termini of UPF1. This phosphorylation can be caused by aberrant translation termination and/or by recruitment of UPF1. 
The phosphorylated UPF1 is bound by the endonuclease SMG6 which cleaves the mRNA at the termination codon. The UPF1 
N-terminus is bound by the SMG5/SMG7 heterodimer which recruits CNOT8 (POP2), a component of the CCR4-NOT 
deadenlyase complex. 
Some observations cannot be explained by a strict SURF model relying on direct physical 
interactions. Firstly, it is not clear how long distances up to 600 nucleotides between the PTC 
and a downstream EJC can be spanned (Neu-Yilik et al., 2001, Boehm et al., 2014). Secondly, 
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the tethering of a UPF3B mutant which is unable to bind UPF2 is still able to induce NMD 
(Gehring et al., 2003). This suggests that the NMD machinery can be recruited in an UPF2-
independent manner. Finally, a combined knockdown of UP3B and its paralog UPF3A also does 
not inhibit NMD of the T-cell receptor-β mRNA, showing that an alternative route to 
communicate the presence of an EJC downstream of an EJC must exist (Chan et al., 2007).  
In tethering assays, more EJC interacting factors have been shown to be able to elicit NMD 
when bound downstream of a termination codon. Both RNPS1 and CASC3 strongly induce 
NMD when tethered to reporter mRNAs, but only RNPS1 requires UPF2 for this effect (Gehring 
et al., 2005, Ciriello, 2014). This observation has led to the hypothesis that different branches 
of NMD activation exist. Whether these branches act on the same set of endogenous NMD 
targets or whether there are subsets of NMD targets with different requirements of factors is 
not clear. A recent study has claimed that RNPS1 is required for the degradation of many 
endogenous NMD targets, whereas CASC3 is not (Mabin et al., 2018). 
Many transcripts undergo NMD even though there is no EJC downstream of the termination 
codon (EJC-independent NMD). In transcripts with a long 3′ UTR, there is large distance of the 
termination codon to the polyA binding protein (PABP). PABP has been shown to promote 
translation termination by promoting the GTP hydrolysis function of eRF3 and to counteract 
NMD when tethered closely downstream of a termination codon (Eberle et al., 2008). 
Furthermore, in an in vitro translation termination system, PABP stimulates translation 
termination by enhancing the recruitment of eRF1 and eRF3 to the ribosome (Ivanov et al., 
2016). Interestingly, in transcripts with a long 3′ UTR endocleavage also occurs at the PTC and 
is strictly UPF2-dependent (Boehm et al., 2014). How the NMD machinery is recruited to 
transcripts with long 3′ UTRs is not known. The 3′ UTR length was shown not to be a predictor 
of NMD sensitivity per se since many transcripts with this feature are insensitive to NMD 
(Singh et al., 2008). A subset of these contain AU-rich sequences directly downstream of the 
termination codon and which render them immune to NMD (Toma et al., 2015).  
Although UPF1 is regarded as the central NMD factor, UPF1-binding in itself is not a trigger for 
NMD since it was found to bind promiscuously to the coding sequence and 3′ UTR of mRNAs 
(Zund et al., 2013). A common denominator in all models of NMD is rather that a translation 
termination event is recognized as aberrant which leads to the activation of the NMD 
machinery. In studies performed in yeast and human cells, it was shown that the ribosome 
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remains longer on PTCs that trigger NMD (Amrani et al., 2004, Peixeiro et al., 2012). This delay 
could potentially signal an aberrant termination event and give time for the recruitment of 
UPF1 by the release factors and subsequent phosphorylation. A downstream bound EJC and 
the distance to PABP could either enhance or decrease this process. UPF3B has also been 
shown to interact in vitro with the release factors and negatively impact translation 
termination, thus establishing a link between the EJC and the termination event (Neu-Yilik et 
al., 2017).  
For a long time, the prevalent view was that NMD would occur exclusively during the first 
round of translation (Schoenberg & Maquat, 2012). Directly after export, transcripts undergo 
the initial round of translation while bound by the CBC (Ryu & Kim, 2017). Either during 
translation or translation-independently, the CBC is replaced by eIF4E which forms the 
translation initiation complex eIF4F together with eIF4A and eIF4G (Sato & Maquat, 2009). 
There is evidence however that EIF4E-bound transcripts are also NMD competent (Durand & 
Lykke-Andersen, 2013, Rufener & Muhlemann, 2013). Supporting this notion, a recent study 
based on live-cell imaging of transcripts degraded by NMD has reported that transcripts 
undergo on average eight rounds of translation before endocleavage occurs (Hoek et al., 
2019). This could be explained by a model in which NMD is a stochastic process and the 
probability of its activation increases or decreases depending on the mRNP composition 
downstream of the termination codon. This recent study also confirmed an earlier observation 
that a subset of transcripts within an NMD-targeted mRNA pool can escape NMD (Trcek et al., 
2013, Hoek et al., 2019). Thus, a variability of NMD efficiency seems to exist between 
subpopulations of mRNA. 
1.3 Monitoring the dynamics of mRNA turnover with viral sequence elements  
The amount of a given transcript in the cell is determined by its rate of transcription and 
degradation. The turnover of mRNAs is therefore a crucial process to enable the regulation of 
gene expression. It also provides a way by which faulty transcripts or exogenous infectious 
RNAs can be removed. The stability of mRNAs can be controlled by many features such as the 
length of its polyA tail, its 5′ cap, sequence or secondary structure elements recognized by 
small RNAs or RNA-binding proteins, and quality control mechanisms. mRNA decay involves 
many nucleolytic pathways acting on a transcript and is often linked to other cellular processes 
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such as transcription or translation. For these reasons, mRNA decay measurements that do 
not disturb cellular processes are helpful to detangle the relative contribution of these 
pathways on the degradation of a given transcript. This chapter describes methods to study 
mRNA degradation and how viral exonuclease-resistant RNA structures could improve their 
readout. 
1.3.1 mRNA turnover  
Both in the nucleus and in the cytoplasm, distinct mRNA decay machineries exist that act in 
canonical mRNA degradation and mRNA quality control mechanisms. The nuclear RNA decay 
machinery consists of the nuclear 5′-3′ exonuclease XRN2 and the RNA exosome which 
possesses 3′-5′ exonuclease and endonuclease activity (Schmid & Jensen, 2018). Nuclear RNAs 
that are targeted towards degradation can arise for many reasons. As described above, XRN2 
functions during transcription in degrading the cleavage fragment caused by 3′ processing. 
Furthermore, it contributes to 5′ trimming of ribosomal pre-RNAs (Wang & Pestov, 2011). 
Pervasive transcription and mistakes during RNA processing lead to the formation of many 
unstable RNA species that will be degraded by the RNA exosome (Peck et al., 2019).  
Bulk degradation of mature mRNAs in the cytoplasm starts by shortening and removing the 
polyA tail (Chen & Shyu, 2011). Two major deadenylation complexes shorten polyA tails in 
mammalian cells: PAN2-PAN3 and CCR4-NOT (Wolf & Passmore, 2014, Collart, 2016). A 
biphasic model according to which PAN2-PAN3 targets longer polyA tails and CCR4-NOT 
subsequently takes over has been assumed for a long time (Yamashita et al., 2005a). Recent 
results suggest that the bulk of deadenylation is carried out by CCR4-NOT and that the catalytic 
subunit CCR4 acts on PABP-bound polyA segments whereas the other catalytic subunit CAF1 
targets free polyA stretches (Yi et al., 2018). Results obtained in yeast have supported this 
cyclic model of deadenylation (Webster et al., 2018).  
Deadenylation promotes the removal of the 5′ cap by the decapping complex. DCP2 removes 
the cap and is aided by its activator DCP1 and the scaffold protein EDC4 (Chang et al., 2014a). 
The exposed 5′ monophosphate end is then vulnerable to exonucleolytic cleavage by the 
cytoplasmic 5′-3′ exonuclease XRN1 (Nagarajan et al., 2013). Deadenylated transcripts are also 
a target for degradation via the RNA exosome (Mitchell et al., 1997, Wang & Kiledjian, 2001). 
Transcripts with a short polyA tail can be uridylated by the terminal uridylyl transferases 
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(TUTases) TUT4 and TUT7 (Chang et al., 2014b, Lim et al., 2014). PABP prevents TUT7 from 
uridylating polyA tails longer than 25 nts (Lim et al., 2014). Uridylated mRNAs undergo decay 
from the 5′ end by decapping and XRN1-dependent decay and from the 3′ end by the exosome 
and the uridylation-specific 3′-5′ exonuclease DIS3L2 (Lim et al., 2014, Thomas et al., 2015). 
Sequences or secondary structures that influence the stability of an mRNA are commonly 
located in the 3′ UTR (Bartel, 2009, Uchida et al., 2019). Small RNAs such as miRNAs, siRNAs 
or piwi RNAs (piRNA) are complementary to target sequences in transcripts (Ha & Kim, 2014). 
Together with members of the AGO protein family, they form RNA-induced silencing 
complexes (RISC). The binding of the RISC to transcripts promotes their translational 
repression or degradation (Huntzinger & Izaurralde, 2011). While miRNAs and siRNAs 
commonly regulate protein levels, piRNAs specifically function in germ cells (Ha & Kim, 2014). 
Another type of sequence element that influences transcript stability is the AU-rich element. 
AU-rich elements are recognized by RNA-binding proteins that will either increase or decrease 
the stability of the mRNA (Garcia-Maurino et al., 2017). AU-rich elements can cause rapid 
degradation via the TIS11 family of RNA-binding proteins, namely TTP and BRF1 and 2 (Sanduja 
et al., 2011). The mode of action is swift deadenylation followed by the degradation of the 
transcript (Wilson & Treisman, 1988). AU-rich elements of this type are a feature of many 
transcripts involved in cell proliferation or immunity which need to be tightly regulated 
(Anderson, 2008). In contrast, the human antigen R (HuR) protein competes with degradation 
promoting factors and generally has an enhancing effect of mRNA stability (Fan & Steitz, 
1998). RBPs that recognize AU-rich elements can also regulate each other and their own 
transcripts, thus forming a complex network (Garcia-Maurino et al., 2017).  
Besides sequence elements, secondary structures can influence transcript stability. This type 
of structure was discovered in the transcripts encoding the ferritin and transferritin receptor 
proteins which function in iron uptake and storage (Hentze et al., 1987, Mullner & Kuhn, 
1988). Five Iron-response elements formed of 30 nt long hairpins in the hTR 3′ UTR lead to the 
degradation of hTR mRNA by endocleavage (Pantopoulos, 2004). The identity of the 
endonuclease is not known (Schoenberg, 2011). When iron levels are low, the hTR transcript 
is stabilized by iron response proteins (IRPs) binding to the IREs, thus promoting iron uptake 
(Mullner et al., 1989). The expression of ferritin which stores iron in the cell is also regulated 
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by an IRE. An IRE in the 5′ UTR of ferritin mRNA is bound by IRP when iron levels are low and 
prevents translation initiation (Gray & Hentze, 1994).  
Another type of stem loop that promotes mRNA degradation is the constitutive decay element 
(CDE) found in the 3′ UTR of cytokine transcripts such as TNF-α and interleukin-6 (Mino et al., 
2015). This structure is recognized by Roquin1 and 2 which recruit the CCR4-NOT 
deadenylation complex (Leppek et al., 2013). Furthermore, the endonuclease ZC3H12A 
cleaves the transcript in the vicinity of the stem loop (Mino et al., 2015).  
Codon optimality is another feature of mRNA that influences its stability. Because certain 
amino acids can be encoded using distinct tRNAs, the restricted availability of these charged 
tRNAs potentially slows down translation. A recent study showed that transcripts with a non-
optimal codon composition are less stable (Wu et al., 2019b). 
Transcript stability is not only controlled by inherent sequences recognized by RNA-binding 
proteins, but also quality control processes coupled to translation. This includes the 
aforementioned nonsense-mediated mRNA decay mechanism that targets transcripts with a 
premature termination codon. Studied mainly in yeast, the no-go decay (NGD) pathway occurs 
when ribosomes encounter blocks such as hairpins or A-stretches during translation which 
lead to ribosome stalling and colliding (Simms et al., 2017). Similarly to NMD, converging 
nucleolytic pathways act on the decay substrate. The endonuclease Cue2 has been identified 
in yeast to cleave transcripts at the position of colliding ribosomes (D'Orazio et al., 2019). 
Exonucleolytic decay especially by XRN1 is however the dominant contributor to the decay of 
NGD targets. Transcripts that completely lack a termination codon are thought to be degraded 
by the non-stop decay (NSD) pathway. Because the translation of the polyA tail into poly-
lysines causes ribosome stalling, NSD might resemble NGD (Shoemaker & Green, 2012). It is 
not known whether NGD or NSD have functions like NMD that go beyond quality control in 
the regulation of gene expression. Since many transcripts are alternatively polyadenylated it 
is possible that some of these will be targeted by NGD (Shoemaker & Green, 2012). 
The modification of RNA bases beyond the 7-methylguanosine cap have also been reported 
to influence transcript stability. N6-methyladenosine (m6A) is the most abundant internal RNA 
modification and has been linked to mRNA instability (Sommer et al., 1978, Ke et al., 2017). 
This reversible modification is added by the m6A methyltransferase METTL3 and removed by 
the m6A demethylase ALKBH (Bokar et al., 1997, Zheng et al., 2013). The YTHFD2 protein 
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serves as a reader for m6A and has been proposed to induce decay by binding to m6A-
methylated mRNA and promoting its location to P-bodies (Wang et al., 2014a). P-bodies are 
membrane-less subcompartments in the cytoplasm which contain mRNA and mRNA decay 
factors and have been implicated as sites of mRNA decay (Luo et al., 2018). This view has been 
challenged however by the observation that preventing the assembly of P-bodies does not 
lead to a reduction in mRNA decay (Eulalio et al., 2007). m6A modifications recognized by 
YTHFD1 have been reported to enhance translation efficiency (Wang et al., 2015). Another 
link to translation comes from the observation that m6A modifications in the 5′ UTR enable 
cap-independent translation (Meyer et al., 2015). It has been proposed that like for AU-rich 
elements, m6A modifications can result in different outcomes depending which factors read 
them (Wang et al., 2015).  
Another RNA modification linked to mRNA stability is found on transcripts in which the first 
nucleotide adjacent to the cap is an adenosine. As in all mRNAs, the first nucleotide is 
methylated at 2′-hydroxide position as part of the cap structure (Ramanathan et al., 2016). In 
up to 75% of mRNAs this Am is additionally modified at the N6 position, resulting in a N6,2′-O-
dimethyladenosine (m6Am) (Mauer et al., 2017, Akichika et al., 2019). This modification 
impairs DCP2’s ability to remove the 5′ cap, thus potentially increasing the stability of a 
transcript (Mauer et al., 2017). Two different studies analyzing a knockout of the responsible 
methyltransferase PCIF1 have come to divergent conclusions with only one of them reporting 
an upregulation of a subset of m6Am-containing transcripts upon PCIF1 depletion (Akichika et 
al., 2019, Boulias et al., 2019). The demethylase FTO has been shown to remove m6Am 
modifications, suggesting it could be a modifier of mRNA stability. Recent evidence however 
has established that the predominant role of FTO lies in the modification of small nuclear RNAs 
involved in splicing (Mauer et al., 2019).  
1.3.2 Viral XRN1-resistant RNAs  
Viruses of the genus flavivirus have developed a specialized secondary structure that protects 
a part of their genome from the degradation of the host’s cytoplasmic XRN1 (Figure 6) (Pijlman 
et al., 2008, Funk et al., 2010, Silva et al., 2010). These viruses possess a single-stranded 
positive sense RNA genome consisting of a 5′ UTR, an open reading frame coding for viral 
structure and replication proteins as well as a 3′ UTR (Chong et al., 2019). At the beginning of 
the 3′ UTR they carry one or two conserved stem loops that fold into a pseudoknot structure. 
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Further downstream, one or more dumbbell-like secondary structures enhance the inhibition 
of XRN1. These structures make the 3′ UTR resistant to degradation by the host’s cellular 
XRN1. The stabilized 3′ UTR can then be processed into functional non-coding RNAs. These 
small RNAs, termed subgenomic flaviviral RNAs (sfRNAs), have been shown to inhibit the 
host’s RNAi response and type-I-interferon response, thereby harming anti-viral defence 
mechinsms (Schnettler et al., 2012, Schuessler et al., 2012). Additionally, sfRNAs bind to RNA-
binding proteins involved in post-transcriptional processes such as splicing, RNA decay and 
translation (Michalski et al., 2019). Also, because XRN1 is stalled at the 3′ UTR, these 
sequences potentially trap XRN1 there, thus reducing the host’s ability to degrade infectious 
RNAs (Michalski et al., 2019). 
Flaviviruses are unique in the fact that they hijack the host’s mRNA decay machinery to 
produce pathogenic RNAs (Slonchak & Khromykh, 2018). The genus contains species such as 
Zika, West Nile, Dengue and Yellow fever virus which are highly pathogenic for humans and 
cause outbreaks affecting millions (Chong et al., 2019). The investigation of features that 
confer their pathogenicity has therefore attracted great interest in the recent years. 
 
Figure 6: Structures of XRN1-resistant RNAs. A: Schematic depiction of one XRN1-resistant element formed of three stem-
loops. B: Structure of the Murray Valley Encephalitis (MVE) xrRNA2 (pdb: 4PQV). The 5′ end of the RNA passes through a ring 
which halts the progression of XRN1 C: Structure of the Zika virus xrRNA1 (pdb: 5TPY). In comparison to the MVE structure the 
knot is in a tighter conformation. The structures were rendered with Chimera v.1.14rc. 
In 2014 the structure of the Murray Valley Encephalitis (MVE) virus’s xrRNA was solved, laying 
the foundations of understanding the mechanism of XRN1-inhibition (Figure 6B) (Chapman et 
al., 2014). The 5′ end of the xrRNA is surrounded by a ring-like structure which is stabilized by 
a three-way junction as well as interactions of the 5′ end with the ring itself. Furthermore, 
interactions between P3 and P4 (Figure 6, depicted in orange) could further stabilize this 
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pseudoknot fold. However, in the MVE structure they are not base-paring. The ring formed of 
P1 and P3 physically blocks XRN1-progression from the 5′ end (Kieft et al., 2015). The 
mechanism of inhibition is specific to the 5′ end, since the viral RNA-polymerase is able to 
progress in 3′ to 5′ direction during RNA replication (Slonchak & Khromykh, 2018). The xrRNA 
structure obtained from the Zika virus confirmed the pseudoknot structure (Figure 6C) 
(Akiyama et al., 2016). Here, interactions between P3 and P4 are stabilized by stacking of the 
P4 helix, thus forming a fully folded xrRNA.  
1.3.3 RNA decay measurements 
Several challenges are linked to measuring mRNA degradation. The degradation of an mRNA 
has to be measured independently of its rate of synthesis. Furthermore, an essential challenge 
in studying mRNA decay is that the transcript escapes detection when it has been degraded. 
This makes it necessary to measure the half-lives transcripts or to use techniques that enable 
the detection of decay intermediates (Wada & Becskei, 2017). Finally, mRNA decay 
measurements often require interfering with endogenous cellular processes which could 
potentially influence the readout of the assay. 
The degradation of a transcript can be measured by studying the amount of mRNAs of the 
same type. A pool of mRNAs can be directly detected on a northern blot using a labelled probe. 
This technique visualizes all RNA species that carry the probe binding site including pre-mRNA 
or alternatively spliced variants. The design of specific probes and the use of radioactive 
labelling can be an obstacle when using this method. More common is the detection by 
quantitative real-time PCR (qPCR) which involves reverse transcribing the RNA into cDNA 
before measuring. This method is well-established in most molecular biology labs. Drawbacks 
include that the primers used have to be vigorously tested before allowing quantitative 
readouts (Bustin et al., 2009). 
When studying an endogenous mRNA species, the amount is determined both by the rate of 
synthesis and decay. Transcription can change dynamically due to the regulation by 
transcription factors. To specifically study the decay kinetics of degradation, several options 
to study half-life times of mRNAs exist. Newly produced mRNAs can be labelled, either using 
radioactive or non-radioactive nucleotides. Transcriptome-wide measurements of mRNA 
decay are also possible: e.g. the SLAM-seq method uses a pulse of 4-thiuridine labeling to 
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distinguish between newly synthesized mRNAs and calculate transcript half-lives (Herzog et 
al., 2017). Both radioactive and non-radioactive types of nucleotides can negatively impact 
the cells metabolism and therefore potentially impact mRNA decay measurements: 
Phosphorous 32 can cause DNA damage and 4-thiouridine which is mostly used in mammalian 
cells disturbs rRNA processing thus leading to nucleolar stress (Burger et al., 2013, Cheng et 
al., 2015). Another approach is to block the synthesis of new transcripts by treating cells with 
transcription inhibitors (Wada & Becskei, 2017). By quantifying the change of existing mRNA 
molecules their half-lives can be determined. A wide array of transcriptional inhibitors with 
different selectivity for RNA polymerases and speed of action exist (Bensaude, 2011). Because 
global transcription is blocked, this treatment can have generally adverse effects on cells 
(Wada & Becskei, 2017). 
Reporter mRNAs that underlie the transcriptional control of an adjustable promoter are a 
useful tool to study mRNA turnover. These constructs can either be stably integrated into a 
genomic locus by stable transfection or transiently expressed from extra-chromosomal 
expression plasmids. Two types of promoters exist for these kinds of studies: firstly the 
transcription can be turned on, e.g. in Tet-On systems (Gossen & Bujard, 1992, Gossen et al., 
1995). Because the rate of transcription is estimated to be constant under these conditions, 
steady state levels of the transcript can be used as a read-out. Promoters that are turned off 
by the addition of a substance, e.g. Tet-Off systems can be used to halt the expression of a 
reporter mRNA so that the half-life of remaining transcript levels can be determined (Rennel 
& Gerwins, 2002).  
Finally, it is possible to visualize mRNA degradation by using imaging approaches. Single-
molecule fluorescent in situ hybridization (smFISH) has revealed insights into mRNA decay 
mechanisms of human, yeast and trypanosome cells (Trcek et al., 2011, Trcek et al., 2013, 
Kramer, 2017). Imaging the turnover of mRNA is also possible in real-time by using arrays of 
binding sites within the mRNA that are bound by fluorescent proteins (Bertrand et al., 1998). 
This has recently been combined with the SunTag system which provides a visual readout of 
translation (Tanenbaum et al., 2014, Yan et al., 2016, Hoek et al., 2019).  
Another common technique of investigating mRNA turnover is a knockdown of factors 
involved in mRNA degradation and measuring the stabilization of their targets. A knockdown 
of XRN1 for example stabilizes decay intermediates resulting from endocleavage, making it 
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possible to map the cleavage sites (Lykke-Andersen et al., 2014). Many pathways that target 
unstable mRNAs are linked however, resulting in the perturbation of not only a single element. 
For example, XRN1 directly interacts with EDC4 of the decapping complex, the decapping 
activator PatL1 and with the CCR4-NOT deadenylation complex (Braun et al., 2012, Chang et 
al., 2019).
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1.4 Aims of this work  
1. Although more than 200 ribosomal biogenesis factors in the nucleolus have been 
described in human cells, it is possible that biogenesis factors located outside of the 
nucleolus have not yet been identified. In embryonic stem cells UBR5 is upregulated and 
is functionally linked to maintain pluripotency. In Saez et al. (2020) an interaction between 
UBR5 and the H/ACA snoRNP in stem cells is reported. This has potential implications for 
rRNAs as the targets of H/ACA pseudouridylation. In this study the consequences of UBR5 
depletion on rRNA maturation and ribosomal biogenesis are investigated. 
2. During splicing, the spliceosome undergoes dramatic compositional changes. EJC 
deposition is known to be splicing-dependent, but structural and temporal details about 
this process have been unclear. The recently published cryo-EM structures of spliceosome 
intermediates have resolved the position of the EJC in relation to the spliceosome for the 
first time. In Gerbracht & Gehring (2018) these structures are described with a focus on 
newly identified interactions between EJC components and spliceosomal proteins. In 
Boehm et al. (2018) the mechanism by which the deposition of an EJC influences the 
splicing of neighboring junctions is elucidated. Although CASC3 is generally described as 
an essential core component of the EJC in the literature, we did not see any mis-splicing 
when we depleted CASC3 in human cells. In Gerbracht et al. (2019) CASC3 knockout cell 
lines are used to address the reported functions of CASC3 in splicing and the nonsense-
mediated mRNA decay mechanism. 
3. Often, multiple nucleolytic pathways are involved in the degradation of a transcript. 
Inserting viral XRN1-resistant RNAs into reporter mRNAs should selectively block 5′-3′ 
degradation and allow for the detection of decay intermediates at the same time. Since 
the accumulation of XRN1-resistant degradation intermediates directly corresponds to 5′-
3′ degradation, they represent a readout of the contribution of 5′-3′ decay. In Boehm et 
al. (2016) multiple decay pathways are analyzed using xrRNAs as a proof of concept. 
Gerbracht et al. (2017) employs xrRNA-based analyses to study the effects of transfection 
methods on the readout of nonsense-mediated decay reporter mRNAs. Voigt et al. (2019) 
provides a step-by-step protocol to study mRNA degradation using xrRNA both with 
biochemical assays and single-molecule imaging tools. 
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UBR5 is an E3 ubiquitin ligase involved in distinct processes such as tran-
scriptional regulation and development. UBR5 is highly upregulated in embry-
onic stem cells (ESCs), whereas its expression decreases with differentiation,
suggesting a role for UBR5 in ESC function. However, little is known about
how UBR5 regulates ESC identity. Here, we define the protein interactome
of UBR5 in ESCs and find interactions with distinct components of the
H/ACA ribonucleoprotein complex, which is required for proper maturation
of ribosomal RNA (rRNA). Notably, loss of UBR5 induces an abnormal
accumulation of rRNA processing intermediates, resulting in diminished ribo-
somal levels. Consequently, lack of UBR5 triggers an increase in p53 levels
and a concomitant decrease in cellular proliferation rates. Thus, our results
indicate a link between UBR5 and rRNA maturation.
Keywords: embryonic stem cells; protein–protein interactions; ribosomal
RNA; ribosome; ubiquitin ligases
UBR5 is an E3 ubiquitin ligase which belongs to the
HECT (homologous to the E6-AP carboxy terminus)
ligase family [1]. This 300 kDa-enzyme is mostly local-
ized in the nucleus [2] and contains several functional
domains. Besides its HECT-ubiquitin ligase domain,
UBR5 also has a UBR box finger-like domain, which
targets proteins containing the destabilizing N-degron
signal toward degradation [3]. Moreover, it contains a
PABC [polyadenylate-binding protein (PABP) C termi-
nus] domain, also known as MLLE domain, which
confers UBR5 the ability to bind mRNA and modu-
late eukaryotic translation initiation [4]. Notably,
UBR5 exhibits E3-independent activity as a transcrip-
tional cofactor for the progesterone receptor and acts
as a binding partner for distinct proteins such as
GW182, CHK2, and DUBA [5–7]. UBR5 was first dis-
covered as a tumor suppressor in a progestin-modify-
ing screening using breast cancer cells [1]. In these
lines, several studies evidenced a role of UBR5 in cell
cycle progression and tumorigenesis [8,9]. UBR5 is
also an important mediator of the DNA damage
response, since it is a substrate of DNA damage
response kinases such as ATM [10,11]. Furthermore,
UBR5 has a role in transcriptional regulation, as it
Abbreviations
GO, gene ontology; hESCs, human embryonic stem cells; mESCs, mouse embryonic stem cells; PABP, polyadenylate-binding protein; RIP,
RNA immunoprecipitation; RNP, ribonucleoprotein; rRNA, ribosomal RNA; snoRNAs, small nucleolar RNAs; snRNA, small nuclear RNA.
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binds and promotes the transactivation of the proges-
terone receptor [2], ubiquitinates the CDK9 subunit of
the positive transcription elongation factor b [12], and
regulates the miRNA pathway [13]. In addition,
Ubr5/ mice embryos are not viable, indicating that
this protein is essential for development [14].
Recently, we have shown that UBR5 is highly
expressed in human embryonic stem cells (hESCs) and
its expression decreases when hESC differentiate, sug-
gesting a role of UBR5 in ESC identity [15]. In these
lines, a study reported that Ubr5 knockdown results in
significant loss of pluripotency markers in mouse ESCs
(mESCs) [16]. Here we examine the role of UBR5 in
ESCs by defining its interactome using immunoprecipi-
tation assays followed by quantitative proteomics. We
find that UBR5 interacts with the H/ACA ribonucleo-
protein (RNP) complex, which participates in the
proper maturation and processing of ribosomal RNA
(rRNA). We further characterize the role of UBR5 in
this system by analyzing pre-rRNA processing and
find that the levels of several pre-rRNA intermediates
are altered in Ubr5/ ESCs. Finally, we show a
decreased translational profile in UBR5-defective cells
accompanied by increased p53 levels and diminished
proliferation rates.
Methods
hESC and mESC lines and culture
The H9 (WA09) hESC line was obtained from the WiCell
Research Institute and was maintained on Geltrex
(ThermoFisher Scientific, Waltham, MA, USA) using
mTeSR1 (Stem Cell Technologies, Cologne, Germany).
Undifferentiated hESC colonies were passaged using a solu-
tion of dispase (2 mgmL1), and scraping the colonies with
a glass pipette. The mESC AN-13 mESC line was obtained
from the Haplobank at the Institute of Molecular Biotech-
nology GmbH. The mESC was cultured in noncoated plates
using DMEM supplemented with 7.25% FBS, 1% Pen/
Strep, 1% nonessential amino acids, 1% Glutamax, 1%
Sodium pyruvate, 50 lM b-mercaptoethanol and human LIF
(12 ng/mL). The cell lines used in this study were tested for
mycoplasma contamination at least once every three weeks.
No mycoplasma contamination was detected. Research
involving hESCs was performed with approval of the Ger-
man Federal competent authority (Robert Koch Institute).
Lentiviral infection of hESCs
Lentivirus (LV)-nontargeting shRNA control, LV-UBR5
shRNA #1 (TRCN0000003411), and LV-UBR5 shRNA #2
(TRCN0000226458) in pLKO.1-puro vector were obtained
from Mission shRNA (Sigma, Hamburg, Germany). Tran-
sient infection experiments were performed as follows. H9
colonies growing on Geltrex were individualized using
Accutase. Hundred thousand cells were plated on Geltrex
plates and incubated with mTesR1 medium containing
10 lM ROCK inhibitor for 1 day. Then, cells were infected
with 5 lL of concentrated lentivirus. Cells were fed with
fresh media the day after to remove the virus. After 1 day,
cells were selected for lentiviral integration using
2 lgmL1 puromycin (ThermoFisher Scientific).
CRISPR/Cas9- mediated KO of mESCs
UBR5 gene knockout was done in mouse embryonic stem
cells carrying a haploid chromosome set [[17]]. These cells
become diploid over time and mutations thus remain
homozygous. For genome engineering CRISPR/Cas9 was
used as previously described [18]. Sequences for small guide
RNAs were designed online (http://crispor.org) and pur-
chased from Sigma (FGuide 1: CACCGTAAATGATTTAC
CATACGGT, RGuide 1: AAACACCGTATGGTAAATCA
TTTAC, FGuide 2: CACCGATTGCTTTAAAACTCCAC
TT, RGuide 2: AAACAAGTGGAGTTTTAAAGCAATC).
The primers were cloned into the Cas9-GFP expressing plas-
mid PX458 (Addgene #48138, gift from Feng Zhang). A
combination of guides and the Cas9-expressing plasmid were
transfected using lipofectamine 3000 (Thermo Fisher Scien-
tific) according to manufacturer’s instructions. Twenty-four
hours post transfection a mixed population of haploid and
diploid ES cells were stained with 10 lg/mL Hoechst 33342
(Thermo Fisher Scientific) for 30 min and sorted according
to their DNA content and GFP expression on a FACSAria
Fusion sorter (BD, Franklin Lakes, NJ, USA). Haploid
GFP-positive cells were single cell sorted into 96-well plates.
Emerging clones were transferred to 24-well plates 7 days
later and genotyped following DNA extraction (DNA
extraction solution, Epicentre Biotechnologies, Madison,
WI, USA) using the following primers; F: GAGAC
CCGCCTGTTTGTTTT, R: CCCAATTGATTCTCTGAG
CCA. Sanger sequencing of PCR products was performed at
Eurofins Genomics GmbH, Ebersberg, Germany. UBR5
knockout clones were selected for diploid cells (FACS after
Hoechst staining) prior to further experiments.
Transfection of HEK293T cells
HEK293T cells (ATCC) were plated on 0.1% gelatin-
coated plates and grown in DMEM supplemented with
10% FBS and 1% MEM nonessential amino acids (Ther-
moFisher Scientific). Cells were transfected once they
reached 80-90% confluency. About 1 lg GFP-UBR5 wild-
type or GFP-UBR5 ΔHECT overexpression plasmid and
1 lg of GAR1-FLAG, NHP2-FLAG or DKC1-
FLAG were used for transfection, using Fugene HD
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(Promega, Mannheim, Germany) following manufacturer’s
instructions. After 24 h incubation in normal medium, the
cells were harvested for further experiments. GFP-UBR5
wild-type and GFP-UBR5 ΔHECT overexpression plasmids
(Addgene plasmids #52050 and # 52051, respectively) were
a gift from D. Saunders and were first published in ref [19].
DKC1, GAR1, and NHP1 were PCR-amplified from HeLa
cDNA and cloned between Xho I/Not I into a modified
pCI-neo (Clontech, Saint-Germain-en-Laye, France) plas-
mid, which contains an N-terminal FLAG-tag sequence
(pCI-FLAG).
Immunoprecipitation of UBR5 for interactome
analysis
The immunoprecipitation was performed under the condi-
tions described in [20]. Briefly, hESCs were lysed in RIPA
buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Tri-
ton x-100, 1% sodium deoxycholate, 1 mM EDTA, 1 mM
PMSF) supplemented with protease inhibitor cocktail
(Roche) and centrifuged at 13 000 g for 15 minutes at
4 °C. About 350 lg of protein was incubated with UBR5
Antibody (Cell Signaling, Frankfurt am Main, Ger-
many, #8755, 1 : 50) or FLAG antibody as a control
(Sigma, F7425, 4 lg). Subsequently, samples were incu-
bated with 100 lL of lMACS Micro Beads for 1 h at 4 °C
and loaded to precleared lMACS column (#130-042-
701). Beads were washed three times with 50 mM Tris (pH
7.5) buffer containing 150 mM NaCl, 5% glycerol, and
0.05% Triton and then washed five times with 50 mM Tris
(pH 7.5) and 150 mM NaCl. Then, columns were subjected
to in-column tryptic digestion containing 7.5 mM ammo-
nium bicarbonate, 2 M urea, 1 mM DTT, and 5 ngmL1
trypsin. Digested peptides were eluted using 50 lL of elu-
tion buffer 1 containing 2 M urea, 7.5 mM Ambic, and
5 mM IAA two times. Digests were incubated over night at
room temperature and samples were stage-tipped the next
day for label-free quantitative proteomics. All samples were
analyzed on a Q-Exactive Plus (Thermo Scientific) mass
spectrometer that was coupled to an EASY nLC 1200
UPLC (Thermo Scientific). All mass spectrometric raw data
were processed with Maxquant and the resulting output
was processed using Perseus. Significant differences between
the groups were assessed using Student’s t-test. A permuta-
tion-based FDR approach was applied to correct for multi-
ple testing (FDR < 0.2 was considered significant).
Protein immunoprecipitation for interaction
analysis
HEK293 cells were lysed in RIPA buffer supplemented
with protease inhibitor cocktail. Lysates were homogenized
by passing 10 times through a 27-gauge (27G) needle
attached to a 1 mL syringe and centrifuged at 13 000 g for
15 min at 4 °C. After preclearing the supernatant with Pro-
tein A agarose beads (Pierce, Schwerte, Germany), the sam-
ples were incubated overnight with UBR5 antibody (Cell
Signaling, #8755, 1 : 50) on the overhead shaker at 4 °C.
Subsequently, samples were incubated with 30 lL of Pro-
tein A beads for 1 h at room temperature. After this incu-
bation, samples were centrifuged 5 min at 5000 g and the
pellet was washed three times with RIPA buffer. For elu-
tion of the proteins, the pellet was incubated with 2x
Laemmli Buffer, boiled for 5 min and centrifuged 5 min at
maximum speed. The supernatant was taken and loaded
onto a SDS/PAGE gel for western blot analysis.
Western blot
Cells were scraped from tissue culture plates by cell scraping
and lysed in protein cell lysis buffer (50 Mm Hepes pH 7.4, 150
MmNaCl, 1 mM EDTA, 1% Triton X-100) supplemented with
2 mM sodium orthovanadate, 1 mM PMSF, and protease inhi-
bitor mix). Lysates were homogenized through syringe needle
(27G) followed by centrifugation at 8000 g for 5 min at 4 °C
and then supernatants were collected. Protein concentrations
were determined with a standard BCA protein assay (Thermo-
Fisher Scientific). Approximately 30 lg of total protein was
separated by SDS/PAGE, transferred to PVDF membranes
(Millipore, Darmstadt, Germany) and subjected to immuno-
blotting. Western blot analysis was performed with anti-UBR5
(Cell Signaling, #8755, 1 : 1000), anti-FLAG (Sigma, F7425,
1 : 5000), anti-DKC1 (Abcam, Cambridge, UK, ab156877,
1 : 1000), anti-RPL7 (Genetex, Irvine, CA, USA, #114727,
1 : 500), anti-RPS27 (Proteintech, Manchester, UK, 15355-1-
AP, 1 : 500), anti p53 (Proteintech, 10442-1-AP, 1 : 1000), and
anti- bActin (Abcam, ab8226, 1 : 10 000).
Immunocytochemistry
Cells were fixed with paraformaldehyde (4% in PBS) for
20 min, followed by permeabilization (0.2% Triton X-100
in PBS for 10 min) and blocking (3% BSA in 0.2% Triton
X-100 in PBS for 10 min). Primary antibody was incubated
for 1.5 h at room temperature [anti-FLAG (Sigma F7425,
1 : 100)] and incubated with secondary antibody [Alexa
Fluor 488 Goat anti-Mouse (ThermoFisher Scientific, #A-
11029, 1 : 500)], Alexa Fluor 568 F(ab’)2 Fragment of
Goat Anti-Rabbit IgG (H+L) (ThermoFisher Scientific,
#A-21069, 1 : 500) ,and Hoechst 33342 (Life Technologies,
Darmstadt, Germany, #1656104) for 1 h at room tempera-
ture. PBS and distilled water wash were followed before the
cover slips were mounted on Mowiol (Sigma, #324590).
Ribosome fractionation
About 5% (w/v) to 50% (w/v) sucrose gradients were pre-
pared from 5% and 50% sucrose solutions [20 mM Tris-
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HCl (pH 7.4), 100 mM NaCl, 10 mM MgCl2] supplemented
with protease inhibitor (Roche, Berlin, Germany), 20 mM
DTT (Sigma), and 0.1 mgmL1 cycloheximide (Sigma) in
11 mL ultracentrifuge polyallomer tubes (Beckman
Coulter, Krefeld, Germany) using gradient maker (Biocomp,
Munich, Germany). For fractionation, mESCs were lysed by
incubation on ice 10 min with polysome extraction buffer
(20 mM Tris-HCl (pH 7.4), 100 mM KCl, 10 mM MgCl2, 1%
Triton X-100) supplemented with 25 UmL1 DNase I, pro-
tease inhibitor, 20 mM DTT, and 0.1 mgmL1 cyclohex-
imide followed by 1 h lysis at 4 °C. Lysates were centrifuged
at 10 000 g for 10 min at 4 °C. The supernatant was col-
lected, loaded on the gradient and centrifuged at 246 942 g
for 3 h at 4 °C using SW-41 rotor and an ultracentrifuge
(Beckman Coulter). The gradients were fractionated in equal
volume while absorbance at 254 nm was recorded by frac-
tion collector (Teledyne ISCO). Protein was extracted from
each fraction by precipitating with Trichloroacetic acid
(Sigma).
RNA immunoprecipitation-quantitative RT-PCR
RIP experiments with anti-UBR5 (Cell Signaling, #8755) and
control anti-FLAG antibodies (Sigma, F7425) in HEK293T
cells overexpressing GFP-UBR5 were performed following
the protocol described in ref [21] with some modifications
[22]. Cells were pelleted by centrifugation at 1000 g for 10
min at 4 °C and washed several times with ice cold PBS. The
final cell pellet was resuspended with an equal volume of
polysome lysis buffer [100mM KCl, 5mM MgCl2, 10mM
HEPES (pH 7.0), 0.5% NP40 (Sigma)] supplemented with 1
mM DTT, 100 per units RNase Out (Invitrogen, Schwerte,
Germany), 400 lM VRC (New England BioLabs, Frankfurt
am Main, Germany), and protease inhibitor. Cell lysates were
incubated on ice for 10min and homogenized through syringe
needle. Antibody coating of protein A beads was prepared by
preswelling Protein A sepharose beads (Thermoscientific) in
NT2 buffer (50 mM Tris–HCl (pH 7.4), 150mM NaCl, 1mM
MgCl2, 0.05% NP40) supplemented with 5% BSA to a final
ratio of 1 : 5 for at least 1 h at 4 °C prior to use. Then, the
antibody was added to bead slurry and incubated for 2 h at
4 °C. Immediately before use, antibody-coated beads were
washed (five times) with ice cold NT2 buffer followed by resus-
pension of beads in ice cold NT2 buffer supplemented with 200
units of an RNase inhibitor, 400 lM vanadyl ribonucleoside
complexes, 1mM DTT, and 20mM EDTA. The cell lysate was
mixed with antibody-coated beads and incubated 2 h at room
temperature. The beads were washed five times with ice cold
NT2 buffer and finally washed with NT2 buffer with 1%
Triton X-100. RNA extraction was done from the immunopre-
cipitated pellet using RNAbee (Tel-Test Inc., Friendswood,
TX, USA). cDNA was generated using qScript cDNA Super-
Mix (Quantabio, Beverly, MA, USA). SybrGreen real-time
qPCR experiments were performed with a 1 : 20 dilution of
cDNA using a CFC384 Real-Time System (Bio-Rad) following
the manufacturer’s instructions. Data were analyzed with the
comparative 2DDCt method (RNA relative fold enrichment in
anti-UBR5 RIP over RIP performed with control FLAG
antibody) after normalization to the corresponding input
values. See Table S1 for details about the primers used for this
assay.
Bromodeoxyuridine proliferation assay
The mESCs were incubated with media containing 10
lMmL1 bromodeoxyuridine (BrdU) for the indicated
times. Cells were fixed with formaldehyde 4% in PBS.
Then, cells were permeabilized with 0.2% Triton X-100 in
PBS for 10 min and blocked with 3% BSA-PBS for 1 h at
room temperature. 2N HCl was added for 15 min at room
temperature. After this, cells were incubated in 0.1 M
sodium tetra-borate for 15 min at room temperature. We
performed overnight incubation with rabbit anti-BrdU
(ABD Serotech, OBT0030, 1 : 1000) at 4 °C followed by
incubation with an anti-rat-AlexaFluor 546 Cross-
Adsorbed (ThermoFisher Scientific, #A11081, 1 : 500) for
1 h. Hoechst 33342 was used to visualize nuclei.
RNA extraction and northern blotting
Total RNA was extracted using RNAbee (Tel-Test Inc.).
About 2.5 lg of total RNA was resolved on a 1% agarose/
Fig. 1. UBR5 interacts with the H/ACA ribonucleoprotein (RNP) complex. (A) Schematic representation of the H/ACA RNP box with its
protein components. (B) Immunoprecipitation with anti-UBR5 antibody in HEK293 overexpressing UBR5-GFP and GAR1-FLAG, NHP2-FLAG
or DKC1-FLAG. Immunoprecipitation was followed by western blot with antibodies against UBR5 or FLAG (right panel). The input samples
were loaded to assess overexpression levels and equal loading of total protein between samples (left panel). The images are representative
of two independent experiments. (C) Immunocytochemistry of HEK293 cells with ectopic expression of UBR5-GFP and GAR1-FLAG, NHP2-
FLAG or DKC1-FLAG. Hoechst staining was used as a marker of nuclei. Scale bar represents 10 lM. The images are representative of three
independent experiments. (D) Ribonucleoprotein immunoprecipitation (RIP) with UBR5 antibody of HEK293T cells overexpressing GFP-
UBR5. Quantitative PCR analysis of the indicated RNAs is expressed as fold enrichment over RIP performed with FLAG control antibody.
Graph (relative enrichment to FLAG antibody) represents the mean  SEM (n = 3). Statistical comparisons were made by Student’s t-test
for unpaired samples [P-value: *(P < 0.05), **(P < 0.01), ***(P < 0.001)]. (E) Lysates of HEK293 overexpressing UBR5-GFP and GAR1-FLAG,
NHP2-FLAG or DKC1-FLAG were treated with RNase A prior to immunoprecipitation with UBR5 antibody. Immunoprecipitation was
followed by western blot with antibodies against UBR5 or FLAG. The images are representative of two independent experiments.
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0.4 M formaldehyde gel using the tricine/triethanolamine
buffer system (ref PMID 23800830). The RNA was blotted
on an uncharged nylon membrane (Roth) by capillary
transfer overnight in 10x SSC buffer. Following UV-
crosslinking, the blots were prehybridised for 1 h in Church
buffer. Hybridization with 50-32P-labeled oligonucleotides
in Church buffer was carried out overnight at 40 °C. The
oligonucleotide sequences were as follows: ITS1 mouse: (50-
GCCGCTCCTCCACAGTCTCCCGTTTAATGATC-30),
ITS2 human: (50-CTGCGAGGGAACCCCCAGCCGCG
CA-30), ITS2 mouse: (50-CTGCGAGCAAACTCCCAGC
CGCGCAGCAC-30). The ITS1 (human) probe was generated
by in vitro transcription with [a-32P]-GTP using the BamHI
linearized pGEM4Z-ITS1 plasmid as a template. The signals
were detected using a Typhoon FLA 7000 (GE Healthcare)
and quantification was performed with Image Quant TL (GE
Healthcare, Solingen, Germany).
Results
UBR5 interacts with the H/ACA
ribonucleoprotein complex
UBR5 is upregulated in both hESCs and mESCs com-
pared with their differentiated counterparts [15,16,20],
suggesting a role for this protein in ESC function. To
gain insights into the function of UBR5, we performed
co-immunoprecipitation experiments of endogenous
UBR5 in hESCs followed by single-shot proteomic
analysis. We identified 101 interactors of UBR5 (Data
S1). Gene Ontology (GO) analysis of UBR5 potential
interactors indicated enrichment for proteins involved
in biological processes such as spliceosome assembly,
small nuclear RNA (snRNA) modification, and rRNA
pseudouridine synthesis (Data S1 and Fig. S1). Inter-
estingly, we found that UBR5 interacts with the pro-
teins (i.e., DKC1, GAR1, NOP10, and NHP2) of the
nucleolar H/ACA RNP complex (Data S1).
The H/ACA RNP box is formed by four different
proteins bound to small nucleolar RNAs (snoRNAs)
(Fig. 1A), and modulates the modification of rRNAs
as well as other RNAs by catalyzing their pseu-
douridylation (i.e., conversion of uridine to pseu-
douridine) [23,24]. The noncoding H/ACA snoRNAs
act as adaptors that link the catalytic protein DKC1
to its targets [25,26]. The three other proteins of the
H/ACA RNP box – GAR1, NOP10, and NHP2 – act
as scaffolding proteins and they are essential for the
proper functioning of the complex [27,28]. We identi-
fied DKC1, GAR1, NOP10, and NHP2 as putative
binding partners of UBR5 in our analysis, suggesting
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Fig. 2. UBR5 does not induce degradation of proteins of the H/ACA RNP complex. (A) Western blot analysis of UBR5WT or UBR5ΔHECT and
GAR1- FLAG, NHP2-FLAG or DKC1-FLAG using UBR5 and FLAG antibodies, respectively. GAR1, NHP2 AND DKC1 were overexpressed
together with either UBR5WT or UBR5ΔHECT in HEK293 cells. b-Actin is the loading control. The images are representative of three
independent experiments. (B) Western blot of endogenous UBR5 and DKC1 in H9 hESC line upon UBR5 knockdown (H9UBR5 KD). b-Actin is
the loading control. The images are representative of three independent experiments. (C) Western blot of UBR5 and DKC1 in mESCs upon
UBR5 knockout (mESCUbr5 KO). b-Actin is the loading control. The images are representative of two independent experiments.
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a role of UBR5 in the regulation of the H/ACA RNP
complex (Data S1). To further assess this interaction,
we overexpressed UBR5 together with GAR1, NHP2,
or DKC1 in HEK293 human cells and performed co-
immunoprecipitation assays followed by western blot.
These experiments confirmed the interaction of UBR5
with GAR1, NHP2, and DKC1 (Fig. 1B). Prompted
by these results, we analyzed the intracellular localiza-
tion of UBR5 and GAR1, NHP2, or DKC1 in
HEK293. Notably, these components of the H/ACA
RNP complex co-localized with UBR5 in the nucleus,
further supporting our interactome analysis (Fig. 1C).
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With the strong interaction between UBR5 and pro-
teins of the H/ACA RNP complex, we examined
whether UBR5 protein also pulls down snoRNAs by
RNA immunoprecipitation (RIP) assays. We assessed
four snoRNAs of the H/ACA RNP complex and
found interaction of UBR5 protein with SNORA73A/
U17 and SNORA5A (Fig. 1D). In contrast, we did
not observe significant interaction of UBR5 with
snoRNAs of the C/D box RNP, a distinct nucleolar
complex that catalyzes 20 O-methylation of rRNA
(Fig. 1D). Since UBR5 protein pulled down snoRNAs
of the H/ACA RNP, we asked whether the interaction
of UBR5 with proteins of this complex is mediated by
RNA. To assess this hypothesis, we performed co-im-
munoprecipitation assays treating the samples with
RNase A prior to immunoprecipitation with UBR5
antibody. Notably, the interactions with GAR1,
NHP2, and DKC1 proteins remained upon RNase A
treatment (Fig. 1E), indicating that this binding is not
due to secondary, RNA-mediated interactions.
Given the role of UBR5 in polyubiquitination and
proteasomal degradation of distinct substrates [15], we
asked whether its interaction with H/ACA proteins
triggers their degradation through the proteasome. For
this purpose, we overexpressed GAR1, NHP2, or
DKC1 with either wild-type UBR5 (UBR5WT) or a
catalytically dead mutant of UBR5 (UBR5ΔHECT)
which lacks the ubiquitin ligase activity. We assessed
the levels of DKC1, NHP2, and GAR1 by western
blot and found no differences upon overexpression of
either UBR5WT or UBR5ΔHECT, indicating that UBR5
does not target them for proteasomal degradation
(Fig. 2A). In addition, we generated two independent
hESC lines with reduced levels of UBR5 (hESCUBR5 KD)
and found no changes in the endogenous levels of
DKC1 (Fig. 2B). Likewise, endogenous DKC1 levels
were not affected in a mESC line in which UBR5 was
knockedout using CRISPR/Cas9 (mESCUbr5 KO)
(Fig. 2C). Thus, our results indicate that UBR5
interacts with distinct proteins of the H/ACA ribonucle-
oprotein complex but it does not induce their proteaso-
mal degradation.
UBR5 is required for the correct maturation of
ribosomal RNA
Given the interaction of UBR5 with the H/ACA RNP
complex, we asked whether UBR5 has a role in the
regulation of rRNA in ESCs. For this purpose, we
assessed the maturation of rRNAs by northern blot
analysis of their precursors in hESCUBR5 KD and mES-
CUBR5 KO. In eukaryotes, the ribosome contains four
distinct rRNAs: the 18S rRNA is present in the 40S
small ribosomal subunit, while the large 60S subunit
contains the 5.8S, 28S, and 5S rRNAs. The 18S, 5.8S,
and 28S rRNA are transcribed by RNA polymerase I
as a single rRNA precursor transcript, the 47S/45S
pre-ribosomal RNA (pre-RNA) [29,30]. Ribosomal
proteins and assembly factors bind co-transcriptionally
to the pre-rRNA, which then undergoes a series of
modifications and processing steps including endonu-
cleolytic cleavage and exonucleolytic trimming [31].
The maturation process can be assessed by radioactive
labeled probes (ITS1 and ITS2) which bind to internal
sequences of the pre-RNA. These sequences flank the
mature rRNA and are eliminated during the sequential
cleavages of the pre-RNA [32] (Fig. 3A).
rRNA precursors of the 18S rRNA were detected
with an ITS1 probe (Fig. 3B,C). In hESCUBR5 KD, the
amount of 34/30S rRNA relative to the 47/45S pre-
rRNA was significantly reduced compared with con-
trol hESCs. The 30S rRNA is further processed to 21S
rRNA by additional cleavage steps at positions 01 and
1. Interestingly, the levels of 21S rRNA remained
unchanged in hESCUBR5 KD when compared with con-
trol hESCs. Since the 47S pre-rRNA can also be pro-
cessed involving an alternative pathway via the 41S
rRNA, the reduced cleavage into 30S rRNA could
Fig. 4. Loss of UBR5 impairs translational profile and triggers a stress response in mESCs. (A) Polysome profiling of mESCWT and
mESCUbr5 KO. Graph is representative of three experiments. (B) Western blot of the ribosomal fractions obtained in (A). Proteins were
isolated from each fraction followed by western blot with antibodies against RPS27 (40S ribosomal subunit) and RPL7A (60S ribosomal
subunit). The image is representative of two experiments. (C) p53 levels in mESCWT and mESCUbr5 KO cells. b-Actin is the loading control.
The image is representative of four experiments. (D) BrDU-positive cells in mESCWT and mESCUbr5 KO after 3 h and 6 h incubation times.
The graph represents mean  SEM of at least 1200 cells scored in four different experiments. Statistical comparisons were made by
Student’s t-test for unpaired samples. [P-value: *(P < 0.05), ***(P < 0.001)]. (E) Percentage of cleaved caspase-3-positive cells in mESCWT
and mESCUbr5 KO upon heat stress at 42 °C (left panel) and 44 °C (right panel) during the indicated periods. Graphs represent mean  SEM
of at least 700 cells scored in four different experiments. No significant differences were found. Statistical comparisons were made by
Student’s t-test for unpaired samples. (F) Percentage of cleaved caspase-3-positive cells upon cyclohexamide treatment for 3 h (left panel)
and 6 h (right panel). Graphs represent mean  SEM of at least 700 cells scored in four different experiments. No significant differences
were found. Statistical comparisons were made by Student’s t-test for unpaired samples.
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potentially be compensated. In mESCUbr5 KO, the
reduction of 34/30S rRNA compared to 47/45S pre-
rRNA was even more dramatic. Moreover, the levels
of 20S rRNA were also affected in these cells. How-
ever, the amounts of 41S rRNA, the intermediate of
the alternative pathway of cleavage at position 2, were
unchanged. Using a probe targeting ITS2, we exam-
ined the 32S and 12S precursor rRNAs in hESC and
mESCs (Fig. 3D,E). Although in hESCsUBR5 KD, the
levels of 12S rRNA relative to 47/45S pre-rRNA were
significantly increased, we did not observe these effects
in mESCUbr5 KO. In both hESCs and mESCs, the
levels of 32S rRNA were not significantly changed
upon loss of UBR5 (Fig. 3D,E). Taken together, our
results indicate that dysfunction of UBR5 could affect
rRNA maturation, particularly conversion into 34/30S
rRNA.
UBR5 deficiency impairs translational profile and
triggers a stress response in mESCs
Since alterations in rRNA might originate defects in the
proper assembly of the ribosomes, we assessed ribo-
some pools in mESCUbr5 KO (Fig. 4A). When compared
with wild-type ESCs, these cells exhibited a decrease in
40S and 60S, as well as in the monosome and polysome
fraction, suggesting lower translational rates in the
absence of UBR5. The levels of 40S (i.e., RPS27) and
60S (i.e., RPL7A) proteins in mESCUBR5 KO cells were
also altered in different ribosome fractions, although the
decrease in RPL7A was more evident than RPS27
(Fig. 4B). Alterations in rRNA synthesis can trigger a
cellular stress response [33,34], which, in turn, increases
p53 levels. Notably, we found increased p53 levels in
mESCUbr5 KO, suggesting the activation of a stress
response in these cells (Fig. 4C). p53-mediated response
toward stress promotes cell cycle arrest to maintain
cellular homeostasis [35]. Importantly, we observed that
the proliferation rates in mESCUbr5 KO cells were signifi-
cantly diminished (Fig. 4D). We then asked whether the
lack of UBR5 sensitized mESCs toward other stressors
which inhibit translation. For this purpose, we exposed
mESCUbr5 KO cells to either heat stress (Fig. 4E) or
cycloheximide (Fig. 4F) and determine the degree of
apoptosis by measuring cleaved caspase-3 levels.
However, we did not find notable differences in the
apoptosis rates in the absence of UBR5. Altogether,
our results suggest that UBR5 participates in the
maturation of rRNA, a process necessary for proper
ribosomal assembly. In the absence of UBR5, ESCs
exhibit defects in their ribosomal content and increased
p53-mediated stress response, resulting in lower
proliferation rates.
Discussion
Growing evidence indicates that UBR5 is involved in
the regulation of distinct RNA-related pathways
[4,12,13]. In mESCs, UBR5 is required for the proper
function of the miRNA machinery by directing the
scaffolding protein GW182 to the miRNA complex
through a ubiquitin ligase-independent mechanism
[13]. This process results in the recruitment of other
downstream effectors like DDX6 and Tob1/2, which
promote the deadenylation and consequent destabiliza-
tion of target mRNAs [36–38]. Moreover, UBR5 phos-
phorylation by p90 ribosomal S6 kinase (p90RSK) is
necessary for the effect of UBR5 on miRNA repres-
sion activity, adding an additional regulatory level
[39]. The effects of UBR5 on the miRNA pathway
could be evolutionary conserved among species as sim-
ilar effects were also reported in Drosophila melanoga-
ster [40]. Additionally, upon UV-induced DNA
damage, UBR5 represses the transcription at the dam-
aged sites by inhibiting the elongation of polymerase
II [41]. UBR5 also interacts with the phosphorylated
form of PIH1D1, which is a subunit of the co-chaper-
one complex R2TP [42]. R2TP is implicated in the
assembly of large complexes such as the H/ACA RNP
complex [43]. However, a direct link between UBR5
and the H/ACA RNP complex has not been previ-
ously reported. Notably, we find an interaction
between UBR5 and the four proteins of the nucleolar
H/ACA complex (i.e., DKC1, GAR1, NOP10, and
NHP2). Besides these proteins, the H/ACA RNP com-
plex contains small nucleolar RNAs (snoRNAs) that
complement rRNA sequences and guide their pseu-
douridylation, a modification required for proper
rRNA processing. As a further indication of the link
of UBR5 with H/ACA RNP, RIP experiments showed
that UBR5 protein also pulls down snoRNAs of this
complex while it does not interact with snoRNAs of
the nucleolar C/D Box RNP. Importantly, our data
suggest that the interaction of UBR5 with proteins of
the H/ACA RNP complex is RNA-independent. Thus,
these direct protein–protein interactions raise the inter-
esting hypothesis that increased levels of UBR5 could
titrate out proteins from the H/ACA RNP complex,
leading to a lower stability of this complex. However,
our results do not support this hypothesis because we
observe that loss of UBR5 impairs the maturation of
rRNA and increases the levels of intermediates, a pro-
cess that could ensue from impaired functioning of the
H/ACA RNP complex. In addition, we show that the
levels of the 40S and 60S subunits of the ribosome, as
well as the monosome and polysomes fractions, are
reduced upon loss of UBR5, correlating with impaired
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rRNA biogenesis. Taken together, these findings sup-
port that UBR5 is important for the function of the
H/ACA RNP complex, but it does not act as a sup-
pressor of its stability/activity. In support of this
hypothesis, ESCs express intrinsic higher levels of
UBR5 protein when compared with their differentiated
counterparts, while they exhibit enhanced global trans-
lation rates [44].
Besides the nucleolar H/ACA RNP complex, small
Cajal body-specific RNAs (scaRNAs) confined to
Cajal bodies in the nucleus also contain similar box H/
ACA domains as well as box C/D domains [45]. As
such, scaRNAs are involved in the pseudouridylation
or 20 O-methylation required for maturation of not
only small nuclear RNAs (snRNAs) but also nucleolar
snoRNAs [45]. Since Cajal bodies contribute to the
biogenesis of nucleolar RNPs [45], it will be fascinating
to examine whether UBR5 interacts with nuclear
RNPs in Cajal bodies and the impact of this interac-
tion in nucleolar rRNA metabolism. Besides its effects
in nucleolar RNP biogenesis, Cajal bodies are also
involved in the proper maturation of snRNAs required
for the assembly of distinct nuclear RNP complexes
such as the spliceosome, which regulates RNA splicing
[46]. Notably, the interactome of UBR5 is highly
enriched in proteins involved in the assembly and
activity of the spliceosome RNP complex (Fig. S1 and
Data S1). Since these data support an interaction
between UBR5 and spliceosome, it will be interesting
to assess a role of UBR5 in the assembly and/or activ-
ity of the spliceosome RNP complex.
The link of UBR5 with rRNA biogenesis indicates a
role in translational rates. Importantly, UBR5 contains
a PABC domain at the C terminus, also known as
MLLE domain, which mediates protein–protein inter-
action through the binding of the (PABP-interacting
motifs) PAM2 peptide motif [47,48]. This PABC
domain is equivalent to the one found in the poly(A)
binding protein (PABPC1), a protein that recognizes 30
mRNA poly(A) tails and plays an essential role in
eukaryotic translation initiation [49,50]. UBR5 and
PABPC1 share common interacting partners, such as
Paip1 [47] and Paip2 [51]. Paip2 is a repressor of trans-
lation initiation which can interact with both PABPC1
and UBR5. When bound to UBR5, Paip2 is ubiquiti-
nated and degraded by the proteasome [51]. Con-
versely, the levels of the repressor increase in the
absence of UBR5 and translation are consequently
inhibited. Thus, UBR5 could modulate translational
rates via both Paip2-mediated mechanisms and the
maturation of rRNA.
As a consequence of perturbations in ribosomal bio-
genesis, cells enter into the so called ‘nucleolar stress’
[52]. Under normal conditions, the E3 ligase Mdm2
interacts with p53 and results in the ubiquitination and
degradation of p53. During nucleolar stress, several
assembly factors, such as Arf or Nucleophosmin1, and
ribosomal proteins bind to Mdm2 preventing its interac-
tion with p53, a process that results in stabilization of
p53 levels [53,54]. In addition, the 5S rRNA also inter-
acts and blocks Mdm2 [55]. As a consequence of p53
accumulation, cell enters in cell cycle arrest to ensure cel-
lular homeostasis until the stress is over. Remarkably,
we find that the levels of p53 levels are increased in mES-
CUBR5 KO cells. This could indicate that UBR5-lacking
cells undergo nucleolar stress, as suggested by the altered
rRNA precursors and polysome levels. Moreover, loss of
UBR5 induces a decline in the proliferation rates of
ESCs, which could be ensue from increased p53 levels. In
these lines, UBR5 is deregulated in many cancer types
and alters p53 levels [56–58]. However, it is unclear
whether UBR5 would act as a tumor suppressor or
oncogene, since both amplifications as well as loss-of-
function mutations have been linked to tumorigenesis.
Thus, the cellular context might be determinant for the
role of UBR5 in p53 regulation and cellular proliferation
[59–61]. Whereas previous studies reported that the role
of UBR5 in the regulation of mRNA machinery is neces-
sary for cell proliferation [13,62], here we provide data
indicating that UBR5 also modulates cell proliferation
via modulation of rRNA maturation. Thus, UBR5 could
impinge upon cellular proliferation through multiple
pathways.
Taken together, our results indicate that UBR5 par-
ticipates in the maturation of rRNA through regulat-
ing the nucleolar H/ACA RNP complex. This
regulatory pathway is required for proper rRNA pro-
cessing and ribosomal assembly. Upon loss of UBR5,
rRNA intermediates accumulate, decreasing the pool
of ribosomes. This perturbation may activate the
nucleolar stress response, triggering the accumulation
of p53 and consequent proliferation arrest. Taking into
consideration the multiple roles of UBR5 in cell cycle
and cellular homeostasis, our findings add an addi-
tional regulation layer to this process.
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Supplementary Figure 1. Gene Ontology analysis of UBR5 potential interactors indicated 
enrichment for proteins involved in RNA metabolism. Bar graph representing the top Gene 
Ontology Biological Processes enriched in the UBR5 interactome (P < 0.05). Analysis was 
performed using PANTHER software and Gene Ontology Consortium. 
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Supplementary Table 1. List of primers used for qPCR. 
Gene Forward (5' → 3') Reverse (5' → 3')
5S rRNA GGCCATACCACCCTGAACGC CAGCACCCGGTATTCCCAGG
SNORA5A CAGTACCTGTCCTATGCATGG ACCAAATTTATCCCTGAGCCT
SNORA30 GCACTTTCACAGTTCCTTCC CAGGGCAAGAATACAATCAAGG
SNORA34 CTGAAGACCAGCAGTTGTACT TGAAATAGCCATTCCCTACTGAG
SNORA73A/U17 ATACACCCGGGAGGTCACTC TGTTTCCTGCATGGTTTGTC
SNORD3/U3 AGAGGTAGCGTTTTCTCCTGAGCG ACCACTCAGACCGCGTTCTC
SNORD46 AAGAATCCTTAGGCGTGGTTG GTAACTATGACAAGTCCTTGCATTG
SNORD68 CGTGATGACATTCTCCGGAA AATCAGATGGAAAAGGGTTCA
SNORD104 CCTGCTGTGATGACATTCCA CAGGCTCAGACTCCAGTTC
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During splicing, the exon junction complex (EJC) is deposited upstream of exon-exon
boundaries. The EJC and its peripheral bound proteins play an essential role in mediating
mRNA export, translation and turnover. However, the exact sequence of EJC assembly
and the involved factors during splicing remain elusive. Recently published structures of
the human C* spliceosome clarified the position of the EJC at this phase of splicing and
have given insight into previously unidentified interactions between the EJC and spliceo-
somal proteins. Here, these new observations are presented and the significance for EJC
assembly is discussed. Furthermore, the vast landscape of EJC interacting proteins and
their manifold functions are described. Finally, the factors involved in EJC disassembly
and recycling are recapitulated. This review aims to integrate structural, biochemical and
physiological data to obtain a comprehensive picture of EJC components during the life-
time of the EJC.
Introduction
RNA-binding proteins are an integral part of messenger ribonucleoproteins and determine the fate of
mRNAs in the cell [1]. A prominent example is the exon junction complex (EJC) which is deposited
at exon-exon junctions of mRNAs during splicing. The EJC remains bound to the mature mRNA
until the first round of translation in the cytoplasm, when it is dissociated from the mRNA and disas-
sembled [2,3]. During the lifetime of a mature mRNA, the EJC recruits peripheral proteins that are
involved in processes such as pre-mRNA splicing, mRNA export, translation and nonsense-mediated
mRNA decay (NMD), reviewed in [4,5]. The EJC therefore serves as a mark that connects splicing
with post-transcriptional regulation of mRNA [5].
The significance of splicing exceeds its basic function that is the removal of introns and subsequent
ligation of exons during the maturation of pre-mRNA. For example, alternative splicing is a regulated
process which is involved in the control of tissue- and development-specific expression of splicing iso-
forms [6]. The splicing reaction is carried out by the spliceosome, a large ribonucleoprotein complex
[7]. The spliceosome consists of five small nuclear RNA molecules with more than 100 associated pro-
teins, which assemble by stepwise binding to the pre-mRNA and catalyze two transesterification steps.
Substantial structural rearrangements and compositional changes occur during splicing, which have
been grouped into characteristic stages (reviewed in ref [8]). Recently, the structures of the human B
(pre-catalytic spliceosome) and C* (catalytically activated before second step) complexes have been
solved by cryo-electron microscopy (cryo-EM) [9–11]. Besides providing valuable insight into the spli-
cing process, these recent structural advancements have shed light on the molecular positioning of the
EJC and interacting proteins. In this review, these recent findings are discussed and put into context
of our understanding of EJC assembly and disassembly.
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The core of the EJC
The EJC is a multiprotein complex formed by four core proteins [12,13]. The DEAD-box protein EIF4A3
(eukaryotic initiation factor 4A3) represents the RNA-binding platform of the EJC [14]. MAGOH and RBM8A
(RNA-binding motif 8A, also known as Y14) form a very stable heterodimer interacting with RNA-bound
EIF4A3 [12,13]. In mammals, two MAGOH paralogues exist (MAGOH and MAGOHB), which can structur-
ally and functionally substitute each other [15]. CASC3 (also known as metastatic lymph node 51, MLN51, or
Barentsz, BTZ), the fourth component of the EJC core, directly binds to EIF4A3 via its SELOR domain [16].
Interestingly, CASC3 is a shuttling protein that resides mainly in the cytoplasm, whereas the other core proteins
are predominantly localized in the nucleus [16,17]. Developmental studies in Drosophila and mouse models
suggest a distinct role of CASC3 in comparison with the other EJC components: While organisms lacking
EIF4A3, MAGOH or RBM8A display severe general developmental impairments, the function of CASC3 in
development seems to be limited to specific cells and tissues [18–20].
Reconstitution studies in vitro have provided valuable insights into the mechanism of EJC assembly and
RNA binding [14]. In the presence of ATP, EIF4A3 adopts a closed conformation, in which it binds to the
phosphate backbone of RNA [12,13]. Since the RNA-binding surface of EIF4A3 does not contact any of the
RNA bases, its RNA binding is sequence-independent [12,13]. MAGOH-RBM8A locks EIF4A3 in its closed
conformation, prevents its conversion to the open conformation and thereby stabilizes EIF4A3 binding to
mRNA [21]. This mechanism ensures that the EJC remains bound to its target mRNA until it is actively
disassembled.
Structural details about EJC assembly
In contrast to the spontaneous association of the four EJC components with RNA in vitro, their deposition in
vivo is strictly splicing-dependent and occurs mainly at a position ∼20–24 nucleotides (nt) upstream of spliced
exon-exon junctions, shown in Figure 1 [22]. This dependency on splicing can be explained by the fact that
EIF4A3 directly interacts with the spliceosomal protein CWC22 [23–25]. CWC22 is an essential splicing factor
that joins the activated spliceosomal Bact complex [26,27]. The two central domains indispensable for CWC22’s
splicing function are the MA3 and the middle of initiation factor 4G (MIF4G) domain, the latter of which
interacts with EIF4A3 (Table 1) [23–25].
In the structures of the human C* spliceosome, the MA3 and MIF4G domains of CWC22 flank the 50 exon
of the mRNA [9,10]. As expected, MIF4G is closely associated with EIF4A3 (Figure 2A). EIF4A3 is localized
20–24 nts upstream of the exon–intron boundary (Figure 1), where it binds six nucleotides of the 50 exon [9].
This position is consistent with the canonical EJC binding site after the completion of splicing. The interaction
of EIF4A3 with the spliceosome is reinforced by the interaction of its N-terminal RecA1 domain with the spli-
ceosomal protein EFTUD2 (Figure 2B). Interestingly, this part of EIF4A3 also interacts with the core protein
CASC3 in atomic structures of the tetrameric EJC [12,13]. In the isolated EJC structure, two regions of
CASC3’s SELOR domain separately interact with the two RecA domains of EIF4A3. The N-terminal stretch
168–196 contacts the RecA2 domain, while the 214–245 stretch of CASC3 is moulded on the RecA1 domain.
Both regions are connected via a flexible linker. In the C* spliceosome, however, only the fragment 170–194 of
CASC3 is present and interacts with RecA2 close to the 50 exon (Figure 1).
The MIF4G domain of CWC22 not only recruits EIF4A3 to the spliceosome, but also interacts with the core
protein RBM8A and with part of the catalytic core of the spliceosome, the GTPase EFTUD2/Snu114. The MA3
domain of CWC22 contacts PRP8, the spliceosome’s catalytic subunit [9,10], which might explain why this
domain is important for the splicing function of CWC22 [27]. An additional CWC22-interacting partner
present in the C* spliceosome is the human step II factor SLU7. The N-terminal part of SLU7 forms a tripod-
like structure and is believed to stabilize the binding of the 50 exon to the spliceosome [9,10]. While SLU7
mainly interacts with PRP8, one leg contacts the MA3 domain and another leg interacts with the MIF4G
domain of CWC22. Thus, CWC22 contacts two of the EJC core components and is directly connected to pro-
teins required for structural integrity and function of the spliceosome. Whether these spliceosomal factors aid
in the recruitment of CWC22 and the EJC or rather stabilize the position of CWC22 in the spliceosome
remains to be determined.
Despite great progress in elucidating the later steps of EJC assembly, the details of earlier stages are vague,
particularly with respect to the MAGOH-RBM8A heterodimer. In good agreement with previous biochemical
data, the stable interaction of MAGOH-RBM8A with the C-complex involves the formation of a trimeric
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pre-EJC comprising MAGOH-RBM8A and EIF4A3 [30]. It seems plausible that MAGOH-RBM8A also con-
tacts earlier spliceosomal complexes, but the molecular details are not known. To gain further insight into this
aspect of EJC assembly, structural details about earlier spliceosomal complexes, such as B* and C, would be
needed. These would also aid in establishing the role of other spliceosomal proteins. For example, the
intron-binding helicase IBP160 (Aquarius) has been reported to function in EJC assembly [31], but is located
on the other side of the EJC in the C* spliceosome.
Figure 1. Coupling of splicing and EJC assembly.
The structure of the B complex is schematically depicted based on the PDB file 5O9Z. EIF4A3 (orange) is recruited to the
spliceosome by CWC22 (purple), which joins the activated B complex (Bact). The CWC22-EIF4A3 structure (PDB 4C9B) is
schematically shown. The RBM8A-MAGOH heterodimer joins the EJC in spliceosomal complex B* or C, whereas CASC3
probably associates shortly afterwards. In the structure of the C* spliceosome (PDB 5XJC), the positioning of all EJC
components is known. After splicing, the EJC remains bound upstream of the exon-exon junction.
Table 1 Overview of the protein domains mentioned.
Protein Domain Size Function Also found in References
CWC22
MA3 ∼120 aa
Protein–protein interaction, regulation of
DEAD-box proteins
eIF4G, NOM1
[23,28,29]
MIF4G ∼200 aa eIF4G, NOM1
EIF4A3 RecA1 ∼170 aa ATP binding and hydrolysis, RNA
binding
RNA helicases [13]
RecA2 ∼160 aa
CASC3 SELOR ∼150 aa Protein–protein interaction – [16]
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Linking the core of the EJC to the functional periphery
The EJC core has the remarkable property of remaining stably associated with the mRNA at the same position,
at which it was originally assembled. In order to regulate different steps of gene expression, the EJC associates
with peripheral EJC proteins, for which it acts as universal RNA-binding adapter (Figure 3A) [32,33]. The
best-understood interactions of peripheral EJC proteins with the EJC core involve the so-called EJC-binding
motif (EBM) [34]. This sequence motif was first described in the human NMD factor UPF3B [35] and was
later shown to be present in additional EJC interacting proteins, including the human proteins SMG6, TDRD3,
GIDRP88, R3HCC1, C2orf68 and RRP12(Figure 3B) [34]. Notably, in most of these proteins, the EBM is
located N- or C-terminally, which could facilitate its association with the EJC. On the EJC, the three proteins
EIF4A3, RBM8A and MAGOH form a contiguous interface, to which the linear EBM binds (Figure 3C) [36].
The functional consequences of binding of EBM-containing proteins to the EJC were studied only for UPF3B
and SMG6, which link the EJC to the NMD-machinery. While UPF3B is believed to attract the NMD factors
UPF2 and UPF1 to aberrant mRNAs [37,38], SMG6 is an endonuclease that cleaves mRNA in the vicinity of
premature translation termination codons [39,40]. However, how the interaction of two potentially competing
NMD factors (UPF3B and SMG6) to the same binding site is regulated remains to be determined.
In addition to its role in NMD, the EJC has been shown to support the export of spliced mRNAs from the
nucleus to the cytoplasm [38]. This function is dependent on the interaction of dedicated export factors, specif-
ically UAP56 (DDX39B) and ALYREF, with the EJC [38]. While little is known about the binding of UAP56 to
the EJC, the interaction of ALYREF and the EJC involves a short linear motif in ALYREF (WxHD) that was
previously identified to mediate binding of CASC3 to EIF4A3 (Figure 3A) [41]. Therefore, binding of ALYREF
to spliced mRNAs in the nucleus requires EIF4A3 as part of the EJC as well as the cap-binding complex
(CBP80/CBP20), which provides an additional binding site and stimulates export [42].
Two additional complexes associate with the EJC, consisting of the proteins RNPS1, SAP18 and either
ACIN1 (Acinus, referred to as ASAP complex) or PNN (Pinin, termed PSAP complex) [32,43]. Both complexes
are composed of known regulators of splicing and may therefore influence the excision of specific introns in an
EJC-dependent manner. How these two complexes are recruited to the EJC and if their interaction requires
additional proteins are currently not known (Figure 3A).
If all these peripheral factors were able to interact with the EJC simultaneously, they may unintendedly
compete with each other. Hence, the dynamic association and dissociation of peripheral EJC proteins is
required in order to regulate all EJC-dependent processes. How the composition of an EJC at a given time
point is determined remains to be elucidated, but the local concentrations of peripheral components probably
play a decisive role. In addition, it is conceivable that specific processes exist to detach or replace proteins that
are no longer needed.
Figure 2. Interactions between EJC components and spliceosomal proteins.
Left: View from the front; Right: View rotated 90°C clockwise about a vertical axis. The interactions of CWC22’s domains
MIF4G and MA3 (purple) are depicted, as well as the interaction between EIF4A3 (orange) and EFTUD2 (dark red). The other
proteins shown are RBM8A (green), MAGOH (blue), SLU7 (yellow) and PRP8 (grey).
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EJC disassembly
The amount of EJC protein components in the cell is limited in comparison to the high number of exon-exon
junctions present in transcripts [44–46]. Therefore, EJC subunits must be efficiently recycled to provide a suffi-
cient supply of EJC components for the assembly of EJCs on all spliced nascent transcripts. Because EJCs aid
in defining premature termination codons in mRNA surveillance, they should remain assembled on exported
mRNA in the cytoplasm until the first round of translation. Indeed, RBM8A has been shown to be associated
with spliced mRNA in the cytoplasm until it is removed during translation [2]. It is conceivable that EJCs, like
many other mRNA-bound proteins, are removed by the processivity of the ribosome, which possesses mRNA
helicase activity [47].
The identification of PYM (Partner of Y14/RBM8A-MAGOH) as an EJC disassembly factor provided a new
perspective on the mechanism of EJC disassembly [46]. It could be shown that PYM is able to dissociate
assembled EJCs from spliced mRNAs in vitro and in vivo. Depletion of PYM increases the amount of EJCs
associated with mRNA, while impairing recycling of EJC components.
Figure 3. Interactions of peripheral EJC proteins with the EJC core.
(A) Model of peripheral EJC proteins binding to the EJC core. Three different types of interactions are shown as examples.
UPF3B and other EBM-containing proteins interact with the EJC core via a composite-binding site formed by EIF4A3, RBM8A
and MAGOH. A short linear motif in ALYREF (WxHD), also present in the EJC protein CASC3, mediates binding to EIF4A3.
Molecular specifications of the interaction of ASAP (ACIN1, RNPS1, SAP18) and PSAP (Pinin, RNPS1, SAP18; not shown)
complexes with the EJC core are unknown. For more details, see main text. (B) Schematic representation of human
EBM-containing proteins reported by Kashima et al. [37]. EBM motifs are displayed as blue boxes. (C) Crystal structure
showing details of the interaction of the UPF3B EBM peptide (blue) with the core of the EJC. The image was created with
PyMOL using the PDB file 2XB2.
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The molecular mechanism of PYM-mediated EJC disassembly involves transient interaction of PYM with
EJC components. PYM was first identified in Drosophila S2 cells as part of a trimeric complex with RBM8A
and MAGOH [48]. The crystal structure of the RBM8A-MAGOH-PYM complex from Drosophila revealed
that the N-terminus of PYM interacts with a region formed by both RBM8A and MAGOH [49]. However,
the RBM8A-MAGOH heterodimer is not able to bind PYM while being present in the EJC, since residues
involved in PYM binding normally interact with EIF4A3 [12]. Interestingly, PYM cannot interact with
RBM8A-MAGOH during EJC assembly and only mature EJCs are susceptible to PYM-binding. The ability
of PYM to discriminate mature EJCs must be regulated to protect nascent EJCs from disassembly. This is
aided by the fact that PYM is mainly located in the cytoplasm [49]. Furthermore, human PYM has been
shown to associate with the 40S ribosomal subunit [50] which could serve to couple EJC disassembly to
translation.
The importance of EJC assembly by PYM in vivo has been addressed in Drosophila, where the EJC is
required for oskar mRNA localization during oogenesis [51]. Using transgenic approaches, it was shown that
increased amounts of Drosophila PYM (DmPYM) lead to the dissociation of EJCs from oskar mRNA.
However, unlike human PYM, the activity of DmPYM is not coupled to translation and it does not interact
with the ribosome. Rather, the regulation of DmPYM seems mediated via its C-terminus [52]. Notably,
DmPYM is dispensable in wild-type Drosophila, but becomes essential in flies that express reduced levels of
y14 (RBM8A in humans) or mago nashi (MAGOH in humans). Therefore, one of the main functions of PYM
in vivo could be to maintain the balance between EJC components and assembled EJCs.
Conclusion and future directions
The recently reported cryo-EM structures have not only improved the mechanistic understanding of EJC posi-
tioning by the spliceosome but also revealed the previously unknown interactions of CWC22 with PRP8,
EFTUD2 and SLU7. The question remains whether these factors aid in positioning CWC22 in the spliceosome
and if additional factors are involved in the recruitment of CWC22. In addition, it will be important to follow
the route of CWC22 after completion of the splicing reaction, since it has to re-associate with EIF4A3 before
the next round of splicing. First of all, it is not clear, how exactly CWC22 dissociates from the spliceosome.
Studies in yeast revealed that when the post-catalytic spliceosome is dissociated into mRNA and intron-lariat
spliceosome by Prp22p (DHX8 in humans), Cwc22p does not have a high affinity for the intron-lariat spliceo-
some [53]. This points to the possibility that Prp22p has a function in Cwc22p recycling, which is supported
by the observation that EJC assembly is disrupted by an ATPase-deficient mutant of DHX8/HRH1 in humans
[54]. The position of DHX8 close to CWC22 in the human C* spliceosome also hints at a potential involve-
ment. The exact connection between human DHX8 and CWC22 in recycling and thus EJC assembly remains
to be determined.
Furthermore, the structures of the C* spliceosome have provided information about previously unidentified
interactions between the EJC and spliceosomal proteins. This includes the interaction between EFTUD2 and
EIF4A3 and a novel interaction between CWC22 and RBM8A. To what extent these interactions contribute to
the assembly or stability of the EJC still needs to be investigated. Nonetheless, these interactions indicate that
EJC assembly occurs via several intermediate stages. In order to characterize these intermediates, however, we
will need to understand how and when exactly the EJC components MAGOH, RBM8A and CASC3 are
recruited to the spliceosome. While structures of the human B and C* spliceosome are available, structures
from the Bact and C complex would allow the disentanglement of the multiple steps involved in EJC assembly.
The disassembly of the EJC from mRNA also warrants further investigations. So far, data on the in vivo
function of PYM have been gathered only in flies. Whether PYM plays a similar role in mammals could be
investigated using transgenic or knockout mice. Since the EJC has diverse functions in mammalian cells, PYM
may be more important here than in flies. Also on the molecular level, there is a lack of clarity. For example,
the connection between EJC disassembly and translation has been discussed controversially. Indeed, the proces-
sivity of the ribosome (or the small subunit) should be sufficient to dismantle EJCs during translation (or scan-
ning). The main reason for linking the activity of PYM to translation could be to prevent premature EJC
disassembly. It will be an important subject for future studies to investigate which mechanisms exist to main-
tain the pool of available EJC components and how EJC disassembly is coupled with the reimport of EJC pro-
teins into the nucleus.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society158
Biochemical Society Transactions (2018) 46 153–161
https://doi.org/10.1042/BST20170059
48
Abbreviations
cryo-EM, cryo-electron microscopy; DmPYM, Drosophila PYM; EBM, EJC-binding motif; EJC, exon junction
complex; MIF4G, middle of initiation factor 4G; NMD, nonsense-mediated mRNA decay; nt, nucleotides; PYM,
Partner of Y14-MAGOH
Author Contribution
All authors wrote and edited the manuscript.
Funding
This research was funded by a Heisenberg-Fellowship [GE2014/5-1] and a grant from the Deutsche
Forschungsgemeinschaft [GE2014/6-1] to N.H.G.
Acknowledgements
We apologize to all authors whose work was inadvertently overlooked. We thank Volker Böhm for his critical
reading of the manuscript and many helpful discussions.
Competing Interests
The Authors declare that there are no competing interests associated with the manuscript.
References
1 Gehring, N.H., Wahle, E. and Fischer, U. (2017) Deciphering the mRNP code: RNA-Bound determinants of post-transcriptional gene regulation. Trends
Biochem. Sci. 42, 369–382 https://doi.org/10.1016/j.tibs.2017.02.004
2 Dostie, J. and Dreyfuss, G. (2002) Translation is required to remove Y14 from mRNAs in the cytoplasm. Curr Biol. 12, 1060–1067 https://doi.org/10.
1016/S0960-9822(02)00902-8
3 Lejeune, F., Ishigaki, Y., Li, X. and Maquat, L.E. (2002) The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in
mammalian cells: dynamics of mRNP remodeling. EMBO J. 21, 3536–3545 https://doi.org/10.1093/emboj/cdf345
4 Boehm, V. and Gehring, N.H. (2016) Exon junction complexes: supervising the gene expression assembly line. Trends Genet. 32, 724–735 https://doi.
org/10.1016/j.tig.2016.09.003
5 Le Hir, H., Saulière, J. and Wang, Z. (2016) The exon junction complex as a node of post-transcriptional networks. Nat. Rev. Mol. Cell Biol. 17, 41–54
https://doi.org/10.1038/nrm.2015.7
6 Gallego-Paez, L.M., Bordone, M.C., Leote, A.C., Saraiva-Agostinho, N., Ascensao-Ferreira, M. and Barbosa-Morais, N.L. (2017) Alternative splicing: the
pledge, the turn, and the prestige: the key role of alternative splicing in human biological systems. Hum. Genet. 136, 1015–1042 https://doi.org/10.
1007/s00439-017-1790-y
7 Wahl, M.C., Will, C.L. and Lührmann, R. (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136, 701–718 https://doi.org/10.
1016/j.cell.2009.02.009
8 Will, C.L. and Luhrmann, R. (2011) Spliceosome structure and function. Cold Spring Harb. Perspect. Biol. 3, a003707 https://doi.org/10.1101/
cshperspect.a003707
9 Zhang, X., Yan, C., Hang, J., Finci, L.I., Lei, J. and Shi, Y. (2017) An atomic structure of the human spliceosome. Cell 169, 918–929.e14 https://doi.
org/10.1016/j.cell.2017.04.033
10 Bertram, K., Agafonov, D.E., Liu, W.-T., Dybkov, O., Will, C.L., Hartmuth, K. et al. (2017) Cryo-EM structure of a human spliceosome activated for step
2 of splicing. Nature 542, 318–323 https://doi.org/10.1038/nature21079
11 Bertram, K., Agafonov, D.E., Dybkov, O., Haselbach, D., Leelaram, M.N., Will, C.L. et al. (2017) Cryo-EM structure of a pre-catalytic human spliceosome
primed for activation. Cell 170, 701–713.e11 https://doi.org/10.1016/j.cell.2017.07.011
12 Bono, F., Ebert, J., Lorentzen, E. and Conti, E. (2006) The crystal structure of the exon junction complex reveals how it maintains a stable grip on
mRNA. Cell 126, 713–725 https://doi.org/10.1016/j.cell.2006.08.006
13 Andersen, C.B., Ballut, L., Johansen, J.S., Chamieh, H., Nielsen, K.H., Oliveira, C.L. et al. (2006) Structure of the exon junction core complex with a
trapped DEAD-box ATPase bound to RNA. Science 313, 1968–1972 https://doi.org/10.1126/science.1131981
14 Ballut, L., Marchadier, B., Baguet, A., Tomasetto, C., Seraphin, B. and Le Hir, H. (2005) The exon junction core complex is locked onto RNA by
inhibition of eIF4AIII ATPase activity. Nat. Struct. Mol. Biol. 12, 861–869 https://doi.org/10.1038/nsmb990
15 Singh, K.K., Wachsmuth, L., Kulozik, A.E. and Gehring, N.H. (2013) Two mammalian MAGOH genes contribute to exon junction complex composition
and nonsense-mediated decay. RNA Biol. 10, 1291–1298 https://doi.org/10.4161/rna.25827
16 Degot, S., Le Hir, H., Alpy, F., Kedinger, V., Stoll, I., Wendling, C. et al. (2004) Association of the breast cancer protein MLN51 with the exon junction
complex via its speckle localizer and RNA binding module. J. Biol. Chem. 279, 33702–33715 https://doi.org/10.1074/jbc.M402754200
17 Baguet, A., Degot, S., Cougot, N., Bertrand, E., Chenard, M.-P., Wendling, C. et al. (2007) The exon-junction-complex-component metastatic lymph
node 51 functions in stress-granule assembly. J. Cell Sci. 120, 2774–2784 https://doi.org/10.1242/jcs.009225
18 Mao, H., Brown, H.E. and Silver, D.L. (2017) Mouse models of Casc3 reveal developmental functions distinct from other components of the exon
junction complex. RNA 23, 23–31 https://doi.org/10.1261/rna.058826.116
19 Ashton-Beaucage, D., Udell, C.M., Lavoie, H., Baril, C., Lefrançois, M., Chagnon, P. et al. (2010) The exon junction complex controls the splicing of
MAPK and other long intron-containing transcripts in Drosophila. Cell 143, 251–262 https://doi.org/10.1016/j.cell.2010.09.014
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 159
Biochemical Society Transactions (2018) 46 153–161
https://doi.org/10.1042/BST20170059
49
20 Roignant, J.-Y. and Treisman, J.E. (2010) Exon junction complex subunits are required to splice Drosophila MAP kinase, a large heterochromatic gene.
Cell 143, 238–250 https://doi.org/10.1016/j.cell.2010.09.036
21 Nielsen, K.H., Chamieh, H., Andersen, C.B.F., Fredslund, F., Hamborg, K., Le Hir, H. et al. (2009) Mechanism of ATP turnover inhibition in the EJC. RNA
15, 67–75 https://doi.org/10.1261/rna.1283109
22 Le Hir, H., Izaurralde, E., Maquat, L.E. and Moore, M.J. (2000) The spliceosome deposits multiple proteins 20–24 nucleotides upstream of mRNA
exon-exon junctions. EMBO J. 19, 6860–6869 https://doi.org/10.1093/emboj/19.24.6860
23 Steckelberg, A.-L., Boehm, V., Gromadzka, A.M. and Gehring, N.H. (2012) CWC22 connects pre-mRNA splicing and exon junction complex assembly.
Cell Rep. 2, 454–461 https://doi.org/10.1016/j.celrep.2012.08.017
24 Barbosa, I., Haque, N., Fiorini, F., Barrandon, C., Tomasetto, C., Blanchette, M. et al. (2012) Human CWC22 escorts the helicase eIF4AIII to
spliceosomes and promotes exon junction complex assembly. Nat. Struct. Mol. Biol. 19, 983–990 https://doi.org/10.1038/nsmb.2380
25 Alexandrov, A., Colognori, D., Shu, M.-D. and Steitz, J.A. (2012) Human spliceosomal protein CWC22 plays a role in coupling splicing to exon junction
complex deposition and nonsense-mediated decay. Proc. Natl Acad. Sci. U.S.A. 109, 21313–21318 https://doi.org/10.1073/pnas.1219725110
26 Agafonov, D.E., Deckert, J., Wolf, E., Odenwalder, P., Bessonov, S., Will, C.L. et al. (2011) Semiquantitative proteomic analysis of the human
spliceosome via a novel two-dimensional gel electrophoresis method. Mol. Cell. Biol. 31, 2667–2682 https://doi.org/10.1128/MCB.05266-11
27 Steckelberg, A.-L., Altmueller, J., Dieterich, C. and Gehring, N.H. (2015) CWC22-dependent pre-mRNA splicing and eIF4A3 binding enables global
deposition of exon junction complexes. Nucleic Acids Res. 43, 4687–4700 https://doi.org/10.1093/nar/gkv320
28 Marintchev, A., Edmonds, K.A., Marintcheva, B., Hendrickson, E., Oberer, M., Suzuki, C. et al. (2009) Topology and regulation of the human eIF4A/4G/
4H helicase complex in translation initiation. Cell 136, 447–460 https://doi.org/10.1016/j.cell.2009.01.014
29 Alexandrov, A., Colognori, D. and Steitz, J.A. (2011) Human eIF4AIII interacts with an eIF4G-like partner, NOM1, revealing an evolutionarily conserved
function outside the exon junction complex. Genes Dev. 25, 1078–1090 https://doi.org/10.1101/gad.2045411
30 Gehring, N.H., Lamprinaki, S., Hentze, M.W. and Kulozik, A.E. (2009) The hierarchy of exon-junction complex assembly by the spliceosome explains key
features of mammalian nonsense-mediated mRNA decay. PLoS Biol. 7, e1000120 https://doi.org/10.1371/journal.pbio.1000120
31 Ideue, T., Sasaki, Y.T.F., Hagiwara, M. and Hirose, T. (2007) Introns play an essential role in splicing-dependent formation of the exon junction complex.
Genes Dev. 21, 1993–1998 https://doi.org/10.1101/gad.1557907
32 Tange, T.O., Shibuya, T., Jurica, M.S. and Moore, M.J. (2005) Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein
core. RNA 11, 1869–1883 https://doi.org/10.1261/rna.2155905
33 Singh, G., Kucukural, A., Cenik, C., Leszyk, J.D., Shaffer, S.A., Weng, Z. et al. (2012) The cellular EJC interactome reveals higher-order mRNP structure
and an EJC-SR protein nexus. Cell 151, 750–764 https://doi.org/10.1016/j.cell.2012.10.007
34 Kashima, I., Jonas, S., Jayachandran, U., Buchwald, G., Conti, E., Lupas, A.N. et al. (2010) SMG6 interacts with the exon junction complex via two
conserved EJC-binding motifs (EBMs) required for nonsense-mediated mRNA decay. Genes Dev. 24, 2440–2450 https://doi.org/10.1101/gad.604610
35 Gehring, N.H., Neu-Yilik, G., Schell, T., Hentze, M.W. and Kulozik, A.E. (2003) Y14 and hUpf3b form an NMD-activating complex. Mol. Cell 11,
939–949 https://doi.org/10.1016/S1097-2765(03)00142-4
36 Buchwald, G., Ebert, J., Basquin, C., Sauliere, J., Jayachandran, U., Bono, F. et al. (2010) Insights into the recruitment of the NMD machinery from the
crystal structure of a core EJC-UPF3b complex. Proc. Natl Acad. Sci. U.S.A. 107, 10050–10055 https://doi.org/10.1073/pnas.1000993107
37 Chamieh, H., Ballut, L., Bonneau, F. and Le Hir, H. (2008) NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its
RNA helicase activity. Nat. Struct. Mol. Biol. 15, 85–93 https://doi.org/10.1038/nsmb1330
38 Le Hir, H., Gatfield, D., Izaurralde, E. and Moore, M.J. (2001) The exon-exon junction complex provides a binding platform for factors involved in mRNA
export and nonsense-mediated mRNA decay. EMBO J. 20, 4987–4997 https://doi.org/10.1093/emboj/20.17.4987
39 Boehm, V., Haberman, N., Ottens, F., Ule, J. and Gehring, N.H. (2014) 30 UTR length and messenger ribonucleoprotein composition determine
endocleavage efficiencies at termination codons. Cell Rep. 9, 555–568 https://doi.org/10.1016/j.celrep.2014.09.012
40 Eberle, A.B., Lykke-Andersen, S., Mühlemann, O. and Jensen, T.H. (2009) SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human
cells. Nat. Struct. Mol. Biol. 16, 49–55 https://doi.org/10.1038/nsmb.1530
41 Gromadzka, A.M., Steckelberg, A.-L., Singh, K.K., Hofmann, K. and Gehring, N.H. (2016) A short conserved motif in ALYREF directs cap- and
EJC-dependent assembly of export complexes on spliced mRNAs. Nucleic Acids Res. 44, 2348–2361 https://doi.org/10.1093/nar/gkw009
42 Cheng, H., Dufu, K., Lee, C.-S., Hsu, J.L., Dias, A. and Reed, R. (2006) Human mRNA export machinery recruited to the 50 end of mRNA. Cell 127,
1389–1400 https://doi.org/10.1016/j.cell.2006.10.044
43 Murachelli, A.G., Ebert, J., Basquin, C., Le Hir, H. and Conti, E. (2012) The structure of the ASAP core complex reveals the existence of a
Pinin-containing PSAP complex. Nat. Struct. Mol. Biol. 19, 378–386 https://doi.org/10.1038/nsmb.2242
44 Deutsch, M. and Long, M. (1999) Intron--exon structures of eukaryotic model organisms. Nucleic Acids Res. 27, 3219–3228 https://doi.org/10.1093/
nar/27.15.3219
45 Jackson, D.A., Iborra, F.J., Manders, E.M.M. and Cook, P.R. (1998) Numbers and organization of RNA polymerases, nascent transcripts, and
transcription units in HeLa nuclei. Mol. Biol. Cell 9, 1523–1536 https://doi.org/10.1091/mbc.9.6.1523
46 Gehring, N.H., Lamprinaki, S., Kulozik, A.E. and Hentze, M.W. (2009) Disassembly of exon junction complexes by PYM. Cell 137, 536–548 https://doi.
org/10.1016/j.cell.2009.02.042
47 Takyar, S., Hickerson, R.P. and Noller, H.F. (2005) mRNA helicase activity of the ribosome. Cell 120, 49–58 https://doi.org/10.1016/j.cell.2004.11.042
48 Forler, D., Köcher, T., Rode, M., Gentzel, M., Izaurralde, E. and Wilm, M. (2003) An efficient protein complex purification method for functional
proteomics in higher eukaryotes. Nat. Biotechnol. 21, 89–92 https://doi.org/10.1038/nbt773
49 Bono, F., Ebert, J., Unterholzner, L., Güttler, T., Izaurralde, E. and Conti, E. (2004) Molecular insights into the interaction of PYM with the Mago-Y14
core of the exon junction complex. EMBO Rep. 5, 304–310 https://doi.org/10.1038/sj.embor.7400091
50 Diem, M.D., Chan, C.C., Younis, I. and Dreyfuss, G. (2007) PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of
spliced mRNAs. Nat. Struct. Mol. Biol. 14, 1173–1179 https://doi.org/10.1038/nsmb1321
51 Hachet, O. and Ephrussi, A. (2004) Splicing of oskar RNA in the nucleus is coupled to its cytoplasmic localization. Nature 428, 959–963 https://doi.org/
10.1038/nature02521
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society160
Biochemical Society Transactions (2018) 46 153–161
https://doi.org/10.1042/BST20170059
50
52 Ghosh, S., Obrdlik, A., Marchand, V. and Ephrussi, A. (2014) The EJC binding and dissociating activity of PYM is regulated in Drosophila. PLoS Genet.
10, e1004455 https://doi.org/10.1371/journal.pgen.1004455
53 Fourmann, J.-B., Schmitzova, J., Christian, H., Urlaub, H., Ficner, R., Boon, K.-L. et al. (2013) Dissection of the factor requirements for spliceosome
disassembly and the elucidation of its dissociation products using a purified splicing system. Genes Dev. 27, 413–428 https://doi.org/10.1101/gad.
207779.112
54 Zhang, Z. and Krainer, A.R. (2007) Splicing remodels messenger ribonucleoprotein architecture via eIF4A3-dependent and -independent recruitment of
exon junction complex components. Proc. Natl Acad. Sci. U.S.A. 104, 11574–11579 https://doi.org/10.1073/pnas.0704946104
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 161
Biochemical Society Transactions (2018) 46 153–161
https://doi.org/10.1042/BST20170059
51
Article
Exon Junction Complexes Suppress Spurious Splice
Sites to Safeguard Transcriptome Integrity
Graphical Abstract
Highlights
d Reduced EJC abundance results in aberrant splicing using
cryptic splice sites
d PSAP/EJC-associated RNPS1 suppresses cryptic and
reconstituted 50 splice sites
d RNA-bound EJC core factors directly mask cryptic 30
splice sites
d RNPS1 and the EJC protect spliced exons by preventing re-
splicing
Authors
Volker Boehm, Thiago Britto-Borges,
Anna-Lena Steckelberg, ...,
Janine Altm€uller, Christoph Dieterich,
Niels H. Gehring
Correspondence
christoph.dieterich@uni-heidelberg.de
(C.D.),
ngehring@uni-koeln.de (N.H.G.)
In Brief
The recognition of authentic splice sites is
important for the accurate maturation of
pre-mRNAs. Boehm et al. demonstrate
that the splicing-dependent deposition of
exon junction complexes (EJCs) on
mRNAs suppresses nearby cryptic splice
sites. Thereby, the EJC precludes re-
splicing of already spliced regions and
maintains the expression of intact
transcripts.
Boehm et al., 2018, Molecular Cell 72, 482–495
November 1, 2018 ª 2018 Elsevier Inc.
https://doi.org/10.1016/j.molcel.2018.08.030
52
Molecular Cell
Article
Exon Junction Complexes
Suppress Spurious Splice Sites
to Safeguard Transcriptome Integrity
Volker Boehm,1 Thiago Britto-Borges,2,3 Anna-Lena Steckelberg,1,4 Kusum K. Singh,1,5 Jennifer V. Gerbracht,1
Elif Gueney,1 Lorea Blazquez,6,7 Janine Altm€uller,8,9,10 Christoph Dieterich,2,3,* and Niels H. Gehring1,11,*
1Institute for Genetics, University of Cologne, 50674 Cologne, Germany
2Section of Bioinformatics and Systems Cardiology, Department of Internal Medicine III and Klaus Tschira Institute for Integrative
Computational Cardiology, University of Heidelberg, 69120 Heidelberg, Germany
3DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany
4Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, CO 80045, USA
5Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, 781039-Guwahati, Assam, India
6Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
7The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
8Cologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany
9Institute of Human Genetics, University of Cologne, 50931 Cologne, Germany
10Center for Molecular Medicine Cologne, University of Cologne, 50937 Cologne, Germany
11Lead Contact
*Correspondence: christoph.dieterich@uni-heidelberg.de (C.D.), ngehring@uni-koeln.de (N.H.G.)
https://doi.org/10.1016/j.molcel.2018.08.030
SUMMARY
Productive splicing of human precursor messenger
RNAs (pre-mRNAs) requires the correct selection
of authentic splice sites (SS) from the large pool of
potential SS. Although SS consensus sequence and
splicing regulatory proteins are known to influence
SS usage, the mechanisms ensuring the effective
suppression of cryptic SS are insufficiently explored.
Here, we find that many aberrant exonic SS are
efficiently silenced by the exon junction complex
(EJC), a multi-protein complex that is deposited on
spliced mRNA near the exon-exon junction. Upon
depletion of EJC proteins, cryptic SS are de-
repressed, leading to the mis-splicing of a broad
set of mRNAs. Mechanistically, the EJC-mediated
recruitment of the splicing regulator RNPS1 inhibits
cryptic 50SS usage, while the deposition of the EJC
core directly masks reconstituted 30SS, thereby
precluding transcript disintegration. Thus, the EJC
protects the transcriptome of mammalian cells from
inadvertent loss of exonic sequences and safe-
guards the expression of intact, full-length mRNAs.
INTRODUCTION
The majority of eukaryotic pre-mRNAs undergo alternative
splicing and produce an assorted set of mRNAs (Lee and Rio,
2015). Splicing of pre-mRNAs not only increases the coding po-
tential of the genome but is also a key regulatory step in gene
expression (Kornblihtt et al., 2013; Nilsen and Graveley, 2010).
In order to execute the two consecutive steps of splicing, the
splicing machinery has to correctly identify the splice sites (SS)
at the 50 and 30 ends of the intron, which have defined consensus
sequences (Papasaikas and Valca´rcel, 2016). Due to the degen-
erate nature of the splice consensus sequences, the cell is faced
with the challenging task to discriminate between authentic and
so-called cryptic SS, which exhibit consensus motifs but are not
intended to be used. Therefore, many different mRNA-binding
proteins assist the spliceosome in the accurate detection of in-
trons and SS. These splicing regulators commonly bind to spe-
cific sequence motifs on the transcript and act as enhancers
(e.g., SR proteins) or silencers (e.g., hnRNP proteins) of splicing
(Han et al., 2010; Long and Caceres, 2009).
In addition to the removal of intronic sequences, splicing also
alters the protein composition of the messenger ribonucleopro-
tein (mRNP). This phenomenon is documented, in particular, for
the exon junction complex (EJC), which is assembled and
deposited onto mRNAs during splicing (Boehm and Gehring,
2016; Le Hir et al., 2016). Binding of the EJC to its canonical
site 24 nucleotides (nt) upstream of exon-exon junctions does
not require a specific RNA-sequence and involves the phos-
phate backbone of the RNA (Andersen et al., 2006; Bono et al.,
2006). The core of the EJC consists of four proteins (EIF4A3,
MAGOH, RBM8A, and CASC3) that can be used as an assembly
platform for other proteins, the so-called peripheral EJC compo-
nents (Singh et al., 2012). The deposition of the EJC is initiated
by the recruitment of the core factor EIF4A3 to the activated
spliceosome by the splicing factor CWC22 (Alexandrov et al.,
2012; Barbosa et al., 2012; Steckelberg et al., 2012).
On the cellular level, EJCs represent central mRNP compo-
nents with diverse functions. Specifically, the EJC serves as
the molecular memory of the splicing process and passes on
this information to later steps of gene expression (Le Hir et al.,
2016; Woodward et al., 2017). In particular, the dynamically
482 Molecular Cell 72, 482–495, November 1, 2018 ª 2018 Elsevier Inc.
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recruited peripheral EJC proteins expand the functional impact
of the EJC on gene expression. EJC components have been
shown to stimulate mRNA transport, increase translation effi-
ciency, and support mRNA surveillance by nonsense-mediated
mRNA decay (NMD) (Boehm and Gehring, 2016; Le Hir et al.,
2016; Woodward et al., 2017). With these functions, the EJC
helps to ensure that correctly processed and error-free tran-
scripts are preferentially expressed. In addition to these post-
splicing processes, the EJC has also been shown to influence
the splicing process of selected mRNAs. For instance, correct
splicing of mapk pre-mRNA and other long intron-containing
transcripts in Drosophila was found to require EJC components
(Ashton-Beaucage et al., 2010; Roignant and Treisman, 2010).
Furthermore, depletion of EJC core factors resulted in the reten-
tion of a suboptimal intron in the piwi transcript (Hayashi et al.,
2014; Malone et al., 2014). It has been suggested that in this
case splicing of the neighboring introns leads to the deposition
of EJCs, which subsequently function as splicing enhancers for
the weak intron. In human cells, depletion of EJC core compo-
nents caused widespread changes in alternative pre-mRNA
splicing (Wang et al., 2014). Different types of alternative splicing
events were observed, of which cassette exons represented the
majority.
In mammals, the known splicing regulators ACIN1, PNN,
RNPS1, and SAP18 are peripheral EJC components, which
have been shown to co-purify with the EJC core (Singh et al.,
2012). Interestingly, RNPS1 and SAP18 form two alternative
complexes with either ACIN1 (also known as Acinus) or PNN
(also known as Pinin), referred to as apoptosis- and splicing-
associated protein (ASAP) or PSAP complex, respectively
(Murachelli et al., 2012). Evidence from studies in Drosophila
suggests that ACIN1 and RNPS1 aid in definition and splicing
of neighboring introns and are involved in the EJC-mediated
splicing regulation (Hayashi et al., 2014; Malone et al., 2014).
Furthermore, RNPS1 is also required for the correct splicing of
mapk and AURKB pre-mRNA in Drosophila and human cells,
respectively (Ashton-Beaucage et al., 2010; Fukumura et al.,
2018; Roignant and Treisman, 2010). Finally, recent transcrip-
tome-wide studies identified alternative splicing changes
in ACIN1- and PNN-depleted cells, suggesting that ASAP
and PSAP complexes can regulate certain EJC-dependent
and -independent splice events (Rodor et al., 2016; Wang
et al., 2018). Despite the identification of various splicing alter-
ations upon EJC depletion in mammalian cells, the molecular
mechanism underlying the EJC-mediated splicing regulation is
mostly uncharacterized. Hence, it is of fundamental importance
to dissect the mechanistic role and functional dependency on
core and peripheral EJC components for splicing regulation.
Here, we investigate the mechanism of splicing modulation by
the EJC. We show that depletion of the EJC-associated splice
factor RNPS1 caused widespread changes in splicing and led
to the usage of cryptic and reconstituted 50SS, which are effi-
ciently repressed in the presence of RNPS1. Moreover, we iden-
tified an EJC-dependent, but RNPS1-independent, mechanism
that prevents splicing involving the usage of cryptic and re-
constituted 30SS. Taken together, the EJC, in cooperation with
RNPS1, prevents the recognition of irregular SS within many
transcripts and thus the formation of incorrect mRNAs.
RESULTS
Given the lack of insight into the mechanism of splicing regula-
tion by the EJC, we set out to investigate the function of the
EJC-associated splice factor RNPS1, a common component
of ASAP and PSAP complexes (Mayeda et al., 1999; Murachelli
et al., 2012; Sakashita et al., 2004) (Figures 1A andS1A). First, we
tested whether RNPS1 is required for the correct splicing of the
MRPL3 transcript, which shows robust exon 4 skipping upon
knockdown of the EJC core protein EIF4A3 (Wang et al., 2014).
Interestingly, siRNA-mediated depletion of RNPS1 quantitatively
recapitulated the 60- to 70-fold increase of EJC-dependent
skipping of MRPL3 exon 4 (Figures 1B and 1C), suggesting a
functional link between EJC- and RNPS1-dependent splicing
regulation.
RNPS1 Recruitment to Spliced mRNPs via the RRM
Domain Is Required for Splicing Regulation
Recent in vivo crosslinking and immunoprecipitation (iCLIP) ex-
periments showed that RNPS1 displays an RNA binding pattern
similar to the EJC core protein EIF4A3 (Hauer et al., 2016).
Hence, we assumed that RNPS1 is positioned on spliced
mRNPs via an interaction with RNA-bound EJCs. To better un-
derstand the interaction between RNPS1 and the EJC, we stud-
ied ASAP/PSAP complex formation and EIF4A3 binding using
co-immunoprecipitation experiments. FLAG-tagged RNPS1
co-precipitated the ASAP/PSAP complex component SAP18
as well as the core EJC protein EIF4A3 (Figure S1B). Mutating
a surface exposed patch on RNPS1 (termed 176; Figure S1C)
that prevents ASAP/PSAP complex formation and co-precipita-
tion of SAP18 also abolished the interaction with EIF4A3 (Fig-
ure S1B), suggesting that RNPS1 interacts with the EJC as
part of the fully assembled ASAP or PSAP complex. We further
investigated the recruitment of RNPS1 to spliced transcripts us-
ing immunoprecipitation of in vitro spliced mRNPs (Steckelberg
andGehring, 2014).While the C-terminal RS/P domain of RNPS1
conferred unspecific binding to spliced and unspliced RNA
(Figures S1D–S1F), the isolated RRM domain of RNPS1, which
is sufficient to form a minimal ASAP/PSAP complex (Murachelli
et al., 2012), co-immunoprecipitated exclusively spliced tran-
scripts. Interestingly, RNPS1 (176), which is deficient in ASAP/
PSAP complex formation and EIF4A3 binding (Figure 1D), also
failed to co-precipitate splicedmRNA (Figures 1E and S1G), indi-
cating that ASAP/PSAP complex formation and splicing-depen-
dent mRNP interaction are functionally linked. Of note, MRPL3
exon skipping observed upon knockdown of RNPS1 could be
rescued by expression of wild-type RNPS1, but not RNPS1
(176) (Figure 1F). We conclude that RNPS1 requires the RRM-
mediated formation of an ASAP/PSAP complex and the interac-
tion with the EJC for its specific association with spliced mRNPs
to modulate splicing.
RNPS1 Depletion Causes Transcriptome-wide Loss of
Exonic Sequences
Having established a molecular link between RNPS1 and the
EJC, we next examined the global role of RNPS1 in splicing regu-
lation. To this end, we sequenced RNA from control- and
RNPS1-depleted cells as well as RNPS1 knockdown cells that
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were complemented with RNPS1 wild-type or RNPS1 (176) (Fig-
ure 2A). Using theMAJIQ algorithm (Vaquero-Garcia et al., 2016)
to identify local splicing variations (LSV), we found that RNPS1
depletion substantially altered the splicing of 318 LSV in 243
genes (Figure 2A; Table S1). The affected genes represented a
diverse group, as no specific enrichment was detectable for
the gene ontology (GO) termsmolecular function, biological pro-
cess, or cellular compartment.
Classification of the splicing alterations revealed that the pre-
dominant group represented exon skipping events, followed by
exon inclusion, alternative 50 or 30SS usage, and intron retention
(Figures 2B and S2A). Remarkably, exon-exon junctions that
were barely or never detected under control conditions (herein
called ‘‘spurious’’ junctions; see STAR Methods for details)
constituted a substantial proportion in all classes of splicing al-
terations except exon inclusion (Figures 2B and 2C). In more
than 30% of the splicing events we observed that RNPS1 deple-
tion leads to the activation of irregular SS, the skipping of consti-
tutive exons, and the formation of unusual transcript variants.
Furthermore, none of the RNPS1-dependent splicing alterations
were found in a recently published atlas of alternative splicing
events in multiple human tissues, cell types, and developmental
stages (VAST-DB) (Tapial et al., 2017). We verified the RNA-seq
results for selected transcripts with RNPS1-dependent exon
skipping, exon inclusion, alternative SS usage, and intron reten-
tion by RT-PCR (Figures 2D–2G and S2B–S2I). In all cases, the
splicing change caused by RNPS1 knockdown was completely
rescued by wild-type RNPS1, but not the RNPS1 (176) mutant,
underscoring that RNPS1-dependent splicing events require
ASAP/PSAP complex formation and recruitment by the EJC.
RNPS1 Suppresses Cryptic 50 Splice Sites
The usage of cryptic and irregular SS in RNPS1-depleted cells
suggests that the recruitment of RNPS1 by the EJC plays a
pivotal role in suppressing these SS under normal conditions.
To identify the molecular mechanism of RNPS1-dependent SS
suppression, we investigated transcripts with RNPS1-depen-
dent alternative 50SS, because this class contained a large pro-
portion of spurious junctions with robust fold changes (Figures
2B and 2C). The majority of spurious 50SS that were upregulated
in RNPS1-depleted cells exhibited a good splice consensus
sequence (Desmet et al., 2009) and were located close to the
50 end of an exon (Figure 3A). Therefore, these 50SS are near
canonical EJC-binding sites, on which EJCs can be deposited
during splicing of the preceding intron. We hypothesized that
RNPS1 bound to an upstream EJC suppresses the usage of
nearby 50SS. To test this model, we took advantage of the
TUFM transcript, in which usage of a cryptic 50SS is upregulated
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Figure 1. RNPS1 Regulates Splice Site Selection via an Interaction with the Exon Junction Complex
(A) Schematic overview of splicing modulation by exon junction complex (EJC) and ASAP/PSAP-complex formation.
(B) RT-PCR analysis of MRPL3 exon 4 skipping with RNA from HeLa cells transfected with the indicated siRNA. MRPL3 exon architecture is depicted sche-
matically; alternatively spliced features are highlighted.
(C) Quantitative RT-PCR analysis of MRPL3 exon 4 skipping normalized to exon3/4 splicing and compared to the Luc control knockdown. n = 3.
(D) Co-immunoprecipitation of EJC core component EIF4A3 and ASAP/PSAP component SAP18 from in vitro splicing experiments with the indicated FLAG-
tagged RNPS1 variants. n = 3.
(E) In vitro splicing of 32P body-labeled MINX mRNA in the presence of FLAG-RNPS1 variants. n = 3.
(F) RT-PCR analysis ofMRPL3 exon 4 skipping with RNA from stable HeLa cells expressing the indicated rescue proteins, transfected with the indicated siRNA.
Western blot analysis of protein expression is shown at the bottom.
All data from the indicated biological replicates show the mean ± SD and were compared to the respective control.
See also Figure S1.
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upon RNPS1 depletion (Figures 2E and 2G). We constructed a
reporter plasmid of the TUFM gene, including the RNPS1-
dependent 50SS as well as upstream and downstream introns
(Figure 3B). In line with our hypothesis, normal splicing of the re-
porter mRNA was observed when the intron upstream of the
cryptic 50SS was present (Figure 3C). In contrast, the irregular
50SS was preferentially used when EJC deposition was pre-
vented by deleting the upstream intron (Figure 3C). These re-
sults, together with our data on the position and strength of
RNPS1-dependent SS (Figure 3A), suggest that EJC-bound
RNPS1 protects a certain region of the downstream exon from
the use of irregular 50SS.
We recognized that our model of RNPS1-dependent 50SS
regulation could also explain exon skipping events, when the
skipped exon starts with a potential 50SS (i.e., contains a GU
or GC dinucleotide at the 50 end as part of a reconstituted SS).
In these cases, the same mechanism that regulates cryptic
50SS could also affect reconstituted SS at the beginning of
exons. This idea was supported by the observation that after
RNPS1-sensitive exon 4 skipping of the RER1 mRNA, a single
guanosine nucleotide remained (Figures 3D–3F), which could
only result from the usage of a reconstituted 50SS. Indeed, the
exon-exon boundary between exon 3 and 4 contains a 50SS,
which can be ligated to the splice acceptor of the downstream
intron causing exon 4 skipping (Figure 3G). This re-splicing of a
reconstituted exonic 50SS resembles the process of sequential
multi-step splicing of introns termed recursive splicing (Sibley
et al., 2016). To test whether exon 4 skipping in the RER1
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Figure 2. Transcriptome-wide Alternative Splicing Events upon RNPS1 Depletion
(A) Simplified overview of experimental RNA-Seq pipeline.
(B) Classification of selected alternatively spliced junctions upon RNPS1 knockdown as exon skipping (ES), exon inclusion (EI), intron-retention (IR), alternative
50 or 30 splice sites (A5SS, A3SS), or exitron (EX) events (see inset). The quantity of spurious junctions for each class is shown in yellow. The change in junction
usage (delta percent spliced in, dPSI) and percent spliced in (PSI) fold change for each class are shown as boxplots on the bottom. The full classification plot is
shown in Figure S2A.
(C) Heatmaps representing junction usage (percent spliced in; PSI) of alternative splicing events in control (Luc) and RNPS1 knockdown are depicted on the left.
The fraction of spurious junctions and the PSI fold change in the same samples are shown on the right. Only junctions with a strong response in RNPS1-depleted
cells with a dPSI of <-0.1 were selected.
(D and E) Sashimi-plots of RNA-Seq data of genes with exon skipping (OCIAD1, D) and alternative 50 splice site (SS) usage (TUFM, E). Only selected splice
junctions are depicted. The thickness and color of the depicted junction represent the junction usage (PSI and dPSI). The counts of reads spanning the indicated
junctions are shown.
(F and G) RT- PCR analysis of the alternative splice events shown in (D) and (E) in theOCIAD1 (F) and the TUFM (G) mRNAs, respectively. Total RNA was isolated
from stable HeLa cells expressing the indicated rescue proteins and transfected with the indicated siRNA. Quantified results from the indicated biological
replicates are shown as mean ± SD and compared to the Luc control knockdown.
See also Figure S2 and Table S1.
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mRNA results from re-splicing, we took advantage of a set of
RER1 reporter plasmids (Figure 3H). When both introns were
present in the reporter (e3-e5), exon 4 was constitutively re-
tained,mimicking the constitutive exon inclusionobserved in vivo
(Figures 3H and 3I). A reporter construct lacking the upstream
intron 3 (Di3), which simulates splicing of this intron without
EJC-deposition, produced exclusively mRNAs lacking exon 4
(Figures 3H and 3I). Together, these data suggest that intron 3
splicing and concomitant EJC deposition suppresses the use
of an adjacent reconstituted SS. When we removed both introns
(Di3+i4) ormutated theGUdinucleotide of the reconstituted 50SS
(Di3 GU-Mut), exon 4 was retained (Figures 3H and 3I). These
findings confirm that in the absence of EJC deposition, the
RER1 transcript undergoes re-splicing using the reconstituted
50SS and the splice acceptor of intron 4. Strikingly, exon skipping
occurred despite the presence of the genuine 50SS of intron 4
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Figure 3. RNPS1 Depletion Leads to Re-splicing of Cryptic and Reconstituted 50 Splice Sites
(A) Depiction of alternative 50SS position of spurious junctions relative to exon boundaries as density plot (bottom) and the corresponding 50 MaxEnt scores (top).
(B and C) TUFM minigene reporter constructs (B) were expressed in HeLa Tet-Off cells and analyzed via RT-PCR (C).
(D) Sashimi-plots of RER1 exon 4 skipping from RNA-Seq data.
(E) IGV snapshot of the guanosine insertion for RER1 reads.
(F) RER1 RT-PCR of RNA from HeLa cells transfected with the indicated siRNA. Sanger sequencing of the exon 4-skipped RER1 PCR product is shown with the
guanosine retained from exon 4 highlighted.
(G) Scheme of RER1 exons 3–5 re-splicing in the presence (top) or absence (bottom) of RNPS1.
(H and I) RER1 minigene reporter constructs (H) were expressed in HeLa Tet-Off cells and analyzed via RT-PCR (I).
(J) HSD17B10 RT-PCR of RNA from HeLa cells transfected with the indicated siRNA. The 50-terminal GU dinucleotide at the exon 5 of HSD17B10 is indicated.
(K and L) HSD17B10 minigene reporter constructs (K) were expressed in HeLa Tet-Off cells and analyzed via RT-PCR (L).
All data from the indicated biological replicates show the mean ± SD and were compared to the respective control.
See also Figure S3.
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that exhibits a stronger SS consensus score compared to the
reconstituted 50SS (Figure S3A). This observation raises the
interesting question of which other determinants affect this SS
selection. Apart from the SS consensus sequence, exonic
splicing enhancer (ESE) or silencer (ESS) motifs greatly influence
the balance of SS usage (Ca´ceres and Hurst, 2013). Upon in-
spection of RER1 exon 4, we suspected that an unfavorable
arrangement of ESE and ESS leads to the selection of the recon-
stituted 50SS. In support of this hypothesis, removal of several
ESSs from the central region of exon 4 and insertion of ESE
motifs at the exon’s 50 end gradually restored the usage of the
canonical intronic SS in the RER1 Di3 reporter (Figures S3A–
S3C). These results indicate that RNPS1 and the EJC directly
or indirectly counteract exonic splicing silencer motifs, effec-
tively leading to the definition of exons and exon inclusion.
In contrast to RER1, where a residual guanosine nucleotide
served as a molecular mark of two consecutive splicing events,
most exon skipping events observed upon RNPS1 knockdown
displayed seamless skipping of one or more exons. We there-
fore investigated whether these splicing events equally relied
on re-splicing or resulted from a direct definition of exon-exon
boundaries across multiple introns. To this end, we generated
reporter constructs of the HSD17B10 transcript, for which a
moderate increase in exon skipping was observed upon deple-
tion of RNPS1 (Figure 3J). Analogous to RER1 splicing, near-
complete exon skipping occurred in an HSD17B10 reporter
transcript lacking the upstream intron, indicating that this event
is indeed a result of re-splicing (Figures 3K and 3L). This remark-
able conversion of the splice pattern is surprising, considering
that this HSD17B10 splicing event was near the detection limit
of the MAJIQ alternative splicing analysis (fourth last record,
Table S1). Importantly, the HSD17B10 re-splicing event is
indistinguishable from regular exon skipping by standard
computational analyses, because the first two nucleotides of
the skipped exon represent the GU dinucleotide of the 50SS.
This observation suggests that other exon skipping events
observed upon RNPS1 knockdown potentially utilize the same
re-splicing mechanism. To estimate the probability of seamless
re-splicing, we identified the 50 terminal dinucleotide of the first
skipped exon in spurious exon skipping events. More than 75%
of the skipped exons exhibited a suitable 50SS on their 50 end,
suggesting that re-splicing is likely responsible for these exon
skipping events (Figure S3D).
The EJC Confers Local Protection from Cryptic Splicing
Based on our observation that compromised EJC deposition
results in aberrant splicing, we tested whether site-directed
positioning of EJC factors on de-repressed mRNAs can restore
normal splicing. To this end, we generated a reporter transcript
with MS2 tethering sites to recruit effector proteins to different
positions upstream of the reconstituted 50SS of HSD17B10
Di4, which constitutively undergoes re-splicing (Figures 4A
and 4B). Tethering of EJC proteins to this mRNA mimics EJC
assembly upstream of exon-exon junctions and thus uncouples
EJC deposition from pre-mRNA splicing. Indeed, tethering of
RNPS1 or the EJC core component RBM8A promoted exon
inclusion over a short distance, but gradually lost its effect
when the distance between the tethering site and the 50SS was
increased (Figure 4B). These results suggest that MS2-mediated
positioning of RNPS1 or EJC components on the mRNA func-
tionally recapitulates splicing-dependent EJC-deposition. Also,
our data suggest that the effect of the EJC and RNPS1 is
confined to a region surrounding the EJC binding site.
RNPS1 in the PSAP Complex Is the Functional
Component for 50 Splice Site Suppression
To uncover the mechanistic details of cryptic SS suppression by
RNPS1, we set out to define theminimal protein domain required
for this process. Using rescue assays, we determined that the
expression of the isolated RRM domain of RNPS1 considerably
rescued RER1 splicing in RNPS1-depleted cells (Figure 4C). This
indicates that the isolated RRM domain of RNPS1 retains some
functional activity, potentially mediated through the recruitment
of other protein factors, such as ASAP/PSAP complex compo-
nents. To test this, we examined the effects of siRNA-mediated
depletion of ASAP/PSAP components. Surprisingly, only the
knockdown of SAP18 and PNN, but not ACIN1, resulted in
RER1 exon skipping (Figures 4D and 4E). Furthermore, expres-
sion of full-length SAP18 or truncated PNN constructs, which
support PSAP formation, restored normal splicing of the
RER1 transcript in SAP18 or PNN-depleted cells, respectively
(Figure 4F). Moreover, tethering of SAP18 or PNN to the
HSD17B10 reporter stimulated exon inclusion (Figures S4A
andS4B), demonstrating that the PSAP complex is the functional
entity involved in EJC-mediated cryptic SS suppression.
To further dissect the hierarchy of EJC- and PSAP-dependent
splicing regulation and to identify the active components of
the PSAP complex, we performed epistasis experiments using
tethering assays in knockdown cells. Tethering of RNPS1 re-
sulted in exon inclusion of the HSD17B10 reporter mRNA even
in EJC- or PSAP-complex depleted cells (Figure 4G). In contrast,
tethered PNN and SAP18 were inactive in the absence of RNPS1
(Figure 4H), and tethering of PSAP-incompatible RNPS1 (176)
led to similar exon inclusion as tethering of the RNPS1 wild-
type protein (Figure 4I). This result supports the hypothesis that
RNPS1 is a key effector of EJC- and PSAP-mediated splicing
regulation, while EJC and other PSAP components are required
primarily for the correct recruitment of RNPS1 to the mRNA.
Based on these findings, we postulate that the PSAP complex,
consisting of PNN, SAP18, and RNPS1, contributes to exon defi-
nition, a function that suppresses exon skipping and resembles
the activity of classical SR proteins (Ibrahim et al., 2005). Sup-
porting this exon definition hypothesis, tethering of SRSF2 or
SRSF11, a reported interaction partner of RNPS1 (Sakashita
et al., 2004), altered the HSD17B10 splicing similar to RNPS1
or RBM8A tethering (Figure S4C). However, EJC-dependent
exon definition functions independently of these SR proteins,
because depletion of SRSF1 and SRSF2 (single or combined)
or SRSF11 did not activate RNPS1-dependent cryptic SS (Fig-
ures S4D–S4F). Finally, tethered nuclear b-galactosidase (NLS-
LacZ, a homotetramer of 120 kDa proteins) had no effect on
exon skipping, indicating that the presence of a large protein
complex is not sufficient to prevent exon skipping (Figure S4C).
Taken together, these results imply that RNPS1 is an essential
effector of SS suppression and is recruited to spliced mRNPs
via the formation of PSAP rather than ASAP complexes.
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EJCs Prevent 30 Splice Sites Usage in an
RNPS1-Independent Manner
Transcripts harboring RNPS1-dependent cryptic or reconsti-
tuted SS also showed splicing defects upon depletion of the
EJC core components EIF4A3 and RBM8A (Figures 1B and
S5A–S5I). Moreover, expression of a dominant-negative splicing
factor that is unable to recruit EIF4A3 to the spliceosome
(CWC22 [171]) and thus enables pre-mRNA splicing without
EJC deposition (Steckelberg et al., 2012) also caused RER1
exon skipping (Figures S5J and S5K). Hence, a clear link
between EJC deposition and splice regulation by RNPS1
exists. However, comparing the identified transcriptome-wide
RNPS1-dependent splicing events with previously published
RNA-Seq data from EIF4A3-depleted cells (Wang et al., 2014),
we noticed that many splicing events induced by EJC
knockdown were not found in RNPS1-depleted cells (Figures
S5L–S5P; Table S2).
Although it is expected that the EJC knockdown strongly
inhibits downstream processes like NMD, leading to the oversta-
bilization of mis-spliced mRNAs, this observation suggested
that additional EJC-dependent (but RNPS1-independent) mech-
anisms act on these mRNAs. The depletion of the EJC core
component EIF4A3 mainly caused exon skipping, similar to
RNPS1 knockdown (Figures 5A and S6A). However, the second
most frequent splicing alteration was the use of alternative 30SS,
an event that was less often observed upon RNPS1 depletion.
This observation indicated a mechanistic difference between
EJC- and PSAP-dependent splicing regulation and prompted
us to investigate this type of splicing dysregulation in more
detail. In search of a possible mechanistic explanation for
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Figure 4. Functional Suppression of Cryptic
Splice Sites by the PSAP Complex
(A) Scheme of HSD17B10 Di4 tethering reporter.
Two ESE-optimized MS2 stem loops were in-
serted at varying distances upstream of the re-
constituted HSD17B10 cryptic splice site, allow-
ing the direct tethering of MS2V5-tagged proteins.
(B) The indicated MS2V5-tethering proteins and
HSD17B10 Di4 reporter with varying spacers were
expressed transiently in HeLa Tet-Off cells and the
splice patterns analyzed by RT-PCR.
(C and F) RT-PCR analysis of RER1 exon skipping
with RNA from stable HeLa cells, expressing the
indicated rescue proteins (RNPS1 variants [C] or
SAP18 and PNN variants [F]), transfected with the
indicated siRNA. Western blot analysis of ex-
pressed FLAG- and FLAG-emGFP-tagged pro-
teins is shown. Tubulin served as loading control.
(D) RT-PCR analysis of RER1 exon skipping
with RNA from HeLa cells transfected with the
indicated siRNA.
(E) Scheme depicting the components of the
ASAP and PSAP complexes.
(G) Dual-inducible stable HeLa cell lines express-
ing both the HSD17B10 Di4 e4-15 reporter and
the indicated MS2V5-tagged RNPS1 protein vari-
ants were transfected with the indicated siRNA.
Splicing of the reporter mRNA and the endoge-
nous RER1 mRNA was analyzed by RT-PCR.
(H) Dual-inducible stable HeLa cell lines express-
ing both theHSD17B10Di4 e4-15 reporter and the
indicated MS2V5-tagged PNN (1-381) or SAP18
protein were transfected with the indicated siRNA.
Splicing of the reporter mRNA and the endoge-
nous RER1 mRNA was analyzed by RT-PCR.
(I) Dual-inducible stable HeLa cell lines expressing
both the HSD17B10 Di4 e4-15 reporter and the
indicated MS2V5-tagged RNPS1 protein variants
were transfected with the indicated siRNA.
Splicing of the reporter mRNA was analyzed by
RT-PCR.
All data from the indicated biological replicates
show the mean ± SD and were compared to the
respective control.
See also Figure S4.
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Figure 5. Inability to Deposit EJCs on mRNA Results in the Usage of Aberrant 30 Splice Sites
(A) Classification of selected alternatively spliced junctions upon EIF4A3 knockdown. The quantity of spurious junctions for each class is shown. The change in
junction usage (delta percent spliced in, dPSI) and PSI fold change for each class are shown as boxplots on the bottom. The full classification plot is shown in
Figure S6A.
(B) Sashimi-plots of multiple RNA-Seq datasets (Luc and RNPS1 versus GFP, EIF4A3, and RBM8A) of ACIN1 exon 14 skipping. The predicted EJC binding site in
relation to the cryptic splice site (SS) and putative branchpoints (BP) is indicated.
(legend continued on next page)
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EJC-dependent splicing regulation, we analyzed theACIN1 tran-
script, in which a cryptic 30SSwas used for splicing upon EIF4A3
or RBM8A, but not RNPS1 depletion (Figures 5B and 5C). We
reasoned that a splicing order in which splicing of intron 14 pre-
cedes splicing of intron 13 could explain the observed splicing
pattern (Figure 5D). Splicing of intron 14 generates a composite
exonic 30SS spanning the junction between exons 14 and 15,
which led to exon skipping if used together with the 50SS of
intron 13. Consistent with our theory, an ACIN1 reporter lacking
intron 14 (Figure 5E) produced almost exclusively the skipped
transcript, whereas a reporter construct with two introns was
normally spliced (Figure 5F). The same order of splicing events
was also observed for ATP5B and ATP5F1 transcripts, for which
mis-splicing is enabled due to the activation of a cryptic 30 splice
acceptor site (Figures 5G–5I). Similarly, splicing of the down-
stream intron precedes splicing of the upstream intron in the
CIAO1 mRNA (Figure S6B–S6J). As a result, the EJC helps to
suppress two cryptic 30SS downstream of the exon-exon junc-
tion by RNPS1-dependent and -independent mechanisms. For
all transcripts analyzed in detail, the predicted EJC binding sites
coincide with putative branchpoints or polypyrimidine tracts of
the EJC-dependent alternative 30SS. Furthermore, the EJC-sup-
pressed alternative 30SS are mainly clustered at EJC binding
sites or at the 50 end of the following exon (Figure S5Q). This
finding suggests that the RNPS1-independent EJC function is
due to direct masking of important splice-regulatory sequences.
This hypothesis was supported by the insertion of hemagglutinin
(HA) tag sequences in the ATP5F1 and ATP5B reporter, which
moved the alternative 30SS sufficiently upstream of EJC deposi-
tion sites, thereby de-repressing and constitutively activating
these SS (Figures 5H and 5I). Taken together, in addition to the
PSAP-mediated splicing regulation, the deposition of EJCs
prevents the loss of exonic sequences via usage of reconstituted
or cryptic 30SS.
EJCs Maintain Transcriptome Integrity and Cellular
Survival
The importance of EJC and RNPS1-dependent SS protection is
underscored by the observation that RBM8A-depleted cells and
to a lesser extend RNPS1-depleted cells showed reduced prolif-
eration (Figure 6A), presumably caused by the activation of
several signaling cascades related to stress and apoptosis (Fig-
ure 6B). As the EJC is involved in a multitude of gene expression
processes—for example, mRNA quality control by NMD—the
cellular stress cannot be solely attributed to the uncontrolled
splicing upon EJC knockdown. However, compared to the com-
bined depletion of RNPS1 and SMG1, which is a central compo-
nent of the NMDmachinery, downregulation of RBM8A caused a
more severe stress phenotype (Figure 6B). We suspected that
normal EJC deposition and concomitant cryptic SS repression
maintains proper transcriptome integrity and is therefore
required for cellular fitness. Indeed, increased production of
several shorter mRNA variants was observed in EJC knock-
downs, when studying genes that harbor more than one EJC-
dependent cryptic SS (Figures 6C–6F). We reasoned that this
shift from productive to non-productive splicing and therefore
the loss of intact, full-length transcripts might have a significant
effect on cellular survival. In addition, we searched for mis-
splicing of genes essential for cellular fitness by comparing the
change of junction usage of EIF4A3-dependent spurious splice
events with the fitness score of the respective gene, determined
by a high-resolution CRISPR-screen (Figure 6G; Hart et al.,
2015). In total, we found 184 mis-spliced genes that were classi-
fied as essential for survival and proliferation. Although many of
the splice changes affect only one exon, we found many essen-
tial genes that produce substantial amounts of mis-spliced
mRNAs, which are expected to encode for non-functional pro-
teins. One example is the transcript of the splicing and DNA
damage repair component PRPF19, for which exon 15 skipping
upon EJC depletion leads to the deletion of two WD40 domains
(Figure 6H), rendering the protein incapable of supporting proper
DNA damage response (Mare´chal et al., 2014). Another essential
target is uridine monophosphate synthetase (UMPS), which is
required for the UMP biosynthesis pathway. UMPS transcripts
lacking exon 2 due to exon skipping generate an early frameshift
and thus lead to the expression of a truncated protein isoform
(Figure 6I). Therefore, the deposition of EJC on nascent mRNAs
has an instant protective effect on gene expression, maintains
the expression of many essential genes, and presumably repre-
sents an essential function of the EJC.
DISCUSSION
The human genome contains many cryptic SS that are usually
used only at a very low frequency despite having similar se-
quences as canonical SS (Buratti et al., 2011). It is assumed
that cryptic SS are suppressed by stronger SS in their vicinity
and are only activated by mutations of nearby authentic SS
(Roca et al., 2003). However, our data suggest that SS selection
is not solely the result of SScompeting for the splicingmachinery.
We find that many cryptic and reconstituted SS are efficiently
silenced under normal conditions by the deposition of an EJC
on adjacent exon-exon junctions. Furthermore, we uncover
several different mechanisms by which EJCs globally inhibit the
use of nearby irregular 50 and 30SS (Figure 7A). Interestingly, a
parallel study reports a similar observation that the splicing of
hundreds of putative RS exons is regulated by the EJC and asso-
ciated factors (Blazquez et al., 2018). Because the EJC itself is
(C) RT-PCR analysis of ACIN1 exon 14 skipping with RNA from HeLa cells transfected with the indicated siRNA.
(D) Scheme indicating the ACIN1 re-splicing mechanism.
(E and F) ACIN1 minigene reporter constructs (E) were expressed in HeLa Tet-Off cells and analyzed via RT-PCR (F).
(G) ATP5F1 and ATP5B RT-PCR of cDNA samples obtained from HeLa cells transfected with the indicated siRNA.
(H and I) ATP5F1 and ATP5Bminigene reporter constructs (H) were expressed in HeLa Tet-Off cells and analyzed via RT-PCR (I). Insertion of 27 nt HA sequences
in exon 4 (ATP5F1) or exon 6 (ATP5B) is schematically depicted.
All data from the indicated biological replicates show the mean ± SD and were compared to the respective control.
See also Figures S5 and S6 and Table S2.
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deposited on the RNA during splicing, this mechanism functions
as a positive feedback loop to reinforce authentic SS and estab-
lishes a hierarchy of preferential SS usage.
Mechanism and Consequences of 50SS Suppression
The position of the EJC at the 30 end of an exon is well suited to
oversee the 50 end of the next exon and to suppress exonic SS.
Our work establishes that the EJC recruits the PSAP complex to
exert an exon inclusion effect that decreases proportionally with
the distance. Consequently, PSAP functionsmainly in the vicinity
of previously spliced introns, so that cryptic SS usage within
already-ligated exons is prevented. In contrast to other splice
factors such as SR proteins, for which several binding se-
quences can be present in an exon (Long and Caceres, 2009),
EJCs recruit PSAP complexes in a splicing-dependent but
sequence-independent manner to a single site at the 30 end of
an exon. Despite its limited binding potential/possibilities, the ef-
ficiency of PSAPs cryptic splice site suppression is remarkable.
In many cases, EJC-regulated cryptic splices are barely used
under normal conditions. While the knockdown of EJC compo-
nents often causes only partial mis-splicing of endogenous
transcripts (presumably due to incomplete knockdown of the
proteins), we observe almost 100% splicing defects in our
reporter constructs when EJC binding was prevented by intron
deletions. Interestingly, there are also similarities between
PSAP complex and SR proteins. For example, we observe a dis-
tance-dependent exonization effect by the PSAP complex, as
has been described for SR proteins (Graveley et al., 1998). While
several components of an EJC-dependent exon definition
complex are now characterized, more work will be needed to
determine the exact mechanism of 50SS suppression. It will be
of particular importance to uncover the process by which the
PSAP complex guides U1 snRNP binding to 50SS.
Mechanism and Consequences of 30SS Protection
In addition to the PSAP-dependent 50SS suppression, we
observed a different, merely steric mechanism in the control of
30SS. We conclude that the binding of the EJC core prevents
the correct recognition of the 30SS by the spliceosome, likely
because factors such as U2AF1/2 are not able to bind to the
A C D
E F
B
G
H I
Figure 6. RNPS1 and EJC Depletion Leads to Transcript Disintegration and Cellular Stress
(A) Proliferation of HeLa cells was measured after knockdown using the indicated siRNA. n = 3.
(B) Induction of stress pathways upon transfection of HeLa cells with the indicated siRNA. The indicated signaling molecules were detected via target-specific
capture antibodies in a sandwich immunoassay. n = 3.
(C–F) Examples for accumulated mis-spliced EIF2S3 (C), DKC1 (D), MPV17 (E), and ATL2 (F) transcripts upon EJC depletion, analyzed by RT-PCR.
(G) Plot of spurious junctions identified in EIF4A3 knockdown RNA-Seq data, comparing the log Bayes factor (BF) gene fitness score against the change in
junction usage (dPSI). More positive scores increase the confidence in the essentiality of the gene. Individual targets are highlighted.
(H and I) Scheme of highlighted targets in (G), depicting the transcript architecture, the strongest alternative splicing event, the expressed protein variants, and the
ratio of mis-splicing in control or EIF4A3 knockdown RNA-Seq data.
All data from the indicated biological replicates show the mean ± SD and were compared to the respective control.
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RNA if an EJC occupies their genuine binding site. A similar inter-
ference with the assembly of the early spliceosome has been re-
ported for a diverse group of repressors of 30SS usage, including
PTB or Sxl (Izquierdo et al., 2005; Valca´rcel et al., 1993). Many of
these factors compete with U2AF for binding to the pyrimidine
tract, and therefore the inhibitory potential of the repressor
depends on its binding strength to the 30SS (Sohail and Xie,
2015). In contrast, the EJC has a clear competitive advantage
over U2AF because its co-spliceosomal deposition ensures
that cryptic or reconstituted SS are nearly immediately rendered
inaccessible. Furthermore, the strong EJC binding to mRNA is
usually only resolved by a translating ribosome in the cytoplasm
(Gehring et al., 2009b). This advantage explains the surprisingly
robust effect of the EJC on the suppression of 30SS.
Significance of the EJC for Gene Expression
It is evident that the complex and heterogeneous architecture of
the human transcriptome demands a mechanism that marks the
position of already spliced introns and prevents re-splicing in
their vicinity. The EJC meets this demand by masking and sup-
pressing aberrant SS and thereby protecting the bound tran-
script from unintentional loss of exonic sequences (Figure 7B).
Conceptually, this protective effect of the EJC is comparable
to the telescripting mechanism in which the U1 snRNP prevents
premature transcription termination by cleavage and polyadeny-
lation of mRNAs in order to ensure transcriptome integrity
(Berg et al., 2012). Similar to U1 depletion resulting in mRNA
A
B
Figure 7. EJC and RNPS1 Protect Spliced
Transcripts from the Usage of Cryptic
Splice Sites
(A) Mechanism of splice site suppression by the
EJC and the RNPS1-containing PSAP complex.
(B) Deposition of EJCs prevents loss of exonic
sequences by masking and suppressing cryptic
splice sites in the vicinity, consequently en-
forcing correct splicing hierarchy. The inability to
assemble EJCs on spliced transcripts results in
the activation of cryptic SS, leading tomis-splicing
events and loss of exonic sequences.
shortening, EJC depletion results in tran-
script disintegration by de-repression of
single or multiple SS in a given transcript
(Figure 7B). Mechanistically, the EJC-
dependent re-splicing events share char-
acteristics with reported multi-step splice
processes such as recursive splicing or
intra-splicing (Parra et al., 2008; Sibley
et al., 2016). Functionally, however, the
EJC-related re-splicing events reported
here result primarily in destructive splice
patterns, whereas canonical recursive
splicing is defined as a productive mech-
anism resulting in the correct excision of
introns.
We speculate that reduced expression
of the EJC core components EIF4A3
andRBM8A can lead to significant changes in the transcriptome,
explaining why the EJC is important for embryonic development
(Mao et al., 2016) and how its misregulation can cause serious
human diseases (Albers et al., 2012; Favaro et al., 2014). In sen-
sitive cells or tissues, these changes in gene expression will
affect cellular fitness and eventually have a negative impact on
tissue differentiation and maintenance. Hence, our work un-
covers EJCs as essential components of a splice-regulatory
pathway that safeguard transcriptome integrity and protect
mRNAs against disruptive splicing events.
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STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal anti-FLAG Sigma-Aldrich Cat# F7425; RRID:AB_439687
Mouse monoclonal anti-beta-Actin Sigma-Aldrich Cat# A5441; RRID:AB_476744
Mouse monoclonal anti-alpha-Tubulin Sigma-Aldrich Cat# T6074; RRID:AB_477582
Rabbit polyclonal anti-V5 QED Bioscience Cat# 18870-01; RRID:AB_215340
Rabbit polyclonal anti-GFP Abcam Cat# ab290; RRID:AB_303395
Rabbit polyclonal anti-SAP18 Abcam Cat# ab31748; RRID:AB_777829
Rabbit polyclonal anti-EIF4A3; raised against an
N-terminal peptide of EIF4A3
GenScript N/A
Peroxidase-AffiniPure Goat Anti-Rabbit Jackson ImmunoResearch
Laboratories
Cat# 111-035-006; RRID:AB_2337936
Peroxidase-AffiniPure Goat Anti-Mouse Jackson ImmunoResearch
Laboratories
Cat# 115-035-003; RRID:AB_10015289
Chemicals, Peptides, and Recombinant Proteins
Doxycycline Takara Bio/Clontech Cat# 8634-1
Cumate 10,000x solution System Biosciences Cat# QM150A-1
Ribo m7G Cap Analog Promega Cat# P1711
30-O-Me-m7G(50)ppp(50)G RNA Cap Structure Analog New England Biolabs Cat# S1411S
a-32P-GTP Hartmann Analytic Cat# FP808
HeLa nuclear extract CIL Biotech Cat# CC-01-20-50
Puromycin Dihydrochlorid Carl Roth Cat# 0240.1
Hygromycin B Gold InvivoGen Cat# ant-hg-1
RNasin Promega Cat# N2111
Critical Commercial Assays
Lipofectamine RNAiMAX Transfection Reagent Thermo Fisher Scientific Cat# 13778150
EZview Red ANTI-FLAG M2 Affinity Gel Sigma-Aldrich Cat# F2426-1ML
Anti-FLAG M2 Magnetic Beads Sigma-Aldrich Cat# M8823-5ML
Amersham ECL Prime Western Blotting Detection
Reagent
GE Healthcare Cat# RPN2236
jetPRIME Transfection Reagent Polyplus Transfection Cat# 114-07
peqGOLD TriFast VWR Cat# 30-2010
ProtoScript II Reverse Transcriptase New England Biolabs Cat# M0368S
GoScript Reverse Transcriptase Promega Cat# A5003
GoScript Reverse Transcription Mix, Oligo(dT) Promega Cat# A2791
GoTaq Green Master Mix Promega Cat# M7123
GoTaq qPCR Master Mix Promega Cat# A6001
PathScan Stress and Apoptosis Signaling
Antibody Array Kit
Cell Signaling Technology Cat# 12856
CellTiter-Glo Luminescent Cell Viability Assay Promega Cat# G7570
Deposited Data
Raw and analyzed data: RNA-seq This paper ArrayExpress: E-MTAB-6564
Raw and analyzed data: RNA-seq Wang et al., 2014 GEO: GSE63091
ENSEMBL Human genome assembly N/A ftp://ftp.ensembl.org/pub/release-90/
fasta/homo_sapiens/dna/RRID:SCR_002344
Mendeley dataset of original Data This paper https://doi.org/10.17632/wt7ybwz82g.1
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental Models: Cell Lines
Human: Flp-In-T-REx-293 Thermo Fisher Scientific Cat# R78007; RRID:CVCL_U427
Human: HeLa Tet-Off Clontech Cat# 631156; RRID:CVCL_V352
Human: HeLa Flp-In T-REx Elena Dobrikova and Matthias
Gromeier, Duke University
Medical Center
N/A
Oligonucleotides
siRNA targeting sequence: Luciferase:
CGUACGCGGAAUACUUCGA
Integrated DNA Technologies N/A
siRNA targeting sequence: RNPS1_3:
AAGGAAGACCAGUAGGAAA
Integrated DNA Technologies N/A
siRNA targeting sequence: RNPS1_A:
GGAUCGCUCAAAAGAUAAA
Integrated DNA Technologies N/A
siRNA targeting sequence: RBM8A:
UUCGCAGAAUAUGGGGAAA
Integrated DNA Technologies N/A
siRNA targeting sequence: EIF4A3:
AGACAUGACUAAAGUGGAA
Integrated DNA Technologies N/A
siRNA targeting sequence: ACIN1_A:
CUGCAGAGCAUGAAGUAAAUU
Integrated DNA Technologies N/A
siRNA targeting sequence: ACIN1_13.1:
UCAGUAUCACCACUGAAUCACUAAA
Integrated DNA Technologies N/A
siRNA targeting sequence: ACIN1_13.2:
CAAGUGAAAACAGACCUGAAAAUGA
Integrated DNA Technologies N/A
siRNA targeting sequence: PNN_1:
GAUUUCUUGAUAAAAAAGGAUUACC
Integrated DNA Technologies N/A
siRNA targeting sequence: PNN_2:
AUACUUCAGGACUAGAAAGAAGUCA
Integrated DNA Technologies N/A
siRNA targeting sequence: SAP18_1:
UCUGCAACCUUGGAUAAAUUAUUTC
Integrated DNA Technologies N/A
siRNA targeting sequence: SAP18_2:
GGAUGCAACCUUGAAAGAACUGACA
Integrated DNA Technologies N/A
siRNA targeting sequence: SMG1:
GUGUAUGUGCGCCAAAGUATT
Integrated DNA Technologies N/A
siRNA targeting sequence: SRSF1:
CCAAGGACAUUGAGGACGU
Integrated DNA Technologies N/A
siRNA targeting sequence: SRSF2:
AAUCCAGGUCGCGAUCGAA
Integrated DNA Technologies N/A
siRNA targeting sequence: SRSF11_13.1:
GUUGAUGUACAGUUUCUGAAAUUGT
Integrated DNA Technologies N/A
siRNA targeting sequence: SRSF11_13.2:
UACUGUUGAUCCCAAGUUGAAUCAT
Integrated DNA Technologies N/A
Primers for RT-PCR and reporters see Table S3 This paper N/A
Recombinant DNA
pcDNA5/FRT/TO Mammalian Expression Vector Thermo Fisher Scientific Cat# V652020
pCI-neo Mammalian Expression Vector Promega Cat# E1841
PB-Cuo-MCS-IRES-GFP-EF1a-CymR-Puro Inducible
cDNA Cloning and Expression Vector
System Biosciences Cat# PBQM812A-1
Software and Algorithms
Flexbar 3.0 Dodt et al., 2012 https://github.com/seqan/flexbar
Bowtie2 Langmead and Salzberg, 2012 http://bowtie-bio.sourceforge.net/
bowtie2/index.shtml
STAR 2.5.3a Dobin et al., 2013 https://github.com/alexdobin/STAR
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents should be directed to and will be fulfilled by the Lead Contact, Niels H. Gehring
(ngehring@uni-koeln.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines
HEK293 Flp-In T-REx (human; sex: female; Thermo Fisher Scientific; RRID:CVCL_U427), HeLa Flp-In T-REx (human; sex: female;
established by Elena Dobrikova and Matthias Gromeier, Duke University Medical Center) and HeLa Tet-Off (human; sex: female;
Clontech; RRID:CVCL_V352) cells were cultured in DMEM (GIBCO) supplemented with 9% fetal bovine serum (GIBCO) and
1x Penicillin Streptomycin (GIBCO). All cells were cultivated at 37C and 5% CO2 in a humidified incubator.
METHOD DETAILS
Stable Cell Lines and Plasmids
Mammalian expression constructs for in vitro splicing assays were inserted into the pCI-neo vector (Promega) with an N-terminal
FLAG tag. MINX and MINX Dintron in vitro splice substrates were described previously (Gehring et al., 2009a; Gehring et al.,
2009b). The point and deletion mutants of RNPS1 were PCR amplified and inserted into pCI-neo-FLAG. Accordingly, GST,
CWC22 WT and CWC22 NK171DE mutant (described in (Steckelberg et al., 2012)) were cloned into pCI-neo-FLAG. For transient
tethering assays, the constructs were subcloned into pCI-neo containing an N-terminal MS2V5 tag. For generating stable teth-
ering cell lines, the constructs together with the MS2V5 tag were inserted in the cumate-inducible PB-CuO-MCS-IRES-GFP-EF1-
CymR-Puro vector (System Biosciences). All reporter constructs were PCR amplified from either HeLa cDNA or genomic DNA
and, if applicable, mutagenized by PCR. The 2xMS2-DESE binding sites were optimized via PCR to remove potential ESE
sequences and inserted with varying spacers into the truncated exon 4 of the HSD17B10 mini-gene. All minigene constructs
were cloned in-frame with an N-terminal FLAG-tag into the pcDNA5/FRT/TO vector (Thermo Fisher Scientific). For generating sta-
ble RNPS1, SAP18 or PNN rescue cell lines, the expression constructs were cloned into the pcDNA5/FRT/TO vector containing
an N-terminal FLAG-tag. To ensure robust expression in rescue assays, selected RNPS1 or PNN constructs were also cloned into
the pcDNA5/FRT/TO vector containing an N-terminal FLAG-emGFP-tag. Standard protocols were used to generate stable rescue
or reporter HeLa Flp-In T-REx cell lines and positive clones were selected with 100-150 mg ml-1 hygromycin B (InvivoGen).
Expression of stable cell lines was induced for minimum 24 h with 1 mg ml-1 doxycycline. Dual-inducible tethering cell lines
were generated by integrating a PB-CuO-MS2V5 construct in stable Flp-In T-REx reporter cell lines. 2 mg ml-1 puromycin was
used for the selection of positive clones. Expression of the dual-inducible cell lines was first induced with 30 mg ml-1 cumate
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Cufflinks 2.2.1 Trapnell et al., 2013 http://cole-trapnell-lab.github.io/cufflinks
Cummerbund Trapnell et al., 2012 http://compbio.mit.edu/cummeRbund/
Majiq 1.0.6 Vaquero-Garcia et al., 2016 https://majiq.biociphers.org/
StringTie 1.3.3b Pertea et al., 2015 https://github.com/gpertea/stringtie
Gffcompare 0.10.1 Geo Pertea https://github.com/gpertea/gffcompare
GraphPad Prism 5.03 GraphPad Software https://www.graphpad.com/scientific-
software/prism/
Superheat R package arXiv:1512.01524 [stat.AP] https://github.com/rlbarter/superheat
UpSet R package Lex et al., 2014 http://caleydo.org/tools/upset/
Euler3 Applet Rodgers et al., 2014 http://www.eulerdiagrams.com/Euler3.html
Human Splicing Finder online tool Desmet et al., 2009 http://www.umd.be/HSF3/
SVM-BPfinder Corvelo et al., 2010 http://regulatorygenomics.upf.edu/
Software/SVM_BP/
Integrative Genomics Viewer (Version 2.3.98) Thorvaldsdo´ttir et al., 2013 http://software.broadinstitute.org/
software/igv/RRID:SCR_011793
Image Lab software Bio-Rad SOFT-LIT-170-9690-ILSPC
ImageQuant TL software GE Healthcare Cat# 29000605
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for 24h, followed by both 1 mg ml-1 doxycycline and 30 mg ml-1 cumate for another 24 h. Mycoplasma contamination was tested
by PCR amplification of mycoplasma-specific genomic DNA (Young et al., 2010) or by using the Mycoplasmacheck service
(Eurofins Genomics).
In Vitro Transcription, In Vitro Splicing and RNP Immunoprecipitation
In vitro transcription and in vitro splicing experiments were performed as described previously (Gehring et al., 2009a). The capped
MINX transcripts were generated by run-off transcription with SP6 polymerase (Promega) in the presence of Ribo m7G Cap Analog
(Promega) and a-32P-GTP (Hartmann Analytic). In vitro splicing reactions were carried out in HeLa nuclear extracts (CIL Biotech)
supplemented with HEK293 whole cell extracts expressing FLAG-tagged proteins. After splicing, immunoprecipitations were car-
ried out with EZview Red ANTI-FLAG M2 Affinity Gel (Sigma-Aldrich) in EJC buffer (20 mM HEPES-KOH pH 7.9, 200 mM NaCl,
2 mM MgCl2, 0.2% Triton X-100, 0.1% Nonidet-P40, 0.05% sodium deoxycholic acid). Subsequently, RNA was extracted from
the bound proteins via peqGOLD TriFast (VWR) and resolved by denaturing PAGE. For detection of co-immunoprecipitated pro-
teins, splicing reactions with 30-O-Me-m7G(50)ppp(50)G RNA Cap Structure Analog (NEB)-capped but non-radioactively labeled
MINX transcripts were performed. Immunoprecipitations were carried out with Anti-FLAG M2 Magnetic Beads (Sigma-Aldrich) in
EJC buffer and co-immunoprecipitated proteins were eluted with SDS-sample buffer, separated by SDS-PAGE, and analyzed
by immunoblotting.
Co-immunoprecipitation
FLAG-tagged proteins were expressed in stable HeLa Flp-In T-REx cells induced for 48 h and immunoprecipitated from 1 mg cell
lysate (in 50 mM Tris [pH 7.2], 150 mM NaCl, 0.5% Triton X-100) for 2 h using Anti-FLAG M2 Magnetic Beads (Sigma-Aldrich)
in the presence or absence of RNase A (50 mg ml-1). Beads were washed four times with lysis buffer and co-immunoprecipitated
proteins were eluted with SDS-sample buffer, separated by SDS-PAGE, and analyzed by immunoblotting. Effectiveness of
RNase A treatment was confirmed by ethidium bromide staining of total RNA isolated after immunoprecipitation.
siRNA Transfections
Cell lines were reverse transfected with 60 pmol siRNA per 2 3 105 cells using 2.5 ml Lipofectamine RNAiMAX (Thermo Fisher
Scientific). Fresh medium was supplied 24 h after siRNA transfection. The used siRNA target sequences are listed in the Key
Resources Table.
Transient Plasmid Transfections
2.8 3 105 HeLa Tet-Off cells were seeded in 6-well plates 24 h before transfection by calcium phosphate precipitation. For reporter
assays, 0.5 mg of a mVenus expression plasmid, 1 mg reporter plasmid and 2 mg fill plasmid encoding for b-globin were transfected.
For tethering experiments 0.5 mg of a mVenus expression plasmid, 0.5 mg reporter plasmid and 1 mg plasmid encoding for MS2V5-
tagged proteins were transfected. Overexpression of proteins in HeLa Flp-In T-REx cells was performed using jetPRIME (Polyplus
Transfection), co-transfecting 0.5 mg of a mVenus expression plasmid and 2 mg of plasmid encoding for FLAG-tagged proteins.
Immunoblot Analysis and Antibodies
SDS-polyacrylamide gel electrophoresis and immunoblot analysis were performed using protein samples derived from peqGOLD
TriFast extractions, parallel transfection harvested with RIPA buffer or samples eluted from Anti-FLAG M2 magnetic beads. All
antibodies (see Key Resources List) were used at 1:3000 dilutions in 50 mM Tris [pH 7.2], 150 mM NaCl with 0.2% Tween-20 and
5% skim milk powder. Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare) in combination with the myECL
Imager (Thermo Fisher Scientific) was used for visualization.
Reverse Transcription, End-Point and Quantitative RT-PCR
Cells were harvestedwith peqGOLDTriFast and RNAextracted according to themanufacturer’s instructions. 1-4 mg of total RNAwas
reverse-transcribed in a 20 ml reaction volume with 10 mM VNN-(dT)20 primer using the ProtoScript II Reverse Transcriptase (NEB),
GoScript Reverse Transcriptase (Promega) or the GoScript Reverse Transcription Mix, Oligo(dT) (Promega). 0.5% of purified cDNA
was used as template in end-point PCRs using the GoTaq Green Master Mix (Promega) and 0.2 mM final concentration of sense and
antisense primer (see Table S3 for sequences). After 30 PCR cycles, the samples were resolved by electrophoresis on ethidium
bromide-stained, 1% agarose TBE gels and visualized by trans-UV illumination using the Gel Doc XR+ (Bio-Rad). Representative
gel images from at least three independent experiments are shown. Sanger sequencing of individual bands was performed using
the service of Eurofins Genomics.
Quantitative RT-PCR were performed with the GoTaq qPCR Master Mix (Promega) using 0.5% of cDNA in 10 ml reactions, 0.2 mM
final concentration of sense and antisense primer (see Table S3 for sequences), and the CFX96 Touch Real-Time PCR Detection
System (Bio-Rad).
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Pathscan and Cell Survival Assays
The PathScan Stress and Apoptosis Signaling Antibody Array Kit (Cell Signaling Technology) was used to detect cellular stress
responses upon depletion of RNPS1, SMG1 or RBM8A. In brief, siRNA-mediated knockdowns of HeLa Flp-In T-REx were performed
in 6-well plates as described above. After 3 days, the cells were harvested in 1x Cell Lysis Buffer and protein concentration was
measured using the Bradford Protein Assay (Bio-Rad). Lysates were diluted to 0.5 mg ml-1 protein concentration and the sandwich
immunoassay was performed according to the manufacturer’s instructions. The cell lysate was incubated with nitrocellulose-coated
glass slides on which target-specific capture antibodies have been spotted in duplicate. Biotinylated detection antibody cocktail in
combination with streptavidin-conjugated HRP and LumiGLO Reagent are then used to visualize the bound detection antibody by
chemiluminescence.
To measure cell proliferation and survival upon EJC component depletion, the CellTiter-Glo Luminescent Cell Viability Assay
(Promega) was used. HeLa Flp-In T-REx were reverse transfected with siRNA as described above and 2000 cells were seeded in
triplicates in 96-well plates suitable for sensitive luminescence measurements. 2 hours after seeding, the first time point was
measured according to the manufacturer’s instructions and subsequent measurements were performed in 24-hour intervals.
RNA-Seq
RNA-Seq analysis was carried out on normal or stable RNPS1-expressing HeLa Flp-In T-REx cells transfected with siRNAs targeting
RNPS1 or the negative control luciferase. Three biological replicates were analyzed for each sample. Total RNA was extracted with
peqGOLD TriFast as described above. Ribosomal depletion and strand specific library preparation was carried out with the TruSeq R
Stranded Total RNA LT (with Ribo-ZeroTM Human/Mouse/Rat) according to the manufacturer’s instructions. After validation (Agilent
2200 TapeStation) and quantification (Invitrogen Qubit System) all 12 transcriptome libraries were pooled. The pool was quantified
using the Peqlab KAPA Library Quantification Kit and the Applied Biosystems 7900HT Sequence Detection System and loaded
on one lane of Illuminas HiSeq4000 sequencer with a 2 3 75bp protocol. The analysis produced 5.3 Gb/sample (4.8-6.6 Gb), corre-
sponding to 35Mread-pairs/sample. Basic read quality check was carried out using FastQC showing > 97.5% of Q30 bases (PF) and
a mean quality score of 39,8.
Read Processing and Mapping
Adaptor sequences and low quality 30 baseswere removedwith Flexbar 3.0. (Dodt et al., 2012). Short reads from the rRNA locuswere
subtracted bymapping against the 45S precursor (Homo sapiens, NR_046235.1) using Bowtie2 (Langmead and Salzberg, 2012). The
remaining reads were aligned against the human genome (version 38, EnsEMBL 90 transcript annotations) using the STAR read
aligner (2.5.3a)(Dobin et al., 2013)
Gene Expression Analysis
We employed the Cuffquant and Cuffdiff software (release 2.2.1) (Trapnell et al., 2013) to estimate gene expression abundance and
differential gene expression for the EnsEMBL reference annotation. The R package Cummerbund (Trapnell et al., 2012) was subse-
quently used to inspect and visualize the results.
Local Splicing Variants Identification
We carried out local splicing variant detection using MAJIQ (1.0.6, without GC correction in the build step)(Vaquero-Garcia et al.,
2016). To this end, we first produced a transcriptome annotation with StringTie (1.3.3b)(Pertea et al., 2015) for each RNA-Seq repli-
cate on the control groups (Luc for RNPS1 versus Luc, GFP for EIF4A3 versusGFP) to comparewith the knockdown conditions. Next,
we combined the annotations using themerge command fromStringTie, with theminimum isoform fraction (-f parameter) set to 0.5 to
eliminate lowly transcribed isoform. Finally, we applied gffcompare (0.10.1) against the human genome annotation with the param-
eters –R (precision correction), -Q (sensitivity correction) and –M (discard single-exons transfrags). The stringent transcriptome anno-
tation enabled us to contrast between conditions as it highlights differential exon usage.
The Voila tabular output was processed and analyzed with Python programming language (3.6). The dataset, which initially con-
tains one local splice variations (LSV) per row, was expanded to provide one exon-exon junctions per row, enabling us to filter the
exon-exon junction given the delta percent spliced in (dPSI) (< 0.1) and their posterior probability P(dPSI) (> 0.90). These cutoffs
were applied to ensure the sensitive detection of alternative splicing events (dPSI <0.1), while keeping only probable splicing events
(P(dPSI) > 0.90). The dPSI between two conditions is calculated by estimating a posterior distribution for the change in the respective
junction’s relative inclusion level (Vaquero-Garcia et al., 2016). For all dPSI calculations the PSI of the RNPS1 or EIF4A3 knockdown
sample was substracted from the PSI of the control (Luc or GFP). Furthermore, we used the bedtools intersect command (pybedtools
0.7.10, bedtools 2.26.0)(Dale et al., 2011; Quinlan and Hall, 2010) to extract the exon coordinates from the StringTie annotation over-
lapping the respective junction. This allowed us to re-classify all junctions based on calculating distances of each exon to junction
connection. Furthermore, junctions were classified as spurious if the PSI in control samples was low (< 0.05) and the junction was
sufficiently upregulated (fold change PSI-KD/PSI-control > 10).
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Gene Ontology Analysis
Enrichment test for biological process, cellular component and molecular function terms was carried out as proposed by (Reimand
et al., 2016), with G:Profiler and Enrichment Map Cytoscape plugin. We have compared genes identified by MAJIQ after filtering for
probable and spurious events against a background of 14,594 multi-exon genes that were expressed (FPKM > 1) in any of the
analyzed sample.
Calculation of MaxEnt Scores, ESE/ESS Composition, Putative Branch Points and Additional Analyses
We used theMaxEnt algorithm (Yeo and Burge, 2004) implemented in the Human Splicing Finder online tool (3.0) (Desmet et al., 2009)
andmaxentpy (https://github.com/kepbod/maxentpy) to calculate splice site strengths. Using the same tools, we analyzed the exonic
splicingenhancer andsilencer compositionof theRER1 reporter.PutativemammalianU2branchpointswerepredictedusing theSVM-
BPfinder online tool (Corvelo et al., 2010). TheASAP structure (PDB ID: 4A8X)(Murachelli et al., 2012) was visualized usingPyMOL (1.8).
The UpSet R package (Lex et al., 2014) and the Euler3 Applet (Rodgers et al., 2014) was used to visually compare the alternative splice
analysis results. Sashimi-plots (Katz et al., 2015) were generated fromdata generated in this study, aswell as available RNA-Seq (GEO
accessionnumberGSE63091) (Wanget al., 2014) data using the integrated functionof the IGV (2.3.98) (Thorvaldsdo´ttir et al., 2013). The
fitness scores were obtained from available data on HeLa cells generated by a high-resolution CRISPR-screen (Hart et al., 2015). The
fitness score is a logBayes factor (BF) for eachgene,whichwascalculatedwithaBayesianAnalysis ofGeneEssentiality algorithm (Hart
et al., 2015). The confidence in the essentiality (higher impact on fitness) of the gene increases with more positive scores. The Bayes
Factor cutoff at 5% false discovery rate for HeLa cells (15.47) was used to discriminate essential and non-essential genes.
Code Availability
For availability of codes that were developed for this project, please contact the corresponding authors.
QUANTIFICATION AND STATISTICAL ANALYSIS
p values < 0.05 were considered significant. Significance in all figures is indicated as follows: ns = not significant, *p = 0.01 to 0.05,
**p = 0.001 to 0.01, ***p < 0.001.
RNP Immunoprecipitation
Signals of 32P-labeled RNAs were scanned using a Typhoon FLA 7000 (GE Healthcare) and quantified using the ImageQuant TL
software (GE Healthcare). Results are shown as mean ± SD. GraphPad Prism 5 was used to determine the statistical significance
by one-way ANOVA with Bonferroni post-test.
End-Point RT-PCR
Bands detected in agarose gels from the indicated biological replicates of end-point PCRs were quantified using the Image Lab 6.0.1
software (Bio-Rad). Results of the indicated band%per lane are shown asmean ± SD. GraphPad Prism 5was used to determine the
statistical significance by one-way ANOVA with Bonferroni post-test. For experiments with only two samples, two-tailed unpaired
Student’s t test was performed with GraphPad Prism 5.
Quantitative RT-PCR
The reactions for each biological replicate were performed in duplicates and the average Ct (threshold cycle) value for retained or
skipped MRPL3 exon 4 was measured. Values for skipped exon were subtracted from values for retained exon to calculate the
DCt. The fold changes were calculated using the DDCt method, using the Luc knockdown as normalization (Schmittgen and Livak,
2008). The mean fold changes were calculated from three biologically independent experiments. Results are shown as mean ± SD.
GraphPad Prism 5 was used to determine the statistical significance by one-way ANOVA with Bonferroni post-test.
Pathscan Assay
Chemiluminescent signals were measured with the ChemiDoc MP Imaging System (Bio-Rad) and quantified using the ImageQuant
TL software (GEHealthcare). All signals were first normalized to the a-tubulin control signal. Then,mean values of three biological and
two technical replicates, as well as differences between knockdown and control samples were calculated. Finally, the mean log2 of
absolute relative signal intensities were plotted using the superheat R package (arXiv:1512.01524v2 [stat.AP]). Results are shown
as mean ± SD. Propagation of error calculations were performed, and GraphPad Prism 5 was used to determine the statistical
significance by one-way ANOVA with Bonferroni post-test.
Survival Assay
Background corrected mean luminescence was calculated and plotted using GraphPad Prism 5. Results are shown as mean ± SD.
GraphPad Prism 5 was used to determine the statistical significance by two-way ANOVA with Bonferroni post-test.
Molecular Cell 72, 482–495.e1–e7, November 1, 2018 e6
72
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession number for the raw RNA-sequencing data reported in this paper is ArrayExpress: E-MTAB-6564.
Data Availability
The authors declare that all the data supporting the findings of this study are available within the article and its Supplementary
Information files and from the corresponding authors upon reasonable request. The raw imaging data can be accessed viaMendeley:
https://doi.org/10.17632/wt7ybwz82g.1.
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Abstract  32 
The exon junction complex (EJC) is an essential constituent and regulator of spliced messenger 33 
ribonucleoprotein particles (mRNPs) in metazoans. As a core component of the EJC, CASC3 was 34 
described to be pivotal for EJC-dependent nuclear and cytoplasmic processes. However, recent 35 
evidence suggests that CASC3 functions differently from other EJC core proteins. Here, we have 36 
established human CASC3 knockout cell lines to elucidate the cellular role of CASC3. In the knockout 37 
cells, overall EJC composition and EJC-dependent splicing are unchanged, whereas mRNA isoforms 38 
targeted by nonsense-mediated decay (NMD) are upregulated on a transcriptome-wide scale. 39 
Mechanistically, recruiting CASC3 to reporter mRNAs by direct tethering or via binding to the EJC 40 
stimulates mRNA decay and endonucleolytic cleavage at the termination codon. Building on existing 41 
EJC-NMD models, we propose that CASC3 equips the EJC with the ability to communicate with the 42 
NMD machinery in the cytoplasm. Collectively, our results characterize CASC3 as a peripheral EJC 43 
protein that tailors the transcriptome by promoting the degradation of EJC-dependent NMD 44 
substrates.  45 
46 
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Introduction 47 
Messenger RNA-binding proteins (mRBPs) determine the stability, location, and fate of bound 48 
mRNAs and are therefore important regulators of post-transcriptional gene expression (Hentze et al., 49 
2018). A central component of spliced mRNPs in metazoans is the exon-junction-complex (EJC), which 50 
is deposited during splicing upstream of exon-exon boundaries (Boehm & Gehring, 2016, Le Hir et al., 51 
2016, Woodward et al., 2017). The heterotetrameric core of the EJC is composed of the proteins 52 
EIF4A3, MAGOH, RBM8A (Y14) and CASC3 (BTZ, MLN51) (Andersen et al., 2006, Bono et al., 2006). 53 
Generally, EJCs serve on spliced mRNAs as a mark that act as a binding platform for peripheral EJC-54 
interacting factors (Singh et al., 2012). The core and peripheral EJC components contribute to different 55 
steps of post-transcriptional gene expression including splicing regulation, mRNA localization, 56 
translation and nonsense-mediated mRNA decay (NMD) (Boehm & Gehring, 2016, Woodward et al., 57 
2017). 58 
The EJC does not form spontaneously, but instead undergoes stepwise assembly in association 59 
with the spliceosome, while it proceeds through different spliceosomal complexes (Gerbracht & 60 
Gehring, 2018). As a first step, the splicing factor CWC22 recruits EIF4A3, to which the MAGOH/RBM8A 61 
heterodimer binds later on (Gehring et al., 2009, Alexandrov et al., 2012, Barbosa et al., 2012, 62 
Steckelberg et al., 2012, Steckelberg et al., 2015). Unlike the three spliceosome-associated EJC 63 
components EIF4A3, MAGOH and RBM8A, the fourth protein CASC3 is absent from the purified 64 
spliceosomal C complex (Bessonov et al., 2008). Furthermore, it cannot be detected in mRNPs formed 65 
on splicing intermediates (Gehring et al., 2009). Therefore, it was suggested that CASC3 binds to the 66 
initially formed trimeric pre-EJC (consisting of EIF4A3, MAGOH and RBM8A) at a later stage. 67 
Interestingly, CASC3 has also been shown to be a shuttling protein that is mainly located in the 68 
cytoplasm, whereas the other EJC components are predominantly detected in the nucleus (Kataoka et 69 
al., 2000, Le Hir et al., 2001, Degot et al., 2002, Palacios et al., 2004, Shibuya et al., 2004). It has 70 
therefore been suggested that CASC3 binds to the EJC in the nucleus and is transported with it into the 71 
cytoplasm (Ballut et al., 2005). A recent study demonstrated that EJCs undergo a compositional switch 72 
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and that the ASAP/PSAP component RNPS1 and the protein CASC3 bind to functionally different 73 
mRNPs and exist in mutually exclusive EJCs (Mabin et al., 2018). While EJCs of nuclear enriched 74 
transcripts were found to interact with RNPS1, the EJCs of cytoplasmic enriched transcripts rather 75 
contained CASC3. This observation is in line with the predominantly cytoplasmic localization of CASC3, 76 
but would argue against a nuclear function.  77 
Another aspect under debate is the involvement of CASC3 in the NMD pathway. According to the 78 
EJC-dependent model of NMD, an EJC present more than 50-55 nucleotides downstream of a 79 
premature termination codon (PTC) triggers degradation by the NMD machinery (Nagy & Maquat, 80 
1998). This quality control mechanism rids the cells from aberrant transcripts that contain PTCs due to 81 
mutations or mis-splicing. Additionally, it serves as a post-transcriptional mechanism of gene 82 
expression, especially when coupled to alternative splicing (Nasif et al., 2018). This is a common 83 
feature of many genes coding for mRBPs, e.g. most SR proteins (Lareau et al., 2007, Ni et al., 2007). 84 
The EJC triggers NMD by interacting with members of the SURF complex resulting in phosphorylation 85 
of the central NMD factor UPF1 (Kashima et al., 2006). Phosphorylated UPF1 then stimulates two 86 
distinct degradation pathways of NMD: The SMG5/7-dependent pathway results in deadenylation and 87 
decapping of the transcript followed by exonucleolytic decay from the 5ʹ end by XRN1 and the 3ʹ end 88 
by the exosome (Loh et al., 2013). Alternatively, the transcript can be cleaved in the vicinity of the PTC 89 
by the endonuclease SMG6 which results in two mRNA fragments that can be exonucleolytically 90 
degraded by XRN1 and the exosome (Huntzinger et al., 2008, Eberle et al., 2009). While these pathways 91 
can act redundantly and in principle compensate for each other, SMG6-dependent endonucleolytic 92 
cleavage (endocleavage) has been shown to be the dominant pathways for NMD in human cells 93 
(Boehm et al., 2014, Lykke-Andersen et al., 2014, Colombo et al., 2017). In cells depleted of CASC3 a 94 
stabilizing effect on PTC-containing reporter mRNAs and selected endogenous targets was reported 95 
(Palacios et al., 2004, Gehring et al., 2005, Gehring et al., 2009). Furthermore, tethering CASC3 to an 96 
mRNA results in UPF1-dependent degradation of the transcript (Gehring et al., 2009). However, a 97 
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recent report has challenged these observations and showed that CASC3 plays a minor role in NMD 98 
and only for certain endogenous targets in contrast to EIF4A3 or RNPS1 (Mabin et al., 2018).  99 
We were intrigued by the contrasting reports about the enigmatic role of CASC3 and decided to 100 
investigate the function of CASC3 and its distinction to the other EJC core components in more detail. 101 
For this purpose, we established HEK 293 CASC3 knockout (KO) cells using CRISPR-Cas9-mediated gene 102 
editing. The CASC3 KO cell lines are unchanged in their composition of the EJC core and peripheral 103 
interacting proteins. However, RNA-sequencing reveals an upregulation of transcript variants 104 
containing premature-termination codons (PTC) as well as the differential expression of many known 105 
NMD targets, indicating a perturbation of this decay pathway. Mechanistically, CASC3 stimulates 106 
SMG6-dependent turnover of NMD targets and likely acts as a link from the EJC to the NMD machinery. 107 
On the basis of these results we propose a revised model of EJC-dependent NMD in human cells. 108 
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Results 109 
CASC3 is dispensable for nuclear EJC functions 110 
Previously, we and others have shown that depletion of EJC core components in human 111 
cells leads to pervasive re-splicing of cryptic splice sites, resulting in aberrant splice variants lacking 112 
exonic sequences (schematically depicted in Supplementary Figure 1)  (Wang et al., 2014, Boehm 113 
et al., 2018). Mechanistically, the EJC prevents the use of cryptic splice sites either by interaction 114 
with the ASAP/PSAP component RNPS1 or by sterically masking splice sites (Boehm et al., 2018). 115 
In keeping with previous observations from HeLa cells, the knockdowns of the EJC core 116 
components EIF4A3 or RBM8A in HEK293 cells resulted in exon-skipping of the mRNAs for RER1, 117 
OCIAD1 and MRPL3 (Figure 1 A-C). Surprisingly, a knockdown of the EJC core factor CASC3 did not 118 
result in mis-splicing of these three selected transcripts. (Figure 1A-C). However, the knockdown 119 
of CASC3 increased the abundance of an alternative transcript isoform of the SR protein SRSF2, 120 
which is known to be targeted by NMD (Figure 1D) (Sureau et al., 2001, Wollerton et al., 2004). 121 
Together, these results indicate that CASC3 contributes to NMD activation by the EJC, but is not 122 
required for EJC-dependent splicing regulation. Given that the generation of EJC-specific splice 123 
isoforms is a readout for EJC assembly, the initial formation of EJCs does not seem to be affected 124 
by the knockdown of CASC3. 125 
EJC assembly is unaffected in CASC3 knockout cells 126 
Although the knockdown efficiency of CASC3 was substantial (Figure 1E), we wished to 127 
exclude that residual amounts of CASC3 prevented a reliable assessment of the protein’s function. 128 
Since CASC3 was found to be non-essential in multiple genome-wide screens of human 129 
immortalized cell lines, we reasoned that knockout (KO) of CASC3 should be feasible (Hart et al., 130 
2015, Hart et al., 2017). Accordingly, we obtained three cell lines by CRISPR-Cas9-mediated gene 131 
editing, designated H, F, and T lacking the CASC3-specific 130 kDa band on a western blot (Figure 132 
2A). In all cell lines we detected genomic insertions of different length and sequence at the 133 
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beginning of the coding region of CASC3, which resulted in frame shifts of the downstream coding 134 
region or, in the case of cell line T, contained in-frame termination codons (Figure 2B, 135 
Supplemental Figure 2A and B). For the cell lines H and F, we observed an additional band of 100 136 
kDa on western blots with antibodies recognizing the C-terminal or central region of CASC3 (Figure 137 
2A, red arrow, Supplementary Figure 2A and C). This cross-reactive protein interacted with FLAG-138 
tagged EIF4A3 and disappeared upon treatment with siRNAs against CASC3 (Figure 2C, 139 
Supplementary Figure 2C and D). This suggests that the cell lines H and F produce an N-terminally 140 
truncated form of CASC3, presumably representing a novel, non-canonical protein product. Such 141 
aberrant proteins have been recently described in a systematic analysis to be common by-products 142 
of CRISPR-Cas9 genome editing (Tuladhar et al., 2019). 143 
To assess the composition of exon junction complexes and their peripheral interacting 144 
proteins in the absence of CASC3 KO, we analyzed the FLAG-tagged EIF4A3 interactome in the cell 145 
line H and wild type cells using mass spectrometry. EIF4A3 was successfully enriched, together 146 
with other known EJC complex members (Supplemental Figure 2E). Although co-precipitated 147 
CASC3 was strongly reduced in the knockout cell line (Supplemental Figure 2G, log2 fold change = 148 
-3.75), it was enriched relative to the control (Supplemental Figure 2F, log2 fold change = 2.43). 149 
This confirmed that residual amounts of CASC3 protein are still present in the knockout cell line H. 150 
When the cells were treated additionally with CASC3 siRNAs, the amount of CASC3 pulled down 151 
by EIF4A3 was reduced to background levels (Figure 2D and E). Therefore, the cell lines H and F are 152 
comparable to a constitutive knockdown of CASC3, whereas the cell line T (without further 153 
treatment) and cell line H in combination with CASC3 siRNA treatment completely lack detectable 154 
CASC3 protein. This set of cell lines enables a hitherto unfeasible analysis of CASC3’s cellular 155 
function as part of the EJC.  156 
 157 
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Strikingly, no other EJC core factor or splicing regulatory EJC component (e.g. ASAP/PSAP) was 158 
significantly altered in the CASC3-depleted condition (Figure 2F). This is in line with our initial 159 
conclusion that splicing-regulatory EJCs can assembly even in the absence of CASC3. Further 160 
support comes from co-immunoprecipitation analysis of EIF4A3, which demonstrated unchanged 161 
interaction with the EJC component MAGOH in the CASC3 knockout cell line H (Supplementary 162 
Figure 2H). In agreement with the data obtained from the knockdown of CASC3 in Figure 1, 163 
transcripts containing EJC-dependent splice sites were correctly spliced in CASC3 KO cells (Figure 164 
2G and H, Supplementary Figure 2I and J), indicating that CASC3 is not necessary for correct and 165 
stable deposition of the EJC during splicing and its subsequent nuclear splice function. The role of 166 
CASC3 during EJC assembly was also characterized by performing in vitro splicing of a MINX intron 167 
in cell lysates obtained from the cell line H (Figure 2I and Supplementary Figure 2K). Notably, the 168 
overall splicing efficiency of the MINX transcript was slightly reduced in the input of CASC3 KO 169 
lysates when compared to wild-type lysates. However, spliced RNA was pulled down to the same 170 
extent by EIF4A3 (2.97% in KO vs. 3.01% in WT), suggesting that EIF4A3 is deposited on spliced 171 
mRNA even when CASC3 is strongly depleted. In the absence of CASC3, the only other protein that 172 
was significantly, although mildly reduced in EIF4A3-IPs was the NMD factor UPF3B (Figure 2F, log2 173 
fold change = -1.52). UPF3B links the EJC to the NMD machinery via direct interactions (Buchwald 174 
et al., 2010) and was recently found to be enriched in cytoplasmic CASC3-loaded EJCs (Mabin et 175 
al., 2018). The reduction of NMD-competent EJCs could contribute to the NMD impairment that 176 
we observed upon loss of CASC3. 177 
CASC3 regulates NMD-sensitive isoforms 178 
To investigate the global effects of CASC3 depletion on the transcriptome, we performed RNA-179 
sequencing (RNA-seq) of the cell lines H and T either treated with CASC3 or control siRNAs (Figure 180 
3A) and identified differentially expressed genes (Supplementary Figure 3A and 3B, Supplementary 181 
Table 4). To exclude clone-specific and siRNA treatment-related effects, we compared the 182 
identified targets between the four conditions. Overall, the high number and the substantial 183 
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overlap of upregulated genes suggests that CASC3 KO mainly results in the accumulation of certain 184 
transcripts (Figure 3B and C, Supplementary Figure 3C). This observation fits with the hypothesis 185 
that CASC3 is required for efficient execution of NMD. Accordingly, several upregulated genes 186 
belong to the class of small RNA (e.g. snoRNA) host genes, which are frequently NMD targets 187 
(Figure 3C and D) (Lykke-Andersen et al., 2014). We validated the upregulation of the snoRNA host 188 
gene ZFAS1 by qPCR, which was even more pronounced in CASC3 KO than UPF1 knockdown cells 189 
(Supplementary Figure 3D and E). Across the top 100 significantly upregulated genes in CASC3 KO, 190 
15 small RNA host genes were identified (Figure 3D). Comparing the differentially expressed genes 191 
to recent transcriptome-wide NMD screens, many of the top 100 significantly upregulated genes 192 
were also differentially expressed in UPF1 and SMG6/7 KD (Figure 3D, 23% and 59%, respectively) 193 
(Colombo et al., 2017, Data ref: Colombo et al., 2017). However, none of the identified targets 194 
were present in an RNPS1 knockdown (Figure 3D) (Boehm et al., 2018, Data ref: Boehm et al., 195 
2018). Collectively, our differential gene expression analysis strengthens the proposed link 196 
between CASC3 and the NMD-machinery.  197 
Next, we analyzed alternative splicing changes in CASC3 KO cells (Figure 3A). Since our earlier 198 
assays showed that CASC3 was not involved in EJC-regulated splicing (Figures 1 and 2), we were 199 
surprised to detect many altered splicing events in CASC3 depleted cells (Supplementary Figure 3F, 200 
Supplementary Table 5). It is remarkable that hardly any alternative splicing events were shared 201 
between RNPS1 knockdown and CASC3 KO cells (Figure 3E, Supplementary Figure 3F). Either 202 
CASC3 regulates an RNPS1-independent set of alternative splice sites or the splicing changes are 203 
due to impaired NMD, which fails to remove NMD-sensitive isoforms. To test these possibilities, 204 
we investigated the functional consequence of CASC3-dependent alternatively splicing on the 205 
transcript isoform level (Figure 3A, Supplementary Figure 4A and B, and Supplementary Table 6). 206 
Strikingly, in all CASC3 KO conditions the majority of upregulated mRNA isoforms contained a 207 
premature termination codon (PTC), rendering the transcripts susceptible to NMD (Figure 4A). On 208 
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the other hand, downregulated isoforms rarely contained a PTC. Among the identified isoform 209 
switches was the NMD target SRSF2, which we confirmed earlier to be CASC3-dependent (Figure 210 
1D). While overall SRSF2 gene expression varied only slightly between wild-type and CASC3 KO 211 
cells, the isoform usage changed dramatically towards the accumulation of NMD-sensitive 212 
transcripts in the CASC3 KO conditions (Figure 4B).   213 
We next validated a set of transcript isoform switches by qPCR (Figure 4C-E, Supplementary Figure 214 
C and D). In the transcript isoforms stabilized by the CASC3 KO and by a UPF1 KD, the inclusion of 215 
intronic regions resulted in the inclusion of PTCs. For example, an NMD-sensitive transcript variant 216 
of the gene TOE1 is produced alongside the canonical isoform by usage of an alternative 3ʹ splice 217 
site (Supplementary Figure 4D). This event was also prominently detected in the SMG6/7 and UPF1 218 
dataset (Supplementary Figure 4E).   219 
The shift of isoform usage from NMD-insensitive to PTC-containing transcripts was also observed 220 
transcriptome-wide in CASC3 KO cells and was comparable to NMD-compromised SMG6/7 or UPF1 221 
depleted cells (Figure 4F). These findings indicate that many transcript isoforms upregulated upon 222 
depletion of CASC3 represent genuine endogenous NMD targets. On the gene level, nearly 50% of 223 
CASC3-dependent alternatively used transcript isoforms were also found in the SMG6/7 or UPF1 224 
conditions (Figure 4G and Supplementary Figure 4F). The incomplete overlap between CASC3 and 225 
SMG6/7 or UPF1 could be due to technical differences of the data sets or because not all NMD 226 
sensitive transcripts in the cell are affected by a knockout of CASC3. This could include transcripts 227 
that are degraded by EJC-independent NMD (Buhler et al., 2006, Metze et al., 2013).  228 
CASC3 stimulates SMG6-dependent endocleavage 229 
To deepen the understanding of how a lack of CASC3 results in reduced NMD efficiency, we 230 
stably integrated the well-established globin NMD reporter PTC39 in WT and CASC3 KO cell lines 231 
(Figure 5A and B, Supplementary Figure 5A) (Thermann et al., 1998). The analysis of a reporter 232 
mRNA enables a read-out of multiple aspects of mRNA degradation: firstly, the total levels of the 233 
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full-length reporter, secondly the contribution of 5ʹ->3ʹ exonucleolytic decay by XRN1 (detection 234 
of xrFrag due to an XRN1-resistant element (Boehm et al., 2016, Voigt et al., 2019); and thirdly the 235 
amount of endonucleolytic cleavage by SMG6 (detection of 3ʹ fragment stabilized by XRN1 236 
knockdown). In both WT and CASC3 KO cell lines the reporter was efficiently degraded, showing 237 
that the NMD pathway is still functional in CASC3 depleted cells. However, full-length reporter 238 
levels in CASC3 KO were slightly higher when compared to wild-type cells (lane 2 vs. lane 5). 239 
Notably, the accumulation of 3ʹ fragments following XRN1 knockdown was clearly reduced in the 240 
CASC3 KO condition (lane 3 vs. lane 6). This difference in endocleavage efficiency was also 241 
observed when expressing a minigene reporter of the endogenous CASC3 target TOE1. While there 242 
was a substantial upregulation of full-length reporter mRNA in CASC3 KO cells, the amount of the 243 
3ʹ fragment was strongly reduced, suggesting that SMG6-dependent endocleavage is inefficient in 244 
CASC3 KO cells (Figure 5C and D, Supplementary Figure 5B-D). To further address this, a TPI 245 
reporter was expressed in combination with knockdowns of XRN1, SMG6 and/or SMG7 (Figure 5E-246 
G). The degree of reporter and 3ʹ fragment stabilization of the TPI reporter following XRN1 247 
knockdown was comparable to the observations made for the globin reporter (lanes 1-3 vs. lanes 248 
6-8). In both WT and CASC3 KO cells, SMG6 knockdown resulted in a drastic reduction of 3ʹ 249 
fragments, as expected (lanes 4 and 9). Notably, a knockdown of SMG7 together with XRN1 250 
revealed a major difference between the cell lines. In WT cells the PTC-containing reporter was 251 
only minimally stabilized by the SMG7/XRN1 knockdown and 3ʹ fragments were unaffected. 252 
Performing a SMG6/XRN1 knockdown in CASC3 KO cells lead to a more dramatic stabilization of 253 
the full-length reporter and a decrease of 3ʹ fragments compared to the XRN1 knockdown 254 
condition (lanes 3 and 5 vs. lanes 8 and 10). Collectively, our results indicate that in CASC3 KO cells 255 
SMG6-mediated endocleavage is impaired. This could explain why the CASC3 KO cells are more 256 
sensitive to a knockdown of SMG7 when compared to wild type cells. 257 
To identify, which part of CASC3 promotes NMD, we employed a tethering reporter that was 258 
designed to monitor mRNA turnover as well as endocleavage at the termination codon (Figure 6A). 259 
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Tethering the full-length CASC3 protein to the MS2 stem loops downstream of the stop codon 260 
resulted in degradation of the reporter compared to tethering of the negative control GST (Figure 261 
6B and C, Supplementary Figure 6A). This degradation was accompanied by the production of 3ʹ 262 
fragments in XRN1 knockdown conditions, indicating that the mechanism of decay is comparable 263 
to the PTC-containing reporter mRNAs (Figure 6B, lane 6). Surprisingly, C-terminally truncated 264 
deletion mutants of CASC3 that contain the first 480 or even 137 amino acid residues were able to 265 
induce degradation of the tethering reporter to a comparable extent as full-length CASC3 (Figure 266 
6B, lanes 3 and 4, 7 and 8).  267 
Finally, CASC3 deletion mutants were expressed in the CASC3 KO cells to identify the minimal 268 
part necessary to rescue the effects on endogenous NMD targets (Figure 6D, Supplementary Figure 269 
6B and C). As in the tethering experiment, expression of full-length CASC3 and the C-terminal 270 
truncated variant 1-480 resulted in transcript isoform levels comparable to wild-type cells for the 271 
targets CLN6 and TOE1 (Figure 6D lanes 1-4). An EJC binding-deficient mutant of CASC3 (188/218 272 
double point mutation) was unable to rescue, supporting the notion that CASC3 is recruited to the 273 
mRNA by binding to the EJC (Figure 6D, lane 5). Deleting the N-terminal 109 amino acids of CASC3 274 
(110-480) did not alter the rescue ability (Figure 6D, lane 6). While in the tethering assay it was 275 
sufficient to place the N-terminus downstream of a termination codon, this part of CASC3 was not 276 
necessary to rescue NMD activity in the KO cells. This suggests that different domains of CASC3 act 277 
in a redundant manner during the activation of NMD by the EJC.  278 
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Discussion 279 
The role of CASC3 within the EJC has been the subject of scientific controversy for many years. 280 
CASC3 has been initially described as an EJC core protein, because it was required for the assembly of 281 
the EJC from recombinant protein components in vitro (Ballut et al., 2005). However, it has been 282 
demonstrated that the mechanism of EJC assembly using recombinant proteins is mechanistically 283 
different from EJC assembly in splicing extracts or in living cell (Steckelberg et al., 2012). Furthermore, 284 
several recent publications challenged the view of CASC3 being an EJC core component. For instance, 285 
CASC3 was reported to be present in substoichiometric amounts compared to the other three EJC core 286 
proteins EIF4A3, RBM8A, and MAGOH in HEK293 (Singh et al., 2012)  and U2OS cells (Beck et al., 2011). 287 
Also, during mouse embryonic brain development CASC3 deficiency results in a different phenotype 288 
than the other EJC core components (Mao et al., 2017). By using CASC3 CRISPR-Cas9 knockout cells, 289 
we unambiguously establish that CASC3 is not required for EJC assembly or EJC-regulated splicing in 290 
the nucleus (Figure 7). Therefore, our molecular analyses fully support the recently emerging view of 291 
defining CASC3 as a peripheral EJC component. As a mainly cytoplasmic component of the EJC we 292 
propose that the principal role of CASC3 is to alter the efficiency by which NMD-sensitive transcript 293 
isoforms are degraded.  294 
Although NMD has been extensively studied in the past decades and many NMD factors have been 295 
identified and characterized, no universal model exists that describes how they work together to elicit 296 
NMD. While a function of CASC3 in NMD has been reported before, previous analyses did not show 297 
consistent results, ranging from a substantial contribution of CASC3 to only a minor role in NMD 298 
(Palacios et al., 2004, Gehring et al., 2005, Gehring et al., 2009, Mabin et al., 2018). In addition, none 299 
of the previous publications performed transcriptome-wide analyses but concentrated on reporter 300 
mRNAs of only a few selected endogenous NMD targets. We reasoned that the inconsistent results in 301 
the literature may be influenced by variable CASC3 knockdown efficiency. By generating CASC3 302 
knockout cell lines, we can for the first time analyze the global effects of a complete depletion of CASC3 303 
on the transcriptome and can exclude that residual CASC3 protein masks these effects. Interestingly, 304 
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the CASC3 knockout had no deleterious effect on the viability of HEK293 cells, unlike the depletion of 305 
the EJC components EIF4A3, RBM8A, or MAGOH. Nonetheless, since CASC3 is required for mouse 306 
embryogenesis and involved in the transport of mRNAs in D. melanogaster, it is likely that CASC3 307 
downregulation in highly specialized cell types such as neurons or in developing tissues would result 308 
in a more severe phenotype compared to HEK293 cells.  309 
In recent years, high-throughput RNA-sequencing became an increasingly important method for 310 
the analysis of NMD. Several RNA-Seq datasets of cells with NMD-factor knockdowns have been 311 
generated and analyzed (Tani et al., 2012, Hurt et al., 2013, Lykke-Andersen et al., 2014, Schmidt et 312 
al., 2015, Colombo et al., 2017). However, these datasets were obtained in different cell lines, with 313 
different amounts of replicates and due to the rapid developments of next-generation sequencing, not 314 
using the same technologies. Furthermore, batch effects and divergent approaches of data analyses 315 
may contribute to the fact that only a minor overlap of NMD targets could be established so far 316 
(Colombo et al., 2017). We compared the results of our CASC3 KO RNA-sequencings to the most recent 317 
and comprehensive NMD factor analysis performed by Colombo et al. (2017). The differential 318 
expression analysis revealed that many of the top upregulated genes in the CASC3 KO datasets are also 319 
significantly affected by UPF1 or SMG6/7 knockdowns (Colombo et al., 2017) and/or encode for small 320 
RNA (sRNA) host genes, a previously described class of NMD targets (Lykke-Andersen et al., 2014).  321 
We detected many alternative splicing events in the CASC3 KO data, which was unexpected given 322 
that CASC3 was apparently dispensable for the nuclear EJC-related functions. However, we could 323 
attribute these splicing patterns to dysfunctional NMD, since isoform-specific algorithms revealed that 324 
predominantly PTC-containing transcripts accumulated. Using all the available bioinformatics analysis 325 
pipelines and a systematic approach to detect affected transcripts under NMD factor 326 
knockdown/knockout conditions could therefore be a crucial step to paint a complete picture of the 327 
regulation of transcripts by NMD in the future. 328 
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How exactly CASC3 activates NMD when bound to an EJC, is not yet fully understood. Previously, 329 
we reported that the presence of EJCs in the 3ʹ UTR enhances endocleavage (Boehm et al., 2014). In 330 
line with the proposed role as a peripheral NMD-activating EJC component, we observed that CASC3 331 
stimulates SMG6-dependent endocleavage, thereby promoting the degradation of NMD-targeted 332 
transcripts. This effect can be recapitulated by tethering full-length CASC3, its N-terminal two thirds 333 
(1-480) or just its N-terminal 137 amino acids to a reporter mRNA. How the small N-terminal region, 334 
which cannot assemble into the EJC or contains any known protein domains or sequence motifs can 335 
elicit NMD remains to be determined. It is also unclear, if the N-terminus activates translation-336 
dependent degradation, as it was previously shown for the full length CASC3 (Boehm et al., 2016). 337 
Since the N-terminal segment of CASC3 is a region of low-complexity it could hypothetically undergo 338 
liquid-liquid phase separation (LLPS) and be present in condensates with mRNA decay factors, such as 339 
processing bodies (P-bodies). In agreement with this idea CASC3 was shown to localize to cytoplasmic 340 
granules when overexpressed (Cougot et al., 2014). 341 
Our data suggest that CASC3 activates NMD by potentially redundant mechanisms. This fits very 342 
well into the general picture of NMD, which uses multiplexed degradation pathways to efficiently and 343 
robustly remove mRNAs. Mechanistically, binding of CASC3 to the EJC could have an indirect effect on 344 
NMD stimulation by increasing the stability of the bound EJC and thus maintaining the possibility of 345 
efficient endonucleolytic cleavage of the transcript. An indication for this role comes from the initial in 346 
vitro observation that CASC3 stabilizes recombinant EJCs (Ballut et al., 2005). Additionally, the 347 
moderately reduced pull-down of UPF3B with EIF4A3 could indicate that cytoplasmic NMD-competent 348 
EJCs are less stable in CASC3 KO cells. Alternatively, CASC3 may directly contribute to the recruitment 349 
of NMD factors. We therefore propose that CASC3 either alone or in conjunction with UPF3B links the 350 
EJC with the NMD machinery. In particular, CASC3 influences the contribution of SMG6-mediated 351 
endonucleolytic and SMG7-dependent exonucleolytic decay pathways to the overall degradation 352 
efficiency of NMD. Accordingly, in wild type cells a knockdown of SMG7 only had a marginal effect on 353 
the abundance of the analyzed NMD reporter mRNA, whereas it clearly impaired NMD in CASC3 KO 354 
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cells. Also, the amount of endocleavage-derived 3ʹ fragments was reduced when CASC3 is depleted, 355 
mirroring the SMG6-knockdown condition.  356 
By integrating CASC3 as a specific NMD-activating factor we can now postulate a modified model 357 
of EJC-dependent NMD, which is also compatible with several molecular properties of the EJC (Figure 358 
7). Since CASC3 is only present in modest amounts in the cytoplasm, it will probably not immediately 359 
associate with all EJCs on recently exported mRNPs. This would also not be necessary, since most EJCs 360 
are located in the coding sequence and will therefore be removed by the first translating ribosome. 361 
However, mRNAs containing PTCs will carry one or more EJCs in their 3ʹ UTR, which are available for 362 
binding of CASC3. The first few translating ribosomes may terminate upstream of CASC3-free EJCs, 363 
which could preferentially trigger SMG7-dependent exonucleolytic degradation. Previously, NMD has 364 
been proposed to occur primarily in the pioneering round of translation when newly synthesized 365 
transcripts are bound to the cap-binding complex (Ishigaki et al., 2001, Maquat et al., 2010). This model 366 
has been challenged and there is evidence that NMD can occur on already translating mRNAs and 367 
possibly with a constant probability during every round of translation (Durand & Lykke-Andersen, 368 
2013, Rufener & Muhlemann, 2013, Hoek et al., 2019). Thus, CASC3 could bind to the EJC at a later 369 
time point and then increase the probability to activate SMG6-mediated endonucleolytic degradation 370 
after each round of termination. Important molecular targets of CASC3 may be mRNAs that escape 371 
initial NMD activation, despite containing a PTC (Trcek et al., 2013, Hoek et al., 2019). CASC3 may help 372 
to reduce the amount of these mRNAs by maintaining the NMD-activating function of the EJC, either 373 
by increasing its stability on the mRNA or via direct interactions with the NMD machinery. This concept 374 
would be consistent with the recent observation that NMD targets undergo several rounds of 375 
translation before endocleavage occurs (Hoek et al., 2019).  376 
In summary, our data paint a picture, in which CASC3 has no essential EJC-related function in the 377 
nucleus, but helps to turn EJCs into a persistent RNA degradation mode. We do not exclude the 378 
possibility that CASC3 is already associated with the EJC in the nucleus. However, our model of delayed 379 
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binding of CASC3 to the EJC in the cytoplasm would explain why only a small amount of CASC3 is 380 
sufficient to activate EJC-dependent NMD. In this model, CASC3 is an indispensable cytoplasmic 381 
component of the EJC that helps to degrade mRNAs that failed to unload all their bound EJCs during 382 
the initial rounds of translation. Thus, the binding of CASC3 to the EJC could signal the final round(s) of 383 
translation of an mRNA.  384 
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Materials and Methods 385 
Cell culture 386 
Flp-In 293 T-REx cells (Thermo Fisher Scientific) were maintained at 37° C, 5% CO2 and 387 
90% humidity in Dublecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific) supplemented 388 
with 9% fetal bovine serum (FBS) and Penicillin-Streptomycin (both Thermo Fisher Scientific). 389 
Tethering experiments were performed in HeLa Tet-Off cells (Clontech) cultured in the same 390 
conditions. 391 
siRNA-mediated knockdowns 392 
The cells were seeded in 6-well plates at a density of 2x105 cells per well and reverse transfected 393 
using 2.5 μl Lipofectamine RNAiMAX and 60 pmol of the respective siRNA(s) according to the 394 
manufacturer’s instructions. In preparation for mass spectrometry, the cells were reverse transfected 395 
in 10 cm dishes using 10 μl Lipofectamine RNAiMAX and 300 pmol siRNA. siRNAs were targeted against 396 
Luciferase (5ʹ-CGTACGCGGAATACTTCGA-3ʹ), EIF4A3 (5ʹ-AGACATGACTAAAGTGGAA-3ʹ), RBM8A (5ʹ-397 
TTCGCAGAATATGGGGAAA-3ʹ), CASC3 (5ʹ-CTGATGACATCAAACCTCGAAGAAT-3ʹ, 5ʹ-398 
CGTCATGAACTTTGGTAATCCCAGT-3ʹ), UPF1 (5ʹ-GATGCAGTTCCGCTCCATT-3ʹ), XRN1 (5ʹ-399 
AGATGAACTTACCGTAGAA-3ʹ), SMG6 (5ʹ-GGGTCACAGTGCTGAAGTA-3ʹ) or SMG7 (5ʹ-400 
CGATTTGGAATACGCTTTA-3ʹ). 401 
Generation of knockout cells using CRISPR-Cas9 402 
The knockouts were performed using the Alt-R CRISPR-Cas9 system (IDT) and reverse transfection 403 
of a Cas9:guideRNA ribonucleoprotein complex using Lipofactamine RNAiMAX (Thermo Fisher 404 
Scientific) according to the manufacturer’s protocol. The crRNA sequences to target CASC3 were 405 
/AlTR1/rGrCrGrCrGrCrUrUrCrGrCrArArGrArCrArCrCrGrGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AlTR2/ 406 
(clone H) and 407 
/AlTR1/rGrUrUrCrGrGrCrCrUrCrCrGrCrGrCrUrGrUrGrArGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AlTR2/ 408 
(clones  F and T). Reverse transfection was performed on 1.5x105 cells per crRNA in 12-well dishes. 409 
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48 hours after transfection the cells were trypsinized, counted and seeded at a density of a single cell 410 
per well in 96-well plates. Cell colonies originating from a single clone were then validated by Sanger 411 
sequencing of the targeted genomic DNA locus and western blotting.  412 
Plasmid transfection 413 
All used plasmids are listed in Supplementary Table 1. To express FLAG-tagged protein constructs 414 
and the reporter mRNAs detected by northern blotting, the cells were stably transfected using the Flp-415 
In T-REx system and the tetracycline inducible pcDNA5/FRT/TO vector (Thermo Fisher Scientific). The 416 
constructs TPI-WT, TPI-PTC, β-globin WT and β-globin PTC are available on Addgene (IDs 108375-417 
108378). 2.5x105 cells were seeded 24 h before transfection in 6-wells. Per well, 1 μg of reporter 418 
construct was transfected together with 1 μg of the Flp recombinase expressing plasmid pOG44 using 419 
the calcium phosphate method. 48 h after transfection, the cells were transferred into 10 cm dishes 420 
and selected with 100 μg/ml hygromycin. After 10 days, the colonies were pooled. Expression of the 421 
reporter mRNA was induced with 1 μg/ml doxycycline for 24 h.  422 
Constructs that express V5-tagged and MS2V5-tagged proteins were stably integrated into the 423 
cells using the PiggyBac (PB) Transposon system and the cumate-inducible PB-CuO-MCS-IRES-GFP-EF1-424 
CymR-Puro vector (System Biosciences). 2.5x105 cells were seeded 24 h before transfection in 6-wells. 425 
2.5 μg of the PB Transposon vector and 0.8 μg of PB Transposase were transfected per well using the 426 
calcium phosphate method. After 48 h, the cells were pooled in 10 cm dishes and positive clones 427 
selected with 2 μg/ml puromycin for a week. Expression of proteins was induced using 30 μg/ml 428 
cumate for 72 h.  429 
The tethering construct pSBtet-Hyg-TPI-4MS2-SMG5-4H was stably integrated into HeLa Tet-Off 430 
cells using the Sleeping Beauty (SB) transposon system (Mates et al., 2009, Kowarz et al., 2015). pSBtet-431 
Hyg was a gift from Eric Kowarz (Addgene plasmid #60508; http://n2t.net/addgene:60508; 432 
RRID:Addgene_60508). pCMV(CAT)T7-SB100 was a gift from Zsuzsanna Izsvak (Addgene plasmid 433 
#34879; http://n2t.net/addgene:34879; RRID:Addgene_34879). 2.5x105 cells were seeded 24 h before 434 
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transfection in 6-wells. Per well, 1 μg of the reporter construct was transfected together with 1.5 μg 435 
of the SB Transposase using the calcium phosphate method. 48 h after transfection, the cells were 436 
transferred into 10 cm dishes and selected with 100 μg/ml hygromycin. After 10 days, the colonies 437 
were pooled. In absence of tetracycline the reporter was constitutively expressed. 438 
RNA-Sequencing and computational analyses 439 
RNA-Seq analysis was carried out with 293 WT cells transfected with Luciferase siRNA and the 440 
CASC3 KO clones H and T transfected with either Luciferase or CASC3 siRNAs. Three biological 441 
replicates were analyzed for each sample. RNA was isolated with the kit NucleoSpin RNA Plus 442 
(Macherey-Nagel). The Lexogen SIRV Set1 Spike-In Control Mix (SKU: 025.03) that provides a set of 443 
external RNA controls was added to the total RNA to enable performance assessment. Mix 0 was added 444 
to replicate 1, mix 1 was added to replicate 2 and mix 3 to replicate 3. The Spike-Ins were not used for 445 
analysis. The library preparation was performed with the TrueSeq Stranded Total RNA kit (Illumina). 446 
First steps of the library preparation involve the removal of ribosomal RNA using biotinylated target-447 
specific oligos combined with Ribo-Zero gold rRNA removal beads from 1ug total RNA input. The Ribo-448 
Zero Human/Mouse/Rat kit depletes samples of cytoplasmic and mitochondrial rRNA. Following 449 
purification, the RNA is fragmented and cleaved. RNA fragments are copied into first strand cDNA using 450 
reverse transcriptase and random primers, followed by second strand cDNA synthesis using DNA 451 
Polymerase I and RNase H. These cDNA fragments then have the addition of a single'A' base and 452 
subsequent ligation of the adapter. The products are purified and enriched with PCR to create the final 453 
cDNA library. After library validation and quantification (Agilent tape station), equimolar amounts of 454 
library were pooled. The pool was quantified by using the Peqlab KAPA Library Quantification Kit and 455 
the Applied Biosystems 7900HT Sequence Detection System and sequenced on an Illumina 456 
NovaSeq6000 sequencing instrument and an PE100 protocol. 457 
Read processing and alignment was performed as described previously (Boehm et al., 2018). In 458 
short, adaptor sequences and low quality bases were removed with Flexbar 3.0 (Dodt et al., 2012). 459 
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Short reads from the rRNA locus were subtracted by mapping against the 45S precursor (Homo 460 
sapiens, NR_046235.1) using Bowtie2 (Langmead & Salzberg, 2012). The remaining reads were aligned 461 
against the human genome (version 38, EnsEMBL 90 transcript annotations) using the STAR read 462 
aligner (version 2.5.3a) (Dobin et al., 2013). 463 
To compute gene differential expression analysis, reads covering exons were counted with 464 
FeatureCounts (version 1.5.1) (Liao et al., 2014) using the ‘—primary’ and ‘—ignoreDup’ parameters. 465 
Differential gene expression analysis was performed with DESeq2 (Love et al., 2014, Ignatiadis et al., 466 
2016) and IWH R packages. Significance thresholds were |log2FoldChange|> 1 and adjusted p-value 467 
(padj) < 0.05. Genes were designated as small RNA (sRNA) host gene, if they contained other Ensembl-468 
annotated genes of biotypes snoRNA or miRNA within their genomic coordinates (Zerbino et al., 2018). 469 
Differential splicing was detected with LeafCutter (version 0.2.7) (Li et al., 2018) with the 470 
parameters min_samples_per_intron = 2 and min_samples_per_group = 2. Significance thresholds 471 
were |deltapsi| > 0.1 and adjusted p-value (p.adjust) < 0.05. 472 
Transcript abundance estimates were computed with Salmon (version 0.13.1) (Patro et al., 2017) 473 
using the the -validateMappings --gcBias parameters. Differential transcript usage was computed with 474 
IsoformSwitchAnalyzeR (version 1.7.1) and the DEXSeq method (Robinson & Oshlack, 2010, Anders et 475 
al., 2012, Ritchie et al., 2015, Soneson et al., 2015, Vitting-Seerup & Sandelin, 2017, Vitting-Seerup & 476 
Sandelin, 2019). Significance thresholds were |dIF| > 0.1 and adjusted p-value 477 
(isoform_switch_q_value) < 0.05. For the Boxplot and Kolmogorov-Smirnoff test, the data were filtered 478 
only for the adjusted p-value. PTC status of transcript isoforms with annotated open reading frame 479 
was determined by IsoformSwitchAnalyzeR using the 50 nt rule of NMD (Weischenfeldt et al., 2012, 480 
Vitting-Seerup et al., 2014, Huber et al., 2015, Vitting-Seerup & Sandelin, 2017). Isoforms with no 481 
annotated open reading frame in Ensembl were designated “NA” in the PTC analysis. 482 
The UPF1 and SMG6/7 (Data ref: Colombo et al., 2017) and RNPS1 (Data ref: Boehm et al., 2018) 483 
knockdown datasets were processed and analyzed with the same programs, program versions, and 484 
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scripts as the CASC3 dataset. All packages used are listed in the respective analysis table 485 
(Supplementary Tables 4-6). Sashimi plots were generated using ggsashimi (Garrido-Martin et al., 486 
2018). Overlaps of data sets were represented via nVenn (Perez-Silva et al., 2018), eulerr (Larsson, 487 
2019) and Upset plots (Lex et al., 2014). Heatmaps were generated using ComplexHeatmap (Gu et al., 488 
2016). 489 
SILAC, co-immunoprecipitation and mass spectrometry 490 
293 WT and 293 CASC3 KO clone H cells expressing either FLAG or FLAG-EIF4A3 were labeled by 491 
maintaining them for 5 passages in DMEM for SILAC medium (Thermo Fisher Scientific) supplemented 492 
with FBS (Silantes), Penicillin-Streptomycin (Thermo Fisher Scientific) and the respective amino acids 493 
at a final concentration of 0.798 mmol/L (Lysine) and 0.398 (Arginine). Unlabeled proline was added 494 
to prevent enzymatic Arginine-to-Proline conversion. The conditions were “light” (unlabeled 495 
Lysine/Arginine), “medium” (Lysine 4/Arginine 6) and “heavy” (Lysine 8/Arginine 10). A label switch 496 
was performed between the three replicates according to the experimental setup listed in 497 
Supplementary Table 2. The expression of FLAG or FLAG-EIF4A3 was induced for 72 h with 1 μg/ml 498 
doxycycline. The cells were lysed in buffer E with RNAse (20 mM HEPES-KOH (pH 7.9), 100 mM KCl, 499 
10% glycerol, 1 mM DTT, Protease Inhibitor, 1 μg/ml RNAse A) and sonicated using the Bandelin 500 
Sonopuls mini20 with 15 pulses (2.5 mm tip in 600 μl volume, 1s, 50% amplitude). 600 μl of a 1.6 mg/ml 501 
total protein lysate were incubated with 30 μl Anti-FLAG M2 magnetic beads (Sigma) at 4° C while 502 
rotating for 2 h. The beads were washed three times for 5 min with EJC-buffer (20 mM HEPES-KOH (pH 503 
7.9), 200 mM NaCl, 2 mM MgCl2, 0.2% Triton X-100, 0.1% NP-40, 0.05% Sodium deoxycholate) and 504 
eluted in 43 μl of a 200 mg/ml dilution of FLAG peptides (Sigma) in 1x TBS. The samples were merged 505 
according to Supplementary Table 2. 1 volume of 10% SDS was added and the samples were reduced 506 
with DTT and alkylated with CAA (final concentrations 5 mM and 40 mM, respectively). Tryptic protein 507 
digestion was performed using a modified version of the single pot solid phase-enhanced sample 508 
preparation (SP3) (Hughes et al., 2014). In brief, reduced and alkylated proteins were supplemented 509 
with paramagnetic Sera-Mag speed beads (Thermo Fisher Scientific) and mixed in a 1:1-ratio with 100% 510 
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acetonitrile (ACN). After 8 min incubation protein-beads-complexes were captured using an in-house 511 
build magnetic rack and two times washed with 70% EtOH. Afterwards, samples were washed once 512 
with 100% ACN, air-dried and reconstituted in 5 μl 50 mM Triethylamonium bicarbonate 513 
supplemented with 0.5 μg trypsin and 0.5 μg LysC and incubated overnight at 37°C. On the next day 514 
the beads were resuspended and mixed with 200 μl ACN, incubated for 8 min and again placed on the 515 
magnetic rack. Tryptic peptides were washed once with 100% ACN, airdried, dissolved in 4% DMSO 516 
and transferred into 96-well PCR tubes. After acidification with 1 μl of 10% formic acid, samples were 517 
ready for LC-MS/MS analysis 518 
 For the MS experiment combined with CASC3 knockdown, the 293 CASC3 KO clone H cells were 519 
treated with siRNA against CASC3 24 h before expression of the FLAG-tagged construct. The cells were 520 
lysed and samples prepared for MS as described above. However, the washing steps were performed 521 
in a less stringent EJC buffer (20 mM HEPES-KOH (pH 7.9), 137 mM NaCl, 2 mM MgCl2, 0.2% Triton X-522 
100, 0.1% NP-40). 523 
Proteomics analysis was performed by data-dependent acquisition using an Easy nLC1200 ultra 524 
high-performance liquid chromatography (UHPLC) system coupled via nanoelectrospray ionization to 525 
a Q Exactive Plus instrument (all Thermo scientific). Tryptic peptides were separated based on their 526 
hydrophobicity using a chromatographic gradient of 60 min with a binary system of buffer A (0.1% 527 
formic acid) and buffer B (80% ACN, 0.1% formic acid). In-house made analytical columns (length: 50 528 
cm, inner diameter: 75 μm) filled with 1.9 μm C18-AQ Reprosil Pur beads (Dr. Maisch) were used for 529 
separation. Buffer B was linearly increased from 3% to 27% over 41 min followed by a steeper increase 530 
to 50% within 8 min. Finally, buffer B was increased to 95% within 1 min and stayed at 95% for 10 min 531 
in order to wash the analytical column. Full MS spectra (300 – 1,750 m/z) were acquired with a 532 
resolution of 70,000, a maximum injection time of 20 ms and an AGC target of 3e6. The top 10 most 533 
abundant peptide ions of each full MS spectrum were selected for HCD fragmentation (NCE: 27) with 534 
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an isolation width of 1.8 m/z and a dynamic exclusion of 10 seconds. MS/MS spectra were measured 535 
with a resolution of 35,000, a maximum injection time of 110 ms and an AGC target of 5e5. 536 
MS RAW files were analysed using the standard settings of the MaxQuant suite (version 1.5.3.8) 537 
with the before mentioned SILAC labels (Cox & Mann, 2008). Peptides were identified by matching 538 
against the human UniProt database using the Andromeda scoring algorithm (Cox et al., 2011). 539 
Carbamidomethylation of cysteine was set as a fixed modification, methionine oxidation and N-540 
terminal acetylation as variable modification. Trypsin/P was selected as digestion protein. A false 541 
discovery Rate (FDR) < 0.01 was used for identification of peptide-spectrum matches and protein 542 
quantification. Data processing and statistical analysis was done in the Perseus software (version 543 
1.5.5.3) (Tyanova et al., 2016). Significantly changed proteins were identified by One-sample t-testing 544 
(H0 = 0, fudge factor S0 = 0.1). The results are listed in Supplementary Table 2 as “Results without 545 
knockdown” (MAP conditions) and “Results with knockdown”. Visualization was performed with the 546 
Instant Clue software (version 0.5.3) (Nolte et al., 2018). 547 
Co-immunoprecipitation experiments followed by western blotting were performed as described 548 
above except that a 15 min incubation step in SDS buffer (600 mM Tris pH 6.8, 100 mM DTT, 10% 549 
Glycerol, 2% SDS, 0.002% Bromophenolblue) was used for elution from the beads.  550 
In vitro splicing assay 551 
FLAG-emGFP and FLAG-EIF4A3 was expressed in 293 WT and 293 CASC3 KO clone H cells for 72 h. 552 
Whole cell lysate preparation and in vitro splicing was performed as previously described (Steckelberg 553 
& Gehring, 2014), however the nuclear extract was substituted with whole cell extract from the 554 
respective cell line. Pulldown efficiency of spliced mRNA was calculated by dividing the amount of 555 
spliced mRNA in the pulldown by the amount in the respective input and dividing the results by 10 556 
since 10% of the input was loaded. 557 
Semi-quantitative and quantitative reverse transcriptase (RT)-PCR 558 
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RNA was extracted using peqGOLD TriFast reagent (VWR) according to the manufacturer’s 559 
instructions. Reverse transcription was performed with GoScript Reverse Transcriptase (Promega) 560 
using 2 μg total RNA and oligo dT primers. Semi-quantitative PCR was carried out with MyTaq Red Mix 561 
(Bioline). Quantitative real time PCR was performed with 16 ng of cDNA per reaction with GoTaq qPCR 562 
Master Mix (Promega) and the CFX96 Touch Real-Time PCR Detection System (Biorad). The average cT 563 
values were calculated from three technical replicates. The mean fold changes from three biological 564 
replicates were calculated according to the ΔΔCt method (Schmittgen & Livak, 2008). When measuring 565 
isoform switches, the fold change of the PTC-containing transcript was normalized to the canonical 566 
transcript. When measuring differential expression, the fold change was normalized to GAPDH. For 567 
each primer pair amplification efficiencies were measured by a 2-fold dilution curve and ranged 568 
between 87 and 100.1%. The primer sequences are listed in Supplementary Table 3. 569 
Western blotting 570 
Protein extraction was performed with peqGOLD TriFast reagent (VWR), separated by SDS-PAGE 571 
gel electrophoresis and transferred to a PVDF membrane (GE Healthcare Life Sciences). The following 572 
antibodies were used: Anti-β-actin (Sigma-Aldrich, #A5441), anti-CASC3 amino acid residues 653-703 573 
(Bethyl Laboratories, #A302-472A-M), anti-CASC3 amino acid residues 367-470 (Atlas Antibodies, 574 
#HPA024592), anti-EIF4A3 (Genscript), anti-FLAG (Cell Signaling Technology, #14793), anti-MAGOH 575 
(Santa Cruz Biotechnology, #sc-271365), anti-RBM8A (Atlas Antibodies, #HPA018403), anti-SMG6 576 
(Abcam, #ab87539), anti-SMG7 (Elabscience, #E-AB-32926), anti-Tubulin (Sigma-Aldrich, #T6074), anti-577 
V5 (QED Bioscience, #18870), anti-XRN1 (Bethyl Laboratories, #A300-443A), anti-rabbit-HRP (Jackson 578 
ImmunoResearch, #111-035-006), anti-mouse-HRP (Jackson ImmunoResearch, #115-035-003). 579 
Detection was performed with Western Lightning Plus-ECL (PerkinElmer) or Amersham ECL prime (Ge 580 
Healthcare Life Sciences) and the chemiluminescence imager Fusion FX6 EDGE (Vilber-Lourmat). 581 
Northern blotting 582 
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The cells were harvested in peqGOLD TriFast reagent (VWR) and total RNA extraction was 583 
performed as recommended by the manufacturer’s protocol. 2.5 μg of total RNA were resolved on a 584 
1% agarose/0.4 M formaldehyde gel using the tricine/triethanolamine buffer system (Mansour & 585 
Pestov, 2013) followed by transfer on a nylon membrane (Roth) in 10x SSC. The blots were incubated 586 
overnight at 65 °C in Church buffer containing [α-32P]-GTP body-labeled RNA probes for detection of 587 
the reporter mRNA. Endogenous 7SL RNA was detected by a 5ʹ-32P-labeled oligonucleotide (5ʹ-588 
TGCTCCGTTTCCGACCTGGGCCGGTTCACCCCTCCTT-3ʹ). The blots were visualized and quantified using a 589 
Typhoon FLA 7000 (GE Healthcare) and ImageQuant TL 1D software. 590 
Data Availability 591 
The datasets produced in this study are available in the following databases. These data will be 592 
made publicly accessible upon publication. 593 
x RNA-seq data have been deposited in the ArrayExpress database (Kolesnikov et al., 2015) at 594 
EMBL-EBI under accession number E-MTAB-8461 595 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8461). 596 
x The mass spectrometry proteomics data have been deposited to the ProteomeXchange 597 
Consortium via the PRIDE (Perez-Riverol et al., 2019) partner repository with the dataset 598 
identifier PXD015754 (https://www.ebi.ac.uk/pride/archive/projects/PXD015754).  599 
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Interrogating the degradation pathways of unstable
mRNAs with XRN1-resistant sequences
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The turnover of messenger RNAs (mRNAs) is a key regulatory step of gene expression in
eukaryotic cells. Due to the complexity of the mammalian degradation machinery, the
contribution of decay factors to the directionality of mRNA decay is poorly understood. Here
we characterize a molecular tool to interrogate mRNA turnover via the detection of XRN1-
resistant decay fragments (xrFrag). Using nonsense-mediated mRNA decay (NMD) as a
model pathway, we establish xrFrag analysis as a robust indicator of accelerated 50–30 mRNA
decay. In tethering assays, monitoring xrFrag accumulation allows to distinguish decapping
and endocleavage activities from deadenylation. Moreover, xrFrag analysis of mRNA degra-
dation induced by miRNAs, AU-rich elements (AREs) as well as the 30 UTRs of cytokine
mRNAs reveals the contribution of 50–30 decay and endonucleolytic cleavage. Our work
uncovers formerly unrecognized modes of mRNA turnover and establishes xrFrag as a
powerful tool for RNA decay analyses.
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D
egradation of messenger RNAs (mRNAs) directly influ-
ences the number of transcripts available for translation
and thereby controls the persistence of the genetic
information1. The regulation of mRNA degradation is widely
used as a molecular principle underlying the correct expression of
genes, for example of the immune system2,3. Many cytokine
mRNAs exhibit short half-life times due to destabilizing
sequences, which allow to fine-tune inflammatory responses4,5.
In addition, the RNA decay machinery monitors the quality of
mRNAs and eliminates faulty transcripts2. A well-studied
example is the degradation of transcripts containing premature
termination codons (PTCs) by the nonsense-mediated mRNA
decay pathway (NMD)6,7.
The process of mRNA decay is regulated by a large number
of trans-acting protein factors. Many of them are mRNA-
binding proteins, which directly interact with their target
mRNAs via specific binding sites8,9. Destabilizing and stabi-
lizing factors antagonistically regulate the turnover of bound
mRNAs. Hence, the combination of RNA-binding proteins
on a given mRNA will eventually determine the half-life
of this mRNA and thereby its fate and potential for protein
production.
Three major pathways of mRNA decay exist in mammalian
cells: 50–30 exonucleolytic-, 30–50 exonucleolytic- and endonu-
cleolytic decay. Deadenylation is considered to be the first and
rate-limiting step during the turnover of normal cellular
mRNAs10. Accelerated deadenylation is often initiated by the
specific recruitment of the CCR4-NOT deadenylase complex, for
example, by the SMG5–SMG7 heterodimer during NMD11. After
deadenylation, further degradation of the mRNA occurs via the
cytoplasmic Lsm1-7-Pat1 complex in combination with the
eIF4E-binding protein 4E-T, which recruit decapping factors to
the 50 end of the deadenylated mRNA12,13. After decapping, the
50–30 exoribonuclease XRN1 recognizes the 50 monophosphate
and degrades the entire transcript14,15. Alternatively, the
deadenylated mRNA may also be eliminated by the cytoplasmic
exosome, a multi-protein complex, via its 30–50 exonucleolytic
subunit DIS3L (ref. 16). Furthermore, transcripts with shortened
poly(A) tails can be 30-oligouridylated by TUTases, activating
different degradation pathways including the 30–50 decay via the
exosome-independent DIS3L2 (refs 17–19).
The decay of mRNA may also be initiated by endonucleo-
lytic cleavage. A few endonucleases have been described in
mammalian cells, amongst them ZC3H12A (Regnase-1) and
the NMD-specific endonuclease SMG6, both of which harbour a
PIN-like RNase domain20. Regnase-1 specifically recognizes
and cleaves a stem–loop structure present in the 30 UTRs
of many cytokine mRNAs, such as TNF-a and Interleukin
6 (ref. 4). In contrast, SMG6 is recruited to PTC-containing
mRNAs and cleaves them in the vicinity of the termination
codon21.
Despite the importance of mRNA turnover for the regulation
of gene expression, little is known about the contribution of
degradation pathways to the decay of individual mRNAs. This
lack of knowledge is partially due to the large variety of
seemingly redundant nucleolytic enzymes. In this study, we
aimed to understand the degradation of different classes of
intrinsically unstable mRNAs in mammalian cells using a virus-
derived RNA sequence. Insertion of XRN1-resistant sequences
(xrRNAs) into different reporter mRNAs allowed to monitor
RNA decay activity of NMD substrates, cytokine 30 UTR-
containing transcripts and mRNAs containing AU-rich- or
microRNAs (miRNA)-responsive elements. Using this method,
we detect for these unstable transcripts a differential contribu-
tion of mRNA degradation pathways, including endocleavage,
deadenylation and decapping.
Results
Monitoring NMD activity using XRN1-resistant RNA elements.
Decapping or endocleavage of mRNAs generates decay inter-
mediates with 50 unprotected ends, which are substrates of the
cytoplasmic 50–30 exonuclease XRN1 (Fig. 1a). The depletion of
XRN1 is commonly used to detect decay intermediates and to
draw conclusions about the mRNA decay mechanism. However,
XRN1 interacts directly with components of the decapping
machinery, suggesting that XRN1 itself modulates the decapping
process22. Hence, we sought to develop a system to monitor 50–30
mRNA decay with minimal cellular invasiveness. A potential
alternative to the knockdown of XRN1 is the incorporation of
viral xrRNA elements in reporter mRNAs (Fig. 1a), which were
previously reported to block the processively degrading XRN1
upstream of the xrRNA structure23. The resulting XRN1-resistant
decay fragments (henceforth called xrFrag) accumulate and can
be used as a readout for mRNA degradation pathways involving
50–30 decay (Fig. 1a).
To test the feasibility of this approach, we inserted an xrRNA
element from the Murray Valley encephalitis (MVE) Virus
downstream of the triosephosphate isomerase (TPI) open reading
frame (ORF; Fig. 1b,c). The MVE xrRNA is structurally and
molecularly well described and consists of two xrRNA sequences
(xrRNA1 and xrRNA2)23. By northern blot analysis of transiently
transfected cells we observed in addition to the control mRNA
two reporter-derived RNA species. The slower migrating band
represents the full-length TPI-xrRNA transcript, whereas the
weak, faster migrating band corresponds in size to the expected
xrFrag and likely results from regular mRNA turnover (Fig. 1d).
Introducing an NMD-activating PTC (PTC160) in the TPI ORF
resulted in decreased steady state reporter levels as well as
increased xrFrag abundance, in line with the enhanced turnover
of this mRNA (Fig. 1d, lane 2). Interestingly, no xrFrags were
detected from reporter mRNAs with single xrRNA sequences
(xrRNA1 or xrRNA2), establishing that two xrRNA structures
(constituting one complete xrRNA element) are required for
efficient XRN1 resistance. To investigate the influence of
upstream RNA elements on xrRNA functionality, we inserted
60 bp sequences with varying GC contents (30–70% GC) derived
from the RAB7A 30 UTR. To the best of our knowledge, this RNA
does not contain decay-inducing features and is recommended as
housekeeping gene for gene expression studies24 (Fig. 1e). To
simulate more challenging potential roadblocks for XRN1, we
inserted 4MS2 binding sites or a very stable stem–loop structure
upstream of the xrRNA (Fig. 1e). All inserts were fully compatible
with xrFrag generation (Fig. 1f), thus establishing that the xrRNA
element can be readily integrated into different reporter systems.
We next asked if the xrFrag could be used to study the
degradation of NMD substrates in more detail. To this end we
expressed wild type (WT) or PTC-containing versions of b-globin
or TPI reporter mRNAs with or without xrRNA sequences
(Fig. 2a and Supplementary Fig. 1a). The presence of the xrRNA
element did not alter the overall degradation efficiency of the
reporter (Fig. 2b and Supplementary Fig. 1b). Furthermore,
an increase of xrFrag levels was consistently detected for both
PTC-containing reporters. The currently assumed major degra-
dation pathway of NMD substrates is the SMG6-catalysed
endonucleolytic cleavage at the stop codon. Of the resulting
unstable 50- and 30 fragments, the 30 fragments are rapidly
removed by XRN1 (refs 25,26). 30 fragments were stabilized by
the knockdown of XRN1 (Fig. 2c) and appeared in addition to the
xrFrag (Fig. 2b and Supplementary Fig. 1b). Depletion of the key
NMD factor UPF1 abolished the difference in xrFrag:reporter
ratios for the WT and PTC reporters, indicating that NMD
activity is required for the increased xrFrag levels. To gain more
insight into the generation of the xrFrag, we established stable
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tetracycline-inducible HeLa cell lines expressing b-globin or TPI
reporter mRNAs with 30 UTR xrRNA elements. Although we
observed qualitatively similar results as with transient transfec-
tions, the overall effects were more pronounced when stable cell
lines were analysed (Fig. 2d,e and Supplementary Fig. 1c,d). To
determine the cellular degradation site of the PTC39 substrate, we
isolated RNAs after sub-cellular fractionation. The full-length
reporter was abundant in the nuclear fraction, but almost
undetectable in the cytoplasm (Supplementary Fig. 1e). In
contrast, xrFrags were preferentially found in the cytoplasm.
These observations demonstrate that the xrFrags accumulate due
to the degradation of the NMD substrate after the export to the
cytosol.
We next examined the kinetics of the synthesis and decay of
the reporter mRNAs by a time-course assay. Whereas the control
WT mRNA increased in abundance during the first 8 h after
induction, no PTC mRNA accumulated when UPF1 was present
(Fig. 2f and Supplementary Fig. 1f). Interestingly, high xrFrag
levels were detected already 4 h after induction. This indicates
very rapid degradation kinetics of the PTC mRNAs, which was
visualized via the concurrent detection of xrFrags. Inhibiting
translation by cycloheximide treatment before induction abol-
ished both, PTC reporter degradation and xrFrag generation
(Supplementary Fig. 1g). Likewise, treating the cells with caffeine,
a known inhibitor of the NMD-kinase SMG1 (ref. 27), resulted in
a dose-dependent increase of PTC-reporter abundance accom-
panied by a decreased accumulation of xrFrag (Supplementary
Fig. 1h). Taken together, the application of xrRNA elements
enables the simultaneous detection of both full-length reporter
mRNAs and 50 processed decay intermediates, which in combi-
nation greatly improves the readout of RNA degradation
analyses.
Next, we monitored the stability of the xrFrag as well as
the TPI–WT and two different NMD substrate mRNAs
(TPI-PTC160 and TPI-SMG5; Fig. 3a) for 6 h after inhibition of
transcription by actinomycin D. Compared with TPI–WT the
degradation of both NMD substrates was accelerated, albeit with
different kinetics (Fig. 3b). In contrast, the xrFrags generated
from the NMD reporter mRNAs were more stable and exhibited
a delay before decay commenced, leading overall to longer
apparent half-life time (Fig. 3b). To further study the turnover of
xrFrags, we chased the decay intermediates of globin-PTC39 with
actinomycin D treatment in XRN1-depleted cells after a 4 h
induction of transcription (Fig. 3c). Interestingly, the readily
visible 30 fragments exhibited a similar decay kinetic as the
xrFrags of control cells. By contrast, in XRN1-depleted cells the
xrFrags increased in abundance during the first 4 h after
transcriptional shutoff. This suggests that residual XRN1
molecules will continue to degrade 30 fragments, leading to a
constant formation of xrFrags from the pool of 30 fragments. We
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control mRNA. (f) Mean values of reporter and xrFrag signal±s.d. (n¼ 3) were quantified and normalized to the TPI reporter without insert. The ratio of
xrFrag to reporter mRNA levels is indicated below the graph.
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therefore hypothesized that in XRN1-depleted cells the produc-
tion of 30 fragments would precede the accumulation of xrFrags.
Indeed, while 30 fragments were more abundant than xrFrags in
the first hours after transcriptional induction, this ratio decreased
after 8 h of continuous PTC reporter expression (Fig. 3d). To
determine whether xrFrags are degraded over time via continuous
50–30 decay, we constructed mRNA reporters containing addi-
tional xrRNA elements (that is, in total 2x- and 3x-xrRNA
elements; Supplementary Fig. 2a). Interestingly, expression of
these reporters resulted in the appearance of additional xrFrags
(Supplementary Fig. 2b,c). This finding suggests that in mamm-
alian cells xrRNAs do not irreversibly trap, but impair XRN1
activity to such an extent that xrFrags can be detected.
Dissecting pathways involved in NMD using xrFrag analysis. In
current models of NMD, phosphorylated and RNA-bound UPF1
serves as a docking platform for a variety of decay-inducing
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factors (Fig. 4a). We decided to determine if the xrRNA system is
able to detect differences between redundant mRNA decay
pathways that are activated during NMD. To this end, we
performed siRNA-mediated knockdowns of SMG6 and SMG7
(Fig. 4b). In line with published data28, the depletion of either
SMG6 or SMG7 did not completely stabilize PTC to WT mRNA
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levels (Fig. 4c and Supplementary Fig. 3a). Nevertheless, we
found that compared with SMG7 depletion, the knockdown of
SMG6 decreased xrFrag:reporter ratios more profoundly for both
b-globin and TPI reporter mRNAs. Furthermore, we detected
almost identical xrFrag:reporter levels for WT and PTC reporter
upon the combined SMG6–SMG7 knockdown, indicating near-
complete NMD inhibition (Fig. 4d and Supplementary Fig. 3b).
Taken together, these results are in line with the current NMD
model, in which SMG6 is the major and SMG7 the alternative
degradation-promoting factor.
We next aimed to distinguish decapping from endocleavage
activities during NMD. To this end, we generated a reporter with
a 50 xrRNA (xrA). We inserted a 50 stem–loop and a NanoLuc
ORF upstream of the xrA to prevent ribosomes from disrupting
the xrRNA structure. Downstream of the xrA, an EMCV IRES
followed by the TPI ORF with or without a second xrRNA (xrB)
was cloned (Supplementary Fig. 4a). The activation of NMD by
IRES-mediated translation will either lead to endocleavage or
decapping and the accumulation of xrFragB or xrFragA,
respectively. We found decreased levels of the PTC-containing
mRNA and increased xrFragB compared with the WT. Surpris-
ingly, strongly reduced amounts of xrFragA were detected, too
(Supplementary Fig. 4b). This finding underlines that as long as
SMG6 is active in the NMD pathway, endocleavage dominates
over decapping. Indeed, increased levels of PTC-containing
xrFragA accumulated in SMG6-depleted cells, leading to identical
xrFrag:reporter ratios of the PTC and the WT construct
(Supplementary Fig. 4c).
If deadenylation-dependent decapping occurs during NMD, we
expect that decapped full-length reporter mRNAs appear when
the decapping machinery or XRN1 are depleted together with
SMG6. Although we readily detect 30 fragments as a result of
endocleavage, knockdown of XRN1 alone lead to only marginally
increased levels of the full-length reporter RNA (Fig. 4e and
Supplementary Fig. 3c,d). To shut down the decapping
machinery, we used siRNAs targeting the catalytic subunit
DCP2 and the scaffold protein EDC4 (also called Hedls)29. We
observed no accumulation of PTC reporter mRNA upon
EDC4þDCP2 depletion. When SMG6 and XRN1 were
depleted together, no 30 fragments were detected and reporter
levels increased twofold compared with SMG6 knockdown
alone, suggesting that 50–30 decay becomes more important
when SMG6 is depleted. Surprisingly, also the combined
SMG6þEDC4þDCP2 knockdown could not fully increase the
PTC reporter to WT levels, even though elevated PTC reporter
levels were observed. Interestingly, the knockdown of UPF1
increased the reporter RNAs more than the combined
SMG6þXRN1 or SMG6þ EDC4þDCP2 depletion, suggesting
that not all degradation during NMD can be attributed to
decapping or endocleavage. However, we cannot exclude the
possibility that the incomplete depletion of the decay factors
contributes to the observed discrepancy. Taken together, xrFrag
analysis suggests that 30–50 degradation pathways contribute to
the removal of NMD substrates, when 50–30 decay is inhibited.
50–30 decay is initiated by decapping and endocleavage. Having
investigated the decay routes of the complex NMD pathway in
detail, we next used the MS2 tethering system to study individual
mRNA-degrading proteins by recruiting them to an xrRNA-
containing reporter mRNA (Fig. 5a).
Tethering of the DCP1 interacting and decapping-promoting
protein PNRC2 reduced the levels of the TPI reporter mRNA
and increased xrFrag levels more than twofold (Fig. 5b). The
W114A mutant of PRNC2, which is unable to bind DCP1
(ref. 30), was inactive in the tethering assay. However, tethering
of the DC mutant, which lacks the C-terminal NR box required
for the UPF1 interaction30, showed a degradation similar to the
WT. In contrast to the decapping factor PNRC2, the
NMD factor SMG7 recruits via its C-terminus the catalytic
subunit POP2 of the CCR4-NOT complex leading to mRNA
deadenylation11. The accelerated deadenylation is followed by
decapping and degradation from the 50 end31. Interestingly,
when we tethered SMG7 full-length or only the C-terminal
domain, which both lead to reduced TPI reporter mRNA, we
detected slightly decreased rather than increased xrFrag
levels (Fig. 5c). We therefore wanted to compare the impact
of decapping, endocleavage or deadenylation on the generation
of xrFrag. To this end we tethered the C-terminal domain of
SMG7 (deadenylation), PNRC2 (decapping) and the EJC core
component BTZ, which was shown to activate endocleavage
via NMD26. Interestingly, tethering of PNRC2 and BTZ resulted
in decreased reporter levels and increased levels of xrFrag,
whereas SMG7 decreased the amounts of the reporter as
well as xrFrag (Fig. 5d). The effects of tethered SMG7 and
PNRC2 were also observed with a reporter (SL-NL-4MS2-
xrRNA), which is inefficiently translated due to a strong stem–
loop in the 50 UTR (Fig. 5e–g). Hence, both proteins act in a
translation-independent manner. Because NMD is a translation-
dependent process, BTZ was inactive when tethered to the non-
translatable SL-NL-4MS2-xrRNA mRNA. Our results suggest
that SMG7-mediated degradation does not only enhance 50–30
decay, but also leads to the degradation of the substrate mRNA
by 30–50 decay. This could also explain the remaining
degradational activity we observed in the analysis of NMD
substrates after combined knockdowns of SMG6 with XRN1 or
decapping factors (Fig. 4e and Supplementary Fig. 3c). To test
this idea, we constructed a tethering reporter containing a
region from the MALAT1 lncRNA, which is cleaved by RNAse P
and leads to the formation of a stable 30 triple helix
(Supplementary Fig. 5a). This structure was shown to stabilize
mRNA, likely by preventing the 30–50 decay machinery
to engage with the protected RNA 30 end32. Tethering of
PNRC2 leads to equal degradation of polyadenylated or triple-
helix-containing RNA (tH), whereas SMG7 preferentially
degraded the polyadenylated reporter mRNA (Supplementary
Fig. 5b,c).
We next asked if the tethering of other deadenylation-
promoting factors would lead to mRNA degradation with
reduced xrFrag accumulation. For these experiments, we chose
the silencing domains of TNRC6A and TNRC6B, which are
involved in the miRNA-induced mRNA decay pathway, as well
as TTP, which mediates the degradation of AU-rich elements
(AREs)-containing mRNAs. These proteins were shown
before to induce degradation by recruitment of deadenylase
complexes, thereby leading to accelerated deadenylation33–35. In
our tethering assay, we could confirm that all tested deade-
nylation-promoting proteins resulted in reporter degradation,
however, no increase in xrFrag was detected for any of
these factors (Fig. 5h). To further delineate the contribution of
deadenylation to the observed decay, we made use of a
reporter in which the xrRNA was located 50 of the MS2
binding sites (Supplementary Fig. 5d). When SMG7-C,
TNRC6A-SD or TNRC6B-SD were tethered, the resulting
xrFrags showed a faster migration (Supplementary Fig. 5e),
which was visible in lane profiles for the respective xrFrag
signals (Supplementary Fig. 5f). Taken together, we find
a differential enhancement of 50–30 degradation when
comparing decapping-, endocleavage- and deadenylation-
promoting factors. The xrRNA analysis therefore represents
an ideal starting point to characterize whether a given protein
induces 50–30 mRNA decay.
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Figure 5 | Characterization of mRNA decay induced by direct protein tethering via xrFrag analysis. (a,e) TPI and NanoLuc tethering reporter mRNAs
with 4MS2 binding sites are depicted as in Fig. 1. (e) The position of the 50 stem–loop inhibiting ribosome scanning is indicated. (b–d, g,h) Northern blots of
RNA samples extracted from HeLa cells transfected with the indicated tethering and reporter constructs. Mean values±s.d. (n¼ 3) for reporter and xrFrag
levels were quantified and normalized to tethered GST, which served as control. The ratio of xrFrag to reporter mRNA levels is indicated below the graph.
Western blots show the expression levels of the MS2V5-tagged constructs with GFP serving as transfection control. Unspecific bands are indicated with
asterisks. (f) Translational efficiency (mean±s.d., n¼ 3) was measured by dual luciferase assay and compared for NanoLuc reporter with or without the 50
stem–loop. Expression of the NanoLuc mRNAs is shown by northern blotting, co-transfected LacZ served as control.
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Characterization of isolated deadenylation-inducing elements.
So far, the xrFrag analysis allowed the dissection of complex
decay pathways (NMD), as well as the characterization of
degradation-inducing proteins (tethering). Next, we wanted to
use xrRNAs to examine the turnover of mRNAs with individual
decay elements, for example ARE and microRNA response
elements (miRE). AREs are mRNA-destabilizing sequences that
are known to work in heterologous reporter mRNAs36. In our
constructs the c-fos or the granulocyte–macrophage colony-
stimulating factor (GM–CSF) ARE were followed by a single
xrRNA element (Fig. 6a). Upon induction of stable cell lines, we
observed increased amounts of xrFrag for both AREs, but
only the GM–CSF ARE also strongly reduced the expression
of the reporter mRNA (Fig. 6b). However, calculating the
xrFrag:reporter ratios indicated that both AREs enhanced 50–30
decay. The decay mediated by the GM–CSF ARE occurred
via deadenylation-dependent decapping, because the reduced
expression as well as increased xrFrag abundance was abolished
by the depletion of either XRN1 or the CCR4-NOT scaffold
protein CNOT1 (Fig. 6c,d).
The expression of many mammalian genes is regulated by
miRNAs, which assemble an RNA-induced silencing complex
onto their target mRNAs and thereby induce their degradation.
We inserted into our reporter two previously described miRE
(ref. 37) containing canonical let-7 and miR-21 binding sites
(Fig. 6e). A reporter with mutated miREs was used as negative
control. In comparison to the miRE (Mut) mRNA, the expression
levels of the miRE (WT) mRNA upon induction of stable cell
lines were strongly reduced (Fig. 6f). Interestingly, the xrFra-
g:reporter ratio was just increased by a factor of B3, indicating
that only some of the degradation occurred by 50–30 decay.
Depletion of CNOT1 restored normal levels of reporter mRNA
and xrFrag, confirming that miRE-mediated mRNA decay
involves deadenylation by the CCR4-NOT complex (Fig. 6g).
Our previous observation of deadenylation induced by TNRC6
tethering further supports this finding (Fig. 5h). In conclusion,
xrRNA and xrFrag analysis can be used to study the
characteristics of short mRNA-destabilizing sequence elements.
Endonucleolytic cleavage within TNF-a and IL6 30 UTRs.
Accelerated turnover of cytokine mRNAs represents a crucial
regulation mechanism of immune responses, which is reported to
utilize multiple decay elements and factors. To study this
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Figure 6 | Isolated ARE and miRNA decay elements induce deadenylation-dependent mRNA degradation. (a,e) Schematic representation of TPI
reporter mRNAs depicted as in Fig. 1, containing (a) the decay-inducing AREs from c-fos and GM–CSF in the 30 UTR or (e) WTor mutated miRE for let-7
and miR-21. (b,c, f,g) Hela Flp-In T-REx cells expressing the indicated constructs were harvested and RNA was extracted and analysed by northern blotting.
(c,g) Knockdown was performed by transfecting the cells with the indicated siRNAs. Expression of reporter mRNAs was induced with 1 mgml 1
doxycycline (þDox) for 24 h. Endogenous 7SL RNA levels are shown as a control. Mean values of reporter and xrFrag signal±s.d. (n¼ 3) were quantified
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degradation pathway using our xrRNA system, we inserted the
ARE- and conserved stem–loop-containing regions of the TNF-a
and IL6 30 UTRs between the TPI ORF and the xrRNA element
(Fig. 7a and Supplementary Fig. 6a,b). As a negative control we
used a similar sized fragment of the RAB7A 30 UTR (ref. 24). For
both reporters (TNF-a and IL6) we observed in transiently
transfected cells a strong reduction of full-length mRNA levels,
which was accompanied by an increase in xrFrag abundance
(Fig. 7b). Hence, TNF-a and IL6 30 UTRs induce mRNA degra-
dation that involves 50–30 decay. In stable cell lines, the TNF-a
and IL6 full-length transcripts were barely detectable 24 h after
induction, whereas the xrFrag levels were strongly increased
compared with the RAB7A control (Fig. 7c). In time-course
assays the RAB7A-containing mRNA increased in expression for
8 h after induction. In contrast, the xrFrag generated from the
degradation of the TNF-a and IL6 reporter mRNAs reached
maximum levels as fast as 4 h after the addition of doxycycline
(Fig. 7d). These fast decay kinetics are similar to those observed in
PTC-containing TPI and globin mRNAs and suggest that TNF-a
and IL6 reporter RNAs are very efficiently degraded. Treating the
cells with the translation inhibitors cycloheximide or puromycin
before induction caused a strong increase of both TNF-a- and
IL6-containing reporter mRNAs and almost indistinguishable
xrFrag:reporter ratios compared with the RAB7A control
(Fig. 7e,f). Hence, the majority of the degradation involves
translation-dependent mechanisms.
TNF-a as well as IL6 mRNAs have been reported to be
degraded by Regnase-1-mediated endonucleolytic cleavage4. In
addition, both 30 UTRs contain several AREs, which can lead to
deadenylation followed by decapping. We reasoned that the
insertion of two xrRNA elements flanking the 30 UTR of a
reporter mRNA would allow to discriminate mRNAs undergoing
decapping and endocleavage. To this end, we constructed
reporter mRNAs with two xrRNA elements, one upstream
(xrA) and one downstream (xrB) of the 30 UTR of interest
(Fig. 8a). Expression of the xrA-RAB7A-xrB control reporter
leads to the production of both xrFrag species with roughly equal
levels (Supplementary Fig. 7a). For the xrA-TNF-a-xrB reporter,
the levels of the longer xrFragA were reduced, whereas the shorter
xrFragB accumulated in a translation-dependent manner
(Supplementary Fig. 7a,b). The production of xrFragB was very
fast and occurred during the first 4 h after induction (Supple-
mentary Fig. 7c).
If both deadenylation-dependent decapping and endocleavage
decay routes are used for the degradation, decapped full-length
transcripts as well as 30 fragments are expected to accumulate in
cells lacking XRN1. Surprisingly, we did not detect increased
amounts of decapped, full-length TNF-a and IL6 reporters in
XRN1-depleted cells (Fig. 8b,c). Instead, we observed additional
bands representing 30 fragments, indicating that the enhanced
50–30 decay involves endonucleolytic cleavage. A conserved stem–
loop in the TNF-a and IL6 30 UTRs has been reported as binding
site of Regnase-1 (ref. 4). We therefore asked, if the observed
30 fragments are generated by endocleavage close to the stem–
loop sequence. To this end, we amplified, cloned and sequenced
the 30 fragments of IL6 and TNF-a. Surprisingly, the cleavage
sites of both reporters were outside the stem–loop sequence,
1–20 nucleotides upstream of the IL6 stem–loop and 132–138
nucleotides downstream of the TNF-a stem–loop (Supple-
mentary Fig. 6a,b). To further analyse the endonucleolytic
cleavage of these transcripts, we generated constructs in which
the observed cleavage sites were deleted (Fig. 8d). Interestingly,
the deletion of the mapped cleavage site resulted in a weak
(TNF-a) or moderate (IL6) increase of the reporter mRNAs and
reduced levels of xrFrag (Fig. 8e). In contrast, the slightly lower
expression levels (compared with RAB7A) of a reporter mRNA
containing the isolated TNF-a cleavage site (Fig. 8d) resulted in
mildly increased xrFrag accumulation (Fig. 8e). Upon XRN1
knockdown, TNF-a and IL6 30 fragment levels were strongly
reduced when the cleavage sites were deleted (Fig. 8f). Strikingly,
in the TNF-a construct which contained the cleavage site, but not
the stem–loop itself, we detected a 30 endocleavage fragment. We
mapped the cleavage site of this mRNA as described above to the
same area as in the full-length TNF-a 30 UTR (Supplementary
Fig. 6a).
In conclusion, the xrFrag analysis helped to identify that
TNF-a and IL6 30 UTRs undergo endocleavage at previously
uncharacterized positions outside the canonical Regnase-1
binding site. However, endocleavage can only partially explain
the rapid degradation of both reporters. Hence, cytokine
degradation also utilizes multiple major decay pathways for
robust mRNA degradation, resembling the complex degradation
mechanism observed for NMD substrates.
Discussion
The analysis of mRNA decay intermediates has greatly facilitated
the understanding of mRNA turnover mechanisms. Previously, a
poly(G) tract was used in yeast to inhibit exonucleases and to
study the directionality of mRNA degradation pathways38,39.
However, poly(G) tracts fail to trap mRNA turnover inter-
mediates in mammalian cells. In this work, we establish a viral-
derived XRN1-resistant RNA sequence (xrRNA) as a molecular
tool to study mRNA decay in mammalian cells. The insertion of
xrRNA into different reporter constructs results in the robust and
reproducible accumulation of degradation intermediates (xrFrag).
Since the xrFrag is produced during the decay of the xrRNA-
bearing mRNA, it enables to unambiguously discriminate mRNA
decay from other causes of reduced mRNA levels. Moreover, the
use of xrRNA to visualize decay intermediates provides insights
into the contribution of 50–30 decay pathways. Amongst its
advantages are the minimal interference with other cellular
processes, simplicity of its application and versatility. Although
high levels of xrFrags could potentially inhibit cellular 50–30 decay
due to the sequestration or inactivation of XRN1, as suggested
previously40 we did not observe signs of such an inhibition. In
fact, we detect only a single xrFrag band on our northern blots,
whereas the primary 30 fragments were detected as an additional
band exclusively in cells lacking XRN1.
Although the xrFrag method generates robust data in our
hands, it also offers the possibility for future improvements. It will
be interesting to explore if any xrRNA sequences can be identified
or evolved that inhibit XRN1 to a greater extent than the MVE
virus xrRNA used in this work. We provide evidence that the
MVE-derived xrFrags represent meta-stable intermediates of
50–30 decay, which will be eventually degraded. It remains to be
determined if more stable xrFrags could allow even deeper
insights into the molecular mechanisms of mRNA degradation.
Interestingly, for exact xrFrag analysis a single xrRNA is superior
to a combination of two or three xrRNAs, which do not
significantly elevate the amount of the 50 xrFrag, but lead to the
accumulation of additional xrFrags. This seemingly paradoxical
observation is explained by the slow, but constant conversion of
longer xrFrags into shorter xrFrags.
Many of the analyses presented in this work employ the xrFrag
method to monitor the contribution of 50–30 decay pathways to
mRNA turnover. However, it is conceivable that xrFrag analysis
may also be used to discriminate deadenylation-dependent and -
independent modes of decay. Due to the small size of the xrFrags,
their running behaviour is highly dependent on their poly(A) tail
lengths. In addition, the defined 50 end of the xrFrags offer
superior resolution compared with the variable 50 ends observed
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for 30 fragments that accumulate upon XRN1 depletion. Although
some of our results indicate that xrFrags allow to assess poly(A)
tail lengths, specific assays such as RNaseH-oligo(dT) digestion or
PAT assays41 are needed to improve this aspect of our
experimental system.
The xrRNA realized its full potential when used in combina-
tion with other approaches and proved to be fully compatible
with mRNA half-life measurements and the knockdown of
specific mRNA decay factors. This allowed to dissect the
contribution of 50–30 decay pathways to the overall degradation
of an mRNA. Furthermore, assessing the pharmacological
inhibition of mRNA decay is very robust with the xrRNA
reporter as shown by our analysis of cycloheximide-, puromycin-
and caffeine-treated cells. Finally, we were able to establish NMD
reporters with a previously unprecedented dynamic range
between WT and PTC-containing mRNAs. Standard NMD
analyses with transiently transfected reporter constructs often
show 5–10-fold differences between the WT and the
PTC-containing steady-state mRNAs. Our system on the one
hand displays a 10–50 fold reduction of the expression of the
NMD substrate compared with its WT counterpart. In addition,
the differential accumulation of xrFrag leads to a dynamic range
of up to three orders of magnitude when the ratio of full-length
reporter and xrFrag is calculated. Furthermore, the knockdown of
the central NMD factor UPF1 increases the expression level of the
PTC-containing mRNA to the level of the WT mRNA. To the
best of our knowledge, this quantitatively complete inhibition
of NMD has not been accomplished with any other assay
to date. The performance of our NMD assay is even more
remarkable in view of the possibility to follow the accumulation
as well as the decay of NMD reporter and xrFrag over time.
The degradation of the substrate mRNA occurs in a very
short time frame and confirms that NMD eliminates bona
fide substrate mRNAs with very rapid kinetics. In contrast,
when XRN1 is abundant the xrFrags decay at a slower rate,
which is similar to the one observed for 30 fragments in XRN1-
depleted cells. The comparable turnover rate of 30 fragments and
xrFrags is striking, given that their accumulation is caused by
fundamentally different mechanisms of XRN1 inhibition. Impor-
tantly, we find that 30 fragments are converted into xrFrags
over time, which explains why xrFrags were still detected in
XRN1-depleted cells.
The xrFrag analysis is also compatible with the tethering of
RNA decay factors, which allows to disentangle complex mRNA
turnover pathways, such as NMD. We show that the direct
tethering of SMG7 to two different reporter mRNAs (translation-
dependent and -independent) reduced the levels of the reporter
mRNA, without substantial increase in the xrFrag:reporter ratio.
The effect of tethered SMG7 was different from that of
the tethered decapping activator PNRC2 or the tethered
EJC-component BTZ, which both increased the amounts of
xrFrags. Furthermore, SMG7 was less active in degrading a
reporter mRNA containing the 30 end of the MALAT1 lncRNA,
which impairs 30-50 decay32,42. Our data are not only in line with
the previously reported contribution of 30–50 decay to the overall
activity of NMD43, but also demonstrates the successful combi-
nation of the xrFrag analysis with well-established tethering
assays.
0.0
0.5
1.0
1.5
0
1
2
3
4
R
el
at
iv
e 
m
R
N
A
le
ve
ls
 (r
ep
ort
er)
R
el
at
iv
e 
m
R
N
A
le
ve
ls
 (r
ep
ort
er)
siRNA Luc XRN1
1 2 3 4 5 6
Reporter
xrFrag
R
AB
7A
TPI-3′UTR-
xrRNA TN
F
IL
6
R
AB
7A
TN
F
IL
6
TPI-xrA-
RAB7A-xrB 764 5321
Stop
pA
TPI-xrA-
TNF-xrB 764 5321
Stop
pA
xrA xrB
TPI-xrRNA
7SL control
xrFrag
3′ fragment
1.0 106 6.350 1.0 31
R
AB
7A
R
AB
7A
TN
F
TN
FTPI-xrA-
3′UTR-xrB
1 2 3 4
TPI-xrRNA
7SL control
LucsiRNA XRN1
xrFragB
xrFragA
3′ fragment
Cloned
3′ UTRTPI
Probe
binding
pATPI-TNF-xrRNA 764 5321
Stop
764 5321
Stop
TPI-IL6-xrRNA pA
Cloned
3′ UTRTPI
Probe
bindingxr
R
N
A
Stem–loop
Stem–loop
WT
Δ Cleavage site (ΔCS)
Only cleavage site (CS)
WT
Δ Cleavage site (ΔCS)
TN
F 
CS
1 2 3
TN
F
TN
F 
ΔC
S
TN
FC
S
IL
6
IL
6 
ΔC
S
XRN1siRNA
TPI-3′UTR-
xrRNA
4
TPI-xrRNA
7SL control
xrFrag
5
3′ fragment
TPI-xrRNA
7SL control
1 2 3 4 5 6
R
AB
7A
TN
F
TN
FΔ
CS
 
IL
6
IL
6Δ
CS
 
xrFrag
0.0
0.5
1.0
1.5
0
1
2
3
Reporter
xrFrag
88 33 2.6 67 9.31.0
xrFrag
Reporter
xrFrag
Reporter
R
el
at
iv
e 
m
R
N
A
le
ve
ls
 (x
rF
rag
)
R
el
at
iv
e 
m
R
N
A
le
ve
ls
 (x
rF
rag
)
TPI-3′UTR-
xrRNA
a b c
d
e
f
Figure 8 | The degradation induced by TNF-a and IL6 30 UTRs involves endocleavage. (a,d) TPI reporter mRNAs with xrRNA-framed RAB7A (control),
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Our analysis of AREs and miREs demonstrates that xrRNAs
can also be used to study individual decay-inducing sequences.
We find that both degradation elements require deadenylation
activity by the CCR4-NOT1 complex, however only for AREs we
observed a substantial increase in 50–30 decay. Combined with the
results of tethered deadenylation-promoting factors, these find-
ings support the notion that shortening of the poly(A) tails is not
exclusively followed by enhanced decapping.
We also analysed mRNA turnover that is mediated by
two well-studied cytokine 30 UTRs, TNF-a and IL6. Different
destabilizing sequences have been identified within these 30 UTRs,
for example, AREs. Furthermore, both 30 UTRs contain a stem–
loop structure, which is recognized by the RNA-decay factors
Regnase-1 and Roquin. It has been suggested that Regnase-1 and
Roquin degrade an overlapping set of mRNAs including
inflammatory mRNAs (for example, TNF-a and IL6) via distinct
mechanisms. Our experiments demonstrate that TNF-a and IL6
30 UTRs are targeted by translation-dependent degradation
including endonucleolytic cleavage in HeLa cells. We mapped
the cleavage sites to positions up- and downstream of the
conserved stem–loop sequences (Supplementary Fig. 6). Our
observations for the IL6 30 UTR are in good agreement with
recently published results, although endocleavage did not occur at
the putative binding site of Regnase-1 (ref. 4). However, the
prominent endonucleolytic cleavage of the TNF-a 30 UTR was
unexpected in light of the preferential Roquin-mediated deade-
nylation that has been reported in the literature4,44. Furthermore,
the site of endonucleolytic cleavage was clearly downstream of the
reported Roquin and Regnase-1 binding sites. Deletion of the
endocleavage sites partially impairs the degradation of TNF-a
and IL6 30 UTR reporter mRNAs, but also indicates that
additional pathways are involved in the turnover of the
reporters. Hence, xrFrag analysis confirms that multiple decay
mechanisms contribute to the efficient mRNA degradation
triggered by TNF-a and IL6 30 UTRs.
In conclusion, we have established xrFrag analysis as a
powerful tool to study mRNA turnover in mammalian cells
and demonstrate its functionality by applying it to several
mRNA decay pathways. Therefore, we envision that the use of
xrRNAs will facilitate the analysis of mRNA decay under
different experimental conditions and in various biological
systems.
Methods
Plasmids and cell culture. Plasmid constructs b-globin WT and PTC39,
TPI–WT and PTC160, TPI-4MS2 tethering reporter, LacZ control plasmid and the
expression vector for MS2V5-BTZ were generated by inserting the respective DNA
fragments26,45 into the pCI-neo vector (Promega). Plasmids encoding for
reporter constructs contained four copies of the northern blot probe binding site,
as indicated in the figures. The MVE virus xrRNA element (nucleotides
10,488–10,725, reference sequence NC_000943.1, Fig. 1b) with a 50 nucleotide
upstream linker was amplified from a gBlocks gene fragment (IDT) and inserted
in the site indicated in the figures. Similarly, the 30 UTR regions of RAB7A
(nucleotides 862–1,311, reference sequence NM_004637.5), TNF-a (nucleotides
1,201–1,639, reference sequence NM_000594.3, Supplementary Fig. 6a) and IL6
(nucleotides 761–1,082, reference sequence NM_000600.4, Supplementary Fig. 6b),
as well as the EMCV IRES and MALAT 30 sequence were amplified from gBlocks
gene fragments (IDT) or HeLa cDNA and cloned in the pCI vector. AREs (ref. 36)
and miREs (ref. 37) were assembled from annealed primers. For stable cell lines,
the reporters were cloned in the pcDNA5/FRT/TO vector. Full-length or mutants
of SMG7, PNRC2, TNRC6A, TNRC6B and TTP were cloned from HeLa cDNA
and inserted into the pCI-MS2V5 tethering vector. The NanoLuc ORF was cloned
in pCI-neo containing a stable 50 stem–loop (kindly provided by Gabriele Neu-
Yilik), which was previously used to prevent cap-dependent translation in IRES-
containing reporter constructs46.
Transient transfections were done in HeLa Tet-Off cells (Clontech).
Standard protocols were used to generate stable HeLa Flp-In T-REx cell lines
(initially established by Elena Dobrikova and Matthias Gromeier, Duke University
Medical Center). Expression of stable cell lines was induced with 1 mgml 1
doxycycline for 24 h or for the indicated time before harvesting. All cell lines were
cultured in DMEM (Gibco) supplemented with 9% foetal bovine serum (Gibco)
and 1 Pen Strep (Gibco) and the cells were incubated at 37 C, 5% CO2 and 90%
humidity. Mycoplasma contamination was tested by PCR amplification of
mycoplasma-specific genomic DNA47.
siRNA transfections. For cells intended to be transiently transfected with
plasmids, 5 105 HeLa Tet-Off cells were grown overnight in 6 cm plates and
forward transfected with 300 pmol siRNA for single or 600 pmol total siRNA for
double knockdowns using Lipofectamine RNAiMAX (Thermo Fisher)26. After 48 h
the cells were counted and transferred to 6-well plates. Stable cell lines were reverse
transfected using 2.5 ml Lipofectamine RNAiMAX and 60 pmol siRNA per 2 105
HeLa cells. The following siRNA target sequences were used: luciferase (50-CGT
ACGCGGAATACTTCGA-30), XRN1 (50-AGATGAACTTACCGTAGAA-30),
UPF1 (50-GATGCAGTTCCGCTCCATT-30), SMG6 (50-GGGTCACAGTGC
TGAAGTA-30), SMG7 (50-CGATTTGGAATACGCTTTA-30), CNOT1 (50-GGA
ACUUGUUUGAAGAAUA-30), DCP2 (50-GGACTGGCTTTCTCGAAGA-30), for
EDC4 an equal mix of EDC4-1 (50-GAGTTAAAGATGTGGTGTA-30) and EDC4-
2 (50-TACACCACATCTTTAACTC-30). The efficiency of the CNOT1 knockdown
was confirmed by semi-qPCR using the following primers: 50-AATGTTGGCCTG
TCTGCAAG-30 , 50-TGTCATTCCAGCAAGAGGGT-30 .
Transient plasmid transfections. 2.8 105 HeLa Tet-Off cells were seeded in
6-well plates 24 h before transfection by calcium phosphate precipitation with
0.5 mg of a mVenus expression plasmid, 2.5 mg control plasmid (LacZ) and 2 mg
plasmid encoding for reporter mRNA. For tethering assays, 1.5 mg reporter, 1.5 mg
of MS2V5-tagged expression plasmid and 3 mg control plasmid (LacZ) were
transfected.
RNA extraction and northern blotting. Total RNA was extracted from individual
replicates with peqGOLD TriFast (Peqlab), resolved on a 1% agarose and 0.4M
formaldehyde gel using the tricine-triethanolamine buffer system48 and analysed
by northern blotting. PSP65-globin plasmid was linearized with BamHI and used
as template for in vitro transcribed [a-32P]-GTP body-labelled RNA probes, which
were used for the detection of all reporter and LacZ control RNA. 7SL endogenous
RNA was detected using a 50-32P-labelled oligonucleotide (50-TGCTCCGTTTCC
GACCTGGGCCGGTTCACCCCTCCTT-30). Signals were scanned using a
Typhoon FLA 7000 (GE Healthcare) and raw unmodified scans were quantified
using ImageQuant TL (GE Healthcare). Representative blots of at least three
replicates are shown. Blots have been cropped and contrast-adjusted for
presentation purposes. Uncropped images of main figures are collectively shown in
Supplementary Fig. 8. As an example, positions of RNA marker bands are shown in
Supplementary Figs 2 and 5. For sub-cellular fractionation, the cells were first
harvested in polysome buffer (10mM NaCl, 10mM MgCl2, 10mM Tris-HCl pH
7.4, 1% Triton X-100, 1% Na-deoxycholate and 1mM DTT). Cytoplasmic and
nuclear fractions were separated by centrifugation and RNA subsequently extracted
from each fraction using peqGOLD TriFast. For mRNA half-life calculations, the
one-phase-decay equation from GraphPad Prism 5 was used.
Immunoblot analysis and antibodies. SDS–polyacrylamide gel electrophoresis
and immunoblot analysis were performed using protein samples derived from
peqGOLD TriFast extractions or parallel transfection harvested with RIPA buffer.
The antibody against tubulin (T6074; 1:3,000 dilution) was from Sigma, the
antibody against V5 (18870; 1:3,000 dilution) was from QED Bioscience, the
antibodies against GFP (ab290; 1:3,000 dilution) and SMG6 (ab87539; 1:1,000
dilution) were from Abcam, the antibodies against XRN1 (A300-443A; 1:2,000
dilution), SMG7 (A302-170A; 1:2,000 dilution) and EDC4 (A300-745A; 1:1,000)
were from Bethyl and the antibody against UPF1 was kindly provided by Jens
Lykke-Andersen (1:1,000 dilution). Secondary horseradish peroxidase-coupled
antibodies against rabbit (111-035-006; 1:3,000 dilution) or mouse (115-035-003;
1:3,000 dilution) were from Jackson ImmunoResearch. Western Lightning Plus-
ECL Enhanced Chemiluminescence Substrate (PerkinElmer) in combination with
the myECL Imager (ThermoFisher) was used for visualization. Blots have been
cropped and contrast-adjusted for presentation purposes. Uncropped images of
main figures including molecular weight markers are collectively shown in
Supplementary Fig. 8.
30 fragment cloning. Total RNA (25 mg) was used for linker ligation using T4
RNA ligase I and 200 pmol of barcoded RNA linker (rGrCrUrGrArUrGrGrC
rGrArUrGrArArUrGrArNrNrNrNrNrNrArArA)26. After RT–PCR with VNN-
oligo(dT)20 primer, TNF-a- or IL6-specific primers together with an adaptor-
specific primer (Adaptor: 50-GCTGATGGCGATCAATGA-30; TNF-a: 50-TTT
TTTTGCGGCCGCCCGGGTCGACTAGTAGGGCGATTACAGACACA-30;
IL6: 50-TTTTTTGCGGCCGCCCGGGTCGACTGAGGTAAGCCTACACTT
TC-30) were used for PCR amplification with Accuprime Taq Polymerase
(Life Technologies). Amplified fragments were subsequently cloned in pGEM-T
vector, sequenced by GATC Biotech and unique clones were used for mapping
analysis.
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Data Availability. The authors declare that all the data supporting the findings of
this study are available within the article and its Supplementary Information files
and from the corresponding authors upon reasonable request.
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Supplementary Figure 1 
NMD-dependent accumulation of xrFrags derived from reporter mRNA degradation 
(a) WT or PTC-containing TPI reporter mRNAs with or without xrRNA are depicted as in Fig. 
1. (b-h) Northern blots of total RNA extracted from transiently transfected HeLa cells (b) or 
stable cell lines (c-h) expressing the indicated reporter mRNAs. Co-transfected LacZ or 
endogenous 7SL served as control RNA. Mean values of reporter and xrFrag signal ± s.d. (n 
= 3) were quantified and for each knockdown or treatment condition the PTC values were 
normalized to the WT. For sub-cellular fractionation (e), the values for reporter and xrFrag 
mRNA levels were normalized to the respective value of the total RNA fraction. The ratio of 
xrFrag to reporter mRNA levels is indicated below all graphs. Successful fractionation was 
confirmed by the nuclear marker UAP56 and the cytoplasmic marker GAPDH (d, f) Western 
blot analysis of total protein extracted from the same samples with UPF1 antibody, tubulin 
served as loading control. 
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Supplementary Figure 2 
Degradation of xrFrags via 5′-3′ decay 
(a) Schematic representation of the PTC-containing TPI reporter mRNAs as in Fig. 1, indicating 
the multiple xrRNA element repeats. (b) Northern blot of total RNA extracted from transiently 
transfected HeLa cells expressing the indicated reporter mRNAs. Co-transfected LacZ served 
as control RNA. (c) Lane profile of the xrFrags shown in (b), indicating the position of xrFragA, 
B and C. 
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Supplementary Figure 3 
NMD utilizes the whole spectrum of degradation pathways 
(a-c) Northern blots of RNA samples extracted from stable HeLa cell lines transfected with the 
indicated siRNAs and expressing the indicated reporter constructs. Endogenous 7SL served 
as control RNA. Mean values of reporter and xrFrag signal ± s.d. (n = 3) were quantified and 
for each knockdown condition the PTC values were normalized to the WT. The ratio of xrFrag 
to reporter mRNA levels is indicated below the graph. (d) Western blot analysis of knockdown 
efficiencies was done with the indicated antibodies, tubulin served as loading control. 
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Supplementary Figure 4 
Degradation of IRES-containing dual xrRNA reporter via SMG6-catalyzed endocleavage 
(a) Schematic representation of the dual xrRNA IRES reporter as in Fig. 1. (b,c) Northern blots 
of RNA samples extracted from HeLa cells transfected with the indicated siRNAs and reporter 
constructs. Co-transfected TPI (b) or globin WT (c) served as control mRNA. Mean values of 
reporter and xrFrag signals ± s.d. (n = 3) were quantified. The ratio of xrFrags to reporter 
mRNA levels is indicated below the graph. 
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Supplementary Figure 5 
Tethered SMG7 induced deadenylation-dependent degradation of reporter mRNAs 
(a) Schematic representation of the non-translatable NanoLuc tethering reporter containing a 
3′ MALAT sequence. To stimulate transport to the cytoplasm 80 template-encoded adenosines 
(pA80) were inserted upstream of the MALAT sequence. The processing by endonucleolytic 
cleavage of masc RNA and subsequent triple helix formation is indicated. (b) Northern blot of 
RNA samples extracted from HeLa cells transfected with the indicated tethering constructs and 
the SL-NL-4MS2-pA80-MALAT reporter. Mean values ± s.d. (n = 3) for polyadenylated reporter 
(pA) and triple helix reporter (tH) levels were quantified and normalized to tethered GST, which 
served as control. The ratio of tH:pA mRNA levels is indicated below the graph. (c) Western 
blot showing the expression levels of the MS2V5-tagged constructs with GFP serving as 
transfection control. Unspecific bands are indicated with asterisks. (d) Schematic 
representation of the TPI-xrRNA-4MS2 tethering reporter with inverted xrRNA and 4MS2 
elements. (e) Northern blot of RNA samples extracted from HeLa cells transfected with the 
indicated tethering constructs and the TPI-xrRNA-4MS2 reporter, LacZ served as control. 
Approximate RNA size is indicated on the left. (f) Lane profiles of the northern blot in (e), with 
size-normalized LacZ control serving as reference point. Due to the differences in reporter and 
xrFrag intensities, the values for GST tethering were plotted on the left axis (1x intensity), for 
SMG7-C, TNRC6A-SD and TNRC6B-SD on the right axis (0.2x intensity). 
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Supplementary Figure 6 
Annotated sequences of cytokine elements 
(a, b) The DNA sequence of the TNF-α and IL6 element used in reporter constructs are shown 
with annotations of sequence motifs. Single or overlapping AREs are annotated according to 
AREsite21. Red and yellow triangles represent cleavage sites identified by sequencing of 
individual unique cloned 3′ fragments. 
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Supplementary Figure 7 
Detection of endocleavage within the TNF-α 3′ UTR framed by two xrRNA elements 
(a-c) Northern blots of total RNA extracted from stable HeLa cell lines expressing the indicated 
dual xrRNA reporter mRNAs. Mean values of reporter and xrFrag signal ± s.d. (n = 3) were 
quantified and for each knockdown condition the PTC values were normalized to the WT. The 
ratio of xrFrag to reporter mRNA levels is indicated below the graph. 
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Supplementary Figure 8 
Uncropped blots of Figures 1-8 as indicated. 
  
)LJXUHI
)LJXUHG
)LJXUHE
)LJXUHF
;5183)
7XEXOLQ



N'D


153
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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Supplementary Figure 8, continued 
Uncropped blots of Figures 1-8 as indicated. 
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The transfer of correct genetic information from the DNA to the translated protein is essential for the survival 
of a cell. Therefore, cellular quality control mechanisms exist, which detect and degrade aberrant transcripts1. 
Nonsense-mediated mRNA decay (NMD) is a translation-coupled quality control pathway in eukaryotic cells 
that targets mRNAs carrying a premature termination codon (PTC)2. Aberrant translation termination at the 
PTC causes stalling of the ribosome and the assembly of a surveillance complex, which recruits RNA degrada-
tion enzymes3. This prevents the production of truncated proteins with a potentially dominant-negative effect4. 
NMD is an important modulator of the phenotype of genetic disorders, as nonsense mutations represent 20% of 
disease-associated single base pair substitutions affecting gene coding regions5. Moreover, NMD acts as a general 
modulator of gene expression, since many transcripts that have arisen from alternative splicing or contain an 
upstream open reading frame or long 3′ UTR are endogenous NMD targets6.
Numerous proteins and factors involved in NMD have been identified, but many questions regarding the 
exact mechanism by which NMD degrades mRNAs remain to be answered7. In the study of NMD, reporter 
mRNAs with and without a PTC are utilized to monitor the degradation of transcripts in standard human cell 
lines such as HeLa and HEK-293 cells. When introduced into the cell via transient transfection, these transcripts 
are expressed from a high number of extrachromosomal plasmids. Alternatively, isogenic cell lines stably express-
ing the reporter constructs can be established. When using a system such as Flp-In T-REx, the target gene is 
inserted at a single site in the cell line of choice. While overall expression levels of the reporter mRNAs are lower, 
previous studies suggest that more pronounced and robust results can be achieved using this approach8. However, 
generation of stable cell lines can be laborious and especially when a high number of reporter constructs are sys-
tematically compared, transient transfections yield faster results.
While studying NMD using many different cell lines, reporter constructs and transfection methods, we 
observed notable discrepancies. Since similar experimental designs are widely used in the field, we sought to sys-
tematically analyze the NMD efficiency in standard human cell lines. We found that not all commonly cultured 
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human cells effectively degrade NMD targets when reporter mRNAs are expressed from extrachromosomal plas-
mid DNA. Additionally, for the widely used HEK-293 cells we observed differential NMD efficiency depending 
on whether stable or transient transfections have been performed.

ơƥǦ͸Ϳ͹Ǥ In order to deter-
mine the degradation efficiency of transfected (i.e. exogenous) NMD targets, we have developed an experimental 
system to compare different cell lines and transfection systems (Fig. 1a). First, we established inducible HeLa and 
HEK-293 Flp-In T-REx stable cell lines (referred to as HeLa FT and 293 FT, respectively) expressing triosephos-
phate isomerase (TPI) or globin reporter mRNA with or without a PTC. In both types of cells, the levels of PTC-
containing full-length reporter mRNA were markedly reduced (Fig. 1b,c), indicating that these transcripts are 
efficiently degraded by NMD. An additional faster migrating band detected by northern blotting corresponds 
to a decay fragment (xrFrag) containing an xrRNA sequence, which is resistant to the 5′–3′ exonuclease XRN18. 
The accumulation of xrFrags correlates with mRNA decay activity and serves as a readout for mRNA degradation 
pathways involving 5′–3′ decay8. When we transiently transfected the TPI and globin NMD reporter constructs 
in HeLa FT cells, the PTC-containing reporter mRNA was also strongly reduced (Fig. 1d). Strikingly, we did not 
observe differences between the WT and PTC constructs in transiently transfected 293 FT cells: the expression 
levels of both mRNAs were comparable and no xrFrags accumulated (Fig. 1e). This result was surprising since 
the reporter mRNA was expressed from the same pcDNA5/FRT/TO plasmid under control of the CMV pro-
moter that was used for generating the stable cell lines. It has been reported before that NMD efficiency can vary 
between different strains of cells, for example for the HeLa cell model system9 or epithelial cells of cystic fibrosis 
patients10. NMD efficiency has also been described to vary between different murine tissues11. In contrast, the 
observation made here is that the degradation of an NMD-target depends on the manner of transfection and not 
on the inherent characteristic of the cell.
ƤǦ͸Ϳ͹
Ǥ Our initial observation was made using the calcium phosphate precipitation method 
for transient transfections. Although calcium phosphate-based transfections are commonly used and led to robust 
NMD readout in HeLa cells, we wanted to test whether the transfection method had an influence on the behavior 
of the reporter mRNA in the cell. To this end, the experiment was repeated using other commonly used reagents 
to transiently transfect cultured cells. However, no substantial differences between wild-type and PTC mRNAs in 
293 FT cells were observed when the constructs were transfected using polyethylenimine (PEI) or Lipofectamine 
2000 (Fig. 2a). Different cellular stress pathways have been previously implicated in the regulation of NMD effi-
ciency12. To rule out that the observed inability to degrade an NMD reporter was due to cellular stress caused in 
response to transient transfections, a mock transfection of 293 FT cells stably expressing globin PTC39 mRNA 
was performed (Fig. 2b). When the stable cell lines were transiently co-transfected with salmon sperm DNA, 
the mRNA expressed from the stably integrated PTC39 construct was still efficiently degraded (Fig. 2b, lane 3). 
The same observation was made when the cells were co-transfected with the lacZ expression plasmid (Fig. 2b, 
lane 4) as well as with a GFP-expressing plasmid (Fig. 2b, lane 5, GFP expression was confirmed by microscopy), 
which were both included in our transient transfections as controls.
For functional NMD, the transcript must be exported to the cytoplasm and be actively translated. We con-
firmed that the reporter mRNA is exported to the cytoplasm via subcellular fractionation (Fig. 2c). Furthermore, 
the translatability of these transcripts was assessed by expressing GFP from transiently transfected plasmids in 
293 FT cells and confirming GFP levels by microscopy.
In stably transfected FT cells, the gene of interest is integrated at a single site in the genome in every cell and 
the total cell population is isogenic. In transiently transfected cells however, the amount of plasmid DNA and 
expressed mRNA varies between cells. To exclude that the apparent inhibition of NMD results from overloading 
individual cells using the transient system, we transfected 293 FT cells with lower amounts of plasmid DNA. We 
estimated that 0.1–0.3 μg of transiently transfected plasmid DNA yields expression levels that are comparable to 
the amount expressed in stable cell lines after 24 h of induction (Fig. 3a). When transfecting 293 FT cells using 
these reduced concentrations, still no degradation of the PTC-containing mRNA could be detected down to 
0.1 μg of transfected plasmid DNA (Fig. 3b). Although the average mRNA levels in stable cell lines and cells trans-
fected with 0.1 μg plasmid DNA were comparable, individual transiently transfected cells might express more 
than the average stably transfected cell. Therefore, we transfected lower amounts of DNA (0.01 and 0.03 μg) and 
quantified reporter mRNA expression by qPCR, since expression levels were too low to be detectable by northern 
blotting (Fig. 3c). Even when using these minimal amounts of transfected reporter DNA, no difference could be 
detected between wild-type and PTC-containing reporter mRNA.
Collectively, these results show that the inability of transiently transfected 293 FT cells to degrade NMD 
reporter mRNAs is independent of transfection reagent and the amount of transfected plasmid DNA. This is in 
line with the fact that HeLa cells, which have been transiently transfected with a high amount of plasmid DNA, 
degrade PTC-containing reporters very efficiently (Fig. 1d).
Ǧ͸Ϳ͹Ǥ To inves-
tigate whether 293 FT cells exhibit a general defect to efficiently degrade unstable mRNAs expressed from tran-
siently transfected plasmids, we studied reporter mRNAs containing the 3′ UTRs from the cytokines TNF-α and 
Interleukin-6 (IL6) in HeLa and 293 FT cells (Fig. 4a). These 3′ UTRs contain several degradation-promoting 
sequences such as AU-rich elements and a decay-inducing stem-loop13. Interestingly, both reporter mRNAs were 
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Figure 1. Transiently transfected 293 FT cells show a strongly reduced NMD efficiency in comparison to stably 
transfected cells. (a) Schematic representation of the experimental setup. The reporter constructs are generated 
by cloning the gene of interest into the pcDNA5/FRT/TO vector. The blue bar represents the coding sequence 
of triosephosphate isomerase (TPI) or β-globin with or without a premature termination codon (PTC) and with 
a normal stop codon (stop). Downstream, a viral XRN1-resistant sequence (xrRNA) is present that allows the 
detection of decay intermediates resulting from 5′–3′ exonucleolytic decay. The grey boxes correspond to four 
repeats of a northern blot probe binding site. Cells are transfected with these constructs using either a stable or 
transient transfection system. Flp-In T-REx (FT) cells constitutively express a Tet repressor (TetR) that blocks 
transcription of the reporter by binding to Tet operators (TetO2) present downstream of the cytomegalovirus 
(CMV) promoter in the reporter construct. Therefore, FT cells are induced with tetracycline(Tet)/doxycycline. 
In non-FT cells, the reporter is always expressed. Unstable reporter mRNAs are degraded with participation 
of the cellular 5′–3′ exonuclease XRN1. Full-length reporter levels and decay fragment (xrFrag) caused by 
stalling of XRN1 at the xrRNA are detected via northern blotting. p(A): poly(A) tail. (b,c) Expression of 
reporter mRNAs in HeLa FT (b) and 293 FT (c) stable cell lines was induced with doxycycline for 24 h and the 
reporter levels detected by northern blotting. The lower band (xrFrag) corresponds to a 5′–3′ exonucleolytic 
decay intermediate. Endogenous 7SL RNA levels were detected and quantified on the same blot and are shown 
as control. The mean values ± SD (n = 3) for relative transcript levels were quantified and the PTC values 
normalized to the wild-type control. The xrRNA/reporter ratio is indicated below the graph. (d,e) HeLa FT 
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degraded in 293 FT cells, although the reduction of full length mRNA as well as accumulation of xrFrags was less 
pronounced than in HeLa FT cells (Fig. 4b,c).
Ǥ In 
order to establish whether the phenomenon of impaired NMD efficiency of transiently transfected cells is limited 
to 293 FT cells, more human cell lines were analyzed (Fig. 5). First, other strains of HeLa and HEK-293 cells were 
examined, which recapitulated the results obtained from their Flp-In T-REx counterparts (Fig. 5a,b). Next, fur-
ther commonly used cancer cell lines were investigated. In U2OS cells that have been transiently transfected with 
globin reporter mRNA with or without a PTC, the full-length reporter levels were reduced, whereas the xrFrag 
accumulated, suggesting efficient NMD (Fig. 5c). In contrast, in MCF-7 cells transfected with the same construct, 
the full-length reporter mRNA levels were not reduced (Fig. 5d), analogous to the observation made in HEK-293 
cells. These findings demonstrate that reduced NMD of transiently expressed reporter mRNAs is not limited to 
HEK-293 cells and that caution should be taken when investigating NMD in human cell lines using a transient 
transfection system.

To the best of our knowledge, this is the first comparison of stably vs. transiently transfected NMD reporters in 
cultured human cells. Of the six different cells lines tested in this study, three (293 FT, 293 MSR and MCF-7) did 
not show efficient degradation of NMD-reporter mRNAs in transient transfection experiments. Importantly, 
HEK-293 and MCF-7 cells are widely used and easy to handle human cell lines and may therefore be chosen for 
transient transfections by a substantial number of laboratories. Considering that we have analyzed only a small 
number of cell lines until now, it may be premature to conclude that NMD substrates are generally less efficiently 
degraded when expressed from transiently transfected reporter constructs. Nonetheless, our results raise the con-
cern that the robustness of NMD assays using transfected reporters may be influenced by a previously unknown 
interference of transient transfections with the NMD competence of certain cell lines. Currently, the reason for 
the impaired NMD of transiently transfected reporters in HEK-293 cells and MCF-7 cells is unclear. We have 
confirmed that mRNAs expressed from extrachromosomal plasmids are transported to the cytoplasm and effi-
ciently translated, two known requirements for the activation of NMD. It is conceivable that transiently expressed 
mRNAs are unable to recruit NMD-promoting messenger ribonucleoprotein (mRNP) components. However, 
the identity of such mRNP components remain to be determined in future experiments. Furthermore, we cannot 
exclude that transiently expressed mRNAs are in general more resistant to mRNA degradation in HEK-293 cells. 
Although the decay of TNF-α and Interleukin-6 3′ UTR-containing reporter mRNAs is more pronounced than 
that our NMD reporter mRNAs, it not does not match the turnover efficiency of reporter mRNAs expressed from 
stably integrated constructs. Taken together, mRNAs/mRNPs expressed by transient transfections may exhibit a 
differential molecular composition or contain certain modifications that render them more resistant to mRNA 
turnover than mRNAs transcribed from chromosomal insertions. Therefore, we strongly suggest to assess NMD 
efficiencies using independent methods. Such initial tests will be particularly important when previously unchar-
acterized cell lines are used or when NMD efficiencies of different cells are compared.
Materials and Methods
Ǥ The plasmid constructs β-globin-WT and -PTC39; TPI-WT and 
-PTC160; TPI-RAB7A, -TNF and -IL6 containing an XRN1-resistant structure from the Murray Valley enceph-
alitis virus were generated by cloning the respective DNA fragments8 into the pcDNA5/FRT/TO vector (Thermo 
Fisher Scientific). The mVenus and lacZ control plasmid were constructed by inserting the respective DNA frag-
ments into the pCI-neo vector (Promega) as described previously14.
HEK-293 Flp-In T-REx (293 FT; Thermo Fisher Scientific), HeLa Flp-In T-REx (HeLa FT; established by Elena 
Dobrikova and Matthias Gromeier, Duke University Medical Center), HeLa Tet-Off (Clontech), GripTite 293 
MSR (Thermo Fisher Scientific), U2OS and MCF-7 cells were cultured in Dulbecco’s Modified Eagle’s Medium 
(Gibco, Life Technologies) supplemented with Penicillin-Streptomycin and 9% FBS. The cells were maintained at 
37 °C, 5% CO2 and 90% humidity.
Establishment of stable cell lines. For stable transfections, HeLa FT or 293 FT cells were seeded at a den-
sity of 2.8 × 105 cells/well in 6-well plates 24 h before transfection. In each well, 2.5 μg of the pcDNA5/FRT/TO 
vector with the gene of interest and 0.5 μg of the pOG44 vector expressing the Flp recombinase were transfected 
with the calcium phosphate method. 48 h after transfection, the cells were transferred to 10 cm culture dishes and 
selected with a hygromycin concentration of 100 μg/ml (293 FT cells) or 150 μg/ml (HeLa FT cells). Expression of 
stable cell lines was induced with 1 μg/ml doxycycline for 24 h.
Transient plasmid transfections. 2.8 × 105 cells were seeded in 6-well plates 24 h before transfection. If 
not indicated otherwise, the cells were transfected using the calcium phosphate method. The indicated amount 
of reporter plasmid was co-transfected with 0.5 μg of the mVenus expression plasmid and 3 μg of the lacZ con-
trol plasmid. Polyethylenimine (PEI) transfections were performed according to the jetPEI protocol (Polyplus 
transfection). Transfections using jetPRIME (Polyplus transfection) and Lipofectamine 2000 (Thermo Fisher 
(d) and 293 FT (e) cells were transiently transfected with 3 μg plasmid DNA per 6-well and transcription was 
induced with doxycycline for 24 h. Reporter mRNA levels were analyzed by northern blotting. LacZ was co-
expressed and serves as a transfection control. The mean values ± SD (n = 3) were quantified and the PTC 
values normalized to the wild-type control. The xrRNA/reporter ratio is shown below the graph.
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Scientific) were performed according to the manufacturer’s instructions. Due to the presence of Tet repressor 
binding sites in the pcDNA5/FRT/TO vector and the constitutive expression of the Tet repressor in the FT cell 
lines, expression from transiently transfected pcDNA5/FRT/TO reporter plasmids in these cells was induced by 
supplementing the medium with 1 μg/ml doxycycline for 24 h.
Ǥ The cells were harvested in polysome buffer (10 mM NaCl, 10 mM MgCl2, 
10 mM Tris-HCl pH 7.4, 1% Triton X-100, 1% Na-deoxycholate and 1 mM DTT). The cytoplasmic and nuclear 
fractions were separated by centrifugation.
Ǥ The cells were harvested in peqGOLD TriFast reagent 
(VWR) and total RNA extraction was performed as recommended by the manufacturer’s protocol. 2.5 μg 
of total RNA were resolved on a 1% agarose/0.4 M formaldehyde gel using the tricine/triethanolamine buffer 
system as described15 followed by transfer on a nylon membrane (Roth) in 10x SSC. The blots were incu-
bated overnight at 65 °C in Church buffer containing [α-32P]-GTP body-labeled RNA probes for detection of 
the reporter and lacZ control RNA. Endogenous 7SL RNA was detected by a 5′-32P-labeled oligonucleotide 
(5′-TGCTCCGTTTCCGACCTGGGCCGGTTCACCCCTCCTT-3′). The blots were visualized and quantified 
using the Typhoon FLA 7000 (GE Healthcare) and ImageQuant TL 1D software.
Western blot analysis. Proteins were extracted using peqGOLD TriFast reagent (VWR), separated 
by SDS-PAGE gel electrophoresis and transferred to nitrocellulose membranes. The following antibodies 
were used: anti-GAPDH (Santa Cruz Biotechnology), peroxidase-coupled secondary anti-mouse (Jackson 
ImmunoResearch). Detection was performed with Western Lightning Plus-ECL (PerkinElmer) and myECL 
Imager (Thermo Fisher Scientific).
ǦǤ 1 μg of total RNA was reverse-transcribed in a 20 μl reaction vol-
ume with an oligo dT primer (5′-TTTTTTTTTTTTTTTTTTTTVNN-3′, 10 μM final concentration) using the 
ProtoScript II Reverse Transcriptase (NEB) according to the manufacturer’s instructions. PCRs were performed 
using one-tenth of the reverse transcription reaction with GoTaq qPCR Master Mix (Promega) and the CFX96 
Touch Real-Time PCR Detection System (Bio-Rad). The reactions were performed in triplicates and the average Ct 
Figure 2. The reduced NMD efficiency in transiently transfected 293 FT cells is not due to transfection 
conditions. (a) Northern blots of the indicated reporter mRNAs. 293 FT cells were transiently transfected with 
0.3 μg of plasmid DNA per 6-well using different transfection reagents. LacZ was co-transfected as a control 
mRNA. The mean reporter values ± SD (n = 3) were quantified and the PTC-reporter levels normalized to the 
wild-type control. The xrRNA/reporter ratio is indicated below the graph. (b) RNA samples were extracted 
from stably transfected 293 FT cells and analyzed by northern blotting. The samples shown in Lanes 3–5 have 
additionally been transiently transfected with salmon sperm DNA (SS DNA), lacZ and a GFP expression 
plasmid, respectively. Endogenous 7SL RNA levels were detected and quantified on the same blot and are 
shown as control. The mean values ± SD (n = 3) were quantified and the values of the co-transfected samples 
normalized to the untransfected PTC control. The xrRNA/reporter ratio is indicated below the graph. (c) 
Northern blot of RNA extracted from the indicated fractions of 293 FT cells transfected with 0.3 μg of plasmid 
DNA per 6-well. Co-transfected lacZ is shown as a control. Endogenous 7SL RNA levels were detected on the 
same blot as control. C: cytoplasmic fraction, N: nuclear fraction. Successful fractionation was confirmed by the 
cytoplasmic marker GAPDH and the localization of the 7SL control RNA.
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Figure 4. Degradation of unstable reporter mRNAs in 293 FT cells. (a) Schematic representation of the 
reporter constructs as in Fig. 1a. Downstream of the TPI gene, the 3′ UTRs of RAB7A (control), TNF-α and IL6 
were cloned. (b,c) HeLa FT (b) and 293 FT (c) cells were transfected with 3 μg plasmid DNA of the indicated 
reporter per 6-well. The reporter levels were analyzed by northern blotting. LacZ was co-transfected as a 
transfection control. The mean reporter values ± SD (n = 3) were quantified and the cytokine reporter mRNAs 
normalized to the RAB7A control. The xrFrag/reporter ratio was calculated and is indicated below the graph.
Figure 3. NMD efficiency in transiently transfected 293 FT cells does not depend on the amount of transfected 
plasmid DNA. (a) Lanes 1–3: 293 FT cells were transfected with the indicated amount of plasmid DNA per 6-well 
and the mRNA was analyzed by northern blotting. LacZ was co-transfected as a control. Lane 4: 293 FT cells stably 
transfected with the indicated construct were induced for 24 h. Endogenous 7SL RNA levels were detected on the 
same blot and are shown as control. (b) Lanes 1–8: 293 FT cells were transfected with the indicated amount of 
plasmid DNA per 6-well and the mRNA was analyzed by northern blotting. LacZ was co-transfected as a control. 
Lanes 9–10: 293 FT cells stably transfected with the indicated construct were induced for 24 h. Endogenous 7SL 
RNA levels were detected and quantified on the same blot and are shown as control. The mean values ± SD (n = 3) 
of the signals were quantified and the PTC-values normalized to the corresponding wild-type control. (c) 293 
FT cells were transiently transfected with the indicated amount of plasmid DNA per 6-well and expression levels 
were measured by qPCR. The reporter mRNA levels were normalized to the co-transfected GFP control. The bars 
represent mean fold changes of PTC-containing reporter vs. wild-type reporter levels ± SD (n = 3).
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(Threshold cycle) value was calculated. Globin mRNAs levels were normalized to mVenus mRNA levels. For 
each primer, a 2-fold standard dilution was performed to calculate the primer efficiencies, which ranged between 
90–100%. The fold changes were calculated using the ΔΔCt method16. The mean fold changes were calculated 
from three biologically independent experiments. Primer sequences were: 5′-CAGGCTGCTGGTGGTCTAC-3′ 
and 5′-CGTGCAGCTTGTCACAGTG-3′ (globin mRNA); 5′-CCATCTTCTTCAAGGACGAC-3′ and 
5′-TGATATAGACGTTGTGGCTG-3′ (mVenus mRNA).
Ǥ The authors declare that the data supporting the findings of this study are 
available within the paper.
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EDITORIAL SUMMARY This protocol describes how to detect RNA decay intermediates in 
human cultured cells. Reporter mRNAs can be detected and quantified with molecular biology 
(northern blot, qPCR) and single-molecule fluorescence microscopy (smFISH, live imaging) 
approaches. 
 
TWEET A new protocol for detecting and quantifying RNA decay intermediates using 
molecular biology and single-molecule imaging approaches. 
 
COVER TEASER Detection of RNA decay intermediates 
 
Up to three primary research articles where the protocol has been used and/or developed: 
1 Boehm, V., Gerbracht, J. V., Marx, M. C. & Gehring, N. H. Interrogating the degradation 
pathways of unstable mRNAs with XRN1-resistant sequences. Nat Commun 7, 13691, 
doi:10.1038/ncomms13691 (2016). 
2 Gerbracht, J. V., Boehm, V. & Gehring, N. H. Plasmid transfection influences the readout of 
nonsense-mediated mRNA decay reporter assays in human cells. Sci Rep 7, 10616, 
doi:10.1038/s41598-017-10847-4 (2017). 
3 Horvathova, I. et al. The Dynamics of mRNA Turnover Revealed by Single-Molecule Imaging 
in Single Cells. Mol Cell 68, 615-625 e619, doi:10.1016/j.molcel.2017.09.030 (2017). 
 
Abstract 
RNA degradation ensures appropriate levels of mRNA transcripts within cells and eliminates 
aberrant RNAs. Detailed studies of RNA degradation dynamics have been prevented by the 
inherent instability of degradation intermediates due to the high processivity of the enzymes 
involved. In order to visualize decay intermediates and to characterize the spatiotemporal 
dynamics of mRNA decay, we have developed a set of methods that apply XRN1-resistant RNA 
sequences (xrRNAs) to protect mRNA transcripts from 5′-3′ exonucleolytic digestion. This 
approach is the only method that can detect the directionality of mRNA degradation and 
allows tracking of degradation products in unperturbed cells. Here, we provide detailed 
procedures for xrRNA reporter design, transfection and cell line generation. We explain how 
to extract xrRNA reporter mRNAs from mammalian cells and their detection and 
quantification using northern blotting and quantitative PCR. The procedure further focuses on 
how to detect and quantify intact reporter mRNAs and XRN1-resistant degradation 
intermediates using single-molecule fluorescent microscopy. It provides detailed instructions 
for sample preparation and image acquisition using fixed as well as living cells. The procedure 
puts special emphasis on detailed descriptions of high-throughput image analysis pipelines, 
which are provided along with the manuscript and were designed to perform spot co-
localization, detection efficiency normalization and the quality control steps necessary for 
result interpretation. The analysis software published here aims to enable non-expert readers 
to detect and quantify RNA decay intermediates within 4-6 days after reporter mRNA 
expression. 
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Introduction 
mRNA decay is a highly regulated process that controls gene expression via multiple 
pathways and through a coordinated series of enzymatic reactions. Accordingly, the regulation 
of mRNA stability affects cellular mRNA levels during normal development as well as in 
response to external perturbations1,2. It is used for example during the inflammatory response, 
where cis-acting AU-rich elements (AREs) serve to regulate inflammatory mediators like TNFα 
via binding of ARE-binding proteins that can increase (HuR) or decrease (e.g. TTP or BRF1) 
mRNA stability3,4. Another class of cis-acting elements termed GREs (GU-rich elements) 
controls mRNA splicing and decay. GREs are bound by CELF proteins, however GRE-mediated 
regulation of mRNA decay is not well understood5. Interestingly, the conditional regulation of 
mRNA half-life also applies during the decay of histone mRNAs, which occurs in a cell cycle-
dependent manner and serves to coordinate histone protein production with DNA synthesis6. 
Canonical mRNA decay is mediated by 5′-3′ and 3′-5′ exonucleases, which depend on 
prior deadenylation, decapping or endonucleolytic cleavage steps7. For most transcripts, decay 
is initiated via poly-A tail shortening by either the PAB-specific ribonuclease 2 and 3 complex 
(Pan2-Pan3), by de-adenylating complexes containing CCR4–NOT subunits or by the poly(A) 
ribonuclease PARN8. mRNA decay proceeds through hydrolyzation of the 5′ cap structure by 
DCP1-DCP2, which generates 5′ phosphorylated mRNAs that are substrates of 5′-3′ 
exonucleolytic decay9,10. Finally, degradation of the mRNA body is carried out in 5′ to 3′ 
direction by the cytoplasmic 5′-3′ exoribonuclease 1 (XRN1) and/or with 3′ to 5′ polarity by 
cytoplasmic exosome components such as RRP44 or EXOSC107. XRN1 has been described to 
be the main 5′-3′ exonuclease responsible for degradation of cellular mRNAs in the 
cytoplasm11. However, due to its high processivity it has not been possible to directly monitor 
XRN1-mediated degradation of individual mRNAs in their cellular context. Instead, existing 
methods had to rely on the stabilization of mRNA decay intermediates via knockdown of 
degradation machinery components, which directly interfere with the cellular processes 
involved in mRNA turnover.  
To visualize the degradation of unstable mRNA species and to assess the spatial and 
temporal dynamics of mRNA turnover, we have developed a set of methods that employ 
flaviviral RNA structures (xrRNAs) to render mRNA reporter transcripts resistant to 
degradation by XRN1 (Figure 1a). These xrRNA sequences block XRN1-mediated decay by 
sequestering the 5′ phosphate on the RNA substrate from the nuclease active site12. Thus, the 
stability of otherwise unstable 5′-3′ degradation intermediates is significantly increased and 
they can be unambiguously distinguished from intact transcripts using northern blotting13,14, 
quantitative real-time PCR (qPCR) (Figure 1b) and fluorescent microscopy15 (Figure 1c). 
 
 
Applications of the method 
The use of xrRNA reporter transcripts enables the assessment of mRNA degradation 
beyond steady state measurements of mRNA abundance and generates a direct read-out 
without the need for depletion of the cellular degradation machinery via RNAi knockdowns. 
The method can be readily implemented in existing workflows since XRN1-resistant decay 
intermediates are detectable via standard molecular biology methods such as northern blot 
or qPCR. In combination with state-of-the-art single-molecule fluorescence microscopy 
techniques, the xrRNA approach provides an easily applicable way to analyze the spatial and 
temporal dynamics of mRNA degradation in fixed and live cells. The technique is fully 
compatible with standard mRNA degradation assays such as half-life measurements when 
factors involved in mRNA degradation are depleted. Additionally, it can be combined with 
tethering assays to monitor the effect of RNA-binding proteins on transcript stability or with 
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staining of different subcellular compartments to assess the influence of spatial heterogeneity 
on mRNA stability.  
Modifications in the xrRNA reporter design allow dissection of the contributions of 
different degradation pathways to the turnover of a transcript (see Experimental Design). 
Specifically, the interplay of exo- and endonucleolytic degradation during the decay of a target 
RNA can be assessed by flanking individual regulatory elements with xrRNA elements. We 
have applied such modifications to study the decay of reporters containing the TNF or IL6 3′ 
UTRs and were able to quantify the contributions of different decay pathways13. In addition, 
we have used xrRNA reporter transcripts to investigate the effect of isolated regulatory 
sequence elements like the 5′-terminal oligopyrimidine element (TOP), AU-rich elements 
(ARE), and siRNA- or miRNA target sequences. In this context, we have developed a method 
for real-time observation of Ago2 slicing of reporter mRNAs15.  
xrRNA reporter transcripts can further be applied to study the spatiotemporal 
dynamics of mRNA turnover using single-molecule methods. So far, we have studied mRNA 
turnover in cytosolic RNA granules such as P-bodies. Our study revealed, that their 
degradation occurs independently in the cytosol and that P-bodies are not sites of reporter 
mRNAs degradation15. 
Our results show that the xrRNA approach represents an ideal starting point to 
investigate the effect of hitherto uncharacterized mRNA sequence elements or putative 
mRNA decay factors. With a few experimental steps, the main degradation pathways can be 
examined and conclusions be drawn about the molecular functions of the respective elements 
and factors. Since XRN1 is highly conserved across eukaryotic species, the methodology can 
be applied to a variety of other experimental systems. It is even conceivable that mRNA 
degradation could be investigated in vivo in well-known model organisms such as fruit flies or 
nematodes using the xrRNA technology. 
An attractive goal for the future is to apply the method to study the turnover of 
endogenous transcripts via integration of xrRNA sequences into genomic loci using 
CRISPR/Cas9. In addition, it is tempting to combine xrRNA fragments with other single-
molecule imaging techniques that can monitor translation via nascent polypeptide labeling to 
assess the correlation of translation and decay16-20. 
 
Comparison with other methods 
Direct monitoring of mRNA turnover has been difficult due to the instable nature of 
mRNA decay intermediates and the high processivity of the exonucleases involved. Instead, 
mRNA degradation rates have been estimated by blocking transcription through application 
of antibiotics such as actinomycin D, in combination with monitoring the decrease of cellular 
mRNA levels over time. As long as mRNA decay rates do not change upon addition of 
actinomycin D, this method can be employed to reliably assess mRNA turnover21. However, 
blocking transcription severely affects cell viability and initiates stress response pathways22. 
Additionally, the global inhibition of transcription also results in the loss of transcripts that 
encode components of the RNA decay machinery, which prevents accurate measurements of 
mRNA stability since decay pathways are perturbed. 
Another common approach involves the depletion of XRN1 to allow detection of 
decay intermediates when studying cytosolic mRNA turnover. However, XRN1 interacts with 
DCP1, a crucial component of the decapping machinery23. The presence of XRN1 therefore 
likely influences the decapping process and its absence affects mRNA decay rates beyond the 
stabilization of decay intermediates. XRN1 knockdown represents a very intrusive approach 
to study mRNA turnover while the use of XRN1-resistant fragments within a specific transcript 
is less invasive and provides an alternative to the depletion of decay pathway components. 
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In contrast to the methods discussed above, the application of xrRNA reporter 
constructs allows simultaneous detection of intact mRNAs and degradation intermediates and 
thereby enables quantification of decay rates. While the insertion of a poly(G) tract allowed 
detection of decay products in yeast24, to our knowledge there is no other method that can 
directly detect decay intermediates in metazoan cells. It is possible, however, to measure 
degradation rates using mRNA synthesis rates. In order to distinguish newly transcribed 
mRNAs from the overall cellular mRNA population, several studies have employed metabolic 
labeling of mRNA using 4-thiouridine. Consequently, metabolic labeling at high temporal 
resolution followed by precise mRNA quantification and computational modeling has been 
applied to determine mRNA transcription and decay rates22. Since metabolic labeling allows 
investigation of a multitude of endogenous transcripts without need for genetic manipulation 
of the target genes, it appears as a cost-effective and minimal interference approach that 
could be easily combined with the use of xrRNA reporter transcripts to study the dynamics of 
a regulatory relationship identified via metabolic labeling in more detail. 
 
Limitations 
The approach described in this protocol is simple, cost-effective and can be of minimal 
invasiveness since it provides an immediate read-out for XRN1-mediated 5′-3′ decay without 
the need for manipulation of the cellular degradation machinery. It is limited by the necessity 
to construct reporter transcripts, which restricts its applicability to endogenous mRNAs or 
high-throughput approaches. However, we believe that the combination of our method with 
established genome editing techniques allows the insertion of xrRNA sequences into genomic 
regions of interest. In this case, however, possible consequences of xrRNA insertions on 
cellular function should be considered. It is also conceivable that prolonging the half-lives of 
decay intermediates could have consequences for global gene expression, (e.g. sequestration 
of critical RNA-binding proteins), however, this is more likely to occur if reporter mRNAs are 
over-expressed from transient transfection. For live cell imaging, two additional transgenes 
(PP7 and MS2 coat proteins) need to be introduced into a cell line along with the mRNA 
reporter. To facilitate experimental set-up, cell lines suitable for single-molecule imaging are 
available from the Chao lab upon request and additional reagents are available at Addgene. 
 
 
Experimental design  
Here, we describe a set of techniques that apply viral xrRNA elements to block XRN1-
mediated 5′-3′ decay and generate stable decay intermediates that can be detected by 
standard RNA molecular biology and imaging techniques. To assay mRNA decay using xrRNA 
reporter transcripts, researchers need to design reporter as well as control constructs (Step 1), 
express them either transiently or generate stable cell lines (Steps 2-3), and perform a standard 
molecular biology (northern blot  (Step 18A), qPCR (Step 18B)) or single-molecule imaging 
experiments (Steps 19-21) as described further below. 
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 Reporter design (Step 1): To function as mRNAs, reporter transcripts need to contain an open 
reading frame (ORF in graphical overview in Figure 2) that can be translated and – ideally – be 
used to assess mRNA translation. To this purpose, we commonly include a Renilla luciferase 
(RL) gene and have utilized a RL activity assay, which is commercially available (Promega) and 
can be used to quantify protein expression25. Alternatively, other ORFs (for instance -globin) 
can also be used to generate different reporter constructs. Their translation can be checked 
by western blot analysis.  
To block exonucleolytic digest by XRN1, we incorporated viral XRN1-resistant RNA 
(xrRNA) fragments downstream of the reporter gene ORF within the 3′ UTR. Many flaviviral 
xrRNA fragments are structurally well described and we generated reporters featuring 
elements of the Murray Valley encephalitis (MVE) virus for molecular biology experiments as 
well as the West Nile virus Kunjin strain (WNVKUN) for single-molecule imaging12. These xrRNA 
elements inhibit XRN1-mediated degradation by the same mechanism and should both be 
suitable for either molecular biology or single-molecule imaging. They consist of two xrRNA 
sequences (xrRNA1 and xrRNA2), which block XRN1 by sequestering the RNA 5′ phosphate 
away from the enzyme26. However, XRN1 is not permanently inhibited by xrRNA fragments. 
Instead, xrRNAs only increase the half-life of the decay intermediates so that these can be 
detected but will eventually also be degraded. At least one full xrRNA element, consisting of 
two xrRNA sequences is needed to allow decay intermediate detection13.  
Introducing xrRNA elements in the 3’ UTR could potentially change the stability of the 
reporter transcript. Therefore, the xrRNA insertion should be designed to not disturb known 
regulatory regions.  In our experience, the position of the xrRNA element relative to the stop 
codon and polyA site does not substantially influence its efficiency. However, we recommend 
to include 50-100 nucleotide spacer regions between xrRNA element, stop codon and polyA 
site. Furthermore, we recommend to generate reporters with and without xrRNA elements to 
check whether expression and turnover of these constructs are altered.  
To allow detection of decay intermediates via northern blotting, it is necessary to 
design probes that anneal downstream of the xrRNA fragments. Thus, we have incorporated 
four repeats of the probe-binding sequence in the 3′ UTR of the reporter constructs. Using 
corresponding probes, XRN1-resistant decay intermediates can be detected as additional, 
faster-migrating bands during northern blot analysis. For qPCR analysis, we further apply 
linkers that are ligated to the isolated mRNA molecules. The 5′ cap structure present on intact 
mRNAs will prevent 5′ linker ligation and therefore linker sequences will allow to specifically 
detect decay intermediates. Standard qPCR analysis with primers complementary to the 
reporter gene and linker regions allows quantification of intact and degraded mRNA fractions 
within one simple and fast experiment. When performing transient transfection, the 
expression of the reporter mRNAs has to be compared to co-transfected stable mRNAs in 
order to control for transfection efficiency. Control transcripts used in the anticipated results 
section of the protocol are plasmids expressing lacZ or mVenus. They can be detected on a 
northern blot by including a northern probe-binding site. Alternatively, in qPCR analysis the 
co-transfected control is measured by a specific set of primers. For analysis of stably 
transfected cell lines, the levels of a constitutively expressed endogenous RNAs are detected 
to control for total RNA amounts. In the anticipated results section, 7SL RNA levels are 
detected in northern blots and GAPDH mRNA levels are measured for qPCR experiments. 
For single-molecule imaging, xrRNA sequences are flanked with orthogonal PP7 and 
MS2 stem loop repeat cassettes27. Since MS2 stem loops are protected from XRN1-mediated 
decay by the xrRNA fragments positioned 5′ of the MS2 cassette, this design allows 
discrimination between intact transcripts (PP7 and MS2) and stabilized degradation 
intermediates (MS2 only). In fixed cells, this can be done via single-molecule fluorescent in 
situ hybridization (smFISH) using probes specifically designed to target the reporter gene/PP7 
and MS2 repeat regions. In live cells, mRNAs can be detected via fluorescently-labeled coat 
183
proteins that recognize PP7 and MS2 repeats. To this aim, PP7 and MS2 coat proteins (PCPs 
and MCPs) fused to spectrally distinct fluorescent proteins (e.g. NLS-PCP-GFP and NLS-MCP-
Halo) are stably integrated into the HeLa cell genome by lentiviral transduction28. In both 
cases, single-molecule resolution is achieved by recruiting multiple copies of PCPs/MCPs to 
each RNA molecule as well as by a reduction of the background fluorescence in the cytosol 
through sequestration of unbound coat proteins to the nucleus via N-terminal nuclear 
localization signals (NLS). The coat protein constructs mentioned throughout this manuscript 
are available via Addgene (IDs 104098, 104099).  
To benchmark detection efficiencies, it is essential to perform all single-molecule 
experiments with a control transcript in addition to the reporter construct. Control transcripts 
should be identical to the mRNA reporter employed but lack the xrRNA fragments between 
the PP7 and MS2 cassettes. This way, decay intermediates are not stabilized. Control 
transcripts should always appear as intact dual-labeled particles in an imaging experiment and 
can be employed to assess detection efficiencies for both fluorescent labels. Reporter and 
control transcript-encoding plasmids that can be used for preliminary experiments or as 
cloning templates are available on Addgene (IDs 104095, 104097, 108366 – 108378). 
Reporter expression (Steps 2-3): xrRNA reporter mRNA-encoding plasmids as described above 
are designed for expression in mammalian cell lines. Reporter transcript-encoding plasmids 
can be transiently transfected or stably integrated into the target cell line (Figure 2). Transient 
transfection is ideal for quickly obtaining results and allows testing of several different 
reporter transcripts before starting the laborious and time-consuming generation of a stable 
cell line.  
Of note, transient transfection can result in significant cell-to-cell variations in 
expression levels, which affects the reproducibility of the performed experiment. For 
reproducible expression levels, we recommend to use an established human cell line (e.g. 
HeLa 11ht) that ideally co-expresses a tetracycline transactivator element to induce reporter 
expression from a tetracycline-inducible locus upon doxycycline addition29. 
During single-molecule imaging experiments, we made similar observations in 
transient and stably transfected cells. However, transient transfection has been reported to 
affect the readout of mRNA decay reporter assays during investigation of NMD substrates in 
certain cell lines14. We therefore recommend starting with transient transfections to test the 
feasibility of an experiment but then to generate stable cell lines to yield robust and 
reproducible results. 
Reporter detection (Steps 3-21): The application of xrRNA reporter transcripts for half-life 
measurements has an important advantage when compared to standard decay assays: It 
provides an additional read-out since it allows direct detection of stabilized decay 
intermediates. Thus, xrRNA reporter transcripts should be applied in qPCR or northern blot 
experiments to allow rapid and reliable quantification of decay intermediates and to 
distinguish mRNA degradation from other possible causes of variations in steady-state 
amounts of an mRNA. 
Single-molecule imaging methods can be used to assay the dynamics and 
spatiotemporal resolution of mRNA decay in single cells. However, while the read-out from 
an imaging experiment can be very informative, it is also more time-consuming to set up and 
needs careful calibration before quantitative interpretation of results can be performed. To 
remedy this need for expert knowledge, the following procedure (Steps 19-21) provides 
detailed instructions as well as test data and data processing workflows to enable all readers 
to apply the detection methods presented here.  
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Materials 
Biological materials 
 Cell lines for molecular biology analysis: HeLa Tet-Off (Clontech/Takara, cat. no. 
631156, RRID:CVCL_V352), Flp-In T-REx 293 (Thermo Fisher Scientific, cat. no. 
R78007, RRID:CVCL_U427) and HeLa Flp-In T-REx (established by Elena Dobrikova 
and Matthias Gromeier, Duke University Medical Center). 
 Cell line for single-molecule imaging: HeLa 11ht (expressing rtTA2-M2 tetracycline 
reverse transactivator) generated for Tet-On transcription of a gene of interest 
inserted into a single locus by flp recombinase29  
! CAUTION Cell lines used in your research should be regularly checked to ensure 
that they are not infected with mycoplasma. 
Reagents 
▲CRITICAL Nuclease-free reagents are required for northern blot and quantitative real-time 
PCR. To avoid contamination and RNA degradation, do not share reagents and kits. Refer to 
the MSDS before handling toxic or hazardous reagents. 
 Mammalian expression vectors for molecular biology analysis: we use the Flp-In T-REx 
Core Kit for cloning and establishing stable inducible cell lines (Thermo Fisher 
Scientific, cat. no. K6500-01). Alternatively, for transient transfection use pCI-neo 
(Promega; cat. no. E1841). Selected reporter plasmids are available on Addgene (IDs 
108366 – 108378). Plasmid information is listed in Supplementary Table 1. 
 Mammalian expression vectors for single-molecule imaging: mRNA reporter 
constructs are expressed from custom-made pSF4 vectors, where they are 
transcribed from a Tet-inducible CMV promoter and flanked by flippase (flp) 
recognition target (FRT) sites for single-locus genomic integration by flp recombinase-
mediated cassette exchange (Addgene IDs 104095, 104097). 
 Lentiviral expression vectors for coat protein integration needed for live cell imaging: 
phage plasmids that express protein of interest from a constitutive UbiC promotor 
(Addgene IDs 104098, 104099). Plasmid information is listed in Supplementary Table 
1. 
! CAUTION Lentiviral particles are a potential biological hazard. All work with 
lentiviruses must be performed according to biosafety level 2 regulations. Follow your 
institutional guidelines regarding risk reduction measures and waste disposal. 
 Oligonucleotide sequences are listed in Supplementary Table 2. 
 DMEM (Dulbecco's Modified Eagle Medium), high glucose with GlutaMAX 
supplement (Thermo Fisher Scientific, cat. no. 61965-059) 
 FluorobriteTM DMEM imaging medium (Thermo Fisher Scientific, cat. no. A1896701) 
 Halo-labeling dye Janelia Fluor 549 (JF549)30 (Tocris, Cat.No.: 6147)  
 FBS (Thermo Fisher Scientific, cat. no. 10270-106) 
 PBS (Thermo Fisher Scientific, cat. no. 14190-169) 
 Doxycycline hyclate (Sigma, cat. no. D9891-1G) 
 Hygromycin B Gold (InvivoGen, cat. no. ant-hg-1) 
 Plasmid transfection reagent of choice (see step 2)  
 peqGOLD TriFast (VWR, cat. no. 30-2010) 
! CAUTION TriFast is toxic and should be used in a fume hood; wear gloves and a lab 
coat. 
 1-Bromo-3-chloropropane (Sigma, cat. no. B9673-200ML) 
! CAUTION 1-Bromo-3-chloropropane is toxic. Handle it inside a fume hood and 
wear gloves and a lab coat. 
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 Precipitation Carrier (Molecular Research Center, cat. no. PC 173)  
 Ethanol (Carl Roth, cat. no. 9065.4) 
! CAUTION Ethanol is flammable; keep away from heat, sparks, and open flames. 
 2-Propanol (Carl Roth, cat. no. 6752.4) 
! CAUTION 2-Propanol is flammable; keep away from heat, sparks, and open flames. 
 Ultra pure water (Merck, cat. no. L0015) 
 SeaKem LE Agarose (Lonza, cat. no. 50005) 
 Formaldehyde solution, ≥37% (wt/vol), non-acidic (Carl Roth, cat. no. P733.1) 
! CAUTION Formaldehyde solutions and formaldehyde vapors are toxic; prepare the 
solutions in a fume hood.  
 Triethanolamine (Carl Roth, cat. no. 6300.1) 
 TRICINE (Carl Roth, cat. no. 6977.3) 
 Formamide, deionized (Carl Roth, cat. no. P040.1) 
! CAUTION Formamide is a toxic material and a teratogen. Handle it inside a fume 
hood; wear protective gloves and a lab coat.  
 Ethylenediamine tetraacetic acid (EDTA; Carl Roth, cat. no. CN06.3) 
 Ethidium Bromide (EtBr) 0.07% (wt/vol) solution (AppliChem, cat. no. A2273,0005)  
! CAUTION Ethidium Bromide is toxic and harmful. Wear gloves and eye glasses 
when you are using this compound. If skin is exposed to EtBr, extensively wash it 
with running water.  
 Glycerol (Carl Roth, cat. no. 3783.1) 
 Bromophenol blue (Sigma, cat. no. B0126-25G) 
 ssRNA Ladder (NEB, cat. no. N0362S) 
 NaCl (Carl Roth, cat. no. 3957.1) 
 tri-Sodium citrate dihydrate (Carl Roth, cat. no. 3580.1) 
 Hydrochloric acid (HCl; Carl Roth, cat. no. 4625.1) 
 SDS ultra-pure (Carl Roth, cat. no. 2326.3) 
! CAUTION This compound is harmful. Avoid inhalation and contact with skin and 
eyes. 
 Di-Sodium hydrogen phosphate (Na2HPO4; Carl Roth, cat. no. P030.2) 
 Sodium hydroxide (NaOH; Carl Roth, cat. no. 6771.1)  
! CAUTION NaOH is corrosive. Wear gloves and handle under fume hood to avoid 
eyes and skin damage.  
 alpha-P32-Guanosine 5′-triphosphate, 800 Ci/mmol, 10 µCi/µl (α-32P-GTP; Hartmann 
Analytic, cat. no. FP-808) 
! CAUTION Follow the applicable local and institutional regulations for handling 
radioactivity. 
 gamma-P32-Adenosine 5'-triphosphate, 800 Ci/mmol, 10 µCi/µl (γ-32P-ATP; 
Hartmann Analytic, cat. no. FP-801)  
! CAUTION Follow the applicable local and institutional regulations for handling 
radioactivity and for the relevant waste disposal policies. 
 SP6 RNA Polymerase (NEB, cat. no. M0207L) 
 NTP Bundle, 4 x 100 mM (ATP, CTP, GTP, UTP) (Jena Bioscience, cat. no. NU-1014S) 
 10x DTT (NEB, cat. no. B1034A) 
 RNAsin, 40 U/µl (Promega, cat. no. N251A) 
 DNAse I, RNAse-free, 1 U/µl (Thermo-Fisher, cat. no. EN0525) 
 mini Quick Spin RNA Columns (Sigma-Aldrich, cat. no. 000000011814427001) 
 T4 Polynucleotide Kinase (10 U/µL) (Thermo-Fisher, cat. no. EK0031) 
 T4 RNA Ligase 1 (NEB, cat. no. M0204S) 
 Biotin-11-UTP (Jena Bioscience, cat. no. NU-821-BIOX) 
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 Tris (Carl Roth, cat. no. AE15.2) 
 Tween 20 (Sigma-Aldrich, cat. no. P1379 
 Albumin Fraction V/Bovine serum albumin (BSA; Carl Roth, cat. no. 8076.2) 
 Streptavidin-HRP (Cell Signaling Technology, cat. no. #3999S) 
 Western Lightning Plus ECL, Perkin Elmer, cat.no. NEL103E001EA) 
 dNTP Mix, Roti®-Mix PCR 3 (Carl-Roth, cat. no. L785.2) 
 GoScript Reverse Transcriptase (Promega, cat. no. A5003) 
 NucleoSpin Gel and PCR Clean-up (Macherey-Nagel, cat. no. 740609.50) 
 GoTaq qPCR Master Mix (Promega, cat. no. A6001) 
 Two sets of Stellaris FISH probes (Biosearch Technologies) annealing to the reporter 
gene or PP7 stem loop cassette (Quasar670) and the MS2 stem loop cassette in the 
3′ UTR (Quasar570)15  
 Paraformaldehyde 20% (wt/vol) aqueous solution (Electron Microscopy Sciences; 
cat. no. 15713)  
! CAUTION It is a hazardous cross-linking agent. Wear protective gloves and handle 
under fume hood. 
 Dextran sulfate sodium salt (Sigma Aldrich; cat. no. D6001) 
 UltraPure 20x SSC Buffer (Life Technologies; cat. no. 15557036) 
 DAPI, dilactate (Sigma; cat. no. D9564) 
 Prolong gold antifade reagent (Molecular Probes, Life Technologies; cat. no. P36934) 
 10x PBS pH 7.4 (Thermo Fisher Scientific; cat.no. AM9624) 
Equipment 
Cell culture 
 Nitrile gloves (TouchnTuff 90-600, Ansell) 
 Serological pipettes (Greiner Bio-one) 
 Fume hood (SafeAir, Hamilton) 
 Refrigerated centrifuge (Eppendorf) 
 Cell culture hood (Maxisafe 2020, Thermo Scientific) 
 Cell culture incubator (CO2 at 5%, humidified, 37 °C) (Galxy 170R, New Brunswick, 
Eppendorf) 
 Automated cell counter (Biorad, cat. no. 1450102) 
 Counting slides (Biorad, cat. no. 1450011) 
 FalconTM 50ml conical centrifuge tubes (Corning, cat. no. 352070) 
 Tissue culture–treated 6-well plates (Corning, cat. no. 3506) 
 Tissue culture–treated 12-well plates (Corning, cat. no. 3513) 
Molecular biology 
 Nanodrop 2000 spectrophotometer (Thermo Scientific, cat. no. ND-2000) 
 Shaking heat block (e.g. HLC Heating-ThermoMixer) 
 Cellulose acetate (CA) 0.2 µm pore size membrane filter (Sartorius, cat. no. 11107--
47----ACN) 
 Microwave 
 Horizontal gel electrophoresis chamber for 20 x 20 cm gels (Carl Roth, Rotiphorese 
Unit PROfessional IV, cat. no. 2941.1) 
 Electrophoresis power supply (e.g. Consort EV243) 
 UV gel imaging system (e.g. Bio-Rad Gel Doc XR+ Gel Documentation System) 
 Sterile disposable scalpel (e.g. Bayha scalpel-blades + handle) 
 Plastic tray (at least 20 x 10 cm) 
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 Rocking platform (e.g. Biometra WT16 rocking platform) 
 Lab dish 35 x 25 x 4 cm (Carl Roth, cat. no. 8455.1) 
 Blotting paper, grade 703 (VWR, cat. no. 732-0591) 
 Roti-Nylon 0.2 (Carl Roth, cat. no. AE50.1) 
 Saran wrap 
 Folded paper hand towels  
 Bio-Link 254 UV crosslinker (Vilber Lourmat, cat. no. BLX 254) 
 Hybridization oven (e.g. Thermo Scientific Hybaid Shake 'n' Stack, VWR cat. no. 
HYBA6243) 
 Hybridization bottle, 250 x 35 mm or 300 x 35 mm (e.g. VWR cat. no. 732-1822 and 
732-1823) 
 Geiger Counter (e.g. Berthold LB 124 SCINT, cat. no. 43727-10) 
 BAS storage phosphor screens, BAS-IP MS 2025 E (VWR, cat. no. 28-9564-75) 
 Imaging cassette (e.g. VWR Exposure cassette, cat. no. 29-1755-24) 
 Phosphorimager (e.g. GE Healthcare Typhoon FLA 7000) 
 Chemiluminescence Imaging System (e.g. Thermo Fisher Scientific myECL Imager) 
 ImageQuant TL 8.1 software for quantification 
(https://www.gelifesciences.com/en/us/shop/protein-analysis/molecular-imaging-
for-proteins/imaging-software/imagequant-tl-8-1-p-00110) 
 Hard-Shell PCR Plates (Bio-Rad, cat. no. HSL9601) 
 Microseal 'B' Adhesive Seals (Bio-Rad, cat. no. MSB1001) 
 CFX96 Real-Time PCR Detection System (Bio-Rad, cat. no. 1855195) 
smFISH 
 Microscopy slides (Menzel Gläser, Thermo Scientific, cat. no. 12164682) 
 Microscope cover glass (⌀ 18 mm for 12-well plate) (Marienfeld Laboratory 
Glassware, Ref: 0111580) 
 Stellaris® FISH probes against the gene of interest (LGC Biosearch Technologies); for 
design instructions see Supplementary Procedure 3. 
 Petri dishes 100x15 mm (VWR, cat. no. 10416-320) 
 Parafilm (Sigma Aldrich, cat. no. P7793) 
 Hybridization incubator at 37˚C (e.g. FisherbrandTM, cat. no. 13-247-30Q) 
 Rubber tubing (Masterflex, cat. no. 6402-24 and Fisher, cat. no. Tygon R-3603) 
 Filter flask (1 liter, Pyrexplus; Fisher Scientific, cat. no. 10-180G) 
 Bottle stopper (Fisherbrand, cat. no. 14-135N) 
 A wide-field epifluorescence microscope for fixed cell imaging (see Equipment setup) 
Live cell imaging 
 A multipoint confocal spinning disk microscope equipped for live cell imaging (see 
Equipment setup) 
 Multi-color calibration slide for channel alignment (e.g. Argolight, type Argo-SLF-
001) 
 Imaging dish (μ-Dish), 35 mm, high, glass bottom (ibidi, cat. no. 81158) 
Image analysis 
 Fiji31 including the TrackMate plugin32 (https://imagej.net/TrackMate) 
 Matlab (Mathworks, https://www.mathworks.com/downloads) running the spot 
detection algorithm AIRLOCALIZE33 (http://www.timotheelionnet.net/software/) 
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 KNIME Analytics Platform (version 3.6.0 or later, 
https://www.knime.com/downloads)34 with additional update sites configured (see 
Equipment setup) 
 Decay analysis workflows and test data available from the Chao lab 
(https://data.fmi.ch/PublicationSupplementRepo/?group=gchao)  
 
Reagent setup 
 20x TT is 0.6 M TRICINE and 0.6 M Triethanolamine. Prepare 1 liter as follows. Add 
89.5 g of triethanolamine and 107.5 g of TRICINE and fill up to 900 ml with autoclaved 
distilled water. Stir until components are dissolved. Bring to 1 liter with autoclaved 
distilled water and filter the solution using a 0.2 µm membrane filter. The buffer can 
be stored at room temperature (15-25 °C) for up to a year. Yellow discoloring can 
occur that from our experience does not affect the buffer’s performance. 
 20% (wt/vol) SDS stock solution: Add autoclaved distilled water to 500 g SDS up to a 
volume of 2.5 liter and stir over night. The stock solution can be stored at room 
temperature for up to a year. 
 RNA sample buffer is 2 µl 0.5 M EDTA pH 8.0, 500 µl deionized Formamide, 35 µl of 
37% (wt/vol) Formaldehyde and 50 µl of 20x TT. Add one drop of 0.07% (wt/vol) EtBr 
solution. The buffer can be stored at -20 °C for up to a year. 
 RNA loading buffer is 50% (vol/vol) glycerol, 1 mM EDTA and 0.25% (wt/vol) 
bromophenol blue. Prepare in autoclaved distilled water. The buffer can be stored at 
room temperature for up to a year. 
 20x SSC is 3 M NaCl and 0.3 M tri-Sodium citrate dihydrate. Prepare 1 liter as follows. 
Add 175.3 g of NaCl and 88.2 g of tri-Sodium citrate dihydrate and fill up to 900 ml 
with distilled water. Adjust the pH to 7.0 with HCl. Autoclave and store at room 
temperature for up to a year. 
 Church buffer is 0.5 M Na2HPO4, 1 mM EDTA, 7% (vol/vol) SDS, pH 7.2. To prepare 1 
liter, first add 500 ml of autoclaved distilled water to 70.98 g of Na2HPO4 and 0.29 g 
of EDTA and adjust pH to 7.2 with NaOH. Add 350 ml of 20% (wt/vol) SDS solution, 
mix and fill up to 1 liter with autoclaved distilled water. Store at room temperature 
for up to a year. 
▲CRITICAL Pre-heat to 65 °C before use or to facilitate proper buffer mixing, 
prolonged storage at 65 °C is not recommended. Discard when buffer turns yellow. 
 Northern wash buffer 1 is 2x SSC and 0.1% (vol/vol) SDS. Prepare 1 liter using 100 ml 
of 20x SSC and 5 ml of 20% (wt/vol) SDS solution, fill up with autoclaved distilled 
water. Store at room temperature for up to a year. 
 Northern wash buffer 2 is 0.2x SSC and 0.1% (vol/vol) SDS. Prepare 1 liter using 10 ml 
of 20x SSC and 5 ml of 20% (wt/vol) SDS solution, fill up with autoclaved distilled 
water. Store at room temperature for up to a year. 
 10x TBS stock is 0.5 M Tris and 1.5 M NaCl. Prepare 1 liter by dissolving 60.5 g Tris and 
87.6 g NaCl in 800 ml of distilled water and adjust the pH to 7.5 with HCl. Bring to 1 
liter with distilled water. Autoclave and store at 4 °C for up to a year. 
 TBS-T is 1x TBS stock solution with 0.2% (vol/vol) Tween 20. Prepare 1 liter by mixing 
100 ml of 10x TBS stock with 2 ml of Tween 20 and filling up with autoclaved distilled 
water. Store at room temperature for up to a year.  
 5% (wt/vol) BSA TBS-T To make 50 ml of this solution, dissolve 2.5 g BSA in 50 ml of 
TBS-T and mix by very mild stirring to avoid foaming. Prepare freshly before use.  
189
 smFISH fixation solution is 4% (vol/vol) paraformaldehyde in 1x PBS. Prepare 50 ml 
using 10 ml (one vial) of 20% paraformaldehyde and 5 ml of 10x PBS, fill up with 
nuclease-free water.  
▲CRITICAL Store at 4 °C for up to one week. Longer storage is not recommended.  
! CAUTION Formaldehyde is an irritant and should be handled under chemical fume 
hood. 
 smFISH hybridization buffer is 10% (wt/vol) dextran sulfate, 10% (vol/vol) formamide 
in 2x SSC supplied with working concentration of fluorescent DNA oligomer probes. 
Prepare 150 μl per 4 coverslips using 75 μl of 20% (wt/vol) dextran sulfate, 15 μl 
formamide, 15 μl 20x SSC and 45 μl nuclease-free water. We recommend preparing 
20% (wt/vol) dextran sulfate in nuclease-free water at least one day in advance as 
dissolution of the dextran sulfate powder may take O/N incubation at 37°C while 
shaking.  
! CAUTION Formamide is an irritant and teratogen that is easily absorbed through the 
skin and should be opened under chemical fume hood when equilibrated to room 
temperature. 
 FISH wash buffer is 10% (vol/vol) formamide in 20x SSC. Prepare 50 ml using 5 ml of 
formamide, 5 ml of 20x SSC and 40ml nuclease-free water.  
▲CRITICAL Store at 4 °C for up to one week. Longer storage is not recommended. 
 DAPI staining solution is 500 ng/ml of DAPI in 1x PBS. Prepare 100 ml using 50 mg 
DAPI dissolved first in 70 ml of nuclease-free water. Then add 10 ml of 10x PBS, filled 
up with nuclease-free water. The solution is stable over months at 4 °C.  
▲CRITICAL DAPI does not dissolve readily in PBS. 
 
Equipment setup 
 For assembly of a table-top aspirator to remove supernatant from coverslips adhere 
to instructions given by Trcek et al. (2012)35. Briefly, place a rubber stopper into a filter 
flask, attach Masterflex tubing to the outlet of the rubber stopper and Tygon tubing 
to the flask outlet itself. Attach a Pasteur pipette to the end of the Masterflex tubing 
and connect the Tygon tubing with the vacuum outlet in the laboratory. 
 For fixed cell imaging, we use a Zeiss Z1 wide-field microscope equipped with an 
AxioCam 506 mono camera and an X-Cite 120 EXFO metal halide light source for 
fluorescence, a halogen light source for transmitted light and a Plan-APOCHROMAT 
100x 1.4 NA oil objective. 
 For live cell imaging, we use an inverted confocal microscope (Olympus IX81) that is 
equipped with a CSU-X1 scanhead (Yokogawa) and two precisely-aligned back-
illuminated EvolveDelta EMCCD cameras (Photometrics). Images are collected using 
a 100x 1.45NA PlanApo TIRFM oil immersion objective (Olympus), green (Semrock, 
FF01-617/73-25) and red (Semrock, FF02-525/40-25) emission filters and solid-state 
lasers (491 nm and 561 nm Cobolt) as excitation sources. The microscope is equipped 
with an incubation chamber that provides heating and CO2 regulation. Before starting 
image acquisition, equilibrate the incubation chamber around the microscope to 37 
°C and 5% CO2. Align cameras using a multi-color calibration slide (e.g. Argo-SLF-001). 
 For data analysis, install the KNIME Analytics Platform (version 3.6.0 or later)34 and 
configure additional update sites (File > Preferences > Install/Update > Available 
Software Sites (using the Add... button) to add the FMI software site 
(https://community.knime.org/download/ch.fmi.knime.plugins.update/). Then add 
the FMI KNIME Plugins via Help > Install New Software… and selecting FMI KNIME 
Plugins from the newly added update site. For additional information concerning 
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installation, refer to the “readme.txt” file provided along with the software and test 
data.  
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Procedure 
Design of reporter mRNA  ● TIMING ~ 1-5 d 
1.  Generate a reporter transcript according to the instructions provided above in 
‘Experimental design’. For initial tests or standard assays, use available reporter plasmids 
from the Chao and Gehring labs (Addgene IDs 104095, 104097, 108366-108367 or 
108375-108376 (see Reagents)). Alternatively, use standard molecular cloning 
approaches to obtain appropriate reporter constructs suitable for either transient 
transfection or stable cell line generation.  
Expression of reporter mRNA 
2.  For expression of reporter mRNAs using either transient transfection, follow option A. For 
stable integration, follow option B. See Experimental design for a discussion of 
advantages and disadvantages of both methods. 
 
A Transient transfection ● TIMING ∼2 d  
(i) Seed cells of choice into 6-well plates at confluencies appropriate for the transfection 
reagent used and grow them overnight in medium appropriate for the cell line being used 
(e.g., for HeLa cells, use DMEM with 10% (vol/vol) FBS).  
▲CRITICAL STEP Prepare 1-2 wells for each experimental sample. Although 1 well yields 
typically enough material for all downstream steps (depending on the transfection 
efficiency), the extra well can be used for western blot or other control analyses.  
(ii) Transfect the cells 16-24 h after seeding with the transfection reagent of choice (may 
require medium change prior to transfection). We routinely perform transient 
transfections using the calcium phosphate method, however other transfection reagents 
have been tested yielding similar results14. The amount of transfected plasmid can be 
adjusted depending on the expected readout, however 0.1-1 µg per well works well with 
most reagents and applications. If possible, include a transfection control, e.g. a plasmid 
encoding for a fluorescent protein in the same well as the experiment.  
(iii) 16-24 h after transfection, inspect transfection efficiency (if controls were included) 
and continue the protocol with successfully transfected samples (step 3). If longer 
expression times are required, change medium and grow cells up to additional 24 h. 
 
B Stable integration ● TIMING ∼14-28 d 
(i) To generate stable cell lines, use a specialized genomic insertion system (e.g. Flp-In T-
REx) and follow the manufacturer's instructions. Commercially available or custom-made 
cell lines can be used for the molecular biology protocol (e.g. Flp-In T-REx 293 from 
ThermoFisher or HeLa Flp-In T-REx). For imaging experiments, we apply a HeLa 11ht cell 
line that allows expression of reporter or control transcripts from a single tetracycline-
regulated locus for transgene expression after recombinase-mediated cassette 
exchange29.  
Preparing samples for northern blotting and qPCR ● TIMING 2-3d 
▲CRITICAL The following sections (Steps 3-18) describe how to detect decay intermediates 
via northern blotting and qPCR. For instructions on how to perform single-molecule imaging 
experiments directly proceed to step 19.  
▲CRITICAL When performing northern blotting or qPCR using transient transfection, skip this 
step and proceed to step 4. 
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3.  For stable cell lines, seed cells in 6-well plates at 40% confluency (approximately 0.3 x 106 
cells) and grow them overnight. If inducible expression systems were used, induce 
expression of the reporter with the recommended concentration of inducing agent.  
▲CRITICAL STEP For the Flp-In™ T-REx 293 Cell Line and HeLa Flp-In T-REx cell line, use 
up to 1 µg/ml doxycycline for efficient induction. Maximum expression levels of reporter 
mRNA are typically observed at around 8 h after induction, although expression can in 
general be performed for up to 24 h. 
RNA extraction ● TIMING 2h 
4. Wash cells with 1 ml of PBS 
5. Harvest cells with peqGOLD TriFast using 1 ml of reagent per 6-well plate well according 
to the manufacturer’s instructions. Transfer to new 1.5-ml microcentrifuge tube. 
▲CRITICAL STEP After addition of TriFast, rapidly pipet each sample up and down 
multiple times in order to reduce the viscosity.  
6. Incubate the samples for 5 min at room temperature.  
■ PAUSE POINT The TriFast samples can be stored for several weeks at -20 °C. 
7. Add 150 µl of 1-Bromo-3-chloropropane to each sample, mix vigorously by shaking and 
incubate for 10 min at room temperature. 
8. Centrifuge the samples at 12,000g for 10 min at 4 °C. 
9. Take 450 µl of the upper aqueous phase and transfer to new 1.5-ml microcentrifuge tube. 
▲CRITICAL STEP Do not transfer or touch the interphase in order to minimize DNA 
contamination. 
10. Add 450 µl of 2-Propanol, vortex and incubate for at least 10 min at 4 °C.  
▲CRITICAL STEP If low yield of RNA is expected, add 1-2 µl of Precipitation Carrier to each 
sample. 
11. Centrifuge the samples at 12,000g for 10 min at 4 °C. 
12. Aspirate the supernatant and wash the pellet with 1 ml of 75% (vol/vol) Ethanol.  
? TROUBLESHOOTING 
13. Centrifuge the samples at 12,000g for 10 min at 4 °C. 
14. Repeat step 12-13. 
15. Aspirate supernatant completely and briefly dry the pellet for 5 min by leaving the lid of 
the 1.5-ml microcentrifuge tube open. 
16. Add 20 µl ultrapure water to the pellet and incubate for 10 min at 50-65 °C on a shaking 
heat block at 500-900 rpm to help complete resuspension of the RNA. 
17. Quantify RNA concentration using a Nanodrop 2000 spectrophotometer.  
▲CRITICAL STEP The concentration should be in the range of 500-2000 ng/µl.  
? TROUBLESHOOTING  
■ PAUSE POINT Purified RNA samples can be stored for several months at -20 °C.  
 
Detection of RNA degradation using northern blotting and qPCR 
18. For northern blotting follow option A, for quantitative RT-PCR follow option B (see 
Experimental Design for details). 
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A Northern blotting ● TIMING 2-3d 
i. Gel electrophoresis (Steps i-viii): To prepare the denaturing 1% (wt/vol) agarose gel 
for electrophoretic separation of RNA samples, boil 2.6 g agarose in 230 ml autoclaved 
distilled water. 
▲CRITICAL STEP The amounts given are for 20 x 20 cm gels, for smaller gels adjust 
the amounts accordingly. 
ii. Under a fume hood add 12.5 ml 20x TT buffer and 10 ml of freshly filtered 37% 
(wt/vol) formaldehyde. Mix well, pour gel in the appropriate tray with the desired 
combs and let the gel solidify for 30 min. 
iii. Transfer the gel to the electrophoresis chamber filled with 1x TT buffer and equilibrate 
the gel for at least 10 min.  
▲CRITICAL STEP To minimize run artifacts, fill the chamber before casting the gel and 
pre-cool the chamber to 4 °C (either on ice or in the cold room). 
iv. For each experimental sample, add 16 µl of RNA sample buffer to a new 1.5-ml 
microcentrifuge tube.  
▲CRITICAL STEP Prepare a sample with RNA marker mixed with RNA sample buffer 
to allow RNA size determination. 
v. Add 2-5 µg of total RNA to the respective 1.5-ml microcentrifuge tube containing the 
RNA sample buffer.  
▲CRITICAL STEP The volume of added RNA solution should not exceed 4 µl, otherwise 
increase the volume of the RNA sample buffer accordingly. 
vi. Incubate the samples for 15 min at 65 °C on a heat block. Cool briefly for 2 min at 4 
°C. 
vii. Add 2 µl of RNA loading buffer to each sample and mix well. 
viii. Load the gel with the samples and run at 160 V for approximately 2-4 h, depending 
on the gel size. Stop the run when the bromophenol blue running front is almost at 
the end of the gel.  
? TROUBLESHOOTING 
 
ix. Capillary transfer (Steps ix-xxiii): Take a picture of the gel using a UV-transilluminator. 
(Figure 3) 
x. Cut the gel with a clean scalpel according to the expected size of the transcript of 
interest and control RNA. For example, when using the -globin reporter which 
generates RNA fragments in a range of 1 – 2 kb and the 7SL RNA control with a size of 
0.3 kb, we recommend cutting the gel above the 28S rRNA and below the 
bromophenol blue running front.  
? TROUBLESHOOTING 
xi. Transfer the gel to a suitable plastic tray and wash for 5 min with sufficient amount of 
autoclaved distilled water (approximately 50 ml) on a rocking platform. 
xii. Bridge a lab dish (35 x 25 cm) with the gel tray (20 x 20 cm). 
xiii. Cover the tray with blotting paper (30 x 20 cm). 
xiv. Fill the lab dish and wet the blotting paper with 10x SSC, remove all air bubbles 
between the paper and the tray with a sterile serological pipette. 
xv. Place the gel upside down on the blotting paper, remove bubbles between gel and 
blotting paper.  
▲CRITICAL STEP Using the smooth bottom side of the gel for contact with the 
membrane prevents transfer artifacts 
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xvi. Cover the remaining surface of the blotting paper and the lab dish with saran wrap to 
prevent bypass transfer of 10x SSC. 
xvii. Wet nylon transfer membrane (approximately 10 x 20 cm) in autoclaved distilled 
water and place on top of the gel, remove air bubbles. 
xviii. Add one piece of wet blotting paper (10 x 20 cm), soaked in autoclaved distilled water, 
remove bubbles. 
xix. Add one piece of dry blotting paper (10 x 20 cm), remove bubbles. 
xx. Place a stack of 5 – 10 cm of folded paper hand towels on top of the blotting stack. 
Ensure that the lowermost paper has no creases, as this will affect the transfer. 
xxi. Add a plastic tray on top of the blotting stack to distribute the weight and add about 
0.5 – 1 kg of weight (e.g. two filled 500 ml glass bottles). 
xxii. Transfer for 4h or overnight.  
xxiii. Disassemble the transfer setup and immobilize the transferred RNA on the nylon 
membrane by UV crosslinking (254 nm, 0.12 J/cm2) from both sides.  
? TROUBLESHOOTING   
■ PAUSE POINT The dry membrane can be stored in a sealed plastic bag for several 
weeks at -20 °C. 
xxiv. Hybridization (Steps xxiv-xxxiv): Prehybridize the nylon membrane for 1-2 h in 25 ml 
of Church buffer while rotating at 65 °C in a hybridization oven. 
xxv. Discard the prehybridization solution and add 20-25 ml of Church buffer containing 
the radioactive northern blot probes (e.g. β-globin reporter probe and 7SL control 
probe). For instructions on how to radioactively label probes, see instructions in 
Supplementary Procedure 1.  
▲CRITICAL STEP We recommend using radioactively labeled RNA probes to achieve 
the highest sensitivity. However, working with radioactive material requires access to 
isotope working facilities and appropriate waste disposal. A non-radioactive 
alternative is to use biotin-linked nucleotides for RNA labeling which can be detected 
by chemiluminescence using peroxidase-coupled streptavidin. Their use is described 
in Supplementary Procedure 2. Potentially, Supplementary Procedure 2 can also be 
adapted to use digoxigenin labeled or CLICK-functionalized nucleotides.   
Incubate over night while rotating at 65 °C in a hybridization oven. 
xxvi. Collect the hybridization solution for potential re-use (may exhibit weaker signals, do 
not use more than twice). 
xxvii. Wash the membrane for 15 min with 20-30 ml of northern wash buffer 1 while 
rotating at 65 °C in a hybridization oven. 
xxviii. Discard the washing solution and repeat step xxvii. 
xxix. Discard the washing solution and wash the membrane for 15 min with 20-30 ml of 
northern wash buffer 2 while rotating at 65 °C in a hybridization oven. 
xxx. Discard the washing solution and repeat step xxix. 
xxxi. Discard the washing solution, take out the membrane and dry the membrane on 
blotting paper for 30 min.  
xxxii. Wrap the membrane in saran wrap, place the membrane in an imaging cassette and 
lay the BAS storage phosphor screen on top. Expose for 4h – 24h.  
■ PAUSE POINT The hybridized membrane can be stored for a few days at room 
temperature. However, the signal will fade due to the short half-life of P32. 
xxxiii. Detect the signal using a phosphorimager.  
? TROUBLESHOOTING 
xxxiv. Quantification (Step xxxiv): Use the ImageQuant TL 8.1 software or similar software 
for quantification (Figure 4). For transiently transfected cells, quantify the intensity of 
full-length reporter RNA, xrRNA decay intermediate and the co-transfected control 
for each experimental sample. Calculate the full-length reporter/co-transfection 
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control and xrRNA decay intermediate/co-transfection control ratios and compare to 
control samples (e.g. control knockdown). For stable transfections, quantify the 
intensity of full-length reporter RNA, xrRNA decay intermediate and the 7SL control 
for each experimental sample. Calculate the full-length reporter/7SL control and 
xrRNA decay intermediate/7SL control ratios and compare to control samples (e.g. 
control knockdown). 
 
B Quantitative real-time PCR ● TIMING 2d 
▲CRITICAL The mRNA levels of the full-length reporter and the XRN1-resistant decay 
intermediate are measured relative to an internal control (Figure 5). In transiently transfected 
samples the internal control is a co-transfected construct. In stably transfected samples, any 
housekeeping gene can be used. 
i. To ligate an RNA-linker to RNA fragments with a 5′ monophosphate, mix the following 
reagents in a nuclease free 1.5 ml tube by pipetting. Incubate at room temperature 
for 2h, then over night at 18 °C. 
Reagents Volume (µl) per reaction 
RNA linker (100 µM) 2 
Buffer T4 RNA Ligase 
(10x) 
3 
RNasin (40 U/µl) 0.5 
ATP (10 mM) 3 
15 µg total RNA x 
H2O  Up to 30  
T4 RNA Ligase I (10 
U/µl) 
1 
Total reaction volume 30  
 
ii. Add the reagents listed in the table below to the linker ligation reaction mix from Step 
i in order to perform reverse transcription. Mix well by pipetting and incubate for 2h 
at 42 °C in a benchtop heater. 
 
Reagents Volume (µl) per reaction 
Linker ligation reaction 
from step i 
30 
VNN-oligo dT20 (100 
µM) 
3 
dNTPs (10 mM each) 3 
GoScript Buffer (5x) 12 
MgCl2 (25 mM) 9 
RNasin (40 U/µl) 1.5 
GoScript Reverse 
Transcriptase (160 U/µl) 
1.5 
Total reaction volume 60 
 
iii. Purify the cDNA using the NucleoSpin Gel and PCR Clean-up kit according to the 
manufacturer’s instructions. Elute in 50 µl of the provided NE buffer. Dilute 1:5 
(vol/vol) in H2O to use in qPCR. 
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iv. To amplify the full-length reporter and XRN1-resistent fragment with qPCR, prepare 
the mix listed below in 96-well plates. For each condition prepare 3 wells (technical 
triplicate).  
▲CRITICAL STEP Exact pipetting is required to minimize variation between triplicates. 
Change tips after each pipetting step to ensure equal amounts of reagents in each 
well. 
 
Reagents Volume (µl) per reaction 
GoTaq qPCR Master Mix 
(2x) 
5 
Sense Primer (10 µM) 0.5 
Antisense Primer (10 
µM) 
0.5 
cDNA (1:5 dilution) 4 
Total reaction volume 10 
 
v. Perform qPCR by placing the 96-well plate in a qPCR machine and follow the program 
described below.  
 
 Step Temperature 
(°C) 
Duration 
(min) 
Cycles 
1 Denaturing 95 3:00  
2 Denaturing 95 0:15  
40 3 Hybridization 
+ Plate Read 
60 0:30 
4 Elongation 72 0:10 
5 Melt Curve + 
Plate Read 
65 to 95 Increment 0.5 
°C/0:05 
 
 
vi. After the run, check the melting curve for non-specific amplification. Only one peak 
should be visible in the melting curve. To confirm, run the qPCR samples on an agarose 
gel. 
vii. Quantification (Steps vii-x): Calculate the fold changes according to the comparative 
CT method36. In brief: Calculate the mean of the technical triplicates (CT mean). 
viii. Deduct the corresponding control (e.g. co-transfected control, housekeeping gene) 
from the CT mean for each target (reporter or decay fragment): ΔCT. 
ix. For each target, deduct the control (e.g. wild type) from the test condition (e.g. 
premature stop codon-containing construct): ΔΔCT. 
x. Calculate the fold change as 2-ΔΔCT. This value is the fold change of the mRNA in the 
test condition compared to the control. 
 
Preparing single-molecule Imaging experiments ● TIMING 2-30d 
▲CRITICAL Single-molecule imaging of mRNA decay intermediates can be performed in fixed 
cells using fluorescent in situ hybridization (smFISH, Step 21 Option A, Figure 6a) or via direct 
observation of labeled reporter transcripts in living cells (Step 21 Option B, Figure 6b). For 
correct interpretation of the imaging data derived from both techniques, first provide the 
controls described in this section. 
19. For benchmarking detection efficiencies, prepare a co-localization control cell line 
analogous to the HeLa 11ht cell line expressing a transcript that is identical to the reporter 
transcript applied for the assay but lacks the xrRNA elements (for information on reporter 
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design see Figure 2 or Experimental design). Alternatively, a control cell line can be 
obtained from the Chao lab upon request. 
▲CRITICAL STEP Preparation of a control cell line with comparable fluorescence levels for 
benchmarking of detection efficiencies is crucial for correct quantification of degradation 
intermediates. 
20. Characterize the reporter gene expression profile over time via luciferase activity assays 
using cells harvested at different time points after induction of reporter gene expression 
as described by Horvathova et al. (2017)15. Alternatively, characterize particle densities in 
the cytosol via imaging trials at different time points after induction to ensure that mRNA 
densities are not too high for accurate single-particle tracking and image analysis. To 
determine optimal particle densities test spot detection and tracking (steps vi-xiii) on 
images obtained on different time points after induction. Only choose such experimental 
conditions that allow accurate tracking of all detected particles. For the HeLa cell lines and 
reporters described here, this should result in not more than a few hundred particles per 
cell. 
 
Detecting RNA degradation using single molecule imaging 
21. Perform the imaging experiments as described in Option A (fixed cells) and Option B (live 
cells). For both (reporter and control) cell lines, collect data on at least three separate 
occasions imaging 10-50 cells each time. 
 
A Fluorescent in situ hybridization ● TIMING 5d 
i. Sample preparation (Steps i-xii): Seed 20,000 cells/well in 1 ml DMEM + 10% (vol/vol) 
FBS + 1% (vol/vol) Pen/Strep onto glass coverslips placed into a 12-well plate. Make 
sure the cells are spread evenly and incubate cells for ~48h.  
▲CRITICAL STEP Shorter or longer growth times are possible but make sure that cells 
have attached on the coverslips to enable imaging of cytoplasmic transcripts. Do not 
let cells become confluent. 
ii. After 48h, induce expression of mRNA reporters by addition of doxycycline for 2h. 
▲CRITICAL STEP Shorter or longer expression times are possible depending on the 
experiment performed (see step 20). Make sure that particle densities in cells are not 
so high that they prevent accurate spot detection.  
iii. After 2h, aspirate media and wash 2x with 1x PBS to remove residual doxycycline-
containing media.  
iv. Either directly fix cells by addition of 1 ml fixation solution per well or re-fill wells with 
1 ml DMEM + 10% (vol/vol) FBS + 1% (vol/vol) Pen/Strep and fix at later time points. 
After addition of fixation solution, incubate 10 min at RT while gently rocking. Aspirate 
fixation solution and wash cells 2x with 1x PBS. 
▲CRITICAL STEP Fixation at different time points after transcription shut-off allows 
quantification of decay dynamics over time. Adjust time points to half-live of intact 
reporter transcripts and stabilized decay intermediates as e.g. determined by qPCR.  
v. For permeabilization of the cell membrane, apply 1 ml 70% (vol/vol) Ethanol per well 
and incubate at 4 °C for at least 1 hour.  
■ PAUSE POINT Incubation period may be O/N or even extended to several days. 
vi. Aspirate supernatant and wash cells 2x with 1x PBS. Add 1 ml of wash buffer per well 
and incubate 5 min while gently rocking. Repeat this washing step once again. 
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▲CRITICAL STEP Do not aspirate wash buffer after the second wash. Make sure that 
coverslips do not dry out. 
vii. Add 150 nM of each FISH probe set (each targeting a region upstream and 
downstream of the xrRNA sequences) to complete the hybridization solution. For 
information on how to design FISH probes see Supplementary Procedure 3. Then 
incubate coverslips with hybridization solution by dropping 35 µl onto the bottom of 
a Petri dish and gently lowering the coverslip (cells facing downwards) into the 
hybridization solution. Shield coverslips from light and incubate the Petri dishes at 37 
°C for at least 4 hours to O/N. Protect coverslips from drying out by providing water 
reservoirs (e.g. 50 ml Falcon tube caps taped to the dish bottom) and by sealing Petri 
dishes with Parafilm. 
▲CRITICAL STEP Make sure that the hybridization solution distributes over the whole 
surface of the coverslip and no air bubbles remain. More than one coverslip can by 
placed into a single Petri dish.  
viii. Provide 1 ml pre-warmed wash buffer in each well of a fresh 12-well plate and place 
coverslips carefully inside (cells facing upwards). Wash the coverslips for 30 min at 
room temperature while rocking the plate. Protect from light. Repeat the 30 min 
washing step once. 
ix. Wash coverslips twice with 1x PBS. 
x. Aspirate PBS and add 1 ml DAPI solution per well to stain cell nuclei. After a few 
seconds, aspirate the DAPI solution and wash 2x with 1x PBS. Leave coverslips in 1x 
PBS to prevent drying out.  
xi. Apply a drop of Prolong Gold mounting medium onto a microscopy glass slide. Take a 
coverslip out of the 12-well plate and remove excessive PBS by gently touching the 
edge of the coverslip with a tissue. Invert the coverslip and place it upside down onto 
the mounting media drop. Store coverslips protected from light O/N to let the 
medium solidify. 
xii. After ~12h, seal coverslips with transparent nail polish and store slides at 4 °C until 
imaging. 
■ PAUSE POINT The coverslips can be stored in the dark at 4 °C for up to 6  months. 
xiii. Image acquisition (Steps xiii-xiv): For image acquisition, use the DAPI channel to 
identify suitable (non-overlapped) cells and avoid bias. 
xiv. Acquire optical sections using 240 nm z-steps, spanning a 5 μm z-depth. Typical 
exposure time for Quasar570 is 1s and for Quasar670 is 2s. 10-50 ms are used to 
acquire each plane in the DAPI channel. 
▲CRITICAL STEP Make sure to use exposure times that do not saturate but are well 
within the dynamic range of the camera.  
? TROUBLESHOOTING 
xv. Spot detection (Steps xv-xxii): Select a representative number of z-stacks for further 
analysis. For training purposes, compare to images provided under 
“Data1/FISH_TestData/1-RawData” for exemplary experimental data and under 
“Data1/FISH_ControlData/1-RawData” for co-localization control data to benchmark 
detection efficiencies. 
xvi. Make sure that the two RNA channels of each z-stack are precisely aligned. Correct 
offset between channels by using e.g. the “Translate” command in the image 
processing software Fiji31. Use the Search Bar (pressing L) in Fiji to find and run the Fiji 
commands mentioned throughout this protocol. 
xvii. Select a single ROI containing a single cell using the rectangular selection tool on all 
channels simultaneously. Prune three-channel z-stacks to match ROI size using the 
“Crop” command. Before cropping, we recommend rotating the image around the 
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position of a particular cell using the “Rotate” command to avoid including parts of 
neighboring cells and background artifacts.  
xviii. Divide channels into individual z-stacks using the “Split Channels” command. 
xix. Project z-stacks onto a single x,y plane by using the “Z Project” command and 
choosing “Maximum Intensity” as projection type. Make sure to only apply the 
maximum projection to in-focus images and project the same number of images for 
all acquired z-stacks. 
xx. Save projected images for all channels via “Save As > Tiff…”. Make sure that individual 
channels are named consistently to allow identification during batch processing in 
AIRLOCALIZE33. Compare to test/control data provided in the “2-ProcessedData” 
folders. 
xxi. Perform spot detection to sub-pixel resolution in AIRLOCALIZE as described 
previously37. 
▲CRITICAL STEP Before applying the batch analysis to data from a particular channel 
and experiment, define intensity thresholds based on the signal-to-noise ratios (SNRs) 
in individual images from that data set and by manually inspecting spot detection 
results of those images.  
? TROUBLESHOOTING 
xxii. Save coordinate files (.loc3) next to image files (.tif) for each channel in a parental 
folder that will serve as input directory for further processing in the KNIME34 
workflow. Compare spot detection results to test and control results provided in the 
“3-AirlocalizeOutput” folders. 
 
xxiii. Spot co-localization and data analysis (Steps xxiii-xxxii): Load the spot co-localization 
workflow called “Segmentation, Spot Colocalization and Detection Efficiency 
Correction” (Software1) available from the Chao lab website 
(https://data.fmi.ch/PublicationSupplementRepo/?group=gchao) in KNIME34. Make 
sure that node #IDs are displayed by clicking on the “Append the IDs to node names” 
icon in the symbol bar. 
▲CRITICAL STEP mRNA turnover can be monitored via the detection of two 
orthogonal fluorescent labels on individual mRNA transcripts. In order to distinguish 
between intact mRNAs and stabilized decay intermediates in a fixed cell experiment, 
it is therefore necessary to co-localize the signal in the two RNA channels. For correct 
interpretation of the co-localization data, it is further necessary to take detection 
efficiencies into account and use them to correct the final particle numbers. Detection 
efficiencies can be determined via co-localization of control data from a cell line that 
expresses a reporter that is always double-labeled because it cannot produce 
stabilized decay intermediates. We have designed a KNIME34 workflow that 
incorporates all of the above analysis steps and allows rapid data correction and 
interpretation. In the following section (Steps xxiv-xxxii), we describe how to use this 
“Segmentation, Spot Colocalization and Detection Efficiency Correction” pipeline 
step-by-step. 
xxiv. Configure and execute the “Configuration” node (# 94):  
  “Input Folder”: Choose the parent folder that contains the processed data 
along with the AIRLOCALIZE output. For the training data provided here, 
choose “Data1/FISH_TestData/3-AirlocalizeOutput”. 
 “Name of the first/second spot channel”: Enter a name that allows 
identification of images from different channels (default Cy3/5). 
  “Name of the segmentation channel”: Enter a name that allows identification 
of images from the channel used for nuclear/cytoplasmic segmentation 
(default DAPI).  
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 “Input Folder Control”: Choose the parental folder that contains the 
processed control data along with the AIRLOCALIZE output. For the control 
data provided here, choose “Data1/FISH_controlData/3-AirlocalizeOutput”. 
xxv. The “Set distance threshold (px)” node (# 42) allows adaptation of the distance used 
to define a spot pair as co-localizing (default = 5 pixel). Make sure the threshold 
matches your image parameters. For definition of a useful distance thresholds look at 
merged and aligned (multi-channel) example images: Magnify until individual pixels 
are visible and count distance (px) between spots belonging to the same channel in 
close proximity. The threshold has to be chosen such that spots originating from the 
same particle in different channels will be identified as co-localizing while neighboring 
spots in the same channel will not. 
xxvi. Check that all data were loaded correctly: Execute and view the “Interactive 
Segmentation View” nodes (# 848 and # 141 for control and test data respectively) in 
the orange data visualization annotation. Scroll through the table to check that 
correct image series were loaded. Open the interactive view panel by clicking on an 
image in the labeling column and switch to the “Bounding Box Renderer” to check 
visually that spot positions and coordinates match.  
? TROUBLESHOOTING 
xxvii. “Calculate detection efficiencies” based on spot co-localization of control data by 
executing node # 854. The branch leading to this node performs pairwise spot co-
localization by first measuring the distances of all spots in the first channel to all spots 
in the second channel. It then defines co-localizing pairs of spots by recursively 
selecting mutual nearest neighbors and classifies spot pairs as co-localizing if their 
distance is below the cut-off defined in step xxv. All not co-localizing spots are defined 
as orphans. Last, the branch calculates detection efficiencies (𝑒𝐶1,𝐶2 in Box 1) from the 
fractions of co-localizing and orphan spots in each cell15.  
▲CRITICAL STEP Inspect the output table to evaluate co-localization results. 
Detection efficiencies for each channel (𝑒𝐶1,𝐶2) are depicted in the last two table 
columns. Make sure that they are as high as possible (𝑒𝐶1,𝐶2 ≈ 0.9). Since in a control 
experiment only dual-labeled particles exist, the vast majority of particles should be 
co-localizing and only very few orphans should be detected.  
? TROUBLESHOOTING 
xxviii. Execute and inspect the output tables generated by node # 881, which activates the 
second branch and performs the co-localization analysis for the test data. It will then 
“Calculate statistics and correct for detection efficiencies” obtained in step xxvii.  
xxix. Execute and inspect the output table generated by node # 886. The branch leading to 
this node calculates a summary of all output data from all cells and filters relevant 
results. The table lists (i) the “Mean(Fraction of colocalizing particles outside)”, which 
corresponds to the average fraction of intact reporter transcripts in the cytoplasm; (ii) 
the “Standard deviation(Fraction of colocalizing particles outside)” corresponding to 
the standard deviation of the average given in (i); (iii) “Count(Cell)”, which is the 
number of cells included in the analysis; (iv) and (v) the “Mean(Detection efficiency 
(C1 or C2))”, that was obtained from the control data and used to correct particle 
numbers in both channels (C1 and C2). 
xxx. Execute the “XLS Sheet Appender” node (# 887) to output all results as a single 
“Results.xlsx” file within the input directory. 
xxxi. Inspect the “selected summary” tab in the output results file. The table lists the same 
output that was explained in step xxix. The main experimental result is the 
“Mean(Fraction of colocalizing particles outside)”, which corresponds to the average 
fraction of intact reporter transcripts in the cytoplasm. 
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xxxii. For training, compare results with the output provided in the “4-KNIMEOutput” 
folder. 
 
B Live cell imaging ● TIMING  3-4d 
▲CRITICAL Live-cell imaging experiments require co-expression of fluorescent coat 
proteins for labeling of mRNA transcripts. To this aim, stably integrate NLS-MCP-Halo 
and NLS-PCP-GFP into the reporter and control cell lines via lentiviral transduction. 
Use FACS to select cells with low expression levels of both coat proteins to minimize 
background fluorescence. For a discussion of different fluorescent proteins and their 
integration using lentiviruses refer to Halstead et al. (2016)28. Alternatively, parental 
11ht cell lines29 that co-express MCP and PCP but do not yet contain reporter 
transcripts are available from the Chao lab upon request. Lentiviral transfer plasmids 
encoding NLS-PCP-GFP and NLS-MCP-Halo are available from Addgene (IDs 104098, 
104099). Transient expression of coat proteins in preliminary experiments is also 
possible but involves parallel uptake of three different plasmids (reporter construct + 
two orthogonal coat proteins). Consequently, identification of cells that express all 
transfected constructs at low fluorescence levels suitable for live cell imaging can be 
experimentally challenging. 
i. Sample preparation (Steps i-iii): Seed 30,000 cells in 2 ml DMEM + 10% (vol/vol) FBS 
+ 1% (vol/vol) Pen/Strep into a 35 mm glass bottom imaging dish (ibidi) approximately 
48 h prior to the experiment.  
▲CRITICAL STEP Take care that cells are homogeneously distributed within the dish 
to allow uniform growth and improve cytoplasmic imaging of transcripts. 
ii. Incubate cells for 2 days at 37 °C and 5% CO2. 
iii. Label Halo-tags by incubation with 1 ml 100 nM JF549 30 in pre-warmed DMEM + 10% 
(vol/vol) FBS. After 30 min at 37 °C and 5% CO2 remove medium, wash 3 times with 
pre-warmed PBS and add pre-warmed FluorobriteTM DMEM + 10% (vol/vol) FBS + 1 
µg/ml
 
doxycycline to induce mRNA expression.  
? TROUBLESHOOTING 
iv. Image acquisition (Steps iv-v): Use the red laser (NLS-MCP-Halo channel) at low 
intensities to identify cells for image acquisition 
v. Collect 10-50 frame image series per region of interest (ROI) in a single plane and 
acquire image series in streaming mode in both channels simultaneously using laser 
powers and camera gain that achieve maximum SNR without saturating the camera. 
In addition, laser powers and exposure time should be adjusted to limit bleaching of 
the sample.  
? TROUBLESHOOTING 
▲CRITICAL STEP For accurate single-particle tracking, exposure times should be no 
longer than 50 ms to ensure that fast particles can be unambiguously identified in 
between frames. 
vi. Single-particle tracking (Steps vi-xiv): Select a representative number of image series 
obtained from three independent experiments for further analysis. Pick images of 
healthy cells with high SNRs and representative particle densities. For training 
purposes, compare to images provided under Data2/Live_TestData/1-RawData for 
exemplary experimental data and under Data2/Live_ControlData/1-RawData for co-
localization control data needed to benchmark detection efficiencies. 
▲CRITICAL STEP To monitor the turnover of individual transcripts, it is necessary to 
reconstruct particle movement over time via SPT using two spectrally distinct 
fluorescent labels. For unbiased co-localization of the two labels, it is essential to 
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determine particle trajectories in both channels individually. Therefore, perform steps 
vi-xiii independently for each channel. 
▲CRITICAL STEP Detailed step-by-step instructions on how to perform single-particle 
tracking (SPT) of reporter mRNAs in TrackMate32 (Fiji) have been published before, 
see Voigt et al. (2018)38. Thus, in the following (steps vii-xiii) we provide only basic 
instructions that enable the reader to proceed with the analysis. 
vii. Make sure that the two channels of each image series are precisely aligned. Correct 
offset between channels by using e.g. the “Translate” command in the image 
processing software Fiji31.  
viii. Select a single ROI using the freehand selection tool. Use the “Restore Selection” 
command to apply the same ROI to both channels. Compare to the processed training 
data in “2-ProcessedData”. 
▲CRITICAL STEP For accurate SPT, select only those areas of the cells that exhibit high 
quality SNR without introducing bias with respect to subcellular localization. 
ix. Use the “Properties” command to calibrate global image parameters.  
x. Decide how many frames to include in the analysis and, if needed, reduce the length 
of the image series accordingly using the “Slice Keeper” function. Accurate tracking 
for co-localization analysis is best performed on a small number of frames (typically 
3-5) since this limits the number of data points that has to be visually inspected.   
xi. Launch the Fiji plugin TrackMate32 while having the first image series selected.  
xii. SPT as performed by TrackMate consists of (i) spot detection and (ii) the linking of 
particle positions in consecutive frames into tracks (tracking). Detect spots using the 
“Laplacian of Gaussian” (LoG) detector and optimized detector settings for the 
detection of single mRNA particles. Use the “Simple LAP tracker” as particle-linking 
algorithm and set maximum linking and gap closing distances to match physiological 
diffusion coefficients. Perform tracking but do not filter tracks as this can be done 
within the co-localization pipeline. For more detailed instructions on how to perform 
SPT of mRNA transcripts in TrackMate see Voigt et al. (2018)38. 
xiii. Export tracking results via the “Analysis” button in the “Display Options” interface. 
Save the resulting “Spots in tracks statistics” table as an .xls file with exactly the same 
name as the input image series. Compare output to the training data output provided 
in “3-TrackMateOutput”. 
xiv. Repeat steps x-xiii for the second channel image series with identical tracking 
parameters. 
 
xv. Identification of decay intermediates via track co-localization (Steps xv-xxv): For 
data preparation, assemble the two .xls files exported after SPT along with the image 
series used for tracking in a single folder for each cell. Combine the folders containing 
tracking and imaging data for each cell in one or several parent folders. Repeat the 
same for the co-localization control data. 
▲CRITICAL STEP In order to distinguish between intact mRNAs and stabilized decay 
intermediates in a live-cell experiment, it is necessary to co-localize the tracks derived 
for both labels using SPT. For correct interpretation of the co-localization data, it is 
further necessary to take detection efficiencies into account and use them to correct 
the final particle numbers. Detection efficiencies can be determined via co-
localization of control data from a cell line that expresses a reporter that must always 
be double-labeled and cannot exhibit stabilized decay intermediates. We have 
designed a KNIME34 workflow that incorporates all of the above analysis steps and 
allows rapid data correction and interpretation. In the following (Steps xvi-xxv), we 
describe how to use this pipeline step-by-step. 
▲CRITICAL STEP Make sure that names of image- and corresponding coordinate files 
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are identical except for the file extension.  
xvi. Load the workflow called “Track-based colocalization analysis (with recursive track 
pairing and particle number correction)” (Software2) available from the Chao lab 
website (https://data.fmi.ch/PublicationSupplementRepo/?group=gchao) in 
KNIME34. Make sure that node #IDs are displayed by clicking on the “Append the IDs 
to node names” icon in the symbol bar. 
xvii. Configure and execute the “Data input” node (# 391):  
 “Input directory”: Choose the parent folder that contains the combined 
tracking and imaging file folders from several cells and experiments (for 
training data provided choose: Data2/Live_TestData/3-TrackMateOutput).  
 “File extension”: Enter the file extension of the coordinate files (xls) derived 
from SPT. 
 “Channel 1 and 2 identifier”: Choose identifiers that distinguish input file 
names belonging to both channels.  
▲CRITICAL STEP Naming depends on the microscope/software used for data 
acquisition. Here, default is set to “Red/Green” but can be any description of a 
wavelength. Choose part of the image file name that allows unambiguous 
identification of each channel.  
 “Load images for quality control”. Tick this option if you want to load image 
files into the pipeline. Identify image files by providing the “image file 
extension” (e.g. tif). Loading image files will increase computational time but 
is preferable in the beginning for quality control reasons. 
 “Distance cut-off (µm)”: Set the distance cut-off that defines a spot pair as co-
localizing within the same reference frame is set to default = 0.3 µm.  
▲CRITICAL STEP Do not modify this parameter in the beginning. Once estimates 
for co-localization rates have been obtained, co-localization can be made more 
stringent by reducing this value. 
  “Pixel size (µm)”: Enter the pixel-size to calibrate imaging data. Default is set 
to 0.09 µm but depends on microscope set-up.  
 “Input directory for control data”: Choose this option to identify the parental 
folder that contains the combined data of the co-localization control (for 
training data provided choose: Data2/Live_ControlData/3-
TrackMateOutput).  
xviii. Configure “Track parameters” in node # 405: Choose the “Minimum track length” 
(default = 3 frames) and the “Minimum number of co-localizations” needed to classify 
a group of tracks as co-localizing (default = 2 events). This value should be adjusted if 
longer trajectories are used for analysis. Execute node # 405. 
xix. To check that all data were loaded correctly, execute and view the “Interactive 
Segmentation View” node (# 454) in the orange data visualization annotation. Scroll 
through table to check that correct image series were loaded. Open the interactive 
view panel by double-clicking on an image in the labeling column and switch to the 
“Bounding Box Renderer” to visually check that spot positions (on images) and 
coordinates (provided by TrackMate output) match. ? TROUBLESHOOTING 
xx. “Calculate detection efficiencies” based on co-localization of control data by 
executing node # 864. For detailed description of track co-localization see Voigt et al. 
(2018)38. Briefly, the branch leading to this node performs pairwise spot co-
localization by first measuring the distances of all spots in the first channel to all spots 
in the second channel. It then defines co-localizing pairs of spots by recursively 
selecting mutual nearest neighbors and classifies spot pairs as co-localizing if their 
distance is below the cut-off defined in step xvii. Next, tracks are classified as co-
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localizing if they contain a minimum number of co-localizing spot pairs (user input 
defined in step xviii, default = 2). All tracks that were not classified as co-localizing are 
called orphans and usually represent stabilized decay intermediates. If they are 
shorter than the minimum track length defined in step xviii (default 3 frames) they 
are excluded from the analysis. Last, the branch calculates detection efficiencies 
(𝑒𝐶1,𝐶2 in Box 1) from the fractions of co-localizing and orphan tracks in each cell
15.  
▲CRITICAL STEP Inspect the output table to evaluate co-localization results. Table 
columns depict: (a) the input file path; (b) the number of co-localizing tracks for each 
channel (𝑛𝐶𝑜𝑙𝑜𝑐 in Box 1); (c) the number of orphan tracks for each channel (𝑛𝐶1,𝐶2); 
(d) the total number of tracks (= co-localizing + orphan) for each channel; (e) the total 
number of particles detected per cell (𝑁 = 𝑛𝐶1 + 𝑛𝐶2 + 𝑛𝐶𝑜𝑙𝑜𝑐 ); and (f) detection 
efficiencies for each channel (𝑒𝐶1,𝐶2). Make sure that detection efficiencies are as high 
as possible (𝑒𝐶1,𝐶2 ≈ 0.9). Since in a control experiment only dual-labeled particles 
exist, the majority of particles should be co-localizing and only very few orphans 
should be detected.  
? TROUBLESHOOTING 
xxi. Execute and inspect the interactive table generated by the “JavaScript Table View” 
node (# 426). It contains the results of the co-localization analysis performed with the 
experimental data. 
xxii. Execute and inspect the interactive table generated by the “JavaScript Table View” 
node (# 439). The table lists original as well as corrected particle numbers per cell. 
Table columns depict: (a-e) as described in step xx; (f) the corrected number of co-
localizing tracks for each channel (𝑚𝐶𝑜𝑙𝑜𝑐); (g) the corrected number of orphan tracks 
for each channel (𝑚𝐶1,𝐶2); and (h) the corrected fraction of co-localizing particles 
(𝑓𝐶𝑜𝑙𝑜𝑐 ), which corresponds to the fraction of intact mRNA transcripts out of all 
particles detected. For details on how corrections are calculated, see Box 1. 
xxiii. In particular, inspect the corrected number of channel 2 orphans. For the 
experimental set-up described above, it corresponds to the corrected number of 
mRNA that are labeled with NLS-PCP-GFP only.  
▲CRITICAL STEP Since such transcripts should not exist under the described 
experimental set-up, this value allows assessment of the co-localization control cell 
line for detection efficiency calculation and should be close to 0. If values are 
significantly below 0, SNR for the control cell line is worse than for the experimental 
cell lines and detection efficiencies are over-correcting the true particle numbers. If 
values are significantly higher than 0, then particle numbers might have been under-
corrected.  
? TROUBLESHOOTING 
xxiv. Execute the “XLS Sheet Appender” node (# 866) to output all results as a single 
“Results.xlsx” file within the input directory.  
xxv. Inspect the output in the “Results.xlsx” file. In particular look at the “Summary – 
Mean” tab: it lists the mean fraction of co-localizing particles (corrected for detection 
efficiency), which corresponds to the average fraction of intact particles observed per 
cell. The output further provides the total number of particles included in the analysis 
(“# Particles”) and the number of cells analysed (“# Cells”). Compare results to the 
output provided for the training data in “4-KNIMEOutput”. 
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Troubleshooting 
Troubleshooting advice can be found in Table 1. 
 
Table 1: Troubleshooting Table 
Step Problem Possible reason Solution 
12 No visible pellet Low amount of RNA in 
samples 
Seed more cells. 
Add Precipitation 
carrier to step 8. 
17 Low RNA yield Pellet lost during 
purification 
Add Precipitation 
carrier to step 8. 
Carefully aspirate 
supernatants, visually 
inspect pellet at all 
times.  
18A viii Bromophenol blue 
running front lost – 7SL 
control detection 
impossible 
Gel ran too long or at 
too high voltage 
Run another gel with 
fresh samples and stop 
the gel run earlier. 
18A ix Smeared lanes RNA degradation Avoid contamination 
with RNAses, obtain 
new RNA samples. 
Clean gel chamber and 
prepare fresh running 
buffer. 
18A xxiii Inefficient/incomplete 
transfer 
Insufficient buffer 
volume or incorrect 
transfer setup 
Repeat the transfer 
procedure with a new 
gel, provide enough 
buffer and adhere to 
the setup instructions. 
Specifically, avoid 
buffer shortcuts from 
the reservoir to the 
paper stack. Check 
successful transfer by 
UV illumination. 
18A xxxiii Faint, faded signal on 
parts of the blot 
Space between 
Phosphor screen and 
the saran-wrapped 
membrane 
Smoothen the 
phosphor screen on the 
membrane to ensure 
close contact. Also, 
remove any bubbles in 
the saran wrap. 
21A xiv Autofluorescence Old or stressed cells Always use fresh cells. 
Avoid using coverslips 
with cells grown to 
saturation. 
Low signal, very low 
background 
Incomplete 
permeabilization of cell 
membrane  
Increase incubation 
time with 
permeabilization 
solution. 
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Too much background 
signal 
Probe hybridization is 
unspecific 
Decrease hybridization 
time. Reduce the 
amount of probe used. 
21A xxii AIRLOCALIZE over-or 
undercounts; 
Unresolvable RNA spots 
Intensity thresholds are 
too high or low; too 
many particles per cell 
Manually optimize 
thresholds determined 
for individual 
conditions; reduce 
induction time. 
21B iv Suboptimal labeling Free fluorescent dye 
remaining in cells; 
labeling time too short 
Increase the number of 
wash steps after 
fluorescent dye 
labeling. Increase 
labeling time. Use fresh 
dye aliquots. 
Autofluorescence Labeling time too long; 
old or stressed cells 
Reduce labeling time to 
below 30 minutes. 
Always use fresh cells. 
Avoid using dishes with 
cells grown to 
saturation.  
21B v Bleaching of fluorescent 
signal 
Limited photostability 
of fluorescent dyes; 
formation of radical 
oxygen species 
Reduce total irradiation 
by adaptation of laser 
intensities and 
exposure time. Use 
specific mounting 
medium designed to 
increase photostability 
of bleaching 
fluorophore. 
21B xix Data files not loaded 
correctly 
Mistake in data 
nomenclature or folder 
organization  
Check that correct input 
file identifiers are 
selected. Remove all 
unnecessary files from 
parent folders. 
Spot positions do not 
match images 
Wrong format of SPT 
output; wrong 
calibration of image 
files 
Re-calibrate images in 
Fiji. Check that 
TrackMate output 
contains spot 
coordinate columns 
(X,Y,Z) incl. column 
headers. 
21B xxi Co-localization rate too 
low 
Channels not aligned 
properly; bad data 
quality 
Manually re-align 
channels (see step 21B 
vii). Repeat image 
acquisition using 
improved laser 
power/gain for limiting 
channel. 
21B xxiii Corrected number of 
channel 2 orphans ≠ 0 
SNRs in control and 
reporter image series 
do not match - 
Inspect raw data and 
choose matching-
quality cells. Repeat 
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potentially because 
image acquisition 
settings do not match 
experiment at identical 
conditions. Re-sort cell 
lines to achieve similar 
fluorescence levels. 
 
Timing 
Step 1, Design of reporter mRNA: 1-5d 
Step 2, Expression of reporter mRNA 
Option A, transient transfection: 2d  
Option B, stable cell line generation: 28d  
Step 3, Preparing samples for northern blotting and qPCR: 2-3d 
Steps 4-17, RNA extraction: 2h 
Step 18, Detection of RNA degradation using northern blotting and qPCR 
Option A, Northern blotting: 2-3d 
Steps i-viii, gel electrophoresis: 5h 
Steps ix-xxiii, capillary transfer: 5-24h 
Steps xxiv-xxxvi, hybridization: 16h – 24h 
Step xxxv, quantification: 30min – 1h 
Option B, qPCR: 2d 
Steps 19-20, Preparing single-molecule imaging experiments: 2-30d 
Step 21, Detection of RNA degradation using single molecule imaging 
Option A, smFISH: 5d 
Steps i-xii, sample preparation: 4d 
Steps xiii-xiv, image acquisition: 3h 
Steps xv-xxii, spot detection: 3h  
Steps xxiii-xxxii, spot co-localization and data analysis: 1h 
Option B, Live cell imaging: 3-4d 
Steps i-iii, sample preparation: 2d 
Steps iv-v, image acquisition: 2h 
Steps vi-xiv, single-particle tracking: 1d 
Steps xv-xxv, Identification of decay intermediates via track co-localization: 1h 
Anticipated Results 
This manuscript provides a range of procedures that apply xrRNA-containing reporters for 
detection and monitoring of mRNA decay. Figure 4 shows the northern blot-based detection 
of a reporter that is degraded by NMD. In Figure 4b the cells have been transiently transfected 
with the reporter plasmid as well as a control plasmid (lacZ). Equal signal of the co-transfected 
control across all samples indicates a consistent transfection efficiency. The signal of the full-
length reporter is reduced when a premature stop codon (PTC) is present in the reporter 
because of its degradation via the NMD pathway. Meanwhile, the faster migrating fragment 
(xrFrag) corresponds to the XRN1-resistant part of the reporter comprising the xrRNA and the 
probe binding sites. Note that in the WT control samples this fragment is also visible due to 
low-level turnover of the reporter. In the PTC samples the xrFrag is enriched, suggesting that 
5’-3’ exonucleolytic decay is involved in the degradation of the transcript. In Figure 4c the 
same reporter as in 3b is stably expressed in a HeLa Flp-In TRex cell line. Here, the levels of 
the endogenous 7SL RNA are detected as a control. In contrast to Figure 4b, the overall signal 
of the wild type reporter is 3.5% that of the transiently transfected reporter. However, 
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degradation of the reporter and accumulation of the decay fragment are much more 
pronounced compared to the transiently transfected cells.  
In Figure 4 the same samples as in Figure 4 are analyzed by qPCR which overall leads 
to similar results. In contrast to the detection by northern blotting, the values are a bit lower. 
Quantifying the northern blot could possibly cause a slight overestimation of the amounts due 
to background. We still recommend performing a northern blot because accurate splicing and 
behavior of the reporter mRNA can be assured this way.  
Raw and processed imaging data as well as spot detection and co-localization analysis 
results obtained from smFISH experiments in cell lines stably expressing reporter and co-
localization control transcripts are provided on our lab-website 
(https://data.fmi.ch/PublicationSupplementRepo/?group=gchao). Representative smFISH  
images are further shown in Figure 6a. Raw and processed imaging data as well as tracking 
and track co-localization analysis results obtained from single-molecule live cell experiments 
in cell lines stably expressing reporter and co-localization control transcripts are provided on 
the Chao lab-website (https://data.fmi.ch/PublicationSupplementRepo/?group=gchao). 
Representative live cell images are shown in Figure 6b. For both experimental setups, data 
can be considered good quality if they yield high detection efficiencies (𝑒𝐶1,𝐶2 ≈ 0.9 for the 
data provided) since in a control experiment the majority of all particles should be co-
localizing and only very few orphans should be detected. To assess whether the quality of 
control and experimental data is comparable (so that detection efficiencies obtained for 
control data can indeed be extrapolated to experimental data) inspect the corrected number 
of channel 2 orphans (provided in each “Results.xlsx” output file in Step 21B xxiv). For the 
experimental set-up described here, this number corresponds to the corrected number of 
mRNAs that are labeled with NLS-PCP-GFP only. Since such transcripts should not exist for the 
described decay reporter, it allows assessment of the quality of the co-localization control 
data and should be close to 0.  
Finally, when examining the overall output (the fraction of intact (co-localizing) 
transcripts) correlate this value to the half-life (e.g. determined via an alternative method) of 
the reporter transcript to evaluate the result. For the training data sets, which were acquired 
2h after induction, the determined fraction of intact transcripts around 0.5 is in good 
agreement with the half-life time of the reporter transcript (1.63 ± 0.24 h). 
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Software 1  
Software 1 provides the custom-made KNIME analysis pipeline (termed “Segmentation, Spot 
Colocalization and Detection Efficiency Correction.knwf”) for analysis of smFISH data. 
Software 2 
Software 2 provides the custom-made KNIME analysis pipeline (termed “Track-based 
colocalization analysis (with recursive track pairing and particle number correction)”) for 
analysis of live cell data. 
Data 1 
This material provides training data to practice smFISH image analysis, spot detection and co-
localization as well as detection efficiency correction (using the KNIME pipeline provided as ). 
Data 2 
This material provides training data to practice live cell data image analysis, tracking and track 
co-localization as well as detection efficiency correction (using the KNIME pipeline provided 
as ). 
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Figure legends 
Figure 1: Graphical overview of the experimental workflow  
(a) Schematic representation of the xrRNA reporter assay: Reporter transcripts contain xrRNA 
sequences, which block XRN1-mediated decay. Thus, decay intermediates are stabilized and 
can be specifically detected along with intact transcripts using the techniques outlined in 
panel b and c. (b) Overview of experimental steps necessary for molecular biology analysis of 
xrRNA reporters after RNA extraction. (c) Overview of experimental steps necessary for single-
molecule imaging-based detection of xrRNA reporter transcripts. 
 
Figure 2: Reporter design 
(a) Schematic overview of the reporter construct design as described in the text. Transcripts 
must encode a reporter gene open reading frame (ORF) to assay mRNA translation and XRN1-
resistant RNA (xrRNA) fragments downstream of the ORF. PP7 and MS2 stem loop cassettes 
are required for single-molecule imaging and need to be positioned upstream and 
downstream of the xrRNA sequences. Alternatively, inserting specific probe-binding regions 
(e.g. part of the β-globin gene) downstream of the xrRNA fragment allows for detection of the 
stabilized decay intermediate via northern blot analysis (e.g. using a β-globin-specific probe). 
(b) Reporter constructs can be transiently transfected or stably integrated into the target cell 
line. (c) Reporter transcript expression leads to production of intact transcripts that can be 
detected as slow migrating bands via northern blot or as dual-labeled spots via imaging. (d) 
Processing by XRN1 degrades reporter transcripts. Stalling of XRN1 at xrRNA sites leads to 
stabilization of decay intermediates that can be detected as faster migrating bands via 
northern blot or as single-labeled spots via imaging. 
 
Figure 3: Denaturing gel electrophoresis of RNA 
Visual inspection of the RNA samples (shown in Figure 3b) after the gel run allows the 
assessment of successful electrophoresis, equal sample loading and RNA integrity. In an intact 
RNA sample, the ratio of 28S and 18S rRNA should be approximately 2:1 (can be 1:1 for certain 
tissues and cell lines). No apparent smearing in the lanes should be visible before the transfer, 
the gel is cut according to the expected size of the transcript of interest and the control RNA. 
For the detection of RNA fragments ranging from 0.3 – 7 kb, cut at the indicated positions. 
PTC = premature stop codon. 
 
Figure 4: Northern blot xrRNA analysis of transcripts degraded by NMD 
(a) Schematic depiction of the reporter mRNA. The reporter consists of the β-globin coding 
sequence (exons shown as orange boxes). The introduction of a premature stop codon (PTC) 
in addition to the normal stop codon (stop) targets the transcript for NMD. Downstream, the 
Murray valley encephalitis (MVE) xrRNA is placed followed by the northern probe binding site. 
Stalling of XRN1 at the xrRNA gives rise to a decay intermediate fragment that can be detected 
on a northern blot (xrFrag). (b) Northern blot of triplicate RNA samples derived from HeLa 
cells that have been either transiently transfected with the vector pcDNA5/FRT/TO-globinWT-
xrRNA4H or pcDNA5/FRT/TO-globinPTC-xrRNA4H (Addgene IDs 108375 and 108376). As 
control for the transient transfection, a lacZ expressing plasmid was co-transfected and used 
for normalization. Below the reporter, a faster migrating fragment (xrFrag) is visible that 
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results from stalling of XRN1 at the xrRNA. (c) The signal intensities of the reporter and xrFrag 
shown in (b) were quantified and normalized to the wild type controls. The values are plotted 
as individual data points and the horizontal bar represents the mean value of each replicate 
(n=3). (d) Northern blot analysis of RNA samples derived from stable HeLa Flp-In T-REx cells 
that express the reporter from the integrated genomic locus. 7SL serves as an endogenous 
control. (e) The signal intensities of the reporter and xrFrag shown in (d) were quantified and 
normalized to the wild type controls. The values are plotted as individual data points and the 
horizontal bar represents the mean value of each replicate (n=3). 
 
Figure 5: qPCR xrRNA analysis of transcripts degraded by NMD 
(a) The analysis was performed for the reporter shown in Figure 3a. One set of primers 
amplifies the globin reporter. The primers are placed in different exons in order to avoid 
amplification of genomic DNA. The XRN1-resistant fragment is amplified by primers that bind 
in the 5′ linker and in a unique sequence in the xrRNA element. (b) For samples from transient 
transfections, the fold change of reporter and xrFrag were calculated by first normalizing to 
the internal co-transfected mVenus control and then normalizing to the respective wild type 
control. The values are plotted as individual data points and the horizontal bar represents the 
mean value of each replicate (n=2). (c) For samples from stable cell lines the fold changes of 
reporter and xrFrag were calculated by first normalizing to the endogenous GAPDH control 
and then normalizing to the wild type control. The values are plotted as individual data points 
and the horizontal bar represents the mean value of each replicate (n=2). 
 
Figure 6: Representative smFISH and live cell imaging data and analysis steps 
(a) Representative smFISH image of a HeLa cell stably expressing NLS-MCP-Halo, NLS-PCP-GFP 
and an xrRNA reporter transcript hybridized with probes against the MS2-containing 3'UTR 
(Ch1, magenta) as well as ORF (Ch2, green). The nucleus was stained using DAPI. Cells were 
induced by addition of doxycycline for 2 h and fixed 2 h after induction was stopped. Dashed 
yellow lines illustrate the region of interest (ROI) for spot detection. Magenta and green circles 
mark detected spots in Ch1 and Ch2. Co-localizing spots represent intact reporter transcripts. 
Magenta-only (orphan) spots are stabilized degradation intermediates. Scale bar = 5 µm. (b) 
Representative live cell image of a HeLa cell stably expressing NLS-MCP-Halo, NLS-PCP-GFP 
and an xrRNA reporter transcript approximately 2 h after induction of expression. Dashed 
yellow lines illustrate the region of interest (ROI) for spot detection. Magenta and green circles 
mark detected spots in Ch1 and Ch2 that were joined into tracks (magenta and green lines) 
when combining spot coordinates from multiple frames. Co-localizing tracks are intact 
reporter transcripts. Orphan tracks are stabilized degradation intermediates. Scale bar = 5 µm.   
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Boxes  
 
Box 1: Detection efficiencies and particle number correction 
For a co-localization control experiment, the detection efficiency (𝑒𝐶1,𝐶2) (as originally derived 
by Horvathova et al. (2017)) can be defined as follows: 
𝑒𝐶1 =
𝑛𝐶1 + 𝑛𝐶𝑜𝑙𝑜𝑐
𝑁
 
And: 
𝑒𝐶2 =
𝑛𝐶2 + 𝑛𝐶𝑜𝑙𝑜𝑐
𝑁
 
with the total number of particles 𝑁 = 𝑛𝐶1 + 𝑛𝐶2 + 𝑛𝐶𝑜𝑙𝑜𝑐  . Using the detection efficiencies 
defined above, the corrected fraction of co-localizing particles (𝑓𝐶𝑜𝑙𝑜𝑐) can be determined by 
application of the true underlying particle numbers (𝑚𝐶1,𝐶2,𝐶𝑜𝑙𝑜𝑐) as follows: 
 
𝑚𝐶1 =
𝑛𝐶1
𝑒𝐶1
− 𝑚𝐶𝑜𝑙𝑜𝑐(1 − 𝑒𝐶2) 
And: 
𝑚𝐶2 =
𝑛𝐶2
𝑒𝐶2
− 𝑚𝐶𝑜𝑙𝑜𝑐(1 − 𝑒𝐶1) 
For determining the true underlying particle numbers: 
𝑚𝐶𝑜𝑙𝑜𝑐 =
𝑛𝐶𝑜𝑙𝑜𝑐
𝑒𝐶1𝑒𝐶2
 
For determining the corrected fraction of co-localizing particles: 
𝑓𝐶𝑜𝑙𝑜𝑐 =
𝑚𝐶𝑜𝑙𝑜𝑐
𝑚𝐶1 + 𝑚𝐶2 +  𝑚𝐶𝑜𝑙𝑜𝑐
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Supplementary Material 
 
Supplementary Procedure 1. Radioactive norther probe labeling. 
This supplementary procedure provides a protocol for radioactive northern probe labeling. 
Supplementary Procedure 2. Non-radioactive northern probe labeling 
This supplementary procedure provides a protocol for non-radioactive northern probe 
labeling using biotin. 
Supplementary Procedure 3. Stellaris FISH probe design.  
This supplementary material provides instructions that aim to help with Stellaris FISH probe 
design.  
Supplementary Table 1. Plasmid information 
This table provides an overview of the plasmids used throughout the procedure. 
Supplementary Table 2. Oligonucleotide sequences  
This table provides an overview of the oligonucleotide sequences applied throughout the 
protocol. 
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Supplementary	Procedure	1.	Radioactive	northern	probe	labeling	
	
The	probe	binding	site	of	the	β-globin	reporter	contains	four	repeats	of	a	100	nt	sequence	
from	the	β-globin	gene.	These	binding	sites	can	be	placed	in	any	reporter	of	choice	to	enable	
detection	by	the	radioactive	β-globin	northern	blot	probe	(e.g.	Addgene	#120390).	
	
1. For	the	in	vitro	transcription	of	the	radioactive	β-globin	northern	blot	probe,	mix	the	
following	reagents	 in	a	nuclease	free	1.5	ml	microcentrifuge	tube	and	 incubate	for	
40	min	at	40	°C	on	a	heat	block.	
	
Reagents	 Volume	(µl)	per	reaction	
10x	transcription	buffer	 2	
Ultra	pure	water	 4		
0.1	M	DTT	 0.5	
10	mM	ATP	 1.2	
10	mM	CTP	 1.2	
10	mM	UTP	 1.2	
RNasin	(40	U/µl)	 0.7	
SP6	RNA	polymerase	 1.2	
BamHI	linearised	plasmid	DNA	
(approx.	 50	 ng/µl)	 (e.g.	
Addgene	#116927)	
3	
α-32P-GTP	(10	µC/µl)	 5	
Total	reaction	volume	 20		
	
	
2. Add	1.5	µl	of	RNase-free	DNAse	I	(1	U/µl),	mix	well	and	incubate	for	20	min	at	37	°C	
on	a	heat	block.	
3. Add	28.5	µl	of	ultra	pure	water,	mix	well.	
4. Purify	 the	 transcribed	probe	using	 the	mini	Quick	Spin	RNA	Columns	 following	 the	
manufacturer’s	instructions.		
5. Use	a	Geiger	counter	to	confirm	the	successful	transcription	and	purification	of	the	
probe.	 Roughly	 equal	 radioactive	 signal	 in	 the	 column	 and	 flow	 through	 indicate	
good	 transcription	 efficiency.	 Alternatively,	 check	 the	 transcription	 by	 denaturing	
PAGE.	
6. Dilute	the	probe	in	20-25	ml	of	Church	buffer	and	use	immediately	for	hybridization	
or	store	at	-20	°C	for	up	to	one	week.	
7. For	the	radioactive	labeling	of	the	7SL	control	northern	blot	probe,	mix	the	following	
reagents	in	a	nuclease	free	1.5	ml	microcentrifuge	tube	and	incubate	for	60	min	at	
37	°C	on	a	heat	block.	
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	Reagents	 Volume	(µl)	per	reaction	
10	mM	7SL	DNA	oligo	 1	
10x	 PNK	 Buffer	 A	 (forward	
reaction)	
2		
Ultra	pure	water	 11	
γ-32P-ATP	(10	µC/µl)	 5	
PNK	enzyme	 1	
Total	reaction	volume	 20	
	
8. Add	30	µl	of	ultra	pure	water,	mix	well.	
9. Purify	 the	 transcribed	probe	using	 the	mini	Quick	Spin	RNA	Columns	 following	 the	
manufacturer’s	instructions.	
10. Use	a	Geiger	counter	to	confirm	the	successful	transcription	and	purification	of	the	
probe.	
11. Dilute	the	probe	in	20-25	ml	of	Church	buffer	and	use	immediately	for	hybridization	
or	store	at	-20	°C	up	to	one	week.	
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Supplementary	Procedure	2.	Non-radioactive	northern	probe	labeling	
	
1. Perform	 in	 vitro	 transcription	 to	 generate	 a	 biotin-labeled	 β-globin	 northern	 blot	
probe	 by	mixing	 the	 following	 reagents	 in	 a	 nuclease	 free	 1.5	ml	microcentrifuge	
tube	and	incubate	for	40	min	at	40	°C	on	a	heat	block.	
Reagents	 Volume	(µl)	per	reaction	
10x	transcription	buffer	 2	
Ultra	pure	water	 7.8	
0.1	M	DTT	 0.5	
10	mM	ATP	 1.2	
10	mM	CTP	 1.2	
10	mM	GTP	 1.2	
10	mM	Biotin-11-UTP	 1.2	
RNasin	(40	U/µl)	 0.7	
SP6	RNA	polymerase	 1.2	
BamHI	linearised	plasmid	DNA	
(approx.	50	ng/µl)	
3	
Total	reaction	volume	 20		
	
	
2. Add	1.5	µl	of	RNase-free	DNAse	I	(1	U/µl),	mix	well	and	incubate	for	20	min	at	37	°C	
on	a	heat	block.	
3. Add	28.5	µl	ultra-pure	H2O	and	mix	well.	
4. Purify	 the	 transcribed	probe	using	 the	mini	Quick	Spin	RNA	Columns	 following	 the	
manufacturer’s	instructions.	
5. Check	 for	 successful	 in	vitro	 transcription	by	 running	5	µl	of	 the	 reaction	mix	on	a	
denaturing	PAGE.	
6. Dilute	the	probe	in	20-25	ml	of	Church	buffer	and	use	immediately	for	hybridization	
or	store	at	-20	°C	for	up	to	one	year.	
7. To	make	a	probe	for	the	detection	of	7SL	RNA,	dilute	a	5’	biotinylated	DNA	oligo	in	
Church	buffer	to	a	final	concentration	of	50	nM.	E.g.	dilute	12.5	µl	of	a	100	µM	DNA	
oligo	stock	solution	in	25	ml	Church	buffer.	
8. Hybridize	the	blot	overnight	at	40°C	in	a	hybridization	oven	while	rotating	
9. Store	the	hybridization	solution	for	later	use	at	-20	°C	(Signal	could	be	weaker	when	
re-used)	
10. Wash	 the	 membrane	 for	 15	 min	 with	 20-30	 ml	 of	 northern	 wash	 buffer	 1	 while	
rotating	at	40	°C	in	a	hybridization	oven.	
11. Discard	the	washing	solution	and	repeat	step	10.	
12. Discard	the	washing	solution	and	wash	the	membrane	for	15	min	with	20-30	ml	of	
northern	wash	buffer	2	while	rotating	at	40	°C	in	a	hybridization	oven.	
13. Discard	the	washing	solution	and	repeat	step	12.	
14. Equilibrate	the	membrane	for	2	min	in	TBS-T.	
15. Block	the	membrane	in	5%	BSA	TBS-T	on	a	rocking	platform	for	1h.	
16. Incubate	the	membrane	in	a	1:10,000	dilution	of	streptavidin-HRP	in	5%	BSA	TBS-T.	
17. Wash	the	membrane	3	times	for	10	min	each	in	TBS-T.	
18. Detect	 the	 signal	 by	 adding	 ECL	 to	 the	 membrane	 and	 visualize	 in	 a	
chemiluminescence	imager.		
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19. Example	gel	image	for	comparison:	See	below,	image	shows	the	same	samples	from	
cells	transiently	expressing	reporter	mRNAs	detected	by	radioactive	(left)	and	biotin	
(right)	labeled	probes.	
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Supplementary	Procedure	3.	Stellaris	FISH	probe	design		
	
-			 For	FISH	probe	design,	use	the	Biosearch	Technologies	web	portal:	
https://www.biosearchtech.com/support/tools/design-software/stellaris-probe-designer	
	
-		 Design	 two	 sets	 of	 DNA	 oligo	 probes	 (up	 to	 48	 probes	 (app.	 20	 nt	 long)	 per	 set,	 if	
sequence	 is	 long	 enough	 use	 masking	 level	 5)	 labeled	 with	 spectrally	 distinct	
fluorophores	(e.g.	Quasar570	and	Quasar670).		
-		 If	possible,	test	both	fluorophores	with	both	probe	sets	to	see	which	combination	yields	
best	labeling	efficiencies	on	the	microscopic	set-up	used.			
-		 Each	 probe	 set	 needs	 to	 target	 a	 region	 of	 interest	 downstream	 and	 upstream	 of	 the	
xrRNA	 fragments	 so	 that	 stabilized	 RNA	 intermediates	 are	 recognized	 by	 only	 a	 single	
probe	set	while	intact	mRNAs	are	recognized	by	both	probe	sets.		
-		 Specifically,	 we	 designed	 probes	 against	 MS2	 repeats	 and	 the	 Renilla	 luciferase	 ORF.	
Probe	sequences	were	published	as	supplemental	data	by	Horvathova	et	al.	(2017).	
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Supplementary	Table	1.	Plasmid	information	
Addgene	
ID	
Plasmid	name	 Features	
108366	 pCI-globin_del5UTR_WT-
xrRNA-4H	
Wild	type	beta-globin	reporter	with	MVE	xrRNA	and	4H	
probe	binding	sites	(Homo	sapiens)	
108367	 pCI-
globin_del5UTR_PTC39-
xrRNA-4H	
PTC39	beta-globin	reporter	with	MVE	xrRNA	and	4H	
probe	binding	sites	(Homo	sapiens)	
108368	 pCI-TPI_WT-xrRNA-4H	 Wild	type	TPI	reporter	with	MVE	xrRNA	and	4H	probe	
binding	sites	(Homo	sapiens)	
108369	 pCI-TPI_PTC160-xrRNA-
4H	
PTC160	TPI	reporter	with	MVE	xrRNA	and	4H	probe	
binding	sites	(Homo	sapiens)	
108370	 pCI-TPI_WT-xrRNA-
4MS2-4H	
Wild	type	TPI	reporter	with	4MS2	binding	sites	
downstream	of	MVE	xrRNA	and	4H	probe	binding	sites	
(Homo	sapiens)	
108371	 pCI-TPI_WT-4MS2-
xrRNA-4H	
Wild	type	TPI	reporter	with	4MS2	binding	sites	
upstream	of	MVE	xrRNA	and	4H	probe	binding	sites	
(Homo	sapiens)	
108372	 pCI-TPI_WT-
RAB7A_3UTR-xrRNA-4H	
Wild	type	TPI	reporter	with	partial	RAB7A	control	3'	
UTR,	MVE	xrRNA	and	4H	probe	binding	sites	(Homo	
sapiens)	
108373	 pCI-TPI_WT-IL6_3UTR-
xrRNA-4H	
Wild	type	TPI	reporter	with	partial	IL6	control	3'	UTR,	
MVE	xrRNA	and	4H	probe	binding	sites	(Homo	sapiens)	
108374	 pCI-TPI_WT-
TNFalpha_3UTR-xrRNA-
4H	
Wild	type	TPI	reporter	with	partial	TNFalpha	control	3'	
UTR,	MVE	xrRNA	and	4H	probe	binding	sites	(Homo	
sapiens)	
108375	 pcDNA5/FRT/TO-
globin_del5UTR_WT-
xrRNA-4H	
Wild	type	beta-globin	reporter	with	MVE	xrRNA	and	4H	
probe	binding	sites	(Homo	sapiens)	
108376	 	pcDNA5/FRT/TO-
globin_del5UTR_PTC39-
xrRNA-4H	
PTC39	beta-globin	reporter	with	MVE	xrRNA	and	4H	
probe	binding	sites	(Homo	sapiens)	
108377	 pcDNA5/FRT/TO-
TPI_WT-xrRNA-4H	
Wild	type	TPI	reporter	with	MVE	xrRNA	and	4H	probe	
binding	sites	(Homo	sapiens)	
108378	 pcDNA5/FRT/TO-
TPI_PTC160-xrRNA-4H	
PTC160	TPI	reporter	with	MVE	xrRNA	and	4H	probe	
binding	sites	(Homo	sapiens)	
120390	 pGEM4Z	globin	NB	Probe	 Allows	in	vitro	SP6	Polymerase	driven	transcription	of	a	
beta	globin	northern	blot	probe		
104095	 pSF4	TetCMV	intron	
Renilla-STOP	24xPP7	
1xfirefly-siRNA	xrRNA12	
24xMS2	SV40	CTE	polyA	
Expresses	xrRNA	reporter	transcripts	in	mammalian	
cells	
104097	 pSF4	TetCMV	intron	
Renilla-STOP	24xPP7	
1xfirefly-siRNA	24xMS2	
SV40	CTE	polyA	
Expresses	co-localization	control	transcripts	in	
mammalian	cells		
	
104098	 phage	UbiC	NLS	HA	
stdMCP	Halo	
Lentiviral	vector	expressing	synonymous	tandem	MS2	
coat	protein	fused	to	Halo.	Used	to	label	mRNAs.		
104099	 phage	UbiC	NLS	HA	
stdPCP	stdGFP	
Lentiviral	vector	expressing	synonymous	tandem	PP7	
coat	protein	fused	to	synonymous	tandem	GFP.	Used	to	
label	mRNAs.		
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Supplementary	Table	2.	Oligonucleotide	sequences	
Name	 Type	 Step	 Sequence	
Human	7SL	 DNA	 Supplementary	
Procedure	1,	
step	7	
TGCTCCGTTTCCGACCTGGGCCGGTTC
ACCCCTCCTT	
Human	7SL	
biotinylated	
5’	biotinylated	
DNA	
Supplementary	
Procedure	2,	
step	7	
/5BiosG/TGCTCCGTTTCCGACCTGGG
CCGGTTCACCCCTCCTT	
RNA	linker	
VBnew2	
RNA	 Step	18	 rGrCrUrGrArUrGrGrCrGrArUrGrArAr
UrGrArNrNrNrNrNrNrArArA	
VNN-oligo-dT20	 DNA	 Step	18	 TTTTTTTTTTTTTTTTTTTTVNN	
Globin_qPCR_se	 DNA	 Step	18	 AAGGCTCATGGCAAGAAAG	
Globin_qPCR_as	 DNA	 Step	18	 ACACCAGCCACCACTTTC	
RNA_Linker_VB
2_only_se	
DNA	 Step	18	 GCTGATGGCGATGAATGA	
MVE-qPCR_as	 DNA	 Step	18	 CCGTGGAGAATCAGCTTTGG	
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3 DISCUSSION 
Post-transcriptional regulation is carried out via multiple RNA species, messenger 
ribonucleoproteins and complex protein machineries across different cellular departments. In 
Figure 7 an overview of these processes and the related published results is provided. The 
publications underlying this cumulative thesis have analyzed and increased the understanding 
of several major aspects of post-transcriptional gene regulation: 1) the characterization of a 
factor involved in the processing of ribosomal RNAs, an essential part of the protein 
biosynthesis machinery (Saez et al., 2020); 2) the splicing-dependent assembly of the EJC in 
the nucleus (Gerbracht & Gehring, 2018); 3) mechanisms of splicing regulation by the EJC and 
associated factors (Boehm et al., 2018, Gerbracht et al., 2019); 4) NMD activation by the EJC 
(Gerbracht et al., 2019); 5) the contribution of degradation pathways to the turnover of 
unstable mRNAs (Boehm et al., 2016, Gerbracht et al., 2017). Finally, using XRN1-resistant 
sequences in reporter mRNAs has been established as a powerful tool to monitor XRN1-
dependent degradation (Boehm et al., 2016, Gerbracht et al., 2017, Voigt et al., 2019). 
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Figure 7: Biological processes underlying the publications of this thesis. Schematic depiction of cellular processes and their 
subcellular location. The references to publications are in order of their appearance in the results section. 
3.1 A link between the E3 ubiquitin ligase UBR5 and ribosomal RNA maturation in 
embryonic stem cells  
Human embryonic stem cells have a distinct molecular makeup to maintain pluripotency. One 
of the post-transcriptional mechanisms involved is the ubiquitin proteasome system (Saez et 
al., 2018). Among other ubiquitin proteasome factors, the E3-ubiquiting ligase UBR5 plays a 
role in preserving the expression of pluripotency factors while inhibiting the expression of 
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differentiation factors (Buckley et al., 2012). Correspondingly, UBR5 expression decreases 
with differentiation (Koyuncu et al., 2018).  
In Saez et al. (2020), an additional layer of UBR5 function in embryonic stem cells is reported. 
UBR5 directly interacts with the proteins GAR1, NHP2 and NOP10 of the H/ACA snoRNP in an 
RNA-independent manner. However, UBR5 does not alter the stability of the H/ACA snoRNP 
proteins, suggesting a role beyond its function as a E3 ubiquiting ligase. Furthermore, UBR5 
interacts with the snoRNAs SNORA73A/U17 and SNORA5A which are members of the H/ACA 
snoRNP. Both SNORA73A and SNORA5A are implicated in the pseudouridylation of sites 
present in the 18S rRNA (Atzorn et al., 2004, Kiss et al., 2004). UBR5 has been previously shown 
to interact with proteins that play a role in a great variety of cellular processes such as the cell 
cycle, transcriptional regulation and the DNA damage response. Not all of these are targeted 
by UBR5’s ligase activity, suggesting that UBR5-mediated ubiquitination is regulated (Shearer 
et al., 2015).  
Tafforeau et al. (2013) have performed an extensive screen to identify processing factors 
involved in rRNA processing. In this study, 625 proteins nucleolus-localizing proteins were 
knocked down individually and the effects on rRNA intermediates was observed. Using this 
approach, 286 factors involved in human rRNA processing were identified. UBR5 does not 
localize to the nucleolus and was therefore not included in this screen. Considering the defects 
in rRNA maturation that are observed upon UBR5 depletion, it is conceivable that an even 
larger number of hitherto unidentified factors contributes to rRNA maturation.  
So far, the analysis of UBR5’s function in rRNA processing has been limited to human and 
murine embryonic stem cells. Since in these cell types UBR5 is upregulated compared to 
differentiated cells the question remains whether UBR5 functions similarly in rRNA processing 
of differentiated cells.  
3.2 New insights into the composition and function of the EJC 
Since the discovery of the EJC, a great variety of EJC-interacting factors have been identified 
and their functions explored. However, many open questions remain. This includes the 
temporal dynamics of EJC assembly and the post-transcriptional EJC-interactome and related 
functions. Analyzing these questions with state-of-the-art technologies such as high-
throughput omics, CRISPR-Cas9 genome editing and cryo-EM has led to a new understanding 
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of many aspects of EJC biology. In Gerbracht & Gehring (2018), the recently published cryo-
EM structures of the human spliceosome are discussed with a focus on interactions between 
the EJC core components and spliceosomal proteins. In Boehm et al. (2018) a transcriptome-
wide analysis of EJC-dependent alternative splicing reveals that the EJC together with the 
splice factor RNPS1 protects splicing fidelity. In Gerbracht et al. (2019) CRISPR-Cas9-generated 
knockout cells and subsequent mass-spectrometry and RNA-sequencing are used to show that 
CASC3’s primary molecular function is not as part of the EJC core as previously believed. 
Instead, CASC3’s main role is as a mediator between the EJC and the NMD machinery, possibly 
as an NMD activating branch besides UPF3B and/or RNPS1.  
3.2.1 Nuclear EJC: Assembly and splicing 
Since the publication of the review Gerbracht & Gehring (2018), three additional human 
spliceosomal structures of intermediates containing the EJC or EJC-related factors have been 
published (Haselbach et al., 2018, Zhan et al., 2018, Zhang et al., 2018, Fica et al., 2019). In 
the following they will be discussed to provide an updated view of EJC assembly in connection 
with splicing (Figure 8). The Bact spliceosome is the earliest stage in which CWC22 is present, 
in agreement with an earlier mass spectrometry-based analysis (Bessonov et al., 2010). 
CWC22 flanks the 5′ exon with its MA3 and MIF4G domains, similarly as in the C* structure. 
The interactions observed in C* between MA3 and PRPF8 (Prp8 in yeast) on the one hand and 
MIF4G and EFTUD2 (Snu114) on the other hand are already established in Bact. There is a newly 
identified interaction between CWC22’s MA3 domain and RNF113A (Cwc24) that is specific 
for the Bact complex. RNF113A as part of the spliceosome core connects the guanosine residue 
at the 5′ end of the intron, PRPF8, CWC27, SNRNP200 (Brr2), and the U2 snRNP. Together with 
the U2 snRNP it separates the 5′ SS from the catalytic center while preventing a premature 
nucleophilic attack by the branch point adenosine. During catalytic activation by DHX16 
(Prp2), RNF113A and CWC27 are released and are already missing in the structure of the late 
Bact complex (Zhang et al., 2018). This results in a conformational change of PRPF8 that secures 
exon binding. (Kastner et al., 2019). At the same time, the 5′ SS is free to access the catalytic 
center allowing the branching reaction to occur. The structure of the B* spliceosome is the 
only stage still missing and it is therefore unclear if and how the MAGOH-RBM8A heterodimer 
associates with EIF4A3 in the B* spliceosome. In the C, C* and post-catalytic complex, all core 
EJC components as well as parts of CASC3 are resolved (Zhan et al., 2018, Fica et al., 2019).  
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Figure 8: Rearrangements of the spliceosome core during the splicing reaction. Shown are the intermediates of the splicing 
reaction with a focus on the changes of snRNP composition and the assembly of the EJC (depicted as in Figure 4). CWC22 is 
shown as a purple oval shape. In red, the yeast ATP-dependent helicases are specified that cause conformational changes 
within the spliceosome (conserved in the human spliceosome). The 5′ splice site (5′ SS) is bound by the U1 snRNP. In the A 
complex, the branch point site (BP) is recognized and bound by the U2 snRNP. The binding of the pre-formed tri-snRNP formed 
of U4, U5 and U6 results in the pre-B complex. CWC22 joins the spliceosome in the activated B-complex. The catalytically 
activated B* complex is ready to perform the first step of the splicing reaction: the nucleophilic attack of the 5′ SS on the 
adenosine at the BP. Since no human B* spliceosomal structure has been published yet, the composition of the EJC at this time 
point is not known. In the C complex, the EJC is present at the 5′ exon. The catalytically active C* spliceosome is primed to 
catalyze the second step of the splicing reaction, the exon ligation reaction. The post-splicing complex (P complex) is 
disassembled by Prp22 (DHX8 in human) which includes the disassociation of CWC22. The exon junction complex stays bound 
upstream of the exon-exon junction in the mature messenger ribonucleoprotein. The intron lariat structure (ILS) is then 
disassembled by PRP43 (DHX15 in human). The black and white squares indicate whether the complexes have been structurally 
resolved in human (homo sapiens, h.s.), or yeast (Saccharomyces cerevisiae, S.c. or Saccharomyces pombe, S.p.). 
Taken together, the structures of the human spliceosome published so far have revealed new 
insights into the sequential assembly of CWC22 and the EJC and many new interaction sites. 
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This includes the contacts between CWC22 and the spliceosomal components RNF113A, 
EFTUD2, PRPF8 and SLU7. To further investigate the functions of these interactions, CWC22 
mutated at the individual contact sites could be expressed in CWC22-depleted cells and the 
effect on splicing of endogenous targets observed by performing RT-PCT. These mutants could 
also be tested for splicing efficiency of a labelled transcript in an in vitro splicing assay 
(Steckelberg & Gehring, 2014). A previously unknown interaction between CWC22 and RBM8A 
has also been found which could potentially function in the recruitment of the MAGOH-
RBM8A heterodimer. Another interesting link revealed by the C* spliceosome structure was 
found between EIF4A3 and the EFTUD2. The functional effects of mutating these sites could 
again be tested in complementation assays with mutated constructs. The Boehm et al. (2018) 
study has identified many targets that need the deposition of the EJC for correct splicing and 
would serve as a readout of EJC assembly. 
In Boehm et al. (2018) it was shown that the EJC can influence splicing via two distinct 
mechanisms: as a binding site for the PSAP complex and by physically masking cryptic splice 
sites. The splicing order of splice junctions within a transcript does not necessarily occur 
linearly in 5′-3′ direction. Cryptic splice sites can arise at newly formed exon-exon junctions 
and have the potential to be used in re-splicing. EJCs that are deposited upstream of exon-
exon junctions can prevent the usage of these cryptic splice sites and thus maintain correct 
splicing. The process in which an intron is spliced in several steps is known as recursive splicing 
and is a productive feature of some long introns (Sibley et al., 2015). In contrast, the re-splicing 
that occurs when the EJC is depleted leads to aberrant transcripts. The human transcriptome 
contains many of such splice sites that are not used when the EJC together with the PSAP is 
present. Potentially, these cryptic splice sites have formed at these positions because there is 
no selective pressure against them as these regions are normally protected by the EJC. 
While a physical block by the EJC explains the protected 3′ splice sites, the mechanism behind 
the splicing regulatory function of RNPS1 has not yet been identified. Tethering SAP18, PNN 
and RNPS1 individually promoted exon inclusion. A PSAP-binding deficient mutant of RNPS1 
was still functional, suggesting that SAP18 and PNN recruit RNPS1 in the tethering assay which 
is the key mediator of the exon defining function of the PSAP. Interestingly, PSAP-dependent 
splicing events do not occur upon the depletion of ACIN1, the component of the alternatively 
formed ASAP complex. Therefore, the PSAP and ASAP complexes regulate different subsets of 
transcripts (Wang et al., 2018). More work is needed to identify the interaction between the 
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EJC and the ASAP/PSAP complexes. The RRM domain of RNPS1 is required to form an 
ASAP/PSAP complex and to interact with EIF4A3 (Boehm et al., 2018). Since neither RNPS1 nor 
SAP18 were found to directly interact with any of the EJC core components, it is either PNN 
that links the PSAP complex to the EJC, or the interaction needs a composite binding site of 
the PSAP complex. ACIN1 on the other hand has been shown to directly interact with a 
complex formed of EIF4A3, MAGOH and RBM8A (Wang et al., 2018). 
Many EJC-dependent targets identified in Boehm et al. (2018) were previously described in an 
earlier study of EJC-dependent splicing and the splicing defects were also detected upon 
CASC3 depletion (Wang et al., 2014b). We could not replicate these results when performing 
an siRNA-mediated knockdown of CASC3 (Gerbracht et al., 2019). Even in CASC3 knockout 
cells these targets were normally spliced (Gerbracht et al., 2019). This leads to the question at 
which stage of EJC assembly CASC3 joins the EJC. Potentially CASC3 is assembled into the EJC 
during splicing but is dispensable for the splicing regulatory effect the EJC exerts. Information 
about the composition of the EJC in the spliceosome comes from in vitro splicing reactions 
followed by either mass-spectrometry analysis or cryo-EM. In the C and C* cryo-EM 
spliceosome structures the EJC proteins are resolved at 8-15 Å and 4-5 Å with the crystal 
structure being modeled into the electron density map (Zhang et al., 2017, Zhan et al., 2018). 
This stands in contrast to mass spectrometry-based analyses of the C spliceosome in which 
EIF4A3, MAGOH and RBM8A were detected, whereas CASC3 was not (Bessonov et al., 2008, 
Agafonov et al., 2011). Because CASC3 contains many intrinsically disordered regions, only 
two fragments are present in the crystal structure of the EJC (Andersen et al., 2006, Bono et 
al., 2006). Only one of those fragments, the 170-194 stretch which interacts with the RecA2 
domain of EIF4A3, is modeled into the spliceosome structures. The space where the more C-
terminally resolved fragment of CASC3 would interact with the RecA1 domain of EIF4A3 is 
occupied by EFTUD2 in the C and C* structures. This discrepancy between the position of 
CASC3 in the spliceosome structure and in the tetrameric EJC structure indicates that CASC3 
can likely only fully bind the EJC after splicing has been completed. Because of the low 
resolution of the electron density maps, it cannot be excluded that the measured density at 
this position may not originate from CASC3 but another factor binding the RecA2 domain.  
A model in which CASC3 binds to the trimeric EJC core primarily after splicing is supported by 
several lines of evidence. Firstly, in in vitro splicing experiments EIF4A3, MAGOH and RBM8A 
require splicing to assemble into the EJC, unlike CASC3 (Gehring et al., 2009a). Secondly, the 
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amount of CASC3 in the cell is limited compared to EIF4A3. RBM8A and MAGOH (Schaab et 
al., 2012, Singh et al., 2012). Therefore, stochastically not every EJC can be loaded with CASC3. 
Finally, a recent publication has shown that RNPS1 and CASC3 do not exist within the same 
EJC (Mabin et al., 2018). RNA-protein immunoprecipitation data has suggested that RNPS1-
containing EJCs are bound to rather nuclear located transcripts, whereas CASC3-containing 
EJCs are associated with predominantly cytoplasmic transcripts. Although CASC3 can 
potentially shuttle between the cytoplasm and the nucleus it remains to be shown whether it 
carries out any function in the nucleus.  
3.2.2 Cytoplasmic EJC: Nonsense-mediated mRNA decay 
RNPS1, CASC3 and UPF3B have been shown to be able to promote NMD in tethering assays 
(Gehring et al., 2003, Gehring et al., 2005, Boehm et al., 2014). Considering the recent 
evidence, RNPS1 probably cannot exist together with CASC3 and UPF3B in the same EJC 
(Mabin et al., 2018). While RNPS1 interacts with the EJC in the nucleus and is essential for its 
splicing regulatory function, it is not yet known whether it is exported as part of the EJC into 
the cytoplasm where it could activate NMD. Individual endogenous targets have been 
reported to be degraded by NMD in an RNPS1-dependent manner (Mabin et al., 2018). Our 
transcriptome-wide analysis however showed that the stabilization of PTC-containing 
transcripts in RNPS1 knockdown was marginal (Gerbracht et al., 2019, Figure 4F). 
We have observed that CASC3 activates NMD via two distinct routes: as part of the EJC and 
via its N-terminus (Gerbracht et al., 2019). Several possibilities for the underlying mechanism 
exist. Since CASC3 has been shown to increase the stability of the EJC when it binds, it could 
promote NMD by preserving NMD-triggering EJCs. The stabilized EJC would then have an 
increased likelihood of recruiting NMD factors during each round of translation. An interesting 
result from the mass spectrometry-based analysis of the EJC composition was that UPF3B is 
slightly less enriched in the EJCs of CASC3 knockout cells when compared to wild type cells 
(Gerbracht et al., 2019). Because UPF3B interacts with the EJC via a trimeric binding site 
formed by EIF4A3, MAGOH and RBM8A, CASC3 may not directly contribute to UPF3B binding. 
A stabilizing effect on the EJC could explain why more UPF3B was pulled down in the wild type 
samples. Alternatively, CASC3 could also be responsible to recruit NMD factors, thereby 
establishing a second route besides UPF3B. To address the question of the relative 
participations of CASC3 and UPF3B, tethering assays could be used. Tethering CASC3 and co-
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depleting UPF3A and UPF3B would reveal whether UPF3B is the factor acting downstream in 
the NMD activating pathway.  
Further studies would be required to disentangle the functions CASC3 has as part of the EJC 
in contrast to potential effects of its N- and C-termini. For this, a deletion construct consisting 
only of the SELOR domain could be helpful. The SELOR domain is sufficient to be assembled 
into the EJC and exert a stabilizing effect (Ballut et al., 2005). A construct which contains the 
SELOR domain together with a downstream located nuclear export signal is able to fully rescue 
the NMD deficiency (Gerbracht et al., 2019). Since SELOR localizes into the nucleus, it would 
have to associate with the EJC there and be exported to the cytoplasm. It would be interesting 
to explore the role of the nuclear export signal regarding CASC3’s ability to promote NMD. 
Next, the NMD-inducing effect of CASC3’s isolated N-terminus should be further investigated. 
Tethered full-length CASC3 has been shown to induce NMD in a translation-dependent 
manner (Boehm et al., 2016). This experiment should be repeated with the isolated CASC3 N-
terminus. The depletion of NMD factors such as UPF2 or UPF3B could help to determine 
whether the N-terminus recruits the known NMD machinery or only selected branches of 
NMD are activated. Potential interaction partners could be identified by expressing the N-
terminus and performing co-immunoprecipitation followed by mass spectrometry.  
CASC3’s function in NMD could also be linked to the temporal dynamics of transcript 
degradation. Transcripts that are directly translated after mRNA export and efficiently 
degraded by NMD perhaps would not be bound by CASC3. Transcripts that are less efficiently 
degraded or potentially escape NMD could have an increased likelihood of harboring EJCs 
containing CASC3. Upon subsequent translation, CASC3 would then increase the possibility of 
successful degradation. Live-cell imaging of NMD transcripts as performed in Hoek et al. 
(2019) in CASC3 knockout cells compared to wild type cells could show whether CASC3 
generally activates NMD. This would mean that degradation should occur after more cycles of 
translation in CASC3 knockout cells compared to wild type cells. If CASC3 acts as a failsafe 
mechanism to increase the degradation of transcripts that were not yet targeted by the NMD 
machinery, then the percentage of mRNAs escaping NMD should be lower in wild type cells 
than in CASC3 knockout cells. A third option is that CASC3 is only needed for the NMD of 
certain transcripts with distinct features. To address this, endogenous NMD targets that are 
affected by the CASC3 knockout could be analyzed regarding certain sequence elements or 
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features such as the position of the PTC in the transcript. The feasibility of such an approach 
has been shown previously by studying the effect of predictive features of NMD on transcript 
abundance (Lindeboom et al., 2016, Lindeboom et al., 2019). 
Since CASC3 was reported to be able to stimulate translation, this could potentially enhance 
its stimulatory effect on NMD. The CASC3 knockout cells would be a good resource to study 
translation efficiency. If CASC3 is a general enhancer of translation, ribosome profiling analysis 
should show fewer ribosomes engaged with transcripts. On the other hand, it is possible that 
CASC3 stimulates the translation of selected mRNAs. A ribo-seq analysis would show if 
individual transcripts are less associated with the translation machinery.  
3.3 Pitfalls of CRISPR-Cas9-mediated generation of knockout cell lines 
Knocking out non-essential genes by CRISPR-Cas9 genome editing has the exciting promise of 
studying the complete absence of a gene product. The advantage to performing siRNA-
mediated knockdowns is that no remaining protein can obscure functional effects.  
The Cas9 nuclease introduces double stranded breaks at the desired locus guided by an RNA. 
Non-homologous end joining (NHEJ) is a naturally occurring DNA repair mechanism of the cell 
which does not need a template. Instead, variable insertion or deletions (indels) are 
introduced at the locus. The introduction of indels at the beginning of an open reading frame 
result in a frameshift and/or the introduction of premature termination codons. Thus, during 
translation of this modified mRNA no functional protein can be produced, and PTC-containing 
mRNAs would be degraded by NMD. This approach has been used in Gerbracht et al. (2019) 
to establish the CASC3 knockout cells. Validating the cell lines by Sanger sequencing of the 
targeted genomic locus and detection of CASC3 protein using two different antibodies showed 
that no full-length CASC3 protein could be produced. The presence of a faint protein band on 
the western blots suggested however that a truncated CASC3 protein was present in two of 
the three established cell lines. It was confirmed by mass-spectrometry that the cell line H 
produces low levels of CASC3 and that this gene product is able to interact with the EJC 
component EIF4A3. Treating the cell line H with siRNAs targeting CASC3 increased the effects 
observed on the NMD machinery, indicating that the truncated CASC3 protein is functional. 
Recently a study investigating an array of 13 knockout cell lines has systematically addressed 
the issue of residual protein production following gene knockout (Tuladhar et al., 2019). It was 
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shown that in approximately one third of cell lines the introduction of indels results in aberrant 
splicing of the mRNA. In approximately one third of cell lines tested, remaining full-length or 
truncated proteins could be identified. Not all were caused by alternative splicing but instead 
also resulted from alternative translation initiation sites. A larger analysis of 192 knockout cell 
lines containing frameshift mutations confirmed the estimate that one third of the cell lines 
produce residual protein (Smits et al., 2019). 
In Gerbracht et al. (2019) we could not detect any alternatively spliced transcripts in the CASC3 
knockout cell lines. The protein present in the cell line H most likely lacks an N-terminal region 
because it was detected with antibodies recognizing the central part and its outermost C-
terminus. Thus, it seems likely that the truncated protein is produced from an alternative 
translation start site, although no canonical AUG start codon is in frame downstream of the 
targeted locus.  
When cell lines produce residual proteins or truncated variants, this could mask effects that 
would be observed in a complete knockout. The occurrence of aberrant splicing or alternative 
translation start sites could potentially also lead to the production of a protein with novel or 
dominant negative functions. Care has to be taken when designing and validating CRISPR 
experiments. The confirmation of protein levels should be carried out by using at least two 
antibodies targeting different regions of the protein. Guide RNAs are often targeted to the 
beginning of an open reading frame to insert the frameshift as early as possible. 
Simultaneously, this increases the chance of a downstream translation initiation event being 
able to produce functional protein. Two guide RNAs targeting different parts of a gene could 
be used to increase the chances of a successful knockout. Using two guide RNAs it is also 
possible to generate clones that lack the entire sequence between them. This was exemplified 
using the gene BUB1 for which a full knockout has not been feasible before (Raaijmakers & 
Medema, 2019). A disadvantage of deleting whole genes is that regulatory sequences 
contained within might be deleted, thereby leading to unpredictable off-target effects. 
3.4 Applications and potential enhancements of the xrRNA method 
In Boehm et al. (2016) and Gerbracht et al. (2017) the analysis of steady-state levels of 
unstable mRNAs using xrRNA-based reporters has led to new biological insights. The relative 
participation of 5′-3′ decay on degradation induced by AU-rich elements, miRNAs and 
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premature termination codons was shown, highlighting the broad applicability of the method 
(Boehm et al., 2016). The analysis also provided the basis to identify new endocleavage sites 
of the cytokine mRNAs TNF-α and interleukin-6. Also, the effect of the transfection method 
on the readout of NMD assays was studied using the xrRNA method (Gerbracht et al., 2017). 
The observation that transiently expressed NMD-sensitive reporters are immune to 
degradation in certain cell types has an impact for researchers wishing to perform similar 
experiments. Finally, in Gerbracht et al. (2019) reporter mRNAs containing xrRNAs where used 
to study their degradation by NMD in CASC3 knockout cells.  
In the flavivirus genus heterogeneous xrRNAs exist that vary in their sequence and 
composition of XRN1-resistant structures in their 3′ UTR (Slonchak & Khromykh, 2018). While 
the XRN1-resistance of many of these xrRNAs have been tested in vitro, it is not known 
whether using a different set of xrRNAs would improve the detection of XRN1-resistant 
intermediates in human cells. The xrRNA pseudoknot structures are commonly followed by 
other types of secondary structures downstream in the 3′ UTR of viruses (Clarke et al., 2015). 
If and how these structures could contribute to XRN1-resistance in reporter assays has not yet 
been tested. We have only used xrRNA-mRNA-reporters in human cells so far. Since sfRNA 
production also occurs in other flaviviral hosts such as mosquitos, it is probable that the 
mechanism of XRN1-inhibition is not limited to human XRN1 (Slonchak & Khromykh, 2018). 
XRN1’s active site which is affected by the xrRNA is highly conserved from arthropods to 
vertebrates (Jones et al., 2013). Thus, the method could be applied in other model organisms 
to study mRNA turnover.  
A high number of XRN1-resistant RNAs in a host cell was proposed to potentially titrate XRN1 
away by acting as a sponge (Charley & Wilusz, 2016). Furthermore, it was shown that sfRNAs 
of Zika and Dengue viruses bind to proteins involved in the host’s post-transcriptional gene 
regulation (Michalski et al., 2019). However, in our reporter assays we could not detect a 
depletion of XRN1 which would have led to 3′ endocleavage fragments in NMD reporters. 
Either the amount of xrRNA carrying mRNAs is too little to act as XRN1-sponges, or sequences 
besides the pseudoknots add to the ability of sfRNA so sequester away proteins.  
Blocking exonucleolytic decay from the 3′ end would help to completely unravel the 
exonucleolytic contributions to the degradation of a transcript. Inhibiting 3′-5′ decay is 
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hampered by the fact that the RNA exosome is a multimeric protein complex, employing many 
different nucleases and that additional exoribonucleases such as DIS3L2 exist.  
In Voigt et al. (2019) the xrRNA method is described in a protocol format with the second half 
focusing on using xrRNAs in single-molecule imaging. An issue that was addressed using this 
approach by Horvathova et al. (2017) was the localization of mRNA turnover in the cell. These 
experiments have shown that the siRNA-induced degradation of a reporter takes place across 
the cytoplasm and is not enriched in P-bodies. Furthermore, xrRNAs were instrumental in 
understanding the dynamics of transcripts moving to P-bodies and stress granules during the 
integrated stress response (Wilbertz et al., 2019). To detect single mRNAs in FISH or live cell 
imaging, the reporter RNAs contain large arrays of PP7 and MS2 stem loops bound by coat 
proteins fused to distinct fluorescent proteins. Concerns were raised in yeast regarding the 
fact that 24 repeats of MS2 binding site bound by MS2-tagged proteins inhibit XRN1-
meadiated degradation (Garcia & Parker, 2015, Garcia & Parker, 2016). Fluorogenic aptamers 
within reporter mRNAs could be a potential solution for this issue. These RNA aptamers bind 
to a fluorogenic dye, thereby forming a fluorescent complex (Bouhedda et al., 2017). While 
this approach needs to be improved before being able to be applied for single-molecule 
imaging, substituting the dye for a fluorogenic protein has already been shown to be 
applicable (Wu et al., 2019a).
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5 SUMMARY 
The output of gene products needs to be regulated in order for cells to function in 
development and react to signals or stress. As a first step of gene expression, genes are 
transcribed into RNA. Messenger RNAs (mRNAs) are produced which carry the genetic 
information from the DNA to ribosomes, the sites of protein biosynthesis in the cell. Also other 
RNA species are transcribed that perform regulatory or catalytical functions within the gene 
expression machinery. All RNAs in the cell undergo processing and quality control as soon as 
they are transcribed. Furthermore, they are bound by RNA binding proteins, forming 
messenger ribonucleoproteins (mRNPs). This process of post-transcriptional gene regulation 
ensures that the produced RNA species are stable and localize to the correct subcellular 
department. In this cumulative thesis three distinct aspects of post-transcriptional gene 
regulation are investigated. 
In the first part the processing of ribosomal RNAs (rRNAs) is analyzed. As the most abundant 
RNA species in the cell, mature rRNAs are derived from a polycistronic precursor RNA that 
undergoes cleavage and modification before being exported into the cytoplasm with 
ribosomal proteins, thus forming mature ribosomal subunits. A myriad of processing factors 
has been described which are involved in rRNA maturation. Here, a link between the ubiquitin 
E3 ligase UBR5 and the ribosomal processing machinery is identified in human embryonic stem 
cells. UBR5 interacts with components of the box H/ACA snoRNP which carries out 
pseudouridylation modifications of rRNAs. It is shown that depletion of UBR5 in stem cells 
impairs rRNA maturation and ribosomal biosynthesis as a whole.  
The second part of this thesis is focused on the exon junction complex (EJC) which is an 
essential RNA-binding complex in metazoan cells. The EJC is deposited during splicing 
upstream of exon-exon junctions of mRNAs and stays bound until it is removed during 
translation. During the lifetime of an mRNA, the EJC fulfills critical functions in splicing, mRNA 
export and translation. It is also important for the mRNA surveillance pathway nonsense-
mediated mRNA decay (NMD). The assembly of the individual EJC components is intimately 
linked to the splicing process, however the exact dynamics and interactions at play are not 
fully understood. The recently published structures of the human spliceosome have given 
insights into the positioning of EJCs components within spliceosome intermediates. These 
advances are discussed in the thesis and conclusions for further studies are drawn. Next, a 
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new function of the EJC in connection with splicing is described: after its deposition, the EJC 
together with associated splicing factors inhibits the usage of potential splice sites in the 
transcriptome, thereby maintaining splicing fidelity. Since this function is only observed for 
three of the four described core EJC components, the molecular function of the fourth EJC 
component CASC3 is investigated. Using CRISPR-Cas9-generated knockout cells it is shown 
that CASC3 is important for the function of the EJC in the NMD pathway.  
Finally, in the last part of the thesis the process of mRNA turnover is described. All mRNAs 
eventually undergo degradation in order to maintain dynamics in gene expression. 
Furthermore, faulty mRNAs are targeted by quality control pathways which leads to their 
degradation. Finally, mRNAs such as cytokine transcripts exist that need to be tightly 
controlled and are therefore unstable. The analysis of mRNA turnover is challenging, since 
different nucleolytic pathways can act on the degradation of transcripts. Here, a novel method 
is presented that employs viral structures which are resistant to the human 5′-3′ exonuclease 
XRN1. By using these structures in unstable reporter transcripts, the participation of exo- and 
endonucleolytic degradation can be determined. This approach is also described in a protocol 
format and can be used to monitor the degradation of mRNAs in single cells using live-cell 
imaging. 
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6 ZUSAMMENFASSUNG 
Die Produktion von Genprodukten muss reguliert werden, damit Zellen in der Entwicklung 
funktionieren und auf Signale oder Stress reagieren können. Als erster Schritt der 
Genexpression werden Gene in RNA transkribiert. Es werden Boten-RNAs (englisch messenger 
RNAs, mRNAs) hergestellt, die die genetische Information von der DNA zu Ribosomen 
transportieren. Auch andere RNA-Spezies, die regulatorische oder katalytische Funktionen 
innerhalb der Genexpressionsmaschine ausführen, werden transkribiert. Alle RNAs in der Zelle 
werden sofort nach ihrer Transkription einer Prozessierung und Qualitätskontrolle 
unterzogen. Darüber hinaus interagieren sie mit RNA-bindende Proteinen  und bilden Boten-
Ribonukleoproteine (englisch messenger ribonucleoproteins, mRNPs). Dieser Prozess der 
posttranskriptionellen Genregulation stellt sicher, dass die produzierten RNA-Spezies stabil 
sind und korrekt in der Zelle lokalisieren. In dieser kumulativen Arbeit werden drei 
verschiedene Aspekte der posttranskriptionellen Genregulation untersucht.  
Im ersten Teil wird die Maturierung von ribosomalen RNAs (rRNAs) analysiert. Als die am 
häufigsten vorkommende RNA-Spezies in der Zelle werden reife rRNAs von einer 
polycistronischen Vorläufer-RNA abgeleitet. Diese wird gespalten und modifiziert, bevor sie 
mit ribosomalen Proteinen in das Zytoplasma exportiert wird. Hierdurch entstehen reife 
ribosomale Untereinheiten. In der Literatur ist eine Vielzahl von Verarbeitungsfaktoren 
beschrieben, die an der Reifung der rRNA beteiligt sind. Hier wird ein funktioneller 
Zusammenhang zwischen der Ubiquitin-E3-Ligase UBR5 und der ribosomalen 
Prozessierungsmaschinerie in humanen embryonalen Stammzellen identifiziert. UBR5 
interagiert mit Komponenten des Box H/ACA-snoRNPs, welcher Pseudouridylierungs-
modifikationen von rRNAs durchführt. Es wird gezeigt, dass die Depletion von UBR5 in 
Stammzellen die Reifung der rRNA und die ribosomale Biogenese insgesamt beeinträchtigt. 
Der zweite Teil dieser Arbeit befasst sich mit dem Exon Junction Complex (EJC), einem 
essentiellen RNA-bindenden Komplex in metazoischen Zellen. Der EJC wird während des 
Spleißens stromaufwärts von Exon-Exon-Grenzen auf mRNAs assembliert und bleibt dort 
gebunden, bis er während der Translation entfernt wird. Während der Lebensdauer einer 
mRNA erfüllt der EJC fundamentelle Aufgaben beim Spleißen, mRNA-Export und bei der 
Translation. Es ist auch wichtig für den mRNA-Qualitätskontrollmechanismus nonsense-
vermittelter mRNA-Abbau (NMD). Die Assemblierung der einzelnen EJC-Komponenten ist eng 
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mit dem Spleißen verbunden, jedoch ist die Dynamik dieses Prozesses nicht vollständig 
bekannt. Die kürzlich veröffentlichten Strukturen des menschlichen Spleißosoms haben 
Einblicke in die Positionierung von EJC-Komponenten innerhalb von Spleißosom-
intermediaten gegeben. Diese Fortschritte werden in dieser Arbeit diskutiert und 
Schlussfolgerungen für weitere Studien gezogen. Als nächstes wird eine neu identifizierte 
Funktion des EJC im Zusammenhang mit Spleißen beschrieben: Nach seiner Positionierung 
hemmt das EJC zusammen mit assoziierten Spleißfaktoren die Verwendung potentieller 
Spleißstellen im Transkriptom, wodurch die Spleißgenauigkeit erhalten bleibt. Da diese 
Funktion nur für drei der vier beschriebenen EJC-Kernkomponenten zutrifft, wird 
anschließend die molekulare Funktion der vierten EJC-Komponente CASC3 untersucht. Mit 
CRISPR-Cas9-generierten Knockout-Zellen wird gezeigt, dass CASC3 für die Funktion des EJC 
im NMD-Signalweg von Bedeutung ist. 
Abschließend wird im letzten Teil der Arbeit der Prozess des mRNA-Abbaus beschrieben. Alle 
mRNAs werden letztendlich degradiert, um die Dynamik der Genexpression 
aufrechtzuerhalten. Darüber hinaus werden fehlerhafte mRNAs durch Qualitätskontrollwege 
angegriffen, die zu ihrem Abbau führen. Schließlich gibt es mRNAs wie Cytokin-Transkripte, 
deren Expression streng kontrolliert werden muss und welche daher instabil sind. Die Analyse 
des mRNA-Abbaus ist eine Herausforderung, da verschiedene nukleolytische Wege auf den 
Abbau von Transkripten einwirken. Hier wird eine neue Methode vorgestellt, die auf viralen 
Strukturen basiert, welche resistent gegen Abbau durch die humane 5′-3′-Exonuklease XRN1 
sind. Durch die Verwendung dieser Strukturen in instabilen Reporter-Transkripten kann die 
Beteiligung des exo- und endonukleolytischen Abbaus bestimmt werden. Dieser Ansatz wird 
auch in einem Protokoll beschrieben und kann darüber hinaus verwendet werden, um den 
Abbau von mRNAs in einzelnen Zellen unter Verwendung von Live-Cell-Imaging zu 
überwachen.
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